 data from 1970
32 saleswomen
22 women
4Ãž analyzes how car culture participants
1199  participants
 data from  3
 data from the 2000
 data  from the 2000
 data from 2000
6,283 NLSY  women
11Although women
1006  servative Protestant women
24 enrolled
 data on most of the 3,143
2010Ãž document how women
21Ãž emphasized  how women
3Ãž The surveyor counts five persons
100,000 persons
100  protest participants
50 participants
150 participants
100 participants
25,000 people
12 people
 data from the 2000
7Ãž and â€œoutsidersâ€ Ã°blind people
50 women
50 cis women
17Some participants
1Ãž explicit exclusion of trans people
total of 43
 data from1996
450 people
total of  12
total of 533
24 women
3,000 people
  data from the 100
 data from the 1980
140 women
1 Many people
1364  nesspeople
62 subjects
total of 32
14 The percentages of women
1995 the percentages enrolled
50 undergraduate women
16 laypeople
1986Ãž gives patients
89 and they were knee patients
12 patients
1599  would often give homeless people
total of 25,136
 data consist of 44,528
7,000 participants
1Ãž which participants
7,490 participants
100  people
100 people
222 people
621 people
1,000 women
1724  The people
2,000 people
total of 31
total of 68
958  men and women
5 shows  how participants
7 focus on participants
4 Although persons
12,686 young  people
total of 133,121
 data from 12
total of  10,902
18 participants
838  ciation participants
824  people
236Ãž more likely than women
23These persons
2 predictions were  based on persons
893  and its regular use among persons
894  paring persons
 data from the 2010
26 women
69 women
335  of participants
14,000 participants
119,000 people
24Some of the people
 data from 2006
11 women
2003Ãž  found amongwomen
200 persons
5,000 people
1,000 people
total of 55
1925 Mussolini  granted women
100 people
1,000 people
1,000  people
50,000 people
271,139 people
total of 100,000
56 potential subjects
60 subjects
854  How would most people
838  How would most people
82  How would most people
1960s describes  women
26 women
69 women
24 women
958  men and women
 data from 1970
32 saleswomen
22 women
5 shows  how participants
7 focus on participants
16 laypeople
7Ãž and â€œoutsidersâ€ Ã°blind people
4Ãž analyzes how car culture participants
1199  participants
335  of participants
14,000 participants
3,000 people
  data from the 100
 data from the 1980
 data from  3
 data from the 2000
 data  from the 2000
 data from 2000
50 women
50 cis women
17Some participants
1Ãž explicit exclusion of trans people
4 Although persons
12,686 young  people
total of 133,121
 data from 12
140 women
119,000 people
24Some of the people
 data from 2006
1986Ãž gives patients
89 and they were knee patients
12 patients
1599  would often give homeless people
6,283 NLSY  women
11Although women
total of 43
 data from1996
11 women
2003Ãž  found amongwomen
200 persons
5,000 people
1,000 people
total of 55
total of 25,136
 data consist of 44,528
1 Many people
1364  nesspeople
1006  servative Protestant women
24 enrolled
 data on most of the 3,143
450 people
total of  10,902
1925 Mussolini  granted women
100 people
1,000 people
1,000  people
50,000 people
271,139 people
total of 100,000
7,000 participants
1Ãž which participants
7,490 participants
100  people
100 people
222 people
621 people
total of  12
2010Ãž document how women
21Ãž emphasized  how women
3Ãž The surveyor counts five persons
62 subjects
total of 32
18 participants
838  ciation participants
824  people
56 potential subjects
60 subjects
854  How would most people
838  How would most people
82  How would most people
1,000 women
1724  The people
2,000 people
total of 31
total of 68
total of 533
14 The percentages of women
1995 the percentages enrolled
100,000 persons
100  protest participants
50 participants
150 participants
100 participants
25,000 people
12 people
 data from the 2000
236Ãž more likely than women
23These persons
2 predictions were  based on persons
893  and its regular use among persons
894  paring persons
 data from the 2010
1960s describes  women
50 undergraduate women
316 patients
5 923 patients
6 816 patients
8507 patients
0 indicates per cent of patients
2982 subjects
170 patients
n=52
n=145
n=9
n=0
n=57
n=42
n=31
n=11
n=15
n= 24
n=8
n=7
n=16
n  =8
n  =7
n  =1
n=17
n=9
n=11
n=12
39   subjects
41 subjects
21 subjects
19 subjects
100 patients
n =   21
n = 19
n = 21
n = 39
n = 38
41 subjects enrolled
11 patients
14 patients
11   patients
3 patients
n= 3
n= 11
n= 6
n= 2
n=264
n= 34
12 participants
1156 participants
400 participants
n = 410
n = 416
841 men had been   enrolled
 data from 46
312 Native American women
273 women
8,000 women
312 women
9 women
3,130 Georgia women
1,600 women
30 Native American women
588   Native American women
5 million Native women
5 women
n=9
n=312
n=273
N=268
total of 273
total of 312
total of 58
total of 62
total   of 40
total of 13
n = 52
100 experiments on two   subjects
1,600 women
5 women
3 women
1 women
0012   â€˜Screening casesâ€™   among women
4,854 randomly selected persons
240 medicated schizophrenic patients
12 patients
N = 38
N = 5
N = 34
N = 30
N = 4,854
total of   342
total of 67
total of 70
154 women
8 women
19 additional women
553 women
14 women
77 additional women
total of 15
total of 7070
total of 138
total of 915
620 patients
217 patients
35 patients
33 patients
171 patients
total of 114
total of 77
9341 persons
2,030 persons
9341 asymptomatic study participants
9341 patients
n=130
n=127
436 patients
577 patients
281 patients
433 patients
41 patients
393 patients
338 patients
4444 patients
95 patients
338   patients
450,000 people
n=393
n=433
n=95
n=338
n=161
n=232
total of 95
total of 577
total of 76
100,000 in   persons
n = 94
n=1
n= 3
n=18
n=2
n=3
n=5
total of 1,458
5082   women
5082   participating women
4072 randomised participants
4072 participants
1000 participants
5806 participants
1263 participants
20,000   participants
674 HPS participants
444 patients
4162 patients
4444 patients
5963 people
20 536 people
total of 20,536
562 participants
671 eligible patients
n=518
N=562
total of 671
n=3
n=4
n=5
N=1644
N=1642
N=1638
N=1636
N=1633
N=1630
N=1647
N=1645
N=1641
N=1591
N=1589
N=1584
N=999
N=1001
N=996
N=974
N=972
N=1611
N=1608
N=1604
N=705
N=704
N=1609
N=1607
N=1602
N=661
N=658
N=659
N=1598
N=1596
N=1590
N=938
N=937
N=936
N=1620
N=1617
N=1612
N=1587
N=1578
N=998
N=1000
N=973
N=970
N=1606
N=1597
N=703
N=701
N=656
N=1595
N=1594
N=933
N=1601
N=1600
N=1603
N=1616
N  =9
N  =1
N=1555
N=1552
N=1542
N=1546
N=1563
N=984
N=983
N=976
N=980
N=989
N=975
N=981
N=1610
N=1618
N=969
N=979
N=1614
N=1599
N=1621
N=956
N=955
N=954
N=957
N=964
N=1615
N=1622
N=971
n=115
total of 480
n = 4
n = 40
n = 3
n = 8
n = 7
n = 5
17 MDD subjects
n = 14
   data from 124
80women
120women
255women
7  whenallbutthreeofthewomen
40women
60women
103  women
1ofwomen
N=40
N=80
N=2879
13 patients
total of 1000
1537 subjects
105 subjects
1428 subjects
141 subjects
97 SSF subjects
3   Proportion of subjects
n=141
n=97
n=1537
n=86
n=244
n=219
n=271
n=177
n=12
n=105
n=265
n=238
n=1384
n=232
total of 21 545
 data from 141
940 patients
37 patients
954 patients
312 MI patients
860 patients
38 patients
42 patients
923 patients
470 patients
462 control patients
111 patients
121 patients
419 patients
404   patients
823 patients
51 patients
74   patients
1 patients
45 patients
65 patients
32 MI patients
32 anterior MI patients
1   patients
N=20201
N=8361
N=1838
N=232
N=708
N=125
N=698
total of 125
total of 20,000
4 persons
2003 and enrolled participants
158 Surveillance Study   participants
41 surveillance   participants
190 participants
164 participants
37 participants
164studyparticipants
43 subjects
5 subjects
46 subjects
49 subjects
26 190      Columns show number of subjects
164subjects
60 164      Columns show number of subjects
227 people
70 people
29 people
37 people
10 of the not fatigued people
n=58
n=55
n=59
n=27
n=28
n = 6
n = 4
n = 3
n = 2
n =   2
n = 1
N=227
n=30
n=67
2003 and enrolled
46 subjects enrolled
350participants
10subjects
5subjects
4subjects
8  femalesubjects
6subjects
6additional  subjects
3subjects
40subjects
22  subjects
27  patients
datafrom6
n = 97
n = 27672
n = 27769
 data from 161
N=852
total of  300
1627patients
3  mayimprovepatients
6patients
3patients
20  highnumberofpatients
n=172
n=167
n=171
n=175
n=277
n=271
n=202
n=192
n=35
n=18
n=17
n=12
n=7
n=6
n=5
n=4
n=3
n=339
n=346
n=548
n=394
N=1627
n=67
n=78
n=99
n=71
N=315
259women
56participants
147participants
252  participants
70participants
45participants
4-Percentageofparticipants
501  people
1030people
295,000people
702people
30  people
175people
11â€™attacksamongpeople
n=201
n=501
n=119
n=390
n=30
n=129
n=372
n=34
n=430
n=71
n=426
n=512
n=45
n=48
n=72
n=121
N=199
N=213
90 subjects
70 subjects
N=70
N=37
N=33
N = 36
N = 33
N=10
N=126
N=56
N= 33
N=143
N=136
N= 37
N=7
23,534menand  women
N=312
100patients
1000in  patients
500patients
2457patients
9212patients
1200troponin-positive  NSTEMIpatients
28,825patients
158,831elderlyMedicarepatients
1000patients
45,852patients
60patients
60 inpatients
60 patients
104 patients
4 probable JE patients
135 patients
n = 86
n = 4
n = 90
36 participants
200 participants
72 patients
3 patients
34 patients
108 patients
54 patients
90 patients
34   patients
total of 36
1,000 persons
1,000 patients
3 million patients
1   million patients
1,000 aspirin users per year for patients
N=   16,598
N=9,129
2000 who had been enrolled
54 participants
48 patients
n=35
n=13
n = 16
n = 53
n = 26
n =   27
n=79
n=54
n=25
n=9
n=1
n=2
n=27
n=26
n=23
n = 1
n=3
total of 4
72 postmenopausal women
131 postmenopausal women
52,705 women
108,411 women
18 patients
159   remaining patients
88 patients
72 patients
14 patients
13 patients
142 patients
284 age- matched patients
984 breast cancer patients
n=72
n=524
n=231
n=103
n=6
n=7
n=50
n=51
n=80
n=54
n=30
n=88
n=56
n=32
n=22
 data from   51
759postmenopausalwomen
4203postmenopausalwomen
1686postmenopausalwomen
1686women
95women
45women
973menandwomen
45participants
n=759
9millionpeople
000 people
21 patients
N = 21
N = 921
N = 851
N = 253
N = 441
N = 421
3 positive subjects
748 stage IV melanoma patients
748 AJCC stage IV melanoma   patients
267 patients
217   patients
141 patients
82 patients
26 patients
15 patients
302 stage I-III patients
709 stage IV melanoma patients
391 stage IV melanoma patients
n=11
n = 302
n = 301
n = 214
n =   215
n = 739
n = 709
n = 391
332 patients
2166 patients
19   patients
357 patients
82 patients
324 patients
8 patients
12 patients
277 patients
36 the patients
107 patients
105 patients
69 patients
3 patients
105 mildly depressed   patients
N=119
N=124
N=81
N=123
N=127
N=82
n=124
n=119
n=81
8870women
6200women
6382women
4  timesthatinwomen
777women
8timestheprevalenceinwomen
31women
838women
504women
145  Urbanwomen
150  Ruralwomen
226  Urbanwomen
739  Ruralwomen
14women
852  Urbanwomen
720  Ruralwomen
364     Urbanwomen
955     Ruralwomen
5000women
838people
617people
3  people
600people
45millionpeople
1981people
2870people
230eligiblepeople
800people
400people
585samplesbelongingtopeople
225people
241people
14  people
6  millionpeople
N = 221
N = 14
N = 3
N = 2
N = 238
N = 585
N = 584
N = 12,375
N = 1,238
N = 0
N = 4
N = 242
N =12,617
N = 1
datafromthe2005
944subjects
6,736U.K.subjects
2minorallele  carrierpatients
4Characteristicsofpatients
1155people
20 patients
17 patients
2 influenza patients
n = 202
n = 150
n=140
n=100
n=40
n=96
n=122
n=77
n=45
n=66
n=35
total of 122
5000participants
429subjects
195 Korean subjects
429patients
40patients
360patients
278patients
4 patients
360 patients
278 patients
n=429
n=113
n=316
34 patients
n=204
n=27
n=2
n=19
n=32
n=6
n=118
n=88
n=13
n=25
n=109
n=101
n=23
n=24
n=10
n=31
n=9
n=195
n=58
1000subjects
45elderlypeople
148patients
120patients
n=1
n=0
n=7
543eligiblesubjects
650subjects
176  interventionsubjects
57controlsubjects
124controlsubjects
29foruniversity-qualified  subjects
23tasksforcontrolsubjects
34tasksfor  interventionsubjects
20people
N=176
N=187
N=56
N=57
N=116
N=124
databasesof16,188
n=120
n=30
n=4
n=6
n=3
n=90
total of 6
30forthefirst  eightparticipants
00fortheremaining  participants
10participants
443participants
32participants
156participants
79consecutiveparticipants
443subjects
135subjects
509subjects
66excludedsubjects
308subjects
50subjects
11subjects
44  subjects
44subjects
132subjects
16,000patients
n=2
N=50
N=21
443subjectsenrolled
N=983
N=535
N=448
n=5
52 female participants
98 participants â€“ these participants
73 participants
137 participants
95 participants
137 included subjects
90 subjects
95 subjects
n = 72
n = 90
n = 95
total of 137
181 adult patients
84 patients
293 contacting patients
181 patients
160 patients
21 patients
127 patients
85 patients
96   patients
42 patients
173 patients
82 patients
91 patients
26 patients
15 patients
n=85
n=96
N=181
N=133
n= 96
n=181
n=133
n=55
n=78
N=293
N=96
N=89
N=83
N=79
N=72
N=1
N=5
N=4
N=3
N=18
N=85
N=80
N=77
N=76
N=67
N=2
N=9
N=112
N=45
N=42
N=25
N=78
N=55
N=30
113,494 participants
N = 113,494
n=21
n=8
n=4
n=3
n=2
n=612
n=61
N=23
n=15
n=17
N=673
n=673
total of 26,166
25  women
1631pregnantwomen
278women
41women
1631women
8  pregnantwomen
41pregnantwomen
41patients
33MApatients
10patients
16patients
15  patients
20patients
18patients
12patients
4patients
26patients
7patients
2patients
9patients
2Migrainesubtypeamongpatients
3Questionnairedatainpatients
4Variousmeasurementsinpatients
n=1631
n=41
n=34
n=7
680participantswere  women
680participants
680patients
680  patients
2  Proportionofpatients
N=370
n=37
N=51
N=621
N=15
N=10
N=89
N=115
N=159
N=170
N=151
N=141
N=204
N=106
N=163
N=148
N=135
N=199
N=540
N=43
2 746   patients
2 445 patients
301 patients
2 445   patients
2   patients
32 200 patients
13 patients
1151 patients
3 268 patients
2 746 patients
2,445   patients
1620 patients
N = 18
N = 4
n = 2 746
n = 5
n = 8
n = 4
n = 1
n = 0
n = 45
n = 10
n = 3
n = 27
total of 13
n=121
n=123
n = 61
n=60
n=79
n=24
n=68
n=33
n=31
n=28
n=89
n=29
n=27
n=21
n=3
n=22
n=11
n=15
n=7
n=58
n=12
n=19
n=72
n=114
n=93
n=87
n=97
n=36
n = 14
n = 65
n=6
n=9
n=95
n=59
n=16
n=13
n=65
n = 34
N=112
n=115
n=108
n=118
n= 121
n=112
9 patients
2 patients
122X   patients
18 study patients
122X homozygous patients
122X patients
1162X patient and the patients
n=9
n=4
n=5
122X patients enrolled
n=2492
n=1250
n=2074
n=19
n=17
N=19
N=14
datafrom2003
5 million people
20 000 people
676 women
n= 2580
n=1601
n=4
n=2
n=3
n=1000
total of 21
total of 7
200 million women
n=6,217
n=3,618
n=4,066
n=3618
total of 11,904
n=2846
n=203
n=68
n=50
n=12
n=6
n=135
n=2643
n=1
n=23
n=7
n=13
n=2
n=4
n=3
n=39
n=29
total of 39
301 participants
21,270 participants
161 patients
73 patients
69 patients
7 patients
149 patients
92 patients
n=161
n=436
n=213
2000 women
518patients
3501patients
834patients
76  ovariancancerpatients
1000 persons
1000   persons
1000 patients
total of 56
10inpatients
N=5830458
1 patients
n=3
n=6
n=396
n=208
n=201
n=191
n=220
n=88
n=61
n=236
n=101
n=144
n=456
n =0
5terminalpatients
5terminal  patients
n=1478
n=1750
n=1217
n=1508
n=1275
n=1514
n=1397
N=1478
N=1750
N=1397
N=1217
N=1508
N=1275
N=1514
n=6587
n=6348
n=3
4825 women
5473 persons
4686 persons
150 subjects
112 subjects
38 patients
27 patients
4519 patients
7 patients
753 patients
64 patients
N = 1890
N = 3853
n=25
n=386
n=900
n=1442
n=1279
n=610
n=183
n=4824
n=12
n=31
n=125
n=249
n=281
n=166
n=54
n=918
n = 25
n = 13
n = 36
n = 17
n=503
n=1136
n=1059
n=336
n=1485
total of 38
 data from 5
n=450
1000 consecutive patients
n=32,298
n=102
n=16
N=548
N=192
total of 9972
402 potential participants
n = 6
N = 342
N = 150
N = 192
N  =  6
N  =  19
N  =  17
N  =  18
N  =  15
N  =  27
N  =  10
N  =  11
n=4
n = 3
n = 4
n = 14
26,786COPDpatients
1dataforindividualpatients
6000patients
156patients
244patients
400patients
26,786patients
23,245patients
3541patients
7201 patients
8312patients
3861patients
1NotonlyCOPDpatients
n=9,434
n=17,352
n=433
n=79
n=445
n=653
n=1207
n=742
n=1465
n=1022
n=78
n=6112
n=432
n=921
n=824
n=408
n=196
n=392
n=1010
n=540
n=994
n=68
n=278
n=671
n=1829
n=281
n=114
n=434
n=634
n=812
n=244
n=92
n=121
n=1323
n=98
96unrelatedFAP  patients
96patients
315disease-  affectedlivingpatients
6ofthesepatients
29patients
81patients
95patients
4patients
2patients
61newpatients
150unrelatedpatients
39082 participants
1 Sociodemographics of all participants
N=39082
n=12080
n=26808
total of 39082
total of 6
n=7,915
n=1,081
n=180
n=12,761
n=19,491
n=6,151
n=297
n=178
n=3,106
n=27,234
n=4,835
96women
7983participants
7129participants
588participants
22056subjects
123 patients
19 outpatients
19 patients
4 additional patients
20 outpatients
71 patients
N = 51
N = 58
n = 34
n = 37
n = 39
n = 40
n = 29
n = 31
n = 94
n = 42
n = 121
n=29
n=34
n=31
n=94
total of 123
100patients
5  Commentaryfromotherpeople
N=57
N=48
N=352
N=201
N=47
N=58
N=357
143 subjects
143 myeloma patients
9486 patients
9321 patients
143   patients
142 patients
142   patients
n=70
n=73
n=52
n=91
n= 70
n=10
n=92
n= 27
total of 279
total of 10,000
143 myeloma patients enrolled
 data set of 143
85for  women
3ofthe  participants
N=253
N=139
N=114
datafrom253
11   pregnant women
286 participants
14 patients
115patients
24,789patients
1070     fewerpatients
13,152hospitalizedpatients
26fortraumapatients
1-Characteristicsofpatients
n=24,789
n=115
n=40
n=4007
n=20,789
n=308
datafrom32
282 persons
108 persons
n=4,469
n=191,109
n=3,437,837
n=108
n=282
n=15
n=135
n=34
n=184
n=3
n=55
n=19
n=77
n=0
n=8
n=2
n=5
n=433
n=1,776
n= 261
n=2470
n=132
n=341
n=58
n=531
n=121
n=558
n=756
n=38
n=94
n=7
n=139
 data from 1990
26persons
5623subjects
781clinicallyevaluatedsubjects
5,623subjects
781subjects
100subjects
210subjects
98subjects
n=469
n=505
n=641
n=781
n=280
n=501
n=1609
n=282
n=5558
n=213
n=421
n=147
n=133
n=114
n=33
n=210
n=100
n=110
139patients
3timeshigherinpatients
1diabeticpatients
38patients
3patients
8patients
462patients
n=44
n=31
n=13
n=46
n=24
n=22
n=49
n=16
n=33
dataofthe139
6,316 patients
6,316patients
2,872 patients
163patients
2,107patients
2,553patients
934patients
1displaystheflowof  participants
n=430
n=446
n=423
N=685
N=301
N=383
N=674
N=337
N=336
2amongstHIV-infected  patients
88  adulttuberculosispatients
36Inimmunocompetentpatients
N=21
N=33
6700 patients
13participants
1Apatients
1A  patients
29patients
13patients
12adultpatients
10age-  matcheduntreatedpatients
12treatedpatients
12patients
5000people
n=4
67 of the patients
31 patients
3 major subclasses of patients
6,934 genes and the   individual patients
16  subclass A patients
98 patients
n = 11
n = 32
n = 98
1 How participants
13 Flow of participants
16 Number of participants
234 subjects
n = 1,368
n = 931
n = 101
N=271
N=264
N=273
n=392
n=332
n=38
n=22
n=1200
n=808
n=264
n=271
n=273
n=24
n=10
n=14
n=247
n=5
n=1
n=8
n=259
n=16
n=248
n=239
n=3
n=224
n=7
n=253
total of 1200
7,383 patients
n=2,219
n=887
274wereenrolled
datafrom2007
1subjects
2subjects
2andAD-FDRsubjects
1subjects
4  subjects
2andAD-FDR  subjects
93patients
93AD patients
1subjectsandADpatients
1subjectsandAD  patients
1subjectsandADpatients
20ADpatients
n=265
6749women
3260patients
n=3
n=1
n=173
n=16
n=47
n=48
n=10
n=9
n=33
n=157
3 patients
295 patients
56 patients
24   of these patients
24 patients
126   patients
n = 24
471 patients
5 patients
394 patients
5   Outpatients
n=774
n=661
n = 85
n = 576
n =435
n = 413
n = 161
n = 87
N=774
N=672
N=744
200subjects
54  Numberofpeople
5    Numberofpeople
n=276
n=18
n=128
n=148
n=316
n=339
n=164
n=175
n=91
n=84
n=80
n=9
n=0
n=7
n=2
n=6
n=3
n=1
n=16
n=5
n=14
n=4
n=10
339childrenwereenrolled
n=7588
n=3709
n=3879
146 patients
1   were patients
2 were patients
3 were patients
295 patients
146 different   patients
3 Basal-like patients
295 breast cancer patients
412 patients
N=0
N=1
N=136
N=295
N=111
N=50
2subjects
3subjects
1150subjects
40insubjects
344subjects
1146subjects
1includedallsubjects
98othersubjects
30subjects
383  Inclusionofsubjects
N=181
N=180
N=385
N=383
N=1150
N=382
N=65
N=66
N=183
N=186
N=67
N=71
N=68
N=72
N=73
N=13
N=14
N=15
N=27
N=26
1150subjectsenrolled
17MRSApositivepatients
9patients
6B  patients
2 participants
600 consecutive   patients
645 eligible stroke patients
29 patients
n=328
n=70
n=120
n=90
n=154
n=48
n=84
n=184
n=260
n=203
n=122
n=396
n=82
n=246
n=13
n=8
n=987
n=172
1999amongwomen
2004weremore  pronouncedforwomen
2000Censuspopulationsofwhitewomen
100,000   subjects
3,847 subjects
6,805 subjects
369 patients
n = 19
n = 4
n = 14
n = 7
n = 10
n = 9
n =   7
n = 5
n   = 7
n = 6
n = 2
n =   19
n = 8
n = 41
n = 3
n = 31
n = 12
n = 18
n =19
total of 104
total of 11
total of 17
total of 24
total of 83
total of 142,205
137patients
n=6
n=4
n=12
173,234subjects
N=46,895
N=5,075
N=44,628
N=4,741
N=181,790
2003  filewereenrolled
189 eligible patients
802 patients
356 relapsed OC patients
201 patients
204 patients
5 patients
2 patients
189 eligible   patients
4 patients
29 patients
177 patients
9 patients
6 patients
122   patients
8 patients
26 patients
704 patients
n=204
n=189
n=96
n=89
n=7
n=2
n=5
n=24
n=13
n=8
n=3
n=93
n=85
n=1
n=6
n=90
n=87
n=20
n=10
n=4
n=58
n=37
n=64
n=32
total of 189
total of 503
total of 475
total of 159
total of 26
2,633 subjects
1,306 subjects
109 patients
1,327 patients
934 patients
927 patients
886 patients
666 patients
2,633 patients
7,911   patients
n=2,011
n=1,334
total of 17
total of 184
total of 2,633
2699 persons
total of 41
69 women
n=335
N = 69
N = 358
total of 4091
1450women
420women
100,000women
208 GC patients
96 EC patients
448A   among GC patients
56   patients
448A among GC patients
13 fold than the patients
448A among   EC patients
n=346
n=208
n=241
n=96
n=6
total of 25
100,000 men and women
473 participants
1displaystheflowofparticipants
811subjects
323 non-suicidal subjects
473 suicidal subjects
473subjects
811 adult patients
N=42
N=41
N=57
N=9
N=8
N=33
N=196
N=127
N=254
N=219
694   participants
total of 9,010
total of 694
4000 diabetic patients
4404 patients
2 diabetic patients
4404 diabetic patients
3953 diabetic patients
255 000 people
n=950
n=4337
n=3953
N=3952
n=3952
n=3901
n=3659
n=3927
N=2725
N=824
n=801
n=688
n=1364
N=249
N=135
N=24
N=869
N=1508
N=390
N=2737
N=4404
total of 4404
total of 3953
4404 patients enrolled
 data from 1998
2   million active patients
7 million patients
n=1
n=5,477
n=38,314
1208 patients
205 patients
1208 new patients
216 patients
0              All patients
1577  TB patients
N=1417
n=1208
n=548
n=484
n=1417
n=440
n=1066
N=1577
N=1343
N=160
N=342
N=440
N=548
N=869
N=44
N=35
N=1208
N=135
N=484
N=724
N=626
N=98
N=469
N=15
3 breast  cancer patients
203subjects
203  subjects
4itisunlikelythatRCTpatients
N=64
N=768
N=12
N=811
N=719
N=413
N=713
N=639
N=58
N=55
N=49
N=24
N=7
N=113
total of 2040
total of 13
 data at each of the 17
200million people
500,000 people
n=840
n=120
n=240
n=2
n=3
n=20
n=10
n=6
 dataset of 119
86patients
363patients
134patients
N=1195
N=1269
N=812
N=863
N=2789
n=31
n=62
403 patients
1,296 patients
171 consecutive patients
2010 Taiwanese patients
n=47
n=42
n=36
n=6
n=16
211   participants
n=50
n=70
n=114
n=73
n=61
n=121
n=131
n=201
n=123
n=235
n = 1
100 rheumatoid arthritis subjects
99 subjects
88 patients
84   patients
79 patients
n=67
n=32
n=17
n=15
n=99
n =32
n =99
63 subjects
519 patients
35 patients
441 patients
278 evaluable patients
433 patients
406 patients
37 patients
163 patients
n=43
n=33
n=6
n=9
n=28
n=148
n=47
n=63
n=111
n=226
n=130
519 patients were enrolled
 data from 6
9   subjects
500 patients
N=54
N=3
n=6
n=3
total of 18
10,000   subjects
504 patients
400 patients
500 patients
13 definite CLR patients
403 patients
78 patients
22 patients
43 patients
700 patients
n = 155
n=53
total of 504
80 otherwise healthy women
79 patients
195 patients
80 patients
4 patients
5 patients
2 ibuprofen patients
78   UTI patients
n=40
n=39
n=9
n=3
n=36
n=33
total of 58
total of 195
1000 patients
174 patients
n = 10
1,701 women
17,017 women
1,702 women
1 million people
N=1701
N=17017
n = 1701
n = 17017
total of 30
658 primary care patients
n=2,342
n  =  2
n  =  1
191 patients
36 patients
51 patients
36   patients
180 patients
131   patients
20 patients
25 patients
17 diabetic patients
6 nondiabetic patients
72 patients
231 patients
111   patients
n=29
n=51
n=20
n=13
n=9
n=5
n=4
n=56
n=28
n=15
n=10
n=38
n=17
n=6
n= 231
n= 111
n= 180
191 patients   were enrolled
 data set of 108
90 patients
64 patients
26 patients
90   patients
276 participants
276 st udy participants
6   participants
39,429 for all participants
276 study participants
15   infected patients
10   patients
3   number of patients
20   Two hundred seventy-six patients
31 patients
32 patients
113 patients
1   age of the patients
9   Eighty-five percent of patients
276 patients
22   patients
12   patients
11   patients
17   HIV-infected patients
19   patients
13   rural AIDS patients
10   immunodeficiency syndrome patients
13   infected patients
920,000 people
112,000 people
N=276
total of 320,000
 data from the 20
n  =  1
n=142
n=1,430
total of 24,935
220 subjects
50   control subjects
26 CRC   subjects
70 treatment-naive CRC subjects
40 pre-treatment CRC subjects
40 pre-treatment CRC patients
46 pre-surgery CRC   patients
40 pre-surgery CRC patients
40 CRC patients
n=222
n=220
n=5000
n=1500
 data from all 90
177   participants
185 participants
362   patients
185   patients
177 patients
2 patients
5 patients
755 general medical and surgical patients
316 patients
1,954 patients
362 patients
n=47
n= 378
n=606
n=282
n=177
n=185
n=251
n=3,455
n=323
n=280
n=1954
n=1592
n=1166
n=788
n=69
n=200
n=67
n=90
n=362
n=280,100
n=0
n= 72
total of 22
total of 82
5754 patients
100 patients
3369 patients
522   patients
1863 patients
800 patients
1000 patients
25 patients
total of 5754
total of 234
total of 1854
total of 37
376,257 women
495,294 women
1000 women
n = 550,000
n = 13
n = 8
 dataset of 647,876
   databases of the 13
12   ACKNOWLEDGEMENTS   The participants
14 subjects
7 lean subjects
n=534
n=603
n=1183
n=262
n=298
n=3
1,503 subjects
886   patients
3 Survival of enrolled patients
total of 4
total of 245
3 Survival of enrolled
9317 men and women
632 white men and women
117 men and women
6654 men   and women
42 men and women
5242 men and women
1037 men and women
1596 men and women
7764 men   and women
63 men and women
8191 men   and women
83 men and women
2401 men and women
4692 men and women
198 men and women
48 men   and women
128 men and women
4391 men and women
95 men and women
144 men and women
81 non allergic men and   women
5887 men and women
1901 men and women
869 men and women
13 subjects
1000 subjects
7 because the subjects
100 subjects
13 male patients
n=12
n=23
n=6
n=8
n=10
n=17
n=25
n =9
n=61
n=53
n=58
n=49
total of 260
total of 303
 data from the 1994
 data   from 7
2 diabetic patients
N = 21
4,334   women
142 control   subjects
140 patients
total of 140
total of 142
2008 and enrolled
543  consecutivelyCOPDpatients
808consecutiveCOPDpatients
543eligiblepatients
543patients
3126patients
6Amongpatients
n=543
n=472
n=71
n=32
n=36
n=12
n=35
n=20
n = 161
n = 300
n = 271
n=271
n=161
n =11
n =150
n =58
n =103
n = 122
n =39
n=65
n=96
total of 300
total of 271
total of 161
N=9
N= 43
n=1
n=3
80 GIST patients
80   patients
29 patients
80 patients
26 patients
48 patients
n=36
n=2
n=27
n=8
n=52
n=7
n=19
n=6
n=1
n=3
n=13
n=21
n=28
n=4
n=25
n=33
total of 80
total of 70
80 patients   enrolled
 data from 10
45 subjects
38 subjects
7 subjects
18 female subjects
20 subjects
7 million people
n=21
n=17
n=18
n=9
n= 21
n= 200
 data from 27
1676 patients
15 improves   patients
1455 unselected AMI patients
9461 patients
102 included participants
100 participants
n = 34
n = 33
n=30
n=10
n=9
n=137
n=35
n=102
n=34
n=1
n=24
n=23
n=33
873 eligible patients
7      All eligible patients
10   Eligible and registered patients
6   of patients
8   patients
900 patients
170 patients
15   eligible patients
909 patients
12      patients
30 patients
11   patients
12   patients
10 patients
13      patients
2   When patients
16   patients
116 patients
76 patients
135 patients
4   patients
1264 patients
2,094 treated patients
14   patients
17   patients
17      differences among patients
2   patients
55 patients
7 patients
48 patients
295 patients
24   patients
9   patients
n=909
n=873
n=441
n=423
n=18
n=8
n=6
n=4
n=432
n=414
n=350
n=77
n=3
n=14
n=5
n=30
n=16
n=347
n=71
n=10
n=2
n=31
n=9
n=118
n=311
n=12
n=128
n=297
n=7
total of 16
10patients
1  millionpeople
n=128,511
n=30,836
n=32,277
3 patients
40,000 White American   patients
7 patients
n=26
n=9
n= 9
n=12
n=14
n=10
n   =18
n=19
n=18
total of 19
total of 30
total of 8
total of 50
500,000   persons
500,000 persons
3000 treated patients
3000   patients
13 patients
405 patients
870 patients
N =   5,831
n = 52
n = 28
n = 16
N     =     1
N = 1,015
n = 659
n = 459
N = 1208
n = 871
n = 572
403 patients
n=45
n=33
n=46
n=44
n=2029
n=47
n=35
n=20
n=28
n=31
n=16
n=43
33askedparticipants
36suggestthatpatients
83patients
300rheumatologyinpatients
288 patients
2 diabetic and hypertensive patients
288 consecutive patients
64 diabetic patients
7  patients
2 diabetic patients
1 patients
104 subjects
5 â€“ Number of subjects
52 patients
72 patients
n=34
n=31
497 women
120   participants
80 patients
56 patients
480 patients
540 patients
179 patients
400 patients
150 patients
930 patients
139 of these patients
791 patients
789 patients
746 patients
722 patients
31 patients
59 patients
791 randomised patients
3 people
n=12
N=86
N=137
n=394
n=395
n=534
n=177
n= 139
n= 358
n= 15
n= 373
n= 21
n= 395
n=1
n= 22
n=396
n= 1
n= 353
n= 20
n= 176
n= 177
n= 534
n= 421
n=102
n=167
n= 113
n= 134
n=32
n=64
n= 43
n= 415
n=6
n= 412
n=3
total of 930
total of 31
total of 59
total   of 722
930 patients were enrolled
262 consecutive subjects
2 diabetic   patients
n=162
n=70
219 patients
18 patients
2932 patients
737 patients
139 patients
313 patients
21   patients
76 patients
25   patients
n=94
n=219
313 patients finally enrolled
285 trauma   patients
total of 143
487 consecutive patients
81 patients
2000 patients
980 patients
60 patients
9 million people
n=3,623
n=2,881
n=20
n=171
n=232
n=190
n=1,515
n=55
n=526
n=107
n=40
n=16
n=9
n=742
n=709
n=74
n=378
n=142
n=18
n=4
n=49
n=26
n=2
n=6
n=5
n=3
n=33
n=12
n=23
 data from 7
6   participants
140 participants
69 patients
n = 0
n = 33
n = 3
n = 2
n = 1
n = 74
n = 71
n   =   7
1333 patients
n=28
n=5
n=9
n=29
n=6
n=7
N=3407
N=91
N=37
N=42
N=5
N=6
N=3
N=11
N=13
N=4
N=10
N=4549
N=3316
N= 2316
N=1809
N=0
total of 42
20 pregnant women
3000   subjects
94 CRC-free subjects
98 younger subjects
300 of the subjects
2 lists the subjects
300 evaluable subjects
104 subjects
10,000 subjects
50 untreated CRC patients
300 colonoscopy patients
8000 asymptomatic patients
306 patients
306 colonoscopy patients
N=448
N=313
N=49
N=303
N=1630
N=216
N=8
total of 224
total of 307
1036   control subjects
7   control subjects
1036 control subjects
855   patients
855 incident patients
41 patients
855   incident patients
798 NPC patients
n = 41
n = 13
n = 773
n   =   7
n   =   1
total of 5
2089 patients
n = 368
n = 296
n = 19
n = 2
n = 72
n = 52
n = 7
n = 1
n = 27
n = 25
n = 13
n= 2
10 participants
703 participants
610 participants
31 trials enrolling participants
446 participants
10 trials enrolling participants
152 participants
52 participants
12 participants
20 participants
412 participants
133 participants
41 participants
1 diabetic participants
133   participants
41 overweight participants
20 diabetic participants
22 participants
85   participants
41   participants
52 diabetic participants
41   overweight participants
2 diabetic participants
2 diabetic subjects
7 people
n=1
n=2
n=7
n=9
n=3
n=23
n=15
n=3666
n=3175
n=3114
n=58
n=491
n=440
n=114
n=77
n=79
n=46
n=44
n=13
n=1292
n=4958
n=0
total of 41
total of 12
16 CCSVI-MS patients
16 MS patients
56 MS patients
n=8
868 patients
868   consecutive patients
17 we   classified patients
17 patients
100 patients
5000 patients
17000 patients
448 patients
105 patients
470 patients
354 patients
647 patients
323 patients
N = 1283
N = 5511
N = 10311
N = 1144
N = 62
N = 4373
N = 871
N = 5697
N = 4323
N=17105
total of 1
total of 60
n  =  3
100 patients
156 patients
183 patients
12 patients
1 infected   patients
151 patients
141 adult patients
132 patients
18 patients
59 patients
19 patients
197 septic   patients
55 septic   patients
101   patients
99 HIV   patients
N=44
N=31
n=273
15,000 patients
322 patients
303 patients
262,700 Medicare patients
4444 patients
n = 4126
total of 35,438
85 women
88   women
n=133
n=151
n=11
n=30
n=15
n=10
n=3
n=5
n=2
n=36
n = 46
n = 7
n = 13
n = 16
n = 3
n = 2
n = 11
n = 0
n = 5
n = 6
n = 79
n = 22
n = 204
n = 173
n = 31
n = 88
n = 85
total of 173
total of 204
total of 2123
573 patients
270   patients
143,000 people
n = 6
n= 573
n= 63
n= 510
n=387
n=123
n= 122
n= 265
n = 265
n=258
n=142
n=43
n=97
n=125
n=122
1i=participants
2i=participants
5259 patients
400 patients
8 RCTs enrolled patients
total of 5259
8 RCTs enrolled
233 patients
7 million of patients
958 consecutive elderly patients
958 patients
725 patients
N = 958
1 patients
1   patients
42 patients
27 patients
35   patients
7 patients
30   patients
n=36
n=40
n=16
n=5
n=4
total of   16
2   were defined as case subjects
2 were   considered control subjects
240 subjects
total of   810
total   of 27
total of 21
total of 59
total of 41,734
total of 11
102 critically ill patients
600 patients
759   patients
42 patients
28 women
500 persons
61   participants
n=508
n=501
n=333
n=315
n=166
n=174
n=338
n=132
n=206
n=300
n=184
n=116
n=240
n=296
n=283
n=218
n=35
n=34
363 women
382   women
20   level of DHEAS among women
16    active women
2 Among parous women
877 controls subjects
19 subjects
17 subjects
2 Number of subjects
22 patients
n =38
n = 12
n = 10
n = 8
n = 9
n = 20
n = 44
total of 363
total of 405
total of 877
total of 382
total of 19
 data from 13
17 Mode During MI practice participants
n= 85
n=14011
n= 16271
n= 13628
n= 95
n= 89
n= 16
n= 21
n= 5468
n= 2260
n= 383
n=13543
n=51
n= 4
n= 6
total of 20
total   of 21739
total of 21
 data of 17
 database from 22
57 women
2D subjects
300,000 IU vitamin D to the subjects
n=41
n=50
total of 100
N  =  1
N  =  5
N  =  3
N  =  2
n = 5,615
n = 5,612
n = 84
n = 5,528
n = 3,365
n = 48
n = 3,317
n = 2,930
n = 2,928
n = 45
n = 2,883
n = 1,916
n = 1,893
n = 26
n = 1,867
12 SLE patients
n = 3
n=10
322 women
479 persons
479 participants
705 participants
14 participants
599 participants
72 participants
48 participants
92   participants
246 participants
7 participants
n=393
n=479
n  =  4
n  =  3
n  =  1
N=372
N=107
n=72
n=407
42   patients
406 patients
43   patients
80   adult patients
118   management of all patients
126   all patients
200 patients
167   two groups of patients
202 patients
204 patients
34 patients
28 patients
35 patients
19 patients
9 patients
191 patients
12 patients
193   In three of these patients
39 patients
15 patients
24 patients
7 patients
215   more common among patients
201 patients
229   patients
230   In the subgroup of patients
231   Among patients
267   population consisted of patients
279   selection of patients
283   the patients
289   care patients
351   well as patients
432   patients
500   a No of patients
91 patients
97 patients
517   Detected Pathogens All patients
n=9
n=25
n=34
n=243
n=92
n=12
n=6 220
n=202
n= 204
n=204
total of 335
94   Patients were enrolled
123   participants
5 participants
10 participants
21 structured questions participants
20 participants
10   participants
116 participants
7 participants
116   interviewed participants
40 participants
48   participants
15 participants
101 participants
50 people
123 people
7 people
n= 123
n= 62
n = 60
n= 2
n= 1
n= 61
n= 55
n= 5
n= 3
n= 0
n=55
n=61
n= 116
n=62
4281 people subjects
108 subjects
4281 people
n=837
n=733
n=694
n=650
n=643
n=724
N=108
N=881
4839 patients
11 patients
2900 patients
n=7
n=9
n=5
n=6
N=405
N=232
N=115
N=58
N=18
N=2
N=21
N=0
N=271
N=40
N=6
N=8
N=5
N=3
N=4
N=1
N=236
2010 Hong Kong   All subjects
54   million general practice patients
2DM patients
n=38
n=28
n=24
n=21
n=17
n=10
n=8
n = 2
n = 3
n = 4
n = 6
n = 8
n=28
n=14
n=8
n=4
n=3
n=10
n=49
n=31
n=48
n=33
n=70
n=21
n=7
n=26
n=12
n=91
n=69
n=22
n=110
n=20
n=145
n=40
n=53
n=34
n=43
n=35
n=19
n=5
3 which assigned patients
1  Characteristics of diabetic patients
2006 529,935 150,401        - Mental health outpatients
400,000 people
n=17,045
n=26,626
n  =  1
n  =  2
n  =  8
n  =  4
949 persons
1237 persons
95 persons
128 persons
15 persons
35 persons
949 older persons
70 million persons
1000 community-dwelling older persons
2 participants
964   participants
253 participants
155 participants
64 patients
n=8
n=1
N=704
N=837
 data from 949
2152 women
18 among   Australian women
45 women
38 women
1   million women
2152 participants
2 participants
8 Indigenous participants
9 Indigenous participants
6 Indigenous participants
26 Indigenous participants
n=1494
n=655
n = 1494
n = 655
n=3
n=1
n=2152
total of 2156
n=32
n=9
total of 65
total of 9
5 asked doctors how many patients
100 CML patients
54   patients
713   women
total of 31
258   identify subjects
420   treatment of patients
570   patients
n = 7616
n=4325
n=1216
n=952
n=1096
n=1061
n=7616
n=5875
n=1741
n=1550
n=468
n=942
n=110
n=81
n=78
n=2
n=39
n=21
n=1161
n=909
n=1041
n=1036
n=1212
n=4
n=945
n=7
n=1089
n=1050
n=11
53   enrolled
 data from the 300
12 patients
92 women
12 Describe the flow of patients
2810 patients
4 tumours and patients
80 patients
1989 â€¦ All   patients
15 compared the   survival of patients
400 patients
750 patients
100 patients
375 patients
325 patients
50 patients
97 patients
99 patients
3        NSCLC patients
284 patients
253 patients
255 patients
106 patients
103 patients
175 patients
128 patients
770 patients
2299 patients
n = 584
n=241
n=229
n=217
n = 106
n = 103
N = 175
total of 10
6 persons
9 persons
2 persons
8 persons
20 persons
98 patients
10 patients
58 patients
119 patients
27 patients
18 eligible patients
10   dementia patients
40 minutes during which patients
13   patients
13 patients
61 dementia patients
n=61
n=50
N=553
n=434
n=79
n=35
n=63
n=96
n=32
n=84
n= 102
n=107
n  =  9
n  =  5
n  =  4
n  =  6
total of 67
12 participants
621 consenting eligible patients
642 patients
598 patients
87 patients
609 patients
23 patients
86 physicians enrolled
n=10
n=8
232 patients
70 patients
68 patients
   data from a 6
3 cohorts of KD and FC subjects
30 FC subjects
441 KD   patients
53 FC patients
783 patients
596   patients
12   KD blood group patients
25 KD urine group patients
5 million people
n=68
n=271
n=55
n=16
n=10
n=21
n=323
n=34
n=83
n=1
n=23
n=113
n=74
n=30
n = 441
n = 342
n = 53
n = 23
n = 16
 data set of 783
1   diabetic patients
n = 89,037
total of 89,037
 data on MDE from 10
6 million   patients
n =   324
n = 405
n= 4
n=4
n=   4
n=6
n=5
359 symptomatic subjects
359 subjects
150 patients
359 patients
239 patients
209 of the patients
71 patients
91 patients
63 patients
101 normal patients
n=150
n=209
n=120
n=239
N=209
1304 subjects
554 C-group subjects
17 subjects
11 control subjects
984 subjects
301 subjects
137   subjects
546 subjects
463 patients
571 patients
n=984
n = 430
n = 554
n = 984
n = 85
n = 216
n = 22
n = 115
n = 447
n = 99
total of 463
total of 571
2max women
total of 4454
 data of 6
29   women
2 million women
32,465 women
64   women
74   women
541 women
3,745 women
796 women
111   these women
864 women
3 million women
1,178,939 women
131   women
164   of women
2,431 women
8 women
4 such women
11 women
239   women
268   among younger women
4 of UK women
314   non-obese women
324   We thank the women
21,828 British men and women
5,992   No. of women
32,465   No. of women
81   participants
83   participants
84   participants
95   were also participants
129   percent of participants
310 000 participants
N=2,431
N=28,866
N=44,787
N=509,874
N=420,712
N=145,551
N=58,015
N=1,178,939
476 patients
34   patients
2   cohorts of people
n  =2
n  =7
120 liver cirrhosis patients
120 patients
22 ELISA were unaware of patients
159 patients
14   patients
29 patients
13 patients
16 patients
22 significantly discriminated patients
n=57
n=40
n=120
29 patients
9   analyzed patients
9 analyzed patients
n = 9
n   = 9
n=12
n=17
n=29
352 participants
14   the blood culture negative patients
n = 5
n=175
n=32
n=67
n=51
n=127
n=108
n=35
n=40
n=106
n=79
n=126
n=20
 data points of Î´ 0
1435 patients
873 patients
411 patients
265   patients
124 Japanese patients
50 consecutive established   RA patients
14 early RA patients
92 RA and UA   patients
309 patients
25   patients
91 RA patients
3435TT patients
2R patients
829TT patients
347CC   patients
1298AA-positive patients
876   patients
210 patients
18,572 patients
7 In DMARD-naÃ¯ve patients
n = 205
n =   484
n=496
n = 38
n = 8
n = 25
n = 84
n = 174
n = 92
n = 48
n = 2614
7 million   participants
55 VS and MCS patients
6 MCS   patients
5 VS patients
12 VS patients
55   patients
18 VS patients
37 MCS   patients
55 patients
37 MCS patients
31 TBI patients
24 non-TBI patients
11 women
09 participants
15 participants
10   participants
09   participants
10 subjects
7 subjects
N=10
N=7
total of 23
n=148
total of 31
n = 12
n = 6
n = 8
n = 3
n =   12
19 subjects
24 patients
12   CF patients
n = 10
n = 8
n = 9
n = 16
n = 7
n = 3
n = 6
n = 4
n =   3
n =   16
n   = 10
N=11314364
1 diabetes subjects
16 subjects
16   subjects
n=52
n=50
N= 16
18 POLY individual patients
14 SJIA patients
31 unique SJIA patients
18 unique PolyJIA patients
15 SJIA patients
7 PolyJIA patients
n=15
n=7
n= 131
n= 50
n=75
n=189
n=119
total of 46
N = 4
n = 6
N = 3
N = 7
n = 3
N = 6
250,000,000 women
N=10
N=5
n=5
N = 6
N = 3
n=4
1 influenza patients
230 patients
1013 patients
1520 patients
197 patients
   database of 3043
 data from 61
70 women
n = 24
n = 12
n=384
n=288
n=48
n=32
n=16
n=36
n=24
n=12
 data of 8
216 participants
127!  Potential participants
153!  participants
240 participants
284!  participants
293!  participants
220 305!  participants
61 participants
316!  Two intervention group participants
325!  participants
352!  less frail participants
355!  participants
20!  participants
35!  people
67!  the proportion of older people
79!  frail older people
111!  frail older people
139!  Community-dwelling older people
208!  people
241 people
17!  Our sample of frail older people
376!  people
392!  frail older people
406!  older people
462!  For frail older people
493!  frail older people
n=149
n=79
n=76
n=140
n=120
n=121
n=1
n= 111
n=107
n=117
n=109
n=111
n=42
n=17
n=23
n=24
41 women
1,292 idiopathic infertility patients
1,292   idiopathic infertility patients
1,657   infertile patients
268 infertility patients
256   infertility patients
768   infertility patients
768 patients
524 infertility patients
768   patients
1,633 patients
n = 2
n = 12
n = 480
n = 524
n = 768
n   =   4
n   =   5
n   =   7
total of 1,292
total of 1,657
total of 450
n=142
n=16
n=10
n=18
5000   patients
70,616 patients
2114 adult patients
197   Outcome of patients
198   patients
110 consecutive patients
272   patients
total of   97
6   subjects
7 patients
n=38
n=20
5 neurologically normal patients
95 epilepsy patients
3 patients
4 patients
4 genotype patients
59 epilepsy patients
3   patients
4   patients
n = 6
n = 4
2 diabetes patients
714 patients
12,000 patients
2 diabetes   patients
25 patients
n=57
n=35
n=7
n=2
n=94
n=43
n=13
n=29
n=17
n=6
n=34
n=45
n=76
n=19
n=8
n=26
n=14
n=10
n=32
n=12
n=9
n=5
n=23
n=24
n=3
n=4
n=48
n=41
100,000 women
5 million women
4 thousand women
60 thousand VIA-positive women
510   people
59,123 women
103,835 women
81,301 of these women
7,406 women
14,012 women
9,792 women
24   and smoking women
49,102 women
17,491 women
24   women
4   women
7   many women
11   women
119 women
1   participants
n=1,451
n=856
n=4,503
n=4,733
n=119
n=45,053
n=54,136
n=59,123
n=49,102
n=240
n=1,211
n=28,949
total of 59,123
total of 49,102
data from Q1
406 participants
29 subjects
406 subjects
31 patients
total of 29
total of 31
total of 97
total of   91
n = 21
n = 5
n = 4
n = 12
n = 101
n = 76
n = 400
n =   12
n = 6
 data from VO2
77 women
n = 123
n = 151
n = 90
n = 119
n = 93
n = 901
n =   100
n = 618
n = 110
n = 228
n = 34
n = 322
n = 53
n = 382
n = 37
n = 158
n = 111
n = 65
n = 165
n = 598
n = 442
n = 36
n = 99
n = 44
n = 42 481
n = 2054
24 active AOSD   patients
20   patients
18 patients
8 patients
3 patients
24 patients
15   AOSD patients
62 patients
24 active AOSD patients
12 AOSD patients
n=31
n=8
n=2
n=0
n=1
n=474
n=306
n=51
n=85
n=70
n=24
n = 24
n=12
n = 33
n = 4,201
n = 5,622
8371 women
132   women
207 women
19864   participants
20773 subjects
19864   subjects
19864 subjects
19864 study subjects
902 subjects
n=3
1 million participants
1,600 subjects
1,468 subjects
1468 subjects
1 disease patients
2D patients
n= 0
 data of 179
 data from the 1000
n=12
n=4
n=5
n=6
217 women
48 women
217 PCOS patients
72 patients
74 patients
33 patients
38 patients
total of 217
total of 128
total of 45
10 participants
973 participants
2891 participants
448 participants
24 patients
N=2891
n = 2891
n = 973
total of 16
18 patients
3 patients
n = 6
n = 4
total of 2890
64 patients
2 diabetic patients
113 patients
25 patients
8 of the patients
4 patients
3 patients
12 renal transplanted patients
n=33
n=64
n=130
n= 64
n=31
n=29
n=28
n=121
n=57
n=50
n=5
n=2
total of 20
total of 113
total of 64
1,746 participants
20   Number of participants
3,647 subjects
1,650 people
n=3,120
n=1,712
n=723
n=989
n=3120
n=1712
total of 1,746
n=9
n=30
n=15
n=3
n=5
7 million participants
20,822   people
4493 adult patients
2007 data on nearly all psoriasis patients
9      patients
1912 RA patients
131 patients
2450 patients
589   patients
600 patients
2450 patients were enrolled
106 HCC patients
n = 64
n = 42
n = 10
total of 101
n=0
n = 0
n =   2,000
n =   0
 data of 30
 dataset of 93
 database of 2000
149 participants
121 participants
75 subjects
n=149
n=59
n=62
n=90
n=13
n=101
n=47
n=54
N=75
n = 149
n = 76
n=73
n=76
77,669 persons
17,007 persons
900 persons
3,557 subjects
217 bipolar patients
n = 2,929,065
n = 1,480,648
n = 1,448,417
n= 25
n = 18
total of 77,669
total of 10,001
total of 900
3 status of the   persons
65229 participants
20,485 patients
3 status of the patients
3 index of patients
2501 CHD patients
4837 patients
7046 eligible patients
778 patients
14      cholesterol-lowering â€“ patients
3 deficient   patients
100 patients
354 patients
4444 patients
18,686 people
n=102
n=100
n=333
n=4848
   data from 27
67 participants
n=50
n=12
64 enrolled
04   Lean subjects
18 study patients
n=6
426   women
762,753 participants
222   Although subjects
267   referent subjects
52   matched AD-free diabetes patients
2DM patients
144   The diabetes patients
9,810 patients
439   care patients
2DM affected people
n=762,753
n=62,988
n=699,795
n=40,232
n=22,756
n=800,000
n=37,247
n=699,765
n=60,646
n=21,487
n=39,159
n=723,451
n=39,302
n=12,898
n=9,810
n=1,509
n=2,904
n=5,397
n=1,945
n=4,094
n=11,103
n=9,262
 data of 800,000
   data of 762,753
 data from 1
2DM were more prevalent among people
N=8
N=13
N=7
N=36
total of 40
2 positive patients
n = 10
n=3
5 Treated participants
n=76
total of 58
4000   participants
1,441   participants
815 participants
539   participants
24,059 patients
183   patients
253 patients
21 patients
204 patients
3,600 patients
74 patients
50 patients
56 patients
66 patients
155 patients
150 patients
total of 224
1,425 subjects
1,425 patients
3 studies focused on   patients
450 patients
total of 7
total of 123
266 women
502 patients
211 patients
22 patients
2 settings involved patients
100 patients
257 were inpatients
396 patients
502   patients
n=396
n=211
n=209
n=187
n=182
n=29
n=502
n=22
n=39
n=240
n=140
n=122
n=6
1 of patients
40 subjects
20163   patients
4 infected patients
12184 patients
11839 patients
2786 patients
2340 patients
3 patients
1 coinfected and monoinfected patients
1 infected patients
1 coinfected patients
1 patients
1,518 patients
200 million people
n= 1
n= 82
n= 125
n= 67
n= 10
n=1
n=2
n=3
2 diabetic patients
2D adult patients
2 diabetes   patients
2 diabetes patients
2   patients
n= 8
n   = 100
n = 60
n = 3
n = 6
n = 4
 data of O2
26,994 MS patients
115,172 ID   patients
1D patients
n=115,172
n= 15,492
n=39,666
n= 4,046
n= 20,574
n= 23,892
n=11,502
n=3,787
n=1,524
total of 26,994
n = 3
n = 30
n = 36
n = 25
n = 10
n = 15
n = 17
n = 4
n =   36
6   patients
38   Control patients
61 patients
62 control patients
1411   patients
139 lithium patients
N = 139
N = 70
100 patients
87 patients
96 patients
38 patients
244 patients
78 patients
76 patients
8 patients
2 patients
5 patients
12 patients
3 â€“ The number of patients
4 â€“ The number of patients
10 people
368   young women
7 women
368 young   women
170,255 patients
9258 women
146 538 participants
369 patients
2,481 patients
n=978
n=647
n=856
total of 369
total of 2,481
35 G > A KRAS mutant patients
12   KRAS mutant patients
35 G > T   KRAS mutant patients
16 patients
16 breast cancer   patients
n=5
n=3
n=2
n=10
n=9
n=13
n=7
n=12
total of   12064
total of   2342
4   participants
13   patients
6   untreated patients
19   patients
8   patients
28 patients
56 patients
17 patients
16 patients
18   patients
4 patients
14 patients
7   patients
2 MEL whereas the other patients
23 patients
15 patients
11 patients
2 patients
11   patients
2   patients
6 patients
6   patients
1 of these patients
14   PFS of patients
18 patients
17   patients
9   patients
5 patients
10   patients
16   PFS rate of the patients
21   enroll more patients
30 patients
100 patients
21 patients
37   patients
29   newly diagnosed patients
n = 15
n = 9
n = 8
n = 5
n =   28
N   =   2
n = 28
total of 28
total of 17
total of 14
total of 15
total of 65
7,447 participants
3,923 participants
20 participants
2,513 participants
59 participants
22 participants
18 participants
1,618 subjects
151 million people
n=1,870
n=33
n=3
n=1446
n=1293
n=1184
 data from 2,513
n=9,379
 data from the 1998
386 subjects
1   patients
13,792 patients
600 patients
200 million people
22   people
1291 men and   women
1,470 participants
179 subjects
1291 subjects
1291 people
N = 103
N = 403
N = 404
N = 381
37   subjects
3   patients
1000 people
total of 1811
53 persons
194   participants
191 participants
195 participants
46 participants
19 participants
194 participants
7 people
n=541
N=185
n=82
n = 48
n=17
n=12
n=8
n=5
n=2
n=46
62 schizophrenic subjects
5   incidence among women
19   women
2   women
98862 participants
116,147 participants
59,125 participants
271,357 participants
274,135 participants
2   participants
n = 0
 data from 274,135
356 men and women
30 patients
7,000 mostly Bemba people
3,729 people
11,000 people
8,000 people
n=379
n=360
n=356
n=354
total      of 48
61 participants
113,000 participants
N=   1105
N= 1099
n = 49
n= 1,105
n= 1,099
N = 1,145
n= 957
n= 1,102
n= 85
n= 24
n= 25
n= 9
n= 21
n= 6
n= 15
n= 11
n= 3
n= 23
 data of 1,145
109 MS   patients
109 patients
26 patients
109 MS patients
109 MS multiple   sclerosis patients
n = 64
n=109
n=45
n=64
109 patients enrolled
11 control subjects
26 new ASP subjects
26 ASP   subjects
430 ASD subjects
26 subjects
430 subjects
26 ASD subjects
26 ASP subject subjects
26 ASP-subjects
26 ASP subjects
26 randomly   referred ASP subjects
430 ASD patients
26 patients
554 patients
26 ASP   patients
n = 26
n   = 430
n=430
n=26
total of 430
total of 26
total of   554
7 million people
n =3382
n =2606
total of 966
1000   women
n=7
n=8
n=9
n=10
n=11
n=15
32   influenza among healthy participants
94,821 participants
206   percentage of female participants
210   participants
1,578 participants
15,592 participants
350   patients
total of 1,356
total of 35 182
total of 94,821
 data are of 65
 data from 33
41 matched control subjects
1 patients
1   patients
104 patients
n=5
n=27
n=74
n=42
n=104
n=79
n=36
 data of NF1
159 participants
39    participants
692 participants
363 participants
212 participants
215   participants
329 participants
335 subjects
391 subjects
67 subjects
165 subjects
83 patients
61 patients
29 patients
418 patients
n=42
n=92
n=537
n=159
n=108
n=24
n=26
n=197
n=190
n=36,913
n=194
n=195
n=13,070
n=347
n=77
n=22
n=6
n=2644
n=1119
n=982
n=3763
n=55
n=17
n = 3763
n = 73
n = 3690
n = 2644
n = 982
n = 63
n = 1
n = 55
n = 18
n = 2
n = 5
n = 10
n = 72
n = 17
total of 3759
total of 3763
32 PE patients
n=32
n=111
n=152
n=5
n=15
n=16
n=17
n = 15
n = 16
n = 17
n = 32
n=0
n=1
n=2
n=3
n=4
n=6
n=7
n=8
n=9
n=10
n=11
total of 11
 dataset of 3020
30 patients
6 million patients
150   patients
90   patients
n=  12
n=  23
n=  7
n=  25
n  =7
n=  11
n=1992
1706 patients
1706   patients
5834 patients
total of 1706
total of 90
17   and women
12   In women
28   of women
2   men and women
314 women
1614 persons
145 persons
116 persons
283 men participants
18 079 participants
3080 participants
1036 participants
17   remarkable benefits people
N = 216
N = 22
N = 10
N=646
N=595
N=207
N=314
24,871 vaccinated women
7 million women
24,871 women
3,690 women
14,085 unvaccinated women
3 doses and these women
115,789 HPV-positive women
18 infection among young women
n=30
70 distribution of patients
n=0
n=383
n=346
n=5
n=10
n=9
n=3
n=4
n=1
n=7
n=2
n=8
n=12
n=11
n=6
n=22
n=20
216 participants
230 participants
16 participants
5 ABOUT HERE      A number of participants
1 diagnoses people
3 people
n=385
n=144
n=63
n=81
n=109
n=107
n=11
n=13
n=120
n=116
n=4
n=12
n=121
n=0
n=117
n=241
n=1
n=2
n=42
n=17
n=23
n=24
total of 216
 data from 109
127 SLE patients
2 RA patients
total of 127
n=3,823
n=4,701
n=1,218
n=725
n=2,374
n=2,935
n=727
n=393
76 patients
50 patients
70,351 pregnant women
n=1,309
n=26,623
n=21,060
n=1,441
total of 70,351
total of 304
20,296 patients
242 patients
2,289 patients
100 patients
n=3432
n=715
n=2717
n =   2717
n=2645
n=4811
N=690
n=4076
n   =   33
n=  40
n=  18
n=   2
n   =   19
n=  3
n=  1
 data from 12
16,781 participants
16,781 subjects
4047 adult patients
404 people
n=16,781
n=4047
n=37
n=3
n=28
n=30
n=91
n=406
n=949
n=468
n=3579
835 participants
n=223
n=435
n = 3,019
n=994
n=2025
n=835
n=524
n=470
n=1038
n=987
n=  52
n=  47
n=  10
n=  98
n=  41
n=  42
total of 16,224
n=15,056,095
n=17,470,479
n=912,167
n=191,262
n=9,901
n=171,427
n=2,727
n=1,969
n=650,848
n= 13,294,819
n= 1,761,276
252 patients
n=3
n=31
n=73
n=7
n=10
70 subjects
61 subjects
total of 82
n = 33
n = 30
n = 27
n = 34
n   = 30
n = 24
n = 36
n = 32
n   = 32
n = 29
n = 37
n   = 26
n = 39
n = 31
n = 11
n = 16
n = 17
n = 19
n = 14
n = 25
n =   52
n = 22
n = 21
n = 50
n = 26
n = 13
n = 23
n = 42
n = 18
n = 8
n = 44
n = 48
n = 41
n = 47
n = 9
n = 28
n = 52
n =   50
n =   22
n = 40
n =   28
 dataset of 12,000
N=421
N=189
N=210
N=81
total of 511
total of 667
500 patients
10 women
96 women
1232 women
357 women
109 women
120   women
34 women
133 ADA-exposed women
7 women
94   ADA-exposed women
58 women
87 women
3907 women
6,273 patients
n=  10
n  =5
n=552
n=49
n=74
n=335
n=36
n=429
n=58
n=94
n=478
total of 58
total of 1232
 data analysis of 127
1307 persons
6696 participants
3496 participants
6696 subjects
9294 subjects
2382 subjects
n=1454
n=464
n=260
n=212
n=1070
n=321
n=204
n=304
n=244
n=127
n=378
n=133
n= 134
N=5242
N=1454
n=5972
N=5389
N=1307
N  =5
N  =1
n=  63
N  =3
n=  61
total of 3496
n = 307
n = 108
n = 29
n = 519
n = 478
n = 457
n = 204
n = 296
n = 369
n = 328
n = 280
total of 534
36   pregnant women
30 women
20 117   women
213   recruiting women
503   preeclamptic women
100   Study participants
431   We thank study participants
n=30
n=8
n=20
n=12
n=4
n=14
n=16
n= 20
560 RM women
89861 women
3805 women
100,000 pregnant women
000 women
978 participants
60 participants
60,000 participants
22   outcome as well as enhance patients
n=1,540
n=1540
n=17
n=19
n  =9
n  =1
n  =7
n  =6
n  =8
n  =2
n=  4
n  =5
n=  25
n  =4
n=  69
n=  61
total of 160
 data pooled from 18
n=7,139
n=4,234
N=536
N=121
n=143
n=10
n=520
n=304
n=216
n=15
n=94
n=113
n=75
n=37
n=8
n=1
n=481
n=48
n=7
n=116
n=42
n=110
n=11
n=88
n=32
n=96
n=24
N=108
n=77
n=2
n=36
n=30
n=17
n=34
n=20
n=22
n=5
n=3
n=9
n=4
n=533
N=106
N=107
 data from a 2006
49 â€“â€œpersons
9,974 patients
5,513 patients
7,261 patients
8 million patients
1 if the two patients
5,513   patients
10K patients
15K patients
81 participants
1 Flow of participants
N=67
n=47
n=46
n=67
n  =6
n=821
n=729
n=316
n=403
n=10
n=32
n=27
n=30
n=34
n=42
n=4
n=1
n=39
n=7
n=33
n=93
35,078 women
6,989 women
n = 21
n = 2,044
n =   2,202
n=   2
n=   3
total of 59,467
117 participants
45 participants
120 participants
1 shows the flow of   participants
85 participants
43 participants
42 participants
18 participants
N=35
n=514
n=234
n=72
n=162
n=280
n=144
n=10
n=6
n=1
n=2
n=117
n=17
n=59
n=58
n=31
n=33
n=28
n=25
N=53
N=56
N=59
N=58
total of 117
total of 85
117 volunteers were enrolled
1390 women
2 IgA seronegative women
31 seropositive subjects
1390 subjects
73 subjects
1065 subjects
921 subjects
16 subjects
23 subjects
2 subjects
356 patients
2 IgA false positive patients
2000 patients
259,013 people
n=1494
n=1540
n=13
n=11
86 patients
604 consecutive patients
523 patients
89 patients
81 patients
83 patients
1      linkage of patients
n=86
n=15
n=49
n=22
n=81
n=  86
n  =2
n  =3
n=  15
n  =4
n  =1
n  =8
n  =6
 data from 86
43 subjects
46   age-matched control subjects
14 TSC   subjects
16 subjects
16 patients
n=14
n=29
n=16
n=46
n = 46
n = 29
n = 14
n = 16
150 participants
200 participants
10 patients
12 patients
81 consecutive patients
10   Age of patients
83   Gender of patients
252   Information about patients
n=88
n=42
N=22
n=1
N=67
381 patients
89 patients
5,707   patients
97 patients
106 RA patients
293 patients
233 patients
1,600 patients
n=162
n = 5,339
n = 456
n=211
7447 participants
153 participants
210 participants
5,505 participants
1,350 participants
1,579 subjects
n=7,447
total of 443
29 â€œhigh costâ€   participants
1206 acute   and rehabilitation inpatients
67 patients
100 patients
2 patients
500 patients
100 cognitively intact patients
n=1206
n=0
71   patients
122   of patients
144   dyskinetic PD patients
235   increased monitoring of patients
247   Another issue facing patients
257   patients
261   on quality of life of patients
274   impacting on the patients
277   quality of life of patients
312   of the care patients
344   patients
364   repertoire of patients
367   the movements patients
372   patients
459   patients
492   systematic across patients
507   progression within patients
520   patients
89 patients
64 patients
69253 subjects
38,947 patients
38,947 pulmonary TB patients
23,917 TB patients
100,000 people
6094 subjects
619 subjects
3322   subjects
28 449 individuals   enrolled
2823 participants
1077 participants
1308 participants
335 participants
505   participants
505 original participants
501 participants
106 participants
n=383
n=346
n=10
n=245
n=352
n=122
n=270
n=367
n=71
n=6
n=3
n= 0
n=30
n=726
n=618
n=22
n=26
n = 20
n=20
n=24
N  =  5
N  =  2
N  =  1
N  =5
N  =  6
N  =  9
N  =4
N  =  7
N = 600
N=605
N=552
N=604
N=599
N=548
N=598
N=597
N=546
N=596
N=667
N=570
N=668
N=571
N=252
N=204
N=122
N=94
N=59
N=45
N  =7
N  =2
N  =6
N  =  8
N  =  3
N=848
N=843
N=348
N=731
N=347
N=733
N=361
N=742
N=334
N=562
N=542
N=528
N=313
N=391
N=328
N=403
N=329
N=397
N=399
N=261
N  =  4
N  =1
N  =8
N  =3
total of 6901
total of 3333
19 patients
22,239 patients
19,725 patients
1,196 patients
845 patients
20 thousand patients
15,000 kJ for women
12   The participants
85   All participants
135   Categorization of the participants
185   Characteristics of participants
189   participants
2378 participants
208 participants
34 subjects
2378 CAD patients
14   diabetes patients
21   patients
22   patients
23   patients
37   among patients
12,536 patients
62   patients
3090 patients
2484 patients
2412 patients
2378 patients
723 patients
183   patients
202   diabetic patients
212   patients
226   diabetic patients
59 patients
258 246   patients
256   patients
258   among non-diabetic patients
265   patients
302   majority of patients
318   dysglycemic patients
319   diabetic patients
3 LCPUFA consumption among patients
361   In this cohort of patients
363   non-diabetic patients
n=53
n=380
n=259
n=84
n=423
n=0
n  =2
n=  10
n=  31
n=  38
n=  25
n=  84
n  =1
n  =3
total of 46
total of 1577
total of 208
1 patients
18 820 patients
2 million people
5   a group of patients
936 patients
134 patients
17   otherwise healthy patients
7 patients
10   these patients
19   among short bowel patients
n=83
n=104
n=219
n=116
N  =6
N  =  83
N  =  10
N  =  11
total of 257
total of 3,500
total of 137
1,751,841 registered patients
270 patients
215 patients
001   Hypertension patients
2,582 people
n=170
n=80,985
n=147
n=73,508
n=80,863
n=81,297
n=462
n=232,986
n=232
n=233,852
 dataset of 1,751,841
 data from 314
100 women
1597   subjects
114 patients
410 SS patients
2489 SLE patients
100   pSS patients
445   pSS patients
133 patients
27 patients
202 SSc patients
176   primary SS patients
20 patients
10 patients
16 patients
400 patients
65 patients
1010 patients
188 patients
35 patients
100   primary Sjogrenâ€™s syndrome patients
133 consecutive patients
43 patients
196   patients
3,849 women
7,786 eligible women
3,243 women
N=3,243
N = 2,546
 data from the 2009
 data from 15
3 women
2 women
5 women
7 patients
23      patients
n=5
n= 3
n= 5
16 patients
13 patients
248 patients
68 patients
33 patients
12   patients
17 patients
19   patients
99 treatment-naÃ¯ve patients
99 patients
7 patients
29 patients
92 patients
23 patients
3   patients
30 patients
19 patients
30   patients
20 patients
2 patients
33 group I patients
30 of group II patients
n=35
n=33
n=31
n=10
n=7
n=92
n=30
n=29
372 nursing home patients
161 patients
3 patients
135 patients
372 patients
2 Characteristics of patients
2 Selection of patients
n   =   1
n = 161
n  =1
491 residents enrolled
119 residents enrolled
372 residents enrolled
67 women
3681 women
2211 women
85 women
400,000 women
n=3681
N=532
N= 922
total of 3681
total   of 85
30 women
12257 participants
2006 NHANES participants
23 magnesium deficient patients
5 magnesium deficient patients
2D among patients
11 magnesium deficient patients
n=16819
n=  69
n=  36
N  =1
22 participants
09 participants
09 all subjects
09 and all subjects
22 subjects
n=22
n=12
n=40
1527 subjects
1159 subjects
6,666 SZ subjects
1,782 Chinese and Japanese SZ   subjects
1021 Irish subjects
626 Irish control   subjects
50,000 subjects
2,496 SZ subjects
1000 subjects
184 MDD and BD subjects
738 SZ subjects
466 German MDD patients
228   MDD patients
300 Caucasian MDD patients
87 patients
206 Han Chinese patients
159 Spanish MDD   outpatients
1809 MDD   outpatients
89 Swedish patients
317 MDD patients
35 SZ patients
31 BD patients
548 BD patients
246 elderly MDD patients
113   Korean patients
364 patients
780 patients
635 patients
n =10
n=422
n=299
n=30
n=15
n=61
49 individuals   enrolled
 data from 1809
 data from 49
 data from 37
7,216 men and women
80 y and women
4145 women
7,447 elderly   participants
n=153
n=78
n=2118
n=2803
n=2295
n=2916
n=2547
n=1753
n=3308
n=2643
n=1265
total of 3071
3,700 patients
total of   53
4,600 is projected to be enrolled
 data from 3
 data from the 3
n=346
n=154
n=104
n=442
n=439
total of 1641
102 subjects
95 subjects
8 subjects
2 diabetes patients
n=8
n=24
n=43
n=10
n=39
n=23
n=40
 data from 8
4 patients
90 patients
25 patients
64 patients
468,561 participants
346,570 participants
n =   372,927
n = 292,026
n = 406,539
total of 468,561
75  Healthy subjects
2D patients
389   patients
2 608   diabetic patients
n=13
n=9
n=4
total of 262
200 participants
200,000 voluntary participants
800 participants
200 patients
610 patients
10 patients
15 patients
3,000 patients
282 patients
n=282
n=610
n=529
n=280
n=200
n=351
n=53
n=51
n=21
n=81
total of 3,000
n=3,885
n=3,852
n=158
n=10
n=200
n=2,084
n=881
n=597
n=323
n=3,248
n=7,353
total of 9,852
26   studies covering men and women
490,288 participants
 data from 4
 data   from the 490,288
n = 28
n = 21
n = 18
n = 25
n = 10
 data from 1950
n=2217
N=1728
N=350
N=1378
20   participants
996 participants
3   inpatients
996 patients
16   activity among patients
25   flow of the patients
15   the flow of patients
27   patients
n=496
n=500
n=54
n=94
n=1
n=4
n=92
n=95
n = 996
n = 496
n = 500
total of 996
63 women
28,354 participants
31,689 subjects
2 diabetic patients
2 diabetes patients
2 diabetic   patients
n=28,354
n=355
n=216
n=653
n=115
n=80
n=1,346
n  =2
N  =7
N  =8
N  =2
n  =5
N=2,250
N=355
N=216
N=653
N=115
2 diabetic patients enrolled
63,084 individuals enrolled
3703 subjects
55,000 patients
3700 patients
n   =   29
n =   197
n = 146
n = 1
n =4
n = 21
n = 35
n =2313
n = 2116
n = 56
n = 23
n = 0
n = 2
n = 31
n = 419
n = 363
300,000   people
2 million people
5 people
n=153
n=15
n=13
n=6
n=40
n=14
n=361
N=46
n=270
N=153
N=176
N  =6
N  =1
N  =9
total of 750
291,169 registered patients
22   patients
296 visually impaired patients
1,751,841 registered patients
8   The included patients
21   patients
2   patients
23   patients
9   stroke patients
42   older people
19   people
 dataset of 291,169
2519 subjects
N=1872
N  =1
41,504 subjects
261 patients
1   patients
4 patients
3 patients
293 patients
11 patients
21 patients
210 patients
178 patients
10 patients
1 patients
162 patients
5 than patients
56 patients
10   patients
n= 261
n=101
n=123
n= 37
total of 495
 data from 96,551
300 patients
3 of patients
50 patients
90 patients
6 patients
136 patients
164 patients
196 patients
1815 participants
1 shows the flow of participants
4 count of participants
2Included only participants
1150 patients
196 patients
175 patients
175 people
n=2608
n=1876
n=937
n=939
n=901
n=354
n=392
n=181
n=232
n=96
n=90
n=6
n=11
n=10
n=75
n=173
n=8
n=624
n=2697
n=89
n=4573
n=87
n=80
n=7
n=12
n=13
n=62
n=184
n=180
n=4
n=643
n=914
n=356
n=423
n=220
n=25
n=36
total of 1815
4 enrolled
n = 5
200,000 people
4   Number of people
66   As many women
243   women
311   pregnant women
90,747 participants
10,015 participants
n=7
n=12
 data from an 86
N=24
100,000 well people
26 normal subjects
62   patients
62 patients
16 patients
13 patients
22 patients
59 patients
13   patients
8 patients
3 patients
5 patients
n=62
96 patients
13,600 patients
96 RCC patients
63 patients
n=410
n=509
n=157
n=66
n=11
n=38
n=2
n=51
n=125
n=37
n=5
n=167
n=50
112,049 women
70,000 women
7610 women
000 women
 data from >70,000
274,135 women
576 women
286 women
577,000   participants
n=249
n=1900
n=128
 data from   21
2,487 patients
n=1081
n=97
n=865
n=441
total of 3,276
 data analysis of 10
953 patients
139 patients
70 patients
139   lithium patients
1862 patients
2 shows the proportion of patients
1,172 patients
24 patients
74 patients
695 outpatients
6,360   patients
2002 among patients
N=1862
 data from 74
75 participants
862 participants
n=452
n=231
n=273
n=956
n=15
n=43
n=5
n=862
n=405
n=156
n=48
n=253
n=848
n=849
1,317 women
438 women
401 women
227 fasting pregnant women
369 women
338 participants
n=438
n=464
n=88
n=26
N=28
n=1,279
n  =  8
n  =  2
n  =  3
n  =  1
n=  22
n  =2
n  =3
n=114
n=36
n=19
n=31
n=42
n = 2
n = 8
total of 75
total of 64
total of 88
3921 control participants
295 subjects
372 subjects
6814 subjects
2023 consecutive patients
2047 patients
n = 18 569
total   of 37,485
 data from 20
25 meeting participants
25 invited participants
1000 participants
2,762,899 participants
108,449 participants
735,143 participants
2,737,152 participants
10,000 participants
90,056 participants
170,000 participants
246 955 participants
44 patients
8 million general population   patients
170,255 patients
32,225 diabetic and nondiabetic patients
175,000   people
n=110
N=12010
n = 95
n = 200
n=137
n=20
n=86
 data from 90,056
 data from 170,000
 data from 27
 data from 175,000
16 studies including men and women
63,189 participants
53987 participants
13,945   participants
n=22
n=5
n=4
n=23
n=14
n=9
n=3
n=7
n=16
n=15
n=11
n=10
768 patients
11   patients
5   excludes many patients
n=768
n=402
n=269
n=293
n=206
n=155
n=355
n=353
n=455
n=55
59   Violence against women
64   Underlying both women
68   women
92   violence against women
171   against women
100 women
150 women
800 women
374 women
343 women
600 women
530 women
334   Approximately a third of women
337   women
349   than among women
351   women
365   Both women
372   women
378   Among women
517   women
676   Domestic Violence against women
644   participants
273   people
5 317   people
580   Many people
n=1583
n=2532
87   towards enrolled
n=13
n=15
n=812
n=890
100,000 people
N =   12
N = 10
N =23
N = 25
N = 450
total of 48
 data ran from 3
454 study participants
4 million participants
454 Tanzanian adult study participants
454 Tanzanian adult   study participants
301 study subjects
3,500 patients
150 patients
721 patients
n=153
n=151
n=150
n=378
n=76
n  =1
N  =1
n=184
n=194
n=60
n=16
n=66
n=62
n=20
n=5
n=69
n=74
n=7
n=1
n=49
n=58
n=33
n=10
total of 454
5 patients
n=62
622   participants
622 participants
4492 EPIC-Oxford participants
150 people
n=8,193
n=617
7,216 men and women
30000 Italian women
7,447 participants
7,216 participants
n = 153
n = 78
n  =2
total of 7,216
170 subjects
N=170
N=171
N  =1
total of 170
total of 243
120   Study subjects
154   subjects
175   All subjects
193   subjects
49   Cancer patients
54   Ovarian cancer patients
60   cancer patients
75   Ovarian cancer patients
95   patients
99   In ovarian cancer patients
102   whether ovarian cancer patients
10,182 patients
6,160 patients
6,590 180   patients
16 patients
49 among patients
228   patients
235   making these patients
291   cancer patients
377   patients
396   patients
10,963 patients
423   patients
273   people
n = 171
n = 172
n = 4
n = 8,810
total of 10,182
 data from the 112
539 persons
124 participants
567 participants
124 of the participants
271 participants
n=539
n=237
n=244
n=405
n=247
n=431
33 subjects
16 and patients
4 patients
6 patients
6   patients
10 Individual   patients
n=8
n=7
n=9
n=10
n=33
n=18
152   All participants
151 participants
202   TB participants
151 consecutive patients
68   pulmonary TB patients
175 patients
24 patients
151 patients
197   TB patients
251   most number of patients
508   initial management of patients
601   characteristics of patients
9 patients
4 HIV-infected patients
27 non-TB patients
n= 5
n=16
n=4
n=3
n=1
N=151
n=74
n=50
n=27
n=145
n=146
n=126
n=141
n=142
n=148
n=135
n=136
151 patients enrolled
40   persons
13   majority of people
total of 144
total of 39
total of 8
total of 26
total of 350
total of 347
total   of 1228
total of   350
total of 65
total of 52
total of 21
total of 15
 data from 144
924,502 male subjects
n = 2087
n = 1092
n = 1090
n = 62
n = 3433
n = 902
n = 3382
n = 51
n = 8
n = 1
n = 2
n = 4
total of 23
total of 108,136
169   subjects
n=375
n=105
100 patients
187   participants
154,504 subjects
254   multimorbid patients
262   giving insured patients
308   clinical management of patients
169   people
185   people
195   majority of people
N = 162,464
N   =   1
N=177,501
n = 162,464
N=120
n=4
n=2
total of 40
total of 162,464
188 DNRCC-Arrest patients
88 DNRCC patients
2,051 Non-DNR patients
2,440 patients
389 patients
188 patients
88 patients
104 patients
88 Non-DNR patients
188 Non-DNR patients
35   patients
41   Non-DNR patients
57   and Non-DNR patients
60   DNRCC-Arrest and Non-DNR patients
N   =   8
N   =   2
N   =   1
N = 88
N = 188
total of 104
total of 88
total of 39
total of 41
141 patients
423 patients
43 patients
400 breast cancer patients
1,000 patients
2 positive patients
14,002 people
423 patients enrolled
67,138 women
85,884 women
459,790 participants
41,479 HPFS participants
67,138   NHS participants
85,884 NHS II participants
2 diabetic patients
2 diabetic   patients
26 million people
366 million people
n  =8
n  =1
total of 15,156
total of 11
 data from 3
 data from 41,479
n=1962
n=1387
3170 children enrolled
324,168 participants
6,339 prostate   cancer patients
20,000 cancer patients
62 prostate cancer patients
2 colorectal cancer patients
4 cancer patients
1,779 breast cancer patients
3 breast cancer   patients
11,863 breast cancer patients
7,081 colorectal cancer patients
8,128 prostate cancer patients
10,969 breast cancer patients
6,666 colorectal cancer patients
7,495 prostate cancer patients
10,853 breast cancer patients
6,540 colorectal cancer patients
7,388 prostate cancer patients
9,971 breast cancer patients
4,762 colorectal cancer patients
6,513 prostate cancer patients
9,814 breast cancer patients
6,339 prostate cancer patients
n=0
n=56
n=10
n=7
n=5
n=9
n=8
n=3
n=17
n=48
n=33
n=36
n=31
n=79
n=88
n=44
1320 patients
3644 patients
2294 patients
2324   not included patients
n = 2230
n = 10
n = 5
n = 42
n = 974
n = 693
n = 627
n = 1320
n = 2309
67 patients
60 randomised patients
n=35
n=32
n=53
n=36
n=15
n=2
n=28
n=26
13  women
14,434 patients
3The denominator is AMI patients
1 The denominator is AMI patients
2 The denominator is AMI patients
100,000 people
1,000 persons
1000 persons
271 subjects
2 diabetic patients
6,103 patients
50 ambulatory patients
7,387 diabetic patients
323 patients
6,103   patients
4,657 patients
7 million people
n=2,808
n=271
n=106
n=5,832
total of 6,103
6 million people
1   pregnant women
53   individual pregnant women
61   women
95   women
129   We studied pregnant women
140   pregnant women
144   all participating women
181   system captured women
222   recruited women
651   and iron-replete women
675   Characteristic All women
457   thalassemia status of all participants
n=468
n=174
n=466
n=213
n=91
724,949 women
1,424,378 participants
35,690 people
total of 35,690
1 also contains details of patients
 data from  2004
77 women
129 consecutive adult   patients
31 additional   patients
2009 all consecutive patients
2013 all consecutive obese   patients
31 additional patients
129 patients
31 additional adult patients
97 obese patients
30 patients
129 adult patients
32 were non-  obese patients
18 adult patients
n=1
n=32
n=97
n=11
n=56
n=40
n=10
n =129
n=129
 data from   129
337 subjects
6423   subjects
10,512 patients
377 patients
n=8,410
n=2,102
n=6,728
n=10,512
n=283
n=155
n=6423
n=1,475
n=627
2 levels of women
46   the women
530 women
200 women
206 patients
124 patients
256   these patients
n = 357
n = 212
n = 380
n = 206
n = 124
n = 528
n = 534
n = 55
n  =3
n  =   35
n  =   21
n  =8
n  =   55
n  =   48
n   =   3
n   =   2
n   =   8
n   =   5
n   =   4
total of 949
total of 106
 databases of the 155
490,288 UK Biobank   participants
11 patients
30 000 participants
N=17
n=5
n  =7
n=  73
n=  90
n=  30
n  =1
n  =5
n  =4
n  =2
n  =9
total of 1023
7   of older women
4   and eight of both men and women
25   women
12   participants
709,499 subjects
225,189 subjects
17   enrolled elderly people
n = 10
n = 9
n = 8
n = 7
17   enrolled
 data from two 21
75 NCWS patients
35 NCWS patients
80 patients
75 patients
30 patients
39 NCWS patients
36 NCWS patients
2 shows the percentage of patients
42 NCWS patients
N=75
N=65
N=50
n=40
n=29
n=6
total of 684
222 patients
1 were patients
2 were patients
3 patients
9,629 patients
4140 patients
5,489 patients
1 patients
2 patients
12 diabetic patients
4,140 patients
2 diabetic patients
112 traumatic brain injured patients
n= 222
n = 143
n=79
n=2,709
n=2,558
 data set of 9,629
N = 5
n=7
n=10
n=5
n=8
N=3
N=5
n=39
N=2
n=42
N=11
n=17
n=16
N=6
n=12
N=4
n=9
N=8
n=6
n=20
n=14
n=4
N=1
n=15
n=43
n=14
n=65439
n=4680
n=4394
n=69946
n=57143
n=19778
n=62119
n=50223
n=19155
total of 107379
90040 mother-child pairs enrolled
50   patients
100   Study participants
7   patients
329 patients
58   patients
80   patients
101   All patients
113   fracture patients
133   All patients
148   All patients
300 patients
370 patients
332 patients
221   patients
224   patients
10 patients
255   missing patients
446 patients
269   included patients
35 273   patients
285   patients
46 patients
228 patients
328   the patients
370   patients
388   fracture patients
450   include patients
30 patients
69 patients
23   patients
17 patients
22 patients
24 patients
11 patients
23 patients
16   patients
14 patients
33 patients
29 patients
n=163
n=166
n=121
n=98
n=95
n=228
n=226
n=203
n= 222
n=466
n=134
n=53
n=22
n=59
n=14
n=162
n=1
n=21
n=165
n=332
n=3
n=19
n=28
769 patients
100 patients
2013 involving men and women
N=169500
N=354927
 data set of 30
 data from all 30
1542 patients
4498 patients
251   patients
205   patients
168 patients
205 patients
247   patients
195 patients
247 patients
117 patients
151 patients
1000 patients
125 consecutive patients
total of 1542
total of 79
9   study subjects
8,341 patients
14   patients
1   Elderly patients
10   dialysis on elderly patients
5   patients
12   patients
15   urbanization level of patients
18   patients
11   models allowed patients
8,341 elderly patients
7   patients
5,807 deaths occurred in elderly patients
8   patients
6,292 patients
2,049 patients
1,984 matched patients
1   patients
9   elderly patients
3   The survival of patients
17   patients
9   patients
6   bias because patients
9   among elderly patients
8   of end-stage renal disease patients
2   incident haemodialysis patients
4   patients
1 Baseline characteristics of patients
n=6,292
n=2,049
total of 8,341
total of 5,807
200 participants
1737 participants
1,588   neurologically-healthy subjects
33,671 patients
3660 elderly people
n = 6
n = 4
 databases from 1946
500 participants
150   surgically treated patients
500 patients
500   severely obese patients
200 patients
150 patients
308 surgical patients
253 patients
500 severely obese patients
n  =1
n=  20
n=  15
n  =2
500 patients enrolled
 data from 500
575 patients
total of 31
 databases from 1980
108   Study setting and participants
262   of participants
497   young people
n=111
n=98
n=105
n=96
n=209
n=1027
n=69
n=537
n=273
n=64
n=57
n=54
n= 98
n=55
n=47
n=45
n= 56
n=49
n=94
n=91
total of 49
total of 1027
n=109
n=287
n = 536
n=295
n =109
n=33
n = 20
n = 109
n =   109
n=81
n=40
n = 33
n = 287
424   women
461   postmenopausal women
124   eligible participants
7172 participants
187   participants
236   excluding participants
n=28
n=0
n=1434
n=1435
n=4311
n=4286
n=4236
n=4291
 data from 7172
2,180 women
2,212 women
5,474 Eligible women
3 women
25 women
5 women
7 women
643,902   persons
N=1105
N=1097
N=2202
N=1075
N=1067
total of 2,142
 data from 7,738
15 000 Swedish men and women
n=1,271
n=4,324
n= 38,588
n =9,647
n = 19,294
n = 9,647
n= 37,620
n = 9,401
n = 18,799
n = 9,420
n=30,941
n=7,174
n=15,694
n=8,073
n=35,332
n=8,815
n=1,767
n=8,839
n=38,581
n=9,645
n=19,290
n=9,646
n = 27,766
n = 30,186
63,189 participants
n =6
n=5
n=4
n=2
n=1
n=14
n=6
n=8
n=22
6,763 women
1 When women
64 participants
1,919 participants
113 participants
1,919 female patients
5 people
1 million   people
n= 483
n=480
n=481
n=475
n=116
n=42
N=1919
n=1919
n=483
total of 6,763
 data   from 113
2,793 women
2 million pregnant women
94   pregnant women
336 women
144   of women
161   Pregnant women
168   amongst women
171   pregnant women
184   data on women
201   For women
216   up of women
265   Following enrolment women
1396 women
294   analysis only included women
300   women
342   Of women
18 women
2,775 women
351   Of women
1,013 women
152 women
393   women
424   Amongst women
434   The proportion of women
475   women
485   and women
474 women
534   those women
578   We thank the participating women
628   treatment of pregnant women
645   women
647   among pregnant women
689   pregnant women
740   women
19 women
457   Few participants
400 study participants
2,793 trial participants
572   patients
n = 279
n = 2,752
n=754
n = 75
n = 1,382
n = 1,393
n = 2,729
n = 2,721
n = 2,714
n = 2,771
n = 2,650
n = 1,374
n = 1,378
n = 754
total of 293
183   enrolled
2,793 were enrolled
531   ultimately enrolled
1,013 participants
2914 participants
1,375 clinical interview participants
1,013   subjects
158 subjects
1,375 subjects
1,375 people
15   people
362 people
1,013 people
n=1,013
n=1,614
n=731
n=1,255
n=683
n=330
n=57
n=39
N=78
N=346
N=556
N=49
N=56
N=255
N=645
N=57
N=15
N=635
N=17
28 subjects
50 patients
45 patients
10 patients
19 patients
5 patients
12 patients
total of 44
15 million people
24 subjects
20 subjects
17   subjects
24 ASD control patients
n = 471
 database of 3
100,000 persons
10   participants
120 participants
62 patients
58 patients
20 patients
35,000 patients
16 patients
120 patients
2 patients
118 patients
4 patients
15      The proportions of patients
25 patients
N=58
N=60
69   of pregnant women
124   ethics but the women
338   proportion of women
12 status of pregnant Indian women
5,184 participants
7,864 participants
5,892 participants
13,983 participants
17   participants
2,652 participants
40 nondiabetics patients
N=14,797
N=9,268
N=1,089
N=315
N=4117
N=1067
N  =5
N  =1
N  =2
N  =3
N  =4
16 patients
160 patients
120 patients
348 patients
   data points from 43,000
33 severe edema subjects
10  B CA  Delayed edematous subjects
70 pediatric patients
70 pediatric TBI patients
70 TBI patients
n = 37
n = 33
n = 36
n = 22
n = 48
n = 6
total of 70
1,577   participants
n=1,577
n=1,197
n=1,167
258 subjects
138 Taiwanese BD subjects
1256 SCZ subjects
139 pediatric subjects
1,816 of these SSRI-treated subjects
294 Taiwanese subjects
24 subjects
6 EM subjects
97 subjects
359 BD patients
88 BD   patients
687 SCZ patients
1435 MDD and BD patients
1,953 patients
2,199 patients
2,200 MDD patients
44 MDD patients
227 MDD patients
1 patients
n=78
n=82
N=82
N=78
N=160
1,049 patients
1,368 patients
total of 848
total of 282
total of 190
total of 172
total of 110
total of 319
2000   patients
1 infected patients
5,144 participants
5,144 trial participants
2   trial participants
N=2659
N=1515
 data from 5,144
2 exists because some people
n=208
n=416
n=153
n=263
n=176
n=110
n=130
2092 subjects
88 subjects
3012 subjects
80 subjects
1 Baseline characteristics of subjects
21 subjects
35 subjects
33 subjects
465 subjects
N=0
total of 3012
total of  371
30 patients
120  patients
480 patients
104  patients
40 patients
116 patients
total of 480
120 patients
47 patients
17 The patients
116 randomised patients
83 patients
33 patients
4 among  patients
150 patients
101 patients
516 de novo CD patients
n=55
n=61
n=16
n=4
n=45
n=38
n=116
n=150
n=300
n=10
n=23
n=47
n=36
total of 120
total of 33
1462 women
1460 women
27 In women
2000 among persons
n=372
n=431
n=398
n=180
n=79
n=1460
total of 1462
 data from  32
3  and patients
N=720
N=708
331 004 patients
19 889 patients
n=124
n=14
total of  19 889
total of 19 889
1260 self-swabbing participants
314 HCP swabbing  participants
n=1260
N=5395
n=314
N=5054
n=27
N=290
n=96
n=3
n=34
N=277
n=931
N=3349
n=258
N=3146
n=329
N=2045
n=56
n=656
N=1574
n=439
N=1254
n=239
n=79
N=309
n=105
n=49
N=1219
n=13
n=7
N=307
n=5
n=30
N=329
N=56
n=19
N=907
n=2
N=253
n=11
N=137
N=464
N=306
n=15
N=30
N=19
n=29
total of 10 448
912 Japanese men and women
548 women
149 women
10 women
66  women
320 women
24 When participants
1445 participants
433 participants
6 participants
912 participants
912  participants
total of 912
128  participants
128 participants
64 participants
128  patients
4 362 624 patients
1000 patients
25 Although patients
8451 patients
1000 surgical patients
1000  patients
1000  surgical patients
1000 elective surgical patients
1000  elective surgical patients
5,451 patients
 data from 2006
12 765 participants
35 Older people
n=3186
n=12 765
n=5050
100 participants
3 patients
10 patients
39 If patients
20 patients
n=0
total of 10
70 participants
70  participants
19 the accounts of patients
70  patients
n=5
31 making  those people
n=2
n=145
n=151
n=171
n=144
n=4
n=216
n=232
n=40
n=901
n=584
n=  14
n=1485
n=655
total of 20
1 Number and percentage of women
159 078 women
496 438 women
62 626 women
2 Number of women
251 confirmed cases  of participants
n=251
n=260
n=512
n=252
212 were enrolled
30 Although participants
n=23
n=10
n=108
n=57
total of 943
total of 20 091
total of 717
total of 512
65 903 persons
52 082 participants
6065  prison participants
9954  participants
n=46 125
n=5957
n=52 082
n=4977
n=46125
n=9954
n= 4977
37 The proportion  of women
n=4
n=670
N=628
  data from 2006
 data from 2010
  data from 2012
 data from 1994
 data from 2012
 data from 1999
30 participants
12 participants
20 participants
80 patients
15 patients
1  This also benefits patients
1 Flow chart of patients
N=585
N=345
n=390
n=195
n=230
n=115
1008 participants
1008 consecutive PCI patients
11 000 patients
13 predisposes  patients
1008 patients
1043 consecutive PCI patients
2 Flow chart of study patients
24 and STEMI patients
5,833 consecutive patients
n=1
n=2
n=18
n=35
n=37
n=5
n=1008
n=665
n=343
n=57
n=52
n=3
n=47
n=34
n=13
n=1007
n=664
n=14
n=8
1649 postmenopausal women
5091 postmenopausal women
17 Subgroups of participants
n=10
7 million  participants
 data from 10
  data from 22
10 participants
62 and get people
278 000 patients
10 IDUs were  defined as patients
8556 patients
1 Characteristics of IDU patients
193 patients
13  Since three patients
306 patients
120 patients
 data from 49
36 The participants
27 Although the participants
3 For some  patients
43 In  patients
n=20
n=120
n=39
n=117
76 870 pregnant women
76 870 women
4  Violence against women
22 All pregnant women
79 363 women
13 475 pregnancies of women
703 women
1700 women
6421 pregnant women
1555 women
n=297
n=41
N=76 870
N=3620
N=2107
N=6257
total of 76 870
total of 4
76 870 women enrolled
2192 patients
13 233 patients
496  patients
891 patients
13 233 registered patients
793 patients
1,399  patients
1 Demographics of patients
16 was more common among patients
16 was more common among  patients
108 929 patients
1 point among patients
n=793
n=1399
n=2192
n=11 041
n=698
n=95
n=996
n=403
n=329
n=636
n=510
n=925
n=44
n=50
N=1399
N=793
N=11 041
N=2192
N=823
N=418
N=891
N=496
N=389
N=164
2505 patients
53 patients
80 patients
100 patients
102 HIV patients
32 In patients
254 patients
n=309
total of 254
13 of  the patients
10 female patients
n=33
n=26
n=16
n=10
n=5
n=52
n=35
n=3
n=2
n=49
n=13
total of 52
8,218 men and women
n=2581
n=7984
n=4027
n=277
n=1090
n=14
n=65
n=86
n=6
n=1535
n=521
n=198
n=150
n=177
 data from 2003
n=2712
total of 443
110 participants
N=70
N=40
n=253
n=185
n=262
n=15
n=276
21 The study populations  were patients
2397  patients
544  patients
61 patients
10 000 people
total of 14
85 women
605 consecutive  patients
6 and the patients
247 patients
2012 ESC  Ranking patients
23  In patients
8901 placebo patients
181 patients
4  In older people
n=48
n=92
n=32
n=40
n=247
n=103
n=293
n=26
300 000 people
100 000 people
 data capture of 90
51 participants
48 Our participants
15 Screening and treating people
n=41
n=51
1 Characteristics of participants
n=3023
n=2556
n=2904
n  =8
n  =6
n  =5
n  =7
n  =9
n=865
n=575
n=686
n=715
n=881
n=709
n=589
n=944
167 women
74 participants
1  shows the flow of participants
141 participants
n=92
n=91
n=85
n=76
n=7
n=15
n=183
N=30
total of 30
total of 420
 data from 6
29 adult  patients
55  paediatric oncology patients
1023 consecutive  outpatients
7 found more people
n=58
n=31
n=26
n=10
n=21
321 patients
93 While some  patients
70  and patients
n=42
n=32
n=23
n=33
n=6
n=3
total of 43
 data of 588
10 000 women
100 000 in men and women
65 million people
N=127 632
n=127 632
 data from 25
24 participants
24 normoalbuminuric  patients
24 fulfilled patients
24 patients
1 diabetic patients
2 diabetic patients
150  patients
150 patients
88 patients
88 patients per month of  people
184 participants
n=364
total of 31
1400  patients
n=5892
n=198 776
n=221
n=14 152
total of 629 024
total of 14373
total of 4477
494 women
3157 women
26 and receive women
3651 eligible women
494  women
238 women
244 women
28 women
27 women
3156 women
n=494
n=3157
n=3156
n=490
n=3145
total of 6072
total of 31
597 women
597 nulliparous women
9 women
n=301
n=296
500 women
200 women
506  participants
500 participants
500 patients
506 patients
n=961
total of 506
120 eligible patients
n=40
total of 28
19 014 patients
19 000 patients
n=15 429
64 exposure participants
64  control participants
300 000 patients
200 study participants
2  Number of  participants
100 participants
14 When patients
44 outpatients
n=2
n=1
n=40
2894 participants
1447 participants
1034 participants
total of 2894
16 patients
45 patients
14 patients
11 patients
n=14
n=8
n=7
2700 people
37 participants
1 Characteristics of participants
293  patients
n=18
n=19
n=37
total of 37
4426 participants
2653 participants
9551 participants
4426 eligible survey participants
 data from 9
1234 women
180 participants
300 participants
60 participants
150 participants
total  of 180
275 patients
39 This  pregnant women
15 000 Swedish men and women
780 people
9  Infants of women
24 as do women
28 and obese women
32  Since infants of women
94  women
43 women
658 women
625 women
100 women
200 women
933 women
n=254
n=184
 data from 43
265 000 participants
38 Our study participants
20 000 participants
45 and Up Study participants
45  and Up participants
45 and Up participants
N=979 834
N=1177
600 eligible patients
600 patients
total of 600
12 participants
61 potential participants
140 million  people
total of 22
total of 61
622 women
1 In  women
10 women
10 eligible women
131 800  women
280  women
308 women
617 women
461 women
1 Percentage of women
n=140
N=617
n=428
total of 622
total of 131 800
511 938 women
2 million women
2 are more prevalent among women
34 and women
n=511 938
n=15 767
n=132 391
n=89 041
n=4120
n=  49
n=  14
n=  21
n=  19
128 HIV-positive women
1  For women
8  Menopausal women
537 women
178  HIV-negative women
188 women
1 Some characteristics of women
n=53
n=62
n=306
n=128
n=178
n=125
n=93
n=124
419 patients
430 known patients
27 patients
14 patients
2 patients
11 patients
366 patients
46 patients
6 patients
46 deceased patients
40 deceased patients
22 patients
75 patients
48 patients
11DS patients
11DS  patients
11Ds patients
n=46
n=19
n=2016
n=1217
n=1570
n=397
n=280
N=70
N=43
N=182
N=197
N=113
N=266
N=214
N=165
5023 acute patients
4535 patients
5023 patients
271 patients
217 patients
1537 patients
2999 patients
1 Inclusion criteria of patients
5024 patients
1419 patients
252 patients
5,024 young stroke  patients
n=1071
n=3396
n=68
n=4535
n=2675
n=1860
n=136
n=443
n=1250
n=2706
n=3469
n=2865
n=4496
n=4502
n=4499
n=4516
n=4505
n=4147
n=4534
n=  10
n=  33
n=  34
n=  92
n=  20
n=  13
total of 5023
total of 5024
total of 4535
total of 1419
5024 patients were enrolled
29 participants
 data from the 2009
3339 participants
4030 participants
n=4030
n=63
N=3339
n  =3
N=1187
31 excluded women
n=632 805
18 354 participants
2 Flow of participants
n=690
n  =1
n=  32
n=  37
434 342 participants
2D cases and number of  participants
45 The number of participants
424 677 participants
290 927 participants
232 097  participants
251 235 participants
total of 10
 data from  11
706  patients
706 patients
480 patients
1 Baseline characteristics of patients
197  patients
178 patients
N=706
n=491
n=215
1103 women
1054 women
N=657
N=164
N=143
N=178
N=172
n=307
n=350
n=7
n=9
total of 23
203 962 women
10 000 women
N=203 962
N=208 161
N=45
N=47
N=53
N=35
total of 203 962
total of 416
n=6
n=4
n=2
n=1
12 participants
2109 participants
1841 participants
2607 NHANES participants
668 participants
8970  participants
4740 diabetic participants
16 Our study similarly excluded participants
2625 participants
2 diabetic patients
13,087  patients
8334 people
89 000 Ukrainian people
13 087 people
2625 people
19 people
n=668
n=846
n=235
n=22
n=38
n=15
n=129
n=58
N=394
N=925
N=659
N=565
total of  2607
4  The prognosis of patients
10  which makes the care of patients
2773 patients
848 patients
296 patients
100 randomly selected patients
192  patients
118 patients
195 patients
n=296
N=296
N=345
N=188
N=335
n=848
n=2773
n=15 395
n=  82
n=  27
n=  17
300  people
100 000 persons
111 patients
111 young patients
873 consecu-  tive patients
14 All patients
111 patients constitute all patients
873  patients
92 patients
12 patients
70 patients
7 patients
8 patients
15 patients
6 patients
3 patients
1 Employment status of patients
26 patients
38 patients
1  Number of patients
39 patients
33 patients
246  patients
71  patients
50 patients
35 patients
25 patients
28 patients
2  Number of  patients
74 patients
177 patients
7  A small proportion of people
n=3
n=10
total of 68
798 732 women
798 674 women
N=798 674
n  =2
n  =1
n  =3
n  =6
8268 women
113 participants
93 550 enlisted patients
N=6561
N=8268
n=  14
N  =1
total of 93 550
4336 women
8028 persons
6986 patients
6354 patients
416 patients
N=460
402 pregnant women
397 pregnant women
80 preg-  nant women
60 pregnant women
47 HBsAg positive women
20 pregnant women
397 participants
402  participants
402 participants
397  antenatal hepatitis B study participants
7 million people
12 The majority of people
24 In northern Uganda where people
n=356
n=382
n=285
n=37
N=397
30 patients
18  involved patients
78 168 pregnant women
1000 women
100 000 women
4606 low-risk women
n=398
n=1814
n=1000
n=215
n=2
n=8
total of 122 739
32 The participants
57 participants
1035 participants
1 Flow chart of participants
1 Characteristics of participants
45 patients
39 people
n=817
n=218
total of 4931
total of 1035
699 patients
346 patients
2712 patients
699  patients
 data from 1990
2008 participants
628 participants
N=1651
N=521
N=355
N=775
N=152
N=214
N=549
total of 2289
19 targeted women
17 000 participants
8 recruited participants
2549 participants
34 studies specifying participants
n=257
n=12
100 participants
100 patients
4 some patients
3057 patients
200 chronic pain patients
100 patients will be enrolled
5018 men and women
9 women
25 639 men and  women
2751  women
5018 participants
N=4712
N=4476
N=4795
n=0
N=25 639
n  =3
n  =1
n  =4
n=  0
total of 5018
total of  38
192 patients
171 patients
38 patients
192  patients
total of 171
11 participants
total of 304
1500 persons
4 million people
5  million patients
total of 16
total of 494 628
 data from 2008
712 postcardiac surgery  participants
712 participants
4 than patients
22 patients
10,811  patients
n=350
n=152
n=410
n=356
total of  712
310 111 persons
1216 persons
859 treatment-naÃ¯ve Korean patients
859 patients
937  consecutive patients
937 patients
1 Baseline characteristics of patients
349 patients
857 included patients
71 patients
3 patients
n=10
n=9
n=3
n=43
n=1
n=4
n=6
n=859
n=533
n=326
total of 937
859 patients  were enrolled
516  patients
516 patients
n=291
n=225
42 women
80 patients
11 patients
69 patients
n=11
n=69
n=48
n=21
total of 38
total of  86
125 million girls  and women
17 million women
38 390 women
97 million  women
32 088 women
66 A  third study compared women
125 million girls and women
17 million female participants
N=57
n=3657
n=3611
n=6564
n=28 940
n=6204
n=12 540
n=12 912
n=36 473
n=32 088
total of 75
3 List of participants
12 patients
14 patients
15 patients
20 patients
10 patients
1322 participants
960 participants
432 patients
461  patients
3295 patients
443 patients
32  patients
6 Some  patients
12 patients
N  =4
N  =2
total of 1322
total of 443
88 315 patients
88 315 consecutive  patients
12  Identification of patients
1007 patients
29,900 patients
645 449 participants
645 449 patients
N=645 449
total of 645 449
 data of 823
2037 women
n=1842
n=1819
n=1050
n=925
n=894
2013 were enrolled
 data from 16
 data  from 39
 data from 11
13 million patients
100 000 patients
32 The remain-  ing patients
38 Of patients
20 comparison patients
530 000 people
13 million people
 database of 13
9 million  patients
33 To document patients
450,000 people
800 000 people
n=6383
n=6987
n=7417
 data from 42
2170  participants
4644 patients
6 Stroke patients
3982 patients
4 Dose effect analysis of patients
2 million people
23 million Taiwanese people
N=89
N=573
N=3982
N=2170
N=434
N=3548
N=1736
total of 2170
 datasets from 2010
144 subjects
144 SAP subjects
27  Compliance of subjects
144 patients
7 of all patients
total of 144
482 patients
419 evaluable patients
106 patients
144  patients
65 patients
146 patients
73  patients
23  Standard care  All patients
n=34
n=31
800 000 people
1500 people
N=80
n=3
35 people
n=110
330 patients
325 patients
1600 participants
18 We proscribed all participants
1678 participants
12 million patients
n=287
n=204
n=825
n=853
n=1678
500 consenting participants
375 participants
52 participants
323 participants
155 participants
118 participants
109 participants
N=375
N=109
total of 170
375 participants were  enrolled
N=2154
n=78
n=42
n=8
N=1107
N=750
N=297
n=2154
total of 2154
total of 10
total of 14
total of 120
14 patients
7 A large proportion of patients
1070 patients
2 diabetic patients
20 study participants
10  participants
1520  patients
total of 49
1316 patients
1395 patients
471  patients
n=328
n=311
n=384
N=293
N=328
N=311
N=384
total of 12 965
total of 1395
726 women
291 women
18 201 women
n=291
n=18 201
n=18 485
n=16 902
n=18 471
n=18 238
n=18 488
n=16 905
n=17 766
n=16 351
study population included 18 492
9  Total participants
38 patients
38  patients
314  million people
763 Dutch patients
576 ethnic  minority patients
17 Non-Dutch  patients
1474 patients
1376 patients
591 ethnic minority patients
20 patients
37  patients
576 ethnic minority patients
57  Percentage of patients
60 patients
600 ethnic minority patients
N=763
N=576
N=284
N=525
N=1339
total of  1376
 data varied from  18
502 712 men and women
2 Mean women
306,620 participants
n=168
23 syphil-  itic patients
59 patients
n=32
n=56
n=59
n=53
total of 112
1 Consort flow-chart of participants
n=14
n=12
n=13
N=26
N=25
total of 31
5056 women
25 167 participants
n=8994
n=4552
n  =8
n  =3
n  =1
n  =9
n  =5
n  =2
n  =4
n=  29
n=  39
n=3646
n=4658
total of 56 634
total of 4
2967 patients
2967  patients
2967 adult patients
3  Some patients
4 These patients
0 patients
2DM patients
total of 2967
total of 5831
496 patients
2321 patients
2146 patients
n=496
n=2321
N=2817
total of 84
total of 361
N=1206
N=381
N=257
N=193
N=94
N=88
30 This age range represents women
total of 57 247
314 migrant patients
418 migrant TB patients
314 patients
total of 314
total of 12
total of 418
total of 64
222 participants
200 participants
208 participants
97 participants
207 participants
20  people
total of 208
749 123 people
n=11
n=106
n=111
n=117
N=180
n=90
N  =1
n  =1
n  =3
n  =2
n=15 745
n=15 375
115 patients
121  patients
62 patients
136 patients
310 patients
total of 62
10 participants
5 participants
3  participants
n=10
N=10
n=2
n=3
n=5
204 participants
144 participants
4 summarises the participants
366 patients
12 patients
4 Summary of patients
77 patients
42  The majority of patients
397 patients
n=359
N=366
N=42
N=229
total of 366
total of 3099
20 women
14 women
4 million people
 data from 284
6 outpatient participants
11 young normal participants
6 patients
19 patients
12 patients
10 â€˜low riskâ€™ patients
10 patients
37 patients
N=12
N=6
total of 28
total of 24
38 668 patients
4842 patients
1110 patients
2675 patients
6 and analysed patients
20 patients
343 patients
2 patients
n=  10
n=  46
n=  26
n=  16
n=  11
n=  48
n=  65
n=  15
n=  95
n=  38
n  =4
n=6509
n=15 337
n=15 867
n=955
total of 57 353
10 476 participants
10 476  participants
11 032 people
244 people
N=3541
217 persons
1252 participants
40 000 clinic patients
19 million people
n=38 635
64  Sample of persons
40  Cohort of persons
24  Cohort of persons
60 partners of persons
n=166
n=64
n=40
n=24
n=21
n=63
n=23
n=39
n=60
n=31
n=19
n=37
n=35
total of 40
28 patients
137 patients
274 patients
43  patients
total of 274
274 patients enrolled
10 million patients
n=1331
n=1545
n=4824
n=4597
n=7094
N  =4
N  =2
N  =1
N  =9
386 participants
50 ethnic minority participants
20 participants
386  patients
50 patients
total of 386
total of 6
58 589 patients
12 The frequency of individual patients
6 if  patients
58 589  patients
1 Characteristics of patients
2138 patients
n=31 049
n=14 189
n=13 351
2138 patients enrolled
713 women
22 as well as  populations of women
19  Study participants
24  All participants
n=713
n=6
n=25
36 subjects
n=18
50 persons
27 Potential subjects
3 million people
N=307
13 129 women
11 included women
7 studies including fertile  women
7 studies including  infertile women
411  women
567 unaffected  women
36 among Caucasian women
total of 13 129
 data from 38
50 056 women
15 women
107 237  patients
1210 patients
106 027  patients
72 patients
106 027 patients
62 patients
n=1210
total of 107 237
 data from 23
822 persons
436 persons
1 influenza  among patients
n=215
n=221
n=6
n=681
n=141
n=35
n=436
n=1
total of  822
802 participants
29 participants
3 indicated â€˜at riskâ€™  participants
34 participants
14 participants
N=696
n=404
n=130
n=106
n=291
n=129
n=28
n=226
n=117
n=47
n=19
n=20
n=133
n=346
n=199
n=91
n=93
n=88
n=34
n=32
n=14
n=7
n=679
n=549
n=526
total of 19
total of 802
total of 70
100 persons
1092 participants
1800 participants
 data are  from 2012
2 million people
n=1386
n=1
N=1386
100 000 patients
10  The reasons people
12 participants
N=50
total of 57
total of 40
total of 150
total of 176
32 and  pregnant women
12 Homeless persons
26 Mentally Ill persons
103 included younger people as participants
112 Since the study comprised participants
500 participants
79 participants
98 103 Twenty-three per cent of  participants
92  where the majority of participants
100 000 participants
18 involving people
5 people
43 At-risk young people
47 Indigenous people
87 and people
86  and people
103 included younger people
109 Studies involving people
n=2133
n=24
n=16
n=18
n=38
n  =2
n  =1
n  =3
n  =5
n=2
n=3
44  were women
36 participants
30 eligible patients
n=18
1000 participants
475  participants
475 participants
27 participants
1000 people
35 000 people
n=8
n=1
n=2
n=5
n=397
n=140
 dataset of the 4100
145 women
71 women
37 women
27 participants
n=71
n=77
n=155
n=156
15 patients
3 billion people
n=272
n=151
n=121
total of 304
total of 117
total of 88
44 participants
19 million  people
n=44
total of 425
n=107
n=189
293 patients
32 The patients
total of 293
32 The patients enrolled
30 818 persons
total  of 30 818
total of 8003
33 patients
23 patients
266 patients
22 patients
8  million people
N=32
N=30
N=20
N=33
N=23
total of 20
33 patients were enrolled
33 patients who were enrolled
46  Presence of non-participants
n=7
49 participants
2 Examples of participants
3 Examples of participants
4 Examples of participants
5 Examples of participants
n=16
n=22
n=27
4315 male patients
2679 male patients
2649 female patients
25 000 patients
30 A higher  proportion of male patients
4001 women
3325  women
3325 women
2402 women
2 women
1537 women
26 For both women
2 participants
1 shows the participants
7 These patients
N=31 115
N=1205
N=1539
N=581
N=4001
N=3057
N=1213
N=1058
N=316
N  =3
N  =2
N  =1
N  =5
N=2402
N=923
N=1907
N=680
 data of <5
5 million people
001  Number of people
037  Number of people
2500 people
045  Number of people
03  Number of people
n=29 757
n=871
n=128
n=743
 data, a list of 791
 data from 44
390 participants
412 randomised participants
204 participants
208 participants
1 Baseline characteristics of participants
2673 patients
n=192
n=198
n=390
1738 persons
56 754 persons
1738 participants
56 754 participants
1 and among participants
1660  matched pairs of participants
1 Characteristics of participants
n=1838
n=67 086
n=2
n=4923
n=2600
n=1
n=354
n=3
n=66
n=1024
n=4347
n=10
n=1738
n=56 754
total of 1660
100 000 men  and women
  data from 1990
16 647 eligible patients
5 we then  grouped patients
16 647 patients
30 and was higher among patients
1 Characteristics of eligible patients
73 106 patients
18 emergency room patients
16 and discharged patients
23 Even though these  patients
total of 29
40 participants
130 consecutive patients
345  DIC patients
8 adult women
1500 participants
150  million people
1 million  people
total of 20
21 The QbTest CPT requires participants
234 participants
178 participants
32 The proportion of patients
71 patients
n=20
n=5
n=3
n=1
n=  37
2600  participants
890 participants
60 participants
2600 participants
30 participants
890 eligible participants
15 participants
176 older people
312 people
305 community dwell-  ing older people
5632 patients
24 The proportion of ED patients
5632 eligible patients
26 For these patients
5632  patients
120 adult patients
7511 patients
1 In patients
14 For  patients
52 patients
60 patients
total of 2
1000  patients
500  patients
5000 registered  patients
500 patients
58 million people
n=56
n=39
N=357
N=161
N=196
N=332
N=331
N=236
total of 1330
total of 332
357 enrolled
357 children were enrolled
961 patients
961 Danish patients
total of 61
40 participants
41 participants
9 participants
81 participants
10 participants
84 participants
69 participants
35 participants
34 participants
32  participants
23 participants
28 participants
393 participants
N=40
N=41
N=81
n=51
n=30
n=23
n=28
n=17
n=13
n=81
n=25
N=66
n=14
N=51
n=12
N=30
n=11
n=4
total  of 50
 database of 54
19 065 women
13  NCCSP recommends women
13 673 women
21 958 women
19 340 women
3 Four-year follow-up of women
1578 women
27 Our population consisting of women
2 Proofer  Number of women
19 065 participants
n=4715
N=606
N=1445
N=32
N=12
N=62
N=6
19 065 participants were enrolled
n=233
n=205
n=113
n=146
n=179
n=240
n=152
n=45
n=131
n=97
n=62
n=74
n=92
n=134
n=69
n=145
n=102
n=68
n=82
n=73
n=28
total of 21
6  participants
3 participants
23  Prefer women
5  Prefer only women
31 million persons
12 persons
982 participants
25  Sampling and participants
29 We asked participants
2 denotes the flow of participants
330 adult patients
10 septic  shock patients
330 patients
192 patients
386 patients
14  enroled patients
184 remaining  patients
1 shows the patients
44 patients
91 patients
38 patients
1 Characteristics of the patients
9,493 patients
n=93
n=91
n=44
total  of 330
total of  192
 data set of 9,493
100 consecutive patients
95 evaluable patients
78 patients
13 patients
100 patients
95 patients
53 patients
20 randomly selected  patients
20 patients
68 patients
100 mg daily  and two patients
47 patients
7 of the  patients
33 patients
20 randomly  selected patients
18 patients
68 allopurinol-treated patients
80 patients
N=100
95 evaluable patients enrolled
n=176
N=176
N=704
44 and women
N=291
n=3
n=6
n=4
n=1290
total of 136 213
total of 10 892
100 000 in women
64 027 women
43 411  women
56 907 women
100 000 women
27 persons
187 persons
23  persons
10 000 screened persons
10 000 screened  persons
176 persons
1000 screened persons
2011  and recruitment of eligible participants
127 301 eligible  participants
127 301 eligible participants
1 Characteristic of participants
194 participants
16 Study participants
19 The participants
379 participants
3 compares endos-  copy participants
194 Aklavik H pylori Project participants
2008  All  participants
1 Continued  All  participants
332 project  participants
2 Aklavik participants
33 Aklavik participants
3 Aklavik endoscopy participants
176 participants
194 endoscoped participants
189 Aklavik H pylori Project participants
65 H pyloriâˆ’ participants
401 individual patients
282 patients
401 H pylori-positive patients
401 unique patients
1040 patients
600 people
22 people
n=194
n=115
30 women
40  participants
40 participants
350 million people
518 participants
66 participants
441 patients
234 patients
60 patients
352 patients
40 patients
10 patients
1 patients
n=  11
n  =2
n=  7
n=  30
n=  10
n=  18
n=  13
n=  6
n=  2
n=  8
N  =1
n=  64
n  =6
n=  46
n=  22
n=  65
n=  77
n=  44
n=  26
n=  24
n=  12
n=  55
n=  38
n=  17
n=  40
n=  19
n=  35
n  =3
n=  25
n=  84
n=  16
n=  1
n=  5
n=  23
n=  89
n=  28
n=  57
n=  51
n=  49
n=  29
n  =7
N  =8
N=58
N=100
3155 patients
42  This study selected patients
3155 study patients
9 Older people
n=2985
n=170
n=3154
 data from 2000
40 participants
28 While participants
n=2
n=20
n=40
total of 40
40 participants were enrolled
1 Recruitment of  participants
13 Relatives of patients
46  patients
46 patients
2577 patients
20 000 compared with patients
2 among patients
n=387
n=149
n=536
n=438
n=318
n=120
n=418
n=268
n=232
n=306
n=113
3  The participants
N=458,322
total of 51
 data from 55
7  of participants
1838 patients
78 patients
1 patients
5637 eli-  gible patients
1916 patients
1838  patients
1358 patients
480 patients
12 It is not known why some  patients
750 people
N=25
 dataset  of 1916
13 and young Swiss women
n=84
 data from 1
1309 patients
534 patients
994 of these patients
994 Follow-up patients
534 Non-FU patients
n=1238
N=994
N=534
N=460
n=994
n=534
4  The time participants
n=10
n=1
n=3
n=20
n=6
n=2
n=4
16 513 patients
8 A recent publication of patients
48 121 patients
1 describes how patients
42 008 patients
25 These patients
N=42 008
N=16 513
n=120
n=334
N=7921
N=8592
n  =1
total of 48 121
23 450 persons
37 890 persons
673 patients
37 506 patients
2005 patients
n=838
n=953
total of 22 705
total of  37 890
total of 37 506
total of 283 306
total of 474 489
500 participants
435 participants
509 adult patients
100 patients
400 patients
509 patients
443 patients
n=14
n=36
n=4
n=1
n=330
n=105
n=328
n=104
n=320
n=321
n=325
n=322
n=319
n=324
n=111
n=108
n=313
n=314
n=316
n=51
total of 509
509 patients were enrolled
324 enrolled
111 enrolled
82 participants
21 participants
82 consecutive outpatients
82 consecutive patients
37 patients
45 patients
4 show the patients
n=15
n=43
n=21
total of 82
82 participants enrolled
21 participants were  enrolled
19 760 patients
19 670 patients
36 While most patients
19 670 newly  diagnosed patients
2 Percentage of patients
n=19 670
n=  11
N  =8
n=333
n=234
n=4211
n=3700
n=251
n=319
N=800
N=20 647
N  =2
N  =1
N  =7
N  =5
N  =3
N  =6
total of 27
total of 4139
n=2773
n=18 000
n=2 737
n=1 904
n=607
n=226
13 754 men and women
5D scores than non-overweight  women
33 Obese women
90 patients
N=13 754
n=7832
n=5922
total of 13 754
total of 69
 data from the 2007
18 non-demented  patients
18 patients
5 These patients
13 patients
5 patients
3 patients
14 No patients
n=18
n=19
400 participants
864 participants
1000 participants
7472 women
22 A sub-  group of women
280 women
001  Single women
n=6820
n=652
n=5280
n=507
n=813
n=2375
n=2582
130 women
20 women
2903 participants
3240 participants
2724  participants
4059 CARDIA participants
4403 Framingham Study  participants
2500  uncomplicated patients
423 patients
n=2903
32 660 women
n=76 766
n=198
n=32 660
n=195
719 random control participants
14  Control participants
719 control participants
171 patients
2  The majority of patients
n=12
n=58
n=137
n=1000
n=171
n=719
63 371 women
5 Older women
30 We additionally excluded women
79 774 women
15 553 women
62 women
682 women
63 371 eligible  â€˜low-riskâ€™ women
39 who planned  nulliparous women
32 but many studies  include women
12 944  women
n=  33
n=  11
n=  18
n=  10
n=  16
total of 79 774
n=2402
n=2486
n=2461
n=2435
n=1043
n=1443
n=1734
n=752
n=570
n=809
n=555
n=537
n=1003
n=558
n=473
n=390
n=42
n=20
n=937
n=707
n=719
160 English hospitals treating patients
1 Comparison of patients
n=69 086
n=2
 data from the 2011
 data from the 2010
1 Overview of study participants
N=17
N=13
N=4
N=5313
N=3756
N=1557
total of 5313
80 033 patients
65 909 patients
8412  patients
3031  patients
1188 consecutive patients
n=65 909
n=99 473
n=19 440
n=2564
total of 8412
132 being women
201 patients
90 participants
n=90
n=45
total of 90
131 811 patients
2 Percentages of patients
3 Health costs and income of patients
898  â€˜untreatedâ€™ patients
5000 patients
342 patients
5900 patients
1 Characteristics of patients
2005 the scheme enrolled
1250 participants
22  For all participants
41 If anonymity of participants
N=8000
50 participants
50 patients
3 Examine the willingness of patients
25 patients
176 potential patients
31 The patients
100 elderly patients
n=25
total of 16
1200 moderate-to-high risk patients
700 patients
1200  patients
800 patients
1200 patients
998 patients
265 patients
29 patients
704 patients
650 patients
567  patients
200 million patients
n=2
n=27
294 were not enrolled
567  patients enrolled
330 community-dwelling patients
330  dyads of patients
36 million people
40s and women
695 participants
175 patients
N=5
N=3
N=9
N=4
total of 520
21  â–¸ Number of people
22  â–¸ Estimated true number of people
 data  from 2003
 data from 2007
14  Potential participants
N=50
N=79
N=20
N=109
N=5
N=124
N=18
N=111
study population included 129
129 children enrolled
n=3
n=1
N=25
n=68
n=34
n=14
total of 74
450 patients
150  patients
7 inpatients
12 outpatients
118,465 patients
6247 patients
n=20
69 H&N patients
38 patients
4 where  people
850 000 people
18 820  patients
n=290
n=120
n=161
n=9
n=148
n=130
n=18
n=201
n=178
n=23
n=92
n=45
n=2
n=112
n=100
n=12
n=166
n=143
n=21
15 591 participants
3070 participants
4662 participants
3 poly-  morphisms may help people
n=14
total of 1532
total of 15
20 participants
40 obese patients
50 patients
16 patients
20 patients
50  patients
270,770 patients
n=1049
n=1229
n=180
n=15
total of 1259
total of 1218
total of  1229
16  consecutive patients
16  patients
113 patients
18 patients
16 patients
5 patients
13 patients
113  fasciectomy-treated patients
2 patients
7 patients
9 patients
10 patients
24 patients
61 patients
total of 113
n=287
n=  81
n=  15
n=  27
n=  84
n=  50
n=  52
n=  44
n  =1
n=  87
 data from  2011
 data analysis from  2008
2  overexpressing patients
10 000 people
9 women
131 patients
17  patients
total of 131
total of 39
 data from 27
33  Data are also collected on patients
1485 patients
468 patients
3744  patients
20  This trial enrolled
137 control participants
100 patients
607 patients
10  Outcome measures  The patients
150 patients
total of 607
2 antibodies among women
85 participants
2 seropositive  participants
1 seropositive participants
2 seropositive participants
2 dually infected participants
80 participants
85 study participants
39 participants
4 participants
11 participants
2 shedding rates  Among participants
1 The proportion of participants
126 patients
2 coinfected patients
n=44
n=41
n=9
n=8
n=6
n=5
n=3
n=1
n=11
n=2
n=85
n=74
n=56
total of 126
total of  198
3570 women
26 women
13 587  participants
13 587 participants
total of 10 017
2000 patients
242 patients
242  patients
234 patients
N=242
N=195
N=47
n=100
n=69
n=139
n=91
n=169
total of 316
total of 208
17  participants
total of 100
30 000  persons
30 329 participants
29 664 REGARDS  participants
n=970
n=28 694
n=257
n=713
n=274
n=2318
 data from the 30 239
 data from the 30 329
2206 participants
15 166 participants
1 Descriptive statistics of patients
n=101
n=1
n=18 290
N=43 454
N=28 477
N=18 290
N=10 187
N=43 449
total of 28 477
total of 43 746
total of 2206
8 contexts where patients
7 patients
total of 70
total of 133
120 participants
100  participants
28 can classify some patients
4 and even  among patients
6 In patients
20 Information about  the patients
120 patients
total of 24
102 postmenopausal women
30 participants
20 patients
70 000 people
N=2693
N=3444
N=180
N=1179
N=1334
n=10
N=2403
N=931
N=25
N=2513
N=3160
total of 3444
  data of 1255
165  patients
30 patients
12  Although patients
16  For patients
53 patients
32 deceased patients
150 patients
N=52
9  Among women
n=2586
n=1020
n=2582
n=148
n=304
n=2175
n=168
n=86
n=82
n=1155
n=829
35 million people
n=246
 data from  2001
 data from  n=246
 data from 30
898 patients
400 000 patients
3201  patients
114 patients
2 study of patients
600 patients
n=45
n=50
n=48
n=222
n=224
n=226
n=73
n=96
n=93
n=98
n=149
n=128
n=133
706  participants
2194  participants
10 patients
1 Cardiac arrest patients
2010 patients
2010  patients
1 contained patients
2  among patients
n=1450
n=  70
n  =3
n=  21
n  =1
n=2900
n  =4
n  =2
n  =8
n  =7
23 participants
39 participants
20 test participants
39  participants
2 diabetic subjects
n=39
n=19
n=20
N=39
n  =3
 data from the 39
90,056 participants
9014 patients
9014  patients
4512 patients
4231 patients
4502 patients
 data from 61
 data  from 90,056
4566 people
2008 over two million people
total of 575
2678 men and women
10 women
04 women
10 people
n  =1
n=1412
n=1263
1240 women
13 541  women
910 women
13 541 women
23 017 women
1003 participants
231 102 patients
14 563 patients
2741  patients
1586  patients
75 million people
200 000 people
n=231 102
total of 204 131
n=26
n=51
n=21
n=37
n=17
n=9
n=45
n=6
n=77
n=56
n=164
n=81
n=83
n=52
n  =8
n  =5
total of 266
n=676
n=585
n=677
n=618
n=1353
n=1203
total of  1500
total of 1353
total of 1500
total of 1283
total of  1203
  data, a total of 1353
n=82
n=71
n=62
total of 27
total of 160
110 depressed  subjects
220 control subjects
14 subjects
121 million people
3135 patients
2840 of those patients
total of 19
n=10
n  =1
n  =2
n  =3
n  =5
n  =6
34 Six studies targeted women
n  =4
2656 men and  women
4807 men  and women
510,000 men and women
1900  participants
31 including  all patients
N= 3608
N = 2656
N=1900
n=1900
8,218 men and women
15,000 observations  among Swedish women
N=2774
n=180
n=536
n=1218
n=80
n=606
n=1709
n=761
n=455
n=1151
n=1818
n=1797
N  =2
n=575
n=570
total  of 2393
total of 2367
2441 women
2172 women
2180 women
2455 women
249 women
31  Among NCSP participants
N=716
N=1456
N=2441
N=4613
N=2172
2958 patients
944 500 individuals enrolled
  data from 944 500
 data from 1
4484 patients
1050 patients
5800  patients
10 500 patients
3  the expected numbers of patients
5596 patients
2 Numbers of eligible patients
3 Exclusions of patients
n=33
n=1721
n=1136
n=18
n=15
n=17 455
n=5596
n=262
n=400
n=35
n=1058
total of 1050
total of 4485
4000 randomly selected adult participants
4000 randomly selected participants
13 538 participants
41 499 participants
3000 random participants
1500 participants
22 500 randomly selected participants
1039 randomly selected participants
278 patients
34 Most of  the patients
53 the same  Fukuda-positive patients
2363 patients
76 206 patients
23 000 patients
50 000 patients
n=508
n  =2
n  =1
n  =3
n  =5
n  =4
n  =6
n  =9
n  =7
total of 38
 databases  of 29
20 women
15 women
29 women
20 All pregnant women
2 Characteristics of study participants
n=260
n=224
n=157
n=67
N=260
N=224
n=481
n=448
n=400
n=454
n=484
n=409
n=411
n=449
839  patients
839 patients
1 among patients
260 patients
400 patients
800 patients
4 Although most of these patients
1  and exacerbation rate of patients
33 So most of the patients
total of 839
n=25
N=200
n=157
253  persons
248 persons
1 shows the  number of persons
253 persons
248  persons
242  persons
42 persons
60 persons
56  persons
46 persons
27 persons
24 persons
n=1756
total of 1632
 data from the 2011
 data from 54
13 864 participants
11  Eligible participants
6 we excluded  participants
47 876 participants
60 participants
1882 participants
929 participants
47 876 patients
13 864 patients
total of 47 876
total of 13 864
total of 929
2151 women
4 women
2151 included women
496 women
1655 women
64 women
40 women
N=2151
n=496
n=1655
total of 2151
total of 13
total of 215
969  participants
n=1083
n=1005
n=1071
n=550
n=163
n=126
n=130
 data consist of a 10
  data from 1972
n=76
n=31
n=64
0=women
19 The pro-  portion of patients
2746 patients
1271 patients
90 depending on  the patients
1 Number of patients
2 Proportion of patients
n=2746
n=1
n=7
n=1078
n=71
n=2
n=1475
n=1271
n  =2
n  =1
n=2738
N=1797
32 Some women
33  Black and African-American women
22 but a study of  women
31 Some African-American  women
37 illustrates how women
47 Vulnerable women
6183  participants
n=80
n  =2
n  =8
n  =3
n  =1
n  =4
350 participants
N=354
N  =3
n  =9
n  =8
n  =7
total of 787
1 women
20 RA  patients
10 patients
8 CD patients
2 patients
N=969
N=50
N=100
40 participants
5 We will exclude studies of patients
50 participants
10 patients
500 patients
28 through interview of the patients
36 a patients
total of 150
total of 500
30 participants
37 intervention patients
44 patients
20 patients
10 patients
40 patients
32 patients
n=2
n=1
n=136
n=154
n=147
n=92
n=88
n=25
n=38
n=20
n=114
n=75
n=103
n=71
n=33
n=32
n=132
n=130
n=30
total of 475
total of 1714
n=2843
n=686
n=722
n=1408
n=1270
n=660
n=610
n=1128
n=70
n=72
n=437
n=833
n=819
n=451
n=134
n=450
n=874
N=396
n=618
n=651
N=1270
total of  4900
total of 1408
N=524
N=245 903
n=78
4487 women
300 million women
4487  Australian women
1462 women
20 000 Dutch men  and women
12 year follow  up of participants
27 000 participants
000 primary care patients
 data from 4
2  When patients
1562 patients
460 patients
total of 30
750 women
319 women
n=5842
n=3897
n=2232
n=2315
n=437
n=321
n=139
n=100
total of 10
total of 1474
total of 587
1 year and pregnant women
7 million  patients
7 million patients
2 million  patients
7  million people
100 000  people
2 million people
7 million people
n=51
n=646 709
n=244 078
n=1 537 178
n=951 332
total of 580 000
total of 2
15  We further excluded participants
129 older patients
22 we categorised patients
128  patients
159 patients
n=51
n=9
n=3
n=2
n=1
n=129
n=15
n=58
n=56
n=114
n=108
n=148
n=54
n=158
1329 participants
1 Characteristics of participants
N=1329
n=1329
n=101
n=68
n=570
n=216
n=374
total of 1329
total of 25
1 In patients
3000 thrombocytopenic adult patients
622 allogeneic transplant patients
1402 BMT patients
58 patients
1,402 patients
n=159
95 women
3 million are women
230 women
95 HIV-positive women
7 women
29 In patients
n=95
total of 230
total of 7
n=814
n=909
n=485
total of 46
total of 31
18 DNA positive young women
2007  among persons
2004  participants
1 Characteristics of study participants
n=1654
n=450
n=399
n=51
n=424
n=440
n=445
n=427
n=442
296 women
590  women
1082 women
1494 women
590 women
240 older participants
n=1397
n=832
n=439
n=1275
n=552
n=334
n=170
n=382
n=126
n=208
total of 296
total of 1082
total of 758
119 reflecting the subset of participants
428 patients
499 patients
500 patients
n=322
n=212
n=134
n=123
N=428
N=134
N=123
n=31
N=256
N=212
N=190
n  =1
total of 1211
total of 576
1476 unrelated healthy control participants
829 patients
421 patients
408 patients
total of 43
2301 women
16  and abuse among women
1908 women
2235  women
43 women
607 women
84  women
56 women
n=229
n=1342
n=959
n=1516
n=509
n=22
n=10
n=72
n=73
total of 2301
12  For patients
n=3
n=1
n=39
total of 40
9  These most marginalised people
n=463
N=72 751
n=294
n=9200
n=15
n=174
n=150
n=148
n=472
total of 50
111 participants
272 participants
272 patients
100 patients
17 patients
n=272
total of 272
766 patients
4249 patients
19 patients
8458 insured patients
100 000 patients
3 They analysed all dialysis  patients
n=3040
n=725
n=1791
n=606
n=999
n=2041
total of 4249
25 patients
36 While all  patients
41 Within the patients
n=8
n=6
n=9
total of 25
total of 92
total of 36
432 randomised patients
432 patients
1328 patients
100 patients
204 patients
20  Further follow-up of patients
87 patients
120 patients
total of  100
4900 participants
5135 participants
total of 4900
total of  4900
total of 5135
 data from 192
493 patients
58 000 patients
74 000  patients
407 prevalent patients
719 patients including  patients
407  patients
204  All patients
548  Proportion of patients
042  Proportion of patients
512  Proportion of patients
947  Proportion of patients
5D patients
N=203
N=204
N=407
total of 719
119 119 Management of patients
118 118 Management of patients
110 110 Early management of patients
108 108 Management of patients
9 large  numbers of people
100 000 people
n=161
n=121
n=119
total of 543
66 participants
2 shows the flow of participants
181 participants
94 participants
59 female participants
1 Characteristics of participants
94 screened participants
724  patients
700 patients
N=54
N=31
n=68
n=3
n=6
n=1
n=9
N=36
N=58
9459 women
9615 women
4370 women
10 women
19,874 Danish  women
n=47
n  =9
n=  94
n=  32
n=  28
n=  23
n=  53
n=  34
n=  21
n  =6
n  =1
total of 9615
study population included 9459
N=12
N=9
N=21
001  Successful people
001  Cool people
001  Rich people
002  Successful people
n=779
n=649
n=3384
788 participants
31 Dietary information of the participants
1839 study participants
91  participants
477 patients
494  patients
n=477
n=1271
n=331
n=146
n=784
n=487
n  =1
n  =6
n  =3
n  =7
n  =4
n=328
n=17 000
total of 31
347 patients
682 patients
29 The mean age of patients
total of 347
total of 752
total of 32
total of 682
32 037 patients
64 312 patients
26 267 patients
11 389 for hospital score for patients
22 122 patients
1274 patients
3059 patients
3059  patients
2959 patients
3035 patients
33 890 patients
1298 patients
700 more patients
100 patients
10 000 patients
9461  patients
n=2806
n=2959
N=1558
N=1401
N=1472
N=1334
n=3035
N=3035
N=1596
N=1439
N=2872
N=1504
N=1368
 dataset of 32 037
74 941 women
24 Two control  subjects
n  =2
n  =4
n  =1
n  =8
n=  21
n=  42
n=  86
n=  16
n=  12
n=  26
total of 217
4 million  people
21 women
n=21
2000 participants
30 participants
43 Potential participants
50 000 patients
25 patients
10 181 routinely attend-  ing patients
9  million people
total of 65
 data of 10 181
71 793  patients
6 and  non-white patients
71 000 patients
71 793 patients
15  As Chinese patients
2004  national surveys of patients
8 million people
n  =4
n=69 276
n=14 591
total of 71 793
 data from 71 793
n=1678
n=912
n=766
n=187
n=174
n=325
n=282
n=160
n=145
n=237
n=231
n=229
n=69
n=326
n=240
n=139
n=207
n=253
n=238
n=111
n=164
n=1026
n=391
n=261
n=166
n=53
n=100
n=48
n=50
n=73
n=52
total of 1678
12 patients
66 patients
18 and patients
250 patients
28 and a trial involving patients
0â€”  before patients
6 cardiac patients
24 patients
150 000 people
832  people
2 participants
6500  substudy patients
6500 patients
10 000 patients
6500 eligible patients
3000 patients
2 AKI substudy patients
2 patients
2  patients
n=4880
n=3690
n=1190
6500 patients will be enrolled
2404 men and women
1580  women
132 people
29  people
n=200
N=2262
N=63
N=74
N=21
n=21
total of 2404
total of 142
total  of 132
  data from 1994
1 Weighted proportions of participants
2 Weighted proportions of participants
1118 patients
410 patients
54 patients
19 In patients
20 Such patients
2 show proportions of patients
39 In patients
30  million people
n=7
n=3
n=17
total of 105
n=2674
n=16 138
n=1000
n=6413
n  =2
28 558 women
57 175 women
24 274women
1070 women
15 000 women
34 000 if all patients
 data from the 2008
1 Characteristics of study participants
16 000 asthma patients
n=38
n=31
n=667
n=18 013
n=33 293
N=14 989
N=1245
n=9564
n=4349
n=474
n=602
n=1090
n=17
n=138
total of 47 614
56 participants
2 participants
40000 subjects
n=8
n=514
N=1798
N=412
n=480
n=483
n=490
n=494
N=251
N=103
N=54
N=78
N=494
total of 56
5139 participants
1259 participants
4635 participants
1057 participants
4494 patients
2236  Number of patients
72 441  Number of patients
87  patients
100 patients
05olderpeople
n=3270
4 For low dependency inpatients
597 137 inpatients
515 408  inpatients
2 508 916 patients
4 Distribution of patients
5 Distribution of patients
869 patients
94 patients
963 patients
736 patients
869  patients
6  Most patients
n=664
n=869
n=94
100 000 residents in these  category women
20  Men and women
100 000 residents in this category women
8550 participants
2000  people
N=1555
N=6995
n=3310
n=3685
N=3310
N=3685
N=1092
total of 8550
 data from 6995
150 new patients
150  patients
n=72
n=81
n=68
n=78
n=69
n=82
total of 100
20 and patients
n=19
total of 7220
872  participants
543 participants
23 pro-  portions of patients
2 diabetic patients
n=43
n=29
n=26
10 patients
14 541 pregnant women
954  women
1 Flow chart of selection  of women
3451 women
13 713 recruited women
1477 women
1268 of the remaining eligible women
792 women
1268 women
1 Characteristics of women
2 Characteristics of women
n=3451
n=5
N=11
n=7
n=971
n=999
n=10262
n=8653
n=3417
n=7927
n=3335
n=8739
n=3425
n=9136
n=3403
n=9365
n=3441
n=10258
N=1268
n=1268
n=269
n=412
n=582
n=256
n=391
n=534
n=267
n=411
n=577
n=261
n=409
n=568
n=580
n=578
n=268
n=581
n=271
n=415
total of 1268
total of 3451
 data varied from 0
n=57
n=38
n=20
n=70
n=28
n=21
n=42
n=29
n  =4
n  =2
n=  29
218 patients
203 patients
91 patients
8  Eligible patients
203 eligible patients
34 patients
20 patients
23 patients
218 potentially eligible patients
N=203
164 participants
n=30 941
n=11 017
n=6876
n=256
n=29 650
n=228
n=27
n=11
1206 women
1293 women
1222  women
16 women
1206  women
n=1293
n=1222
n=464
n=323
n=79
n=340
n=796
n=268
n=60
n=27
n=343
n=123
n=41
n=13
n=90
n=19
n=263
n=129
n=45
n=141
n=76
n=4
n=16
n=3
n=101
total of 1293
1094 patients
196 patients
1134 patients
1094  patients
50 psychotic patients
n=380
n=523
n=7
n=3
n=4
total of 1134
4  Psychiatric patients
11 In patients
1482 patients
100 patients
150 patients
125 patients
90 patients
96 patients
48 patients
total of 1482
total of 150
 data of GLP-1
1 Age of women
1 Mean age of women
total of 1
2033 patients
17 In large studies of patients
162 000 patients
5000 patients
N=2033
N=698
N=481
N=556
N=289
N=702
N=484
N=558
total of 2033
 database of  162 000
21  Pregnant women
1000 participants
 data from 54
17 persons
1193  participants
n=334
n=529
n=330
n=70
n=241
n=257
n=23
total of 46
12 000 randomly selected participants
6070 participants
N=2357
N=671
N=679
N=2363
N=6070
N=1437
N=2460
N=1890
N=283
20 women
10 RCT participants
20 participants
117  RCT participants
59  Study participants
117 patients
20  people
n=20
n=117
4079 ever married women
14 Those women
12 961 women
12 699 women
4079 ever married  women
701 pregnant women
n=4079
2328 participants
2328 non-  pregnant participants
18 All participants
1985 than  the participants
1 Characteristics of participants
n=1150
n=1178
n=256
n=245
1213 participants
1213  participants
250 participants
50 000 participants
100 people
10 people
2 people
n=450
n=768
N=2
total of 1213
total  of 1213
total of 116
350 partici-  pants enrolled
311 former participants
444 invited participants
378  participants
001 versus lean  participants
n=14
n=10
n  =1
n=134
n=64
n=113
1 Demographic features of subjects
7 All subjects
19 patients
2 Clinical characteristics of patients
3 Radiologic findings of patients
10  patients
17 Four patients
19 BAL findings of patients
n=14
n=5
37  Targeted engagement at women
total of 97 700
48 215 postmenopausal women
48 215 women
39 121 women
38 969  women
4 Most women
74  among women
48 000 women
455 women
452 women
50 639 women
202 638 apparently healthy  women
14  The women
9398  women
593 women
47 994 women
8771 women
39 123  women
102 women
47 994  women
39 353 women
8871 women
39 123 women
384 women
154 women
15 so the  women
200 women
1 UKCTOCS  participants
3302 participants
n=50 639
n=50 640
n=101 359
29 665 control  participants
15 054  patients
2 diabetes patients
21  Older people
n=6015
n=53
n=29
n=5933
n=29 665
total of 15 054
total of 5933
15 145 Chinese men and women
7588 women
16 500 people
N=15 145
total of 16 500
37 patients
26 patients
5  In patients
26  patients
11 patients
26 control  patients
15  None of the control group patients
248 patients
95th  centile among healthy participants
40  NSTEMI participants
9 the number of NSTEMI participants
102 patients
147 patients
102  patients
58 patients
13 patients
7  patients
8 patients
1967 patients
19 patients
27 patients
58  patients
3 million people
n=8
n=4
n=9
n=53
n=28
n=3
n=23
total of 102
n=10 190
n=137
n=165
n=68
n=920
n=8900
n=2019
N  =4
N  =7
N  =8
N  =3
N  =5
N  =6
N  =2
7 million people
22  A study of people
45 760 of  these people
n=86
n=45 760
6 Sexual minority women
n=0
n=1
n=215
n=10
n=12
n=2
n=200
n=15
n=127
1508 participants
247  participants
45 and Up Study participants
2800 eligible people
5  Trade people
N=1261
n=1261
 data from the 45
1100 patients
12 262 patients
17 370 patients
17,370  patients
50 patients
n=7614
n=1686
1  participants
11 000 eligible  patient participants
29 Pilot participants
11 311 eligible patient participants
11 302 participants
2  Pilot participants
11 302  associated eligible patients
18  The CAPE registry tracks patients
1800 enrolled patients
1800 patients
n=2503
n=8799
n=11 302
n=10 652
n=10
86 per eligible enrolled
1800 enrolled
175 participants
183 patients
35 patients
15 patients
90 patients
90  patients
100 000 persons
372  patients
100  patients
186 patients
8 adult SVT patients
125 000 people
2822  patients
255 patients
25  people
30 participants
120 participants
22 In  patients
30 patients
30  patients
80  patients
210 million people
48 outpatients
23 We defined stable patients
15 We excluded patients
381 patients
82 outpatients
53 patients
65 stable patients
17 patients
48 stable patients
22 patients
21 patients
23 patients
12 patients
total of 82
total of 22
53 patients enrolled
2008 participants
2 Only participants
 data  from the 2008
11 900 patients
12 000 patients
total of 70
total of 44
total of 26
total of 325 922
923 women
1 Married women
4 Knowledge  enables women
1997 women
20 women
3 Distribution of women
n=1965
total of 1997
total of 12
1822 included patients
1822 patients
2195 patients
373 patients
200 patients
1484 patients
208 patients
1614 patients
1822  patients
400 women
999  patients
100  patients
509  patients
n=27
7000 substudy eligible patients
4494 adult patients
157 patients
191 patients
28 patients
40 patients
110  patients
20 patients
7500 patients
7000 SIRS patients
18  In all SIRS patients
1 SIRS patients
7000 patients
4200 patients
2 Subpopulation of SIRS patients
800  patients
800 patients
n=6598
n=4668
n=1930
n=4231
n=3016
n=1215
643  patients
n  =5
n  =3
N=656
n=131
n=525
n  =4
36  Recruitment of the study participants
300  individuals per group of participants
10  patients
2 diabetes  patients
22 000 people
64  people
n=1057
n=863
n=1011
n=597
n=340
160 patients
80 patients
6336  patients
n=30
n=20
n=10
total of 160
36 Involving patients
N=80
525  women
267 control women
1992 and the  women
210 g alcohol and  the women
988 middle-  aged Finnish participants
3  million participants
1023 participants
988 participants
2 diabetic  patients
n=1045
n=41
n=161
n=767
n=76
n=720
n=124
n=144
n=319
n=81
n=82
n=298
n=103
n=314
n=83
n=105
n=16
n=2
n=9
n=8
n=15
n=17
n=53
total of 520
2 cohorts of patients
214 patients
450 surviving  patients
6 patients
20 patients
46  Almost half of the patients
2143 patients
520 patients
6000 people
n=117
7 million  participants
1 475 347 people
792 560 people
4 million people
2010  Correponding number of people
38 people
78 828 people
31 282 people
5000 people
n=198 086
n=128 982
n=128 983
n=28 489
n=1 475 347
n=1 477 600
total of  78 828
8423 participants
857  participants
16 All participants
10 994 participants
n=7983
n=3011
n=4919
n=29
N=8423
N=4919
13 patients
21 Almost  two-thirds of patients
6 and the age of the patients
n=82
n=163
n=245
n=19
n=24
n=9
total of 245
total of 8
total of 13
565 patients
total of 14
30  participants
30 participants
8  Among patients
22 patients
25 patients
n  =1
n=  21
n=  51
n=  38
n=  69
n=  71
n=  49
n=  25
n=  35
n=  30
n=  47
n=  43
n=  18
n=17
45 women
44 participants
88 participants
45 female participants
122 participants
n=99
105 participants
223 patients
112 patients
111  patients
250 patients
111 patients
109 patients
106 patients
41  patients
3 patients
n=112
n=111
total of 4
 data from a 2
n=721 915
N=722 464
N=428
N=52
N=120 846
N=430
N=4280
total of 167
607  participants
600 participants
41  RESULTS  The flow of participants
3 Flow of participants
7  CTC typically requires patients
100 people
2500 people
n=17
46 subjects
13 subjects
10 They also  reported three subjects
32 ALS patients
13 patients
100 000  people
3800 people
4100 people
4500 people
4100  people
100 000 people
27  Indigenous people
38 people
n  =1
n=4
n=2
n=1
n=7
n=3
n=5
n=6
n=13
n=9
175 participants
350 participants
2 The flow of  participants
31 patients
29 patients
85 patients
10 patients
31 consecutive patients
7 We included only patients
4 patients
13  patients
3 patients
14 patients
28 patients
11  patients
2 patients
13 as  well as patients
n=30
n=2
n=12
n=7
n=1
n=19
n=4
n=31
n=29
1400 young people
1 Young people
21 and yet young people
5  The other eight asked young people
17  studies focused on young people
29 Young people
19 Young  people
29 While sometimes young people
12b The aspirations of young people
28 Young people
12c  Vicious circles  Young people
78  Some young people
N  =3
N  =1
  databases from 1997
12 patients
10 044 patients
6742 patients
5027 patients
6033  patients
455 patients
460 patients
n=740
n=810
n=249
n=10 044
n=6033
total of 10 044
32 women
47 patients
44 All patients
45 patients
N=11
N=6
N=5
N=10
N=7
N=8
N=26
N=21
N=36
N=20
N=16
804 persons
609  cancer patients
1 Should women
7  The women
7 million women
8  participants
19 the participants
n=19
n=16
n=17
n=9
total of 62
100 000 people
100 000  people
total of 164 752
total of 55
43 Flows of patients
300 participants
80 participants
300  participants
total of 16
10 participants
N=179
N=147
total of 179
total of  70
7150 participants
6744  participants
total of 6744
15 considered women
28 women
6 million women
142,475 women
15 women
8 mention exclusion of such patients
24 000 inpatients
225 000 outpatients
3 For women
24  Rural women
N=11835
N=12 561
total of 11 835
N=9183
N=8762
N=8974
N=4753
N=1147
N=350
N=692
n=15
n=9
n=7
n=11
n=6
n=2
n=12
n=  14
n=31
n=28
n=488
n=571
n=174
n=454
n=115
n=58
n=28
N=269
N=305
n=574
n=572
n=569
n=563
n=559
n=561
n=556
n=433
n=557
n=521
n=535
n=441
n=173
N=234
N=254
n=472
n=486
n=485
n=479
n=475
n=471
n=404
n=402
n=453
n=467
n=163
n=482
n=478
n=469
n=468
n=461
n=324
n=323
n=409
n=358
n=61
total of 574
64  million people
40 participants
n=990
n=68
n=33
n=88
n=37
n=42
n=825
n=139
n=454
n=56
total of 990
2DM participants
2 diabetes mellitus participants
3986 participants
1990 participants
3620 participants
4008 participants
2005 participants
2003 participants
2 diabetic patients
total of 380
total of 4008
n=21
total of 48
total of 352
total of 11
n=5
n=3553
n=5680
n=4596
n=4636
n=3774
n=1224
n=3629
n=231
n=374
n=2646
n=4157
n=2428
n  =4
n  =1
n  =2
n  =3
n  =8
n=1004
n=769
n=263
n=935
n=985
n=291
  data from the 2012
16 715 opioid-dependent people
9645 people
n=13 199
n=5011
n=12 852
n=46
n=37
n=11
n=32
n=17
n=16 715
n=3863
n=51
n=43
n  =1
197  women
10 persons
594 participants
11 All ECHOES participants
6162  participants
594 ECHOES participants
1 year less than participants
3960 patients
782 patients
928 patients
3346 patients
n  =3
n  =1
n  =8
n  =2
n  =6
n  =5
total of 6162
27 participants
11 participants
11 jury participants
15 Indeed some patients
n=12
n=15
N=11
n=10
N=25
320  patients
27 The  benefit of using the participants
40 participants
20 participants
1895 participants
1556  participants
1556 participants
371 million people
total of 1895
509  participants
21 participants
829 participants
2 Baseline characteristics of participants
5 among participants
380 participants
n=509
n=117
n=392
n  =1
n  =3
N=380
N=777
N=509
total of 829
16 local women
233 700 women
200 women
300 women
33 We recruited  women
16 women
10 in-depth groups of  women
n=16
total of 16
2 diabetes  outpatients
2  diabetes outpatients
169 patients
2 diabetes outpatients
15 000 patients
19 and patients
007  diabetes outpatients
8 Depression among people
n=99
n=70
n=169
85  of the cohort participants
N=7320
n=5792
n=214
n=675
n=639
n=11 648
N  =7
n  =5
n  =2
n  =6
43 postmenopau-  sal women
43 postmenopausal women
2392 participants
2 Characteristics of participants
N=1930
N=3601
N=117
n=156
N  =1
N  =7
N  =2
N  =4
N  =6
N  =9
N  =3
N=469
N=826
N=297
N=800
N=2329
N=613
N=130
N=207
N=76
N=200
149 patients
189 patients
4  The distribution of the patients
189 epilepsy patients
2 and the drug  state of the patients
22 In paediatric patients
n=189
18 consecutive women
10 women
28 women
1665 women
28 PE  women
18 women
8 women
10  women
05 versus women
19 women
5 women
26 women
10 consecutive  women
n=10
n=18
total of 1665
total of 28
15 patients
65 participants
147 participants
3141 patients
65 patients
n=3141
n=3076
15  enrolled
90 056 participants
34 925 patients
13 029 patients
22 patients
61 458 patients
89  All patients
4444 patients
 data  from 90 056
819 701 individual patients
819 701  individual patients
n=819 701
n=2 186 642
n=5410
n=301 008
total of 5410
354 204 patients
22 000  people
N=354 204
N=15 102
1  If the same participants
15 In human subjects
270 participants
480 participants
270 patients
2 Many patients
4 particularly among  patients
361 patients
38 patients
110 patients
40 patients
150 000 people
468 participants
00 after participants
486 patients
60 The investigator will  train patients
total of 29
total of 468
6 While LBQ women
34  women
45 and young women
20 persons
40 participants
n=440
n=44
586 000 people
347 patients
7 In patients
9  Since patients
327 patients
001  Number of patients
220  patients
61 Thai patients
91 Nepalese patients
100 000 people
n=54
n=347
n=1735
total of 347
n=70
n=91
n=827
study population  includes 104 635
 data from 6
5  Most patients
7350 patients
 data from 21
100 000  women
100 000 persons
50  more persons
100 000  persons
14 977 unique patients
244 196 patients
10  In patients
14 977 patients
N=21 576
N=515 990
total of  14 977
total of 515 990
433 patients
1 patients
8 patients
468  patients
total of 433
total of 468
21 participants
12 participants
306 randomised patients
27 patients
13 patients
20 patients
1749 patients
319 patients
306 patients
21 patients
118 patients
167 eligible  patients
5mTW than did the patients
1 Flow chart of patients
39 The patients
40 Only a few patients
3 but patients
N=167
n=105
n=62
n=  10
n=  62
N  =1
n=  52
n=  60
n=  55
n=  27
n=  43
n=  35
total of 306
total of 62
n=705
N  =5
N  =7
N=705
108 participants
1447 patients
108 patients
25 randomised patients
180 patients
2000 patients
100  patients
200 patients
1447 individual patients
1235 patients
980 patients
216 patients
216 ran-  domised patients
1230 patients
1230  non-randomised patients
23 patients
1446 patients
216  randomised patients
24  â–¸ Two patients
543 patients
N=108
N=1446
N=216
N=862
total of 2319
1447 patients were  enrolled
5 Flow chart of enrolled
824 women
780 women
7 million people
n=32 034
n=6092
n=160
n=5
n=6
n=4
n=9
n=8056
n=85
n=75
n=824
n=82
n=9689
n=29
n=1510
n=15
n=312
n=10 754
n=320
n=92
n=2420
total of 25
39 Pacifica  people
n=7
n=1
n=6
n=9
n=2
n=4
n = 20
total of 26
total of 105
33  Many of the participants
6 million women
n=276
n=11 233
n=2776
n=5349
n=3108
492 patients
75 patients
151  patients
320 patients
n=141
n=151
total of 66
3506 persons
452 participants
99 pregnant women
420 pregnant women
99 pregnant  women
95 patients
22 patients
62 patients
25 patients
1b-exposed patients
400 000 people
N=96
N=86
N=88
N=14
N=63
N=552
N=1105
1951 women
2364  pregnant women
600 000  people
n=4
n=49
n=41
n=44
n=139
n=135
n=827
n=579
n=545
n=994
n=957
total of 1951
691 738 women
293 840 low-risk women
100  women
100 women
288 309 women
29 597 low-risk primiparous women
79 792 low-risk  primiparous women
39  Babies of primiparous women
22 With more women
42 In this study low-risk women
n=83 573
n=204 399
n=28 703
n=99 212
n=29 597
n=79 792
n=79 791
n=58 300
n=179 003
n=194
n=68
n=20 194
n=192
n=19 921
total of 67
304 symptomatic patients
304 paediatric patients
17 In patients
304 patients
28 newly diagnosed patients
715 patients
130 patients
23  In contrast patients
n=130
n=62
n=45
n=67
n=15
n=8
n=12
n=3
n=5
n=2
n=55
 data of 715
1073 participants
1 Characteristics of participants
2327 participants
44 participants
332 participants
n=1073
n=591
n=363
n=39
n=14
n=43
n=18
n=5
n=62
n=49
79 participants
1000 participants
12 participants
999 participants
889 participants
1 Characteristics of participants
1000 ambulatory patients
6529 potentially eligible patients
405 patients
505  patients
10 patients
n=999
total of 79
33 253 participants
8651 patients
804 patients
1000 patients
1000  patients
10 008 people
N=33 253
total of 33 253
total of 159
37 276 men and women
7620 women
391 women
53 women
100 000 population in men and women
384 women
100 000 population in men and  women
37276 men and women
276 men and women
7  Most patients
11 878 patients
14,434 myocardial infarction patients
2005 To determine whether patients
N  =3
N  =2
N  =1
N  =8
N  =5
N  =4
N  =6
N  =7
N  =9
total of 11 690
total of 100
15 women
3 no  Some participants
49 people
263  people
20 people
29 and Japanese participants
508 patients
500 patients
N=500
total of 508
total of 178
508 patients were enrolled
750 eligible  patients
65 at-risk patients
n=40
n=2073
n=460
2425 patients
2071  patients
1699 Greek patients
354 patients
2 wild-type patients
2071 patients
354 consecutive patients
2  wild-type patients
2 patients
total of 2425
158 women
4 persons
5 persons
N=183
N=74
N=42
N=11
N=71
N=17
N=6
N=16
N=14
N=28
N=12
N=5
N=7
N=4
N=8
N=30
 data analysis of the 2012
1  patients
2 patients are returning patients
3 patients
1=patients
2=patients
3=patients
total of 1500
19 participants
10 participants
n=50
total of 6664
total of 74
total of 49
929 participants
929  patients
929 patients
861 patients
14 Anaemic patients
15 In patients
N=258
N=603
11 Patients were enrolled
929 patients enrolled
4354 women
4727 women
3329  Australian women
416 women
180 Northern European women
234 Southern  European women
195 Asian women
12 Most participants
27 000 participants
2 women
45 000 patients per  year. These patients
30 The patients
total of 80
1000 participants
8 a significant proportion of people
n=1
n=601
n=598
n  =7
n  =3
n  =1
14 Can those admitted as inpatients
17 Are patients
n=22
n=14
n=13
3680 patients
5 Among  non-surgical patients
158 patients
3680  patients
N=191
N=3489
1 Characteristics of participants
13 participants
n=255
n=32
n=35
n=42
2500 patients
9 only focuses on patients
n=24
n=22
n=38
n=2
n=1
n=21
n=8
n=14
n=11
n=5
n=16
n=19
n=12
n=3
 data from 68
total of 98
total of 1951
n=764
N=342
N=222
n  =2
4 patients
3 patients
total of 10
total of 25
total of  74
11 For lower risk patients
n=144
total of 43
10 514 patients
3000 patients
420patients
3233 patients
n  =2
n  =1
n  =5
total of 3233
total of 38
413 study participants
N=3
n=413
473 women
197 patients
10 patients
18 patients
40 patients
129  patients
1 The proportion of patients
total of 271
total of 960
240  patients
240 patients
total of 240
3265 women
3265  women
850  women
1 Smoking status of all women
850 preg-  nant women
2 Comparison of eligible women
12 Previous cohorts have  women
2500 potential participants
850 participants
N=488
N=1101
N=625
N=966
N=850
N=116
N=362
N=3265
850  women enrolled
204 participants
204 patients
29  We are stratifying patients
total of 204
186 Japanese patients
8  Because patients
186 patients
59 patients
16 total aut-  opsied patients
184 patients
139 patients
179 patients
54 patients
78 cases were of  male patients
11 patients
3  patients
n=  13
n=  59
n=  8
n=  75
n=  57
n  =3
n  =4
n=  12
n=  55
n  =5
n  =1
n  =2
n=  2
n=  33
n=  31
n=  3
n=  10
n=  26
n  =6
n=  29
n=45
n=7
n=43
n=23
n=6
n=18
n=4
n=38
n=5
n=11
n=1
n=8
n=0
n=13
n=2
n=139
n=75
n=121
n=58
n=33
n=10
n=62
n=64
n=53
n=881
n=466
n=186
n=71
total of 184
 data of 186
 data of  186
140 women
1 Baseline characteristics of women
417 participants
195 UFO  participants
n=858
N=424
n=140
n=277
total of 650
50  women
30 As some women
30 women
1000  women
407 women
814 women
1078 women
285 women
60  participants
n=904
n=66
48  patients
100  patients
n=761
n=242
total of  60
1910 participants
9 because a small number of patients
total of 10
1 Characteristics of participants
20 000 patients
2748 patients
20 questions about patients
39 and infrequently check their patients
2 Proportion of patients
n=670
n=683
n=880
n=477
n=38
n=2145
n=603
164 138 women
104 310 women
430,920 men and women
200 000 participants
5408 participants
5251 participants
n=164 005
n=104 310
5 people
n=18 558
N=7156
N=106
N=85
n=7347
N=5317
N=2030
 data from the 1958
n=15
n=9
n=4
n=5
100 000 women
112 patients were women
112 female Han Chinese  patients
112 patients
77 patients
118 patients
32 patients
745 patients
total of 112
total of 37 128
total of 122
 database of 100
 dataset of 40
22 569 women
1 Percentages of men and women
25  and women
250  patients
n=1102
n=153
n=73
n=1333
n=916
n=611
n=294
n=405
n=289
n=111
n=1112
n=686
n=426
n=625
n=476
n=51
n=244
n=150
n=173
n=54
n=163
n=116
n=133
n=1609
n=847
n=317
n=129
n=72
n=57
n=127
n=66
n=59
n=918
n=567
n=492
n=409
n=267
n=982
n=524
n=444
n=849
n=469
n=370
149 women
n=244
n  =2
total of 255
 data from 6
93 We will provide participants
8  patients
2 diabetes patients
30 people
500 million people
total of 598
total of 114
total of 83
12 participants
11 participants
1000  participants
17 Clinicians influence their patients
9 A small proportion of  people
12 people
11 people
35 people
 data set of 602
150 patients
90 patients
1 diabetes patients
total of 150
150 patients will be enrolled
90 patients enrolled
n=29
n=26
n=14
n=21
n=8
total of  254
n=22
n=39
n=19
n=20
13 patients
14 000 patients
n=36
n=75
n=3
n=4
n=60
n=15
750 participants
90 000 Australian patients
359 patients
750 patients
6336  patients
4000 people
n=12
100 women
n=35
n=36
n=30
 data from the 2010
 data from the 2007
1537 eligible women
1154 women
1745  Australian women
n=4299
n=0
N=511
N=1026
1000 IPC participants
1000 IPC  participants
n=70
1000 patients
82 396 randomised patients
78 296 patients
22 included patients
79 808 patients
n=21
n=18 201
n=18 113
n=14 264
n=6706
n=21 105
N=83 015
160 participants
1451 participants
19 The participants
n=95
n=10
1990 and enrolled
11 980 pregnant women
11 980 pregnant  women
2522 participants
N=2522
n=288
n=464
n=1589
n=520
n=237
n=2348
n=403
n=55
total of 2810
37 million people
total of 942
total of 5314
N=3137
N=2968
n=2004
n=903
n=230
n=1017
n=470
n=121
n=987
n=433
n=109
3 and of women
687 opioid-dependent  patients
42 676 patients
1263 patients
227  patients
576 control patients
4398 patients
2 diabetic patients
50 045 people
N=576
N=687
N=71
N=593
N=23
n=0
total of 2382
total of 576
50 consecutive patients
50 patients
6336  patients
23 patients
n=58
n=23
47 Significantly more women
4351  South African adult participants
n=4351
N=4351
total of 5089
 data from the 2000
5000  people
total of 21
n=300
total of 300
205 401  participants
205 923 eligible participants
1898 eligible participants
72 438 eligible participants
28 did not specify if participants
138 302 participants
15 042 participants
9610 participants
2407 participants
13 669 participants
3071 participants
35 192participants
323 participants
1530 participants
399 participants
1329 participants
804 participants
140 000 participants
n=200
580 deaths  among the TCS participants
2  million people
total of 580
n=16 015
n=16 542
n=523
n=4
n=978
n=2794
n=477
n=3299
total of 118 581
total of 17
 data from the 2009
 data from the 2003
12  men than women
185 000 people
1  million people
24 participants
20 trial participants
33 participants
20  trial participants
2 Qualitative study participants
4 Details of interview participants
26 and was a benefit participants
1710 patients
3  For hospitalised patients
23 The total number of patients
36 patients
18 ITT patients
1674 patients
1381  patients
716  patients
402 patients
314 patients
638 patients
1173  patients
624 patients
549 patients
698 patients
639  patients
203 patients
1521 patients
1425 patients
88 patients
N  =1
total of 1710
total of 310
1710 patients enrolled
203 patients were enrolled
3 women
12 participants
7 participants
5 participants
24 participants
3 participants
16 did not exclude ACLR participants
29 All of  the ACLR participants
65 female patients
n=12
n=7
n=5
n=32
n=21
n=8
 data of 61
30 The CGSQ  asked participants
4 asked participants
N=205
N=107
n=80
n=84
total of 134
1 study used  all female participants
total of 1024
3503 White British  women
16 than White British  women
11 113 women
3503 White British women
20 at the time these women
16 than White British women
9451 participants
n=64
n=1598
n=345
N  =9
N  =3
N  =8
N  =1
486  invited participants
431 enrolled participants
24 In this study the participants
890  patients
total of 22
431 enrolled
383 patients
16 patients
166 patients
254 patients
14 patients
173 patients
222 patients
29 patients
n=383
n=100
n=218
n=27
n=69
n=16
n=53
N=3915
n=3915
total of 3915
250 participants
10 participants
238 participants
46 Analysis of participants
120 clinical trial participants
247 participants
129 participants
118 participants
395  How were participants
498  Describe how participants
79 million people
n=125
n=3
n=6
N=247
n=247
n=17
n=9
n=91
n=156
n=129
n=118
n=62
n=185
total of  34
total of 1200
250 participants enrolled
1200 infants were enrolled
 data from 247
1424 persons
973 patients
17 patients
153 of these patients
43 patients
212 smear-positive  patients
n=930
n=600
n=330
n=973
n=153
n=110
total of 1424
364 were not enrolled
1002 were enrolled
2096 patients
205 patients
N=18
N=33
N=7
N=3
N=2
N=9
n=43
n=10
310 511 patients
95 977 patients
11 653 patients
7 Referral of all these patients
1989  patients
310 511 patients. After excluding patients
99 165 patients
481 patients
19 of these patients
73 patients
1 Baseline characteristics of patients
n=95 977
n=75
n=37
n=23
n=68
n=40
n=34
n=29
n=28
N=8738
n=11 653
n=48
n=38
total of 481
100 000 persons
1000 persons
36 million  people
1175 participants
41 patients
14 patients
25 patients
100 patients
11 000 patients
11 210 patients
22 000 people
56 million people
56 million  people
n=12
n=27
total of 360
total of 180 000
60 404 men and women
267 153 men and women
100 000 participants
60 404 participants
1 Characteristics of participants
20 A  validation study using participants
361 participants
7  we excluded people
n=9411
n=964
n=673
n=1893
n=1950
n=263
n=213
n=3857
n=13 635
n=15 059
n=12 486
n=7685
n=26 922
n=10 430
n=2959
n=4043
n=1446
n=1933
n=2203
n=669
n=1552
100 000 participants enrolled
 data from the 45
7038 eligible pregnant women
total of 100 000
total of 24 256
13 Equally pregnant  women
120 participants
19  Indigenous people
N=121
N=7
total of 120
 data. A total of 120
 data  from the 2008
34  patients
62 patients
253 patients
121  patients
62  patients
250  patients
1 million people
n=930
n=570
n=360
total of 980
n=20
n=421
n=86
n=527
total of 630
total of 852 799
100 participants
total of  4
n=1011
n=425
n=211
n=214
7 million  participants
 data ranged from 6
620 participants
1000 patients
1900 patients
1 patients
19 patients
n=155
n=293
n=310
n=243
n=21
n=46
n=150
total of  1321
total of 310
total of 25
2911 women
61  sedentary people
10 people
total of 2093
n=5327
n=24 436
N=877 778
total of 105 677
 data from  2004
2010 and a comparison cohort of  women
2010 and a  comparison cohort of women
2010 and a comparison cohort of women
304 803  women
22 We identified all female patients
2010 and excluded  patients
428 patients
62 376 patients
n=62 376
n=304 803
7510 consecutive patients
6591 patients
7510 patients
123 patients
796  patients
1 Baseline characteristics of patients
2 Treatment characteristics of patients
560 patients
9461  patients
634 consecutive patients
11,483 patients
n=4182
n=2187
n=222
total of 7510
total of 796
7800 participants
n=868
n=617
n=251
n=377
n=125
n=191
n=32
n=28
n=3421
n=4562
n=4923
n=257
n=97
n=101
n=24
n=41
n=234
n=634
265 patients
233 patients
145 patients
1 Study patients
n=60
n=205
1003 participants
103 inhabitants  younger participants
471 patients
n=1326
total of 1003
 data from the 2006
6363 women
40 This  may be because women
total of 12 429
total of 11 144
900 patients
2800 patients
500  patients
800 patients
300 patients
600  control patients
1 112 831 women
1379 women
603 women
540 women
277 women
574 women
12 women
26  followed women
27 compared women
N=64
N=532
N=51
N=72
total of 1 112 831
total of 1379
5 transgender women
n=31
n=24
n=7
n=17
n=14
8444 women
n=2125
total of 536
total of 7881
 data from 1998
 data sets from 2003
 data sets from 1998
  data sets from 1998
 data  sets from 2003
594 patients
1669 patients
1320 patients
40 patients
297 patients
541 evaluable  patients
40  elderly patients
n=2
3  A majority of ED patients
528 patients
110 patients
625 patients
60 participants
107  participants
36 and enable trial participants
15 participants
20 and help patients
26 Many patients
658 patients
total of 60
173  participants
132 participants
75 participants
18 participants
57 participants
24 and empowered the participants
75 people
670 000  people
n=132
n=75
n=98
1166  participants
23  The number of participants
30 women
17 women
9  women
16 women
7 women
30 participants
1 as the throughput  of patients
40 These  demonstrate how patients
8,769  early-stage breast cancer patients
n=6
n=3
210 potential participants
300 participants
210  potential participants
30 participants
1 Baseline characteristics of participants
3 million people
n=19
n=30
n=98
n=26
n=24
n=32
n=13
n=3
n=4
n=12
n=18
500 participants
22 Never-takers  are patients
450 patients
1000 participants
4899 people
n=1000
n=23
n=214
n=239
n=198
n=189
N=1000
N=999
total of 11 453
50 patients
633  patients
367 patients
1511 patients
01  Proportion of patients
001  Proportion of patients
98  Proportion of patients
2300 consecutive  patients
n=2
N=148
n=30
n=1
N=106
N=49
N=72
N=76
N=23
N=125
total of 148
170000 participants
56 963 patients
3 Only patients
8714 patients
48 249 patients
11  Real-world  patients
2008  Number of patients
11  Real-world patients
2,532 patients
3 million people
18,686 people
5963 people
N=32 582
N=20 499
N=41 552
N=34 682
N=1428
N=607
N=406
N=45 463
N=33 219
N=12 541
 data from 170000
606 included patients
616  patients
10 patients
606 patients
606 study patients
334 patients
79 patients
14 829 participants
1306  patients
56 patients
20,053 patients
total of 751
total of 12
12 women
13 Normal weight women
n=10
n=12
88 billion people
286  Young people
664  Middle-aged people
000  Older people
total of 8553
101 participants
39  Guideline care  All participants
11 These people
N=12612001180808
2  Pregnant women
188 pregnant women
7145 pregnant women
2375 pregnant  women
2251 pregnant women
188 preg-  nant women
4 pregnant women
n=1040
n=119
n=1525
n=1450
n=1319
n=351
n=323
2 400 542 patients
n=2862
n  =2
n=10
n=2913
total of 2946
total of 2926
10 participants
10 trial participants
40 participants
10 start-up participants
17  In patients
22 HCV vasculitis  patients
255  patients
N=40
total of 3
700 000  people
700 000 people
4 and preg-  nant women
19 Pregnant women
10 106 women
422 participants
10 000  participants
16 and many patients
20 While the majority of patients
10 patients
140 patients
60 participants
26 All participants
64 comparator participants
20 older people
n=20
n=10
n=50
n=5
9028 participants
7568 participants
1 Characteristics of the study participants
2 Characteristics of study participants
1460 patients
1247 patients
31 patients
182 patients
2 diabetic  patients
n=3517
n=2769
n=1282
n=346
n=4513
n=2709
total of 9028
 data of 7568
 data from 20
257  women
258 women
412 patients
11 In patients
2  patients
21 patients
4 Chest X-ray stages of patients
N=196
N=28
n=418
n=412
total of 29
2 Rate of persons
14 LHINs reflect patients
n=105
250 participants
13e participants
5 reports the number of people
31 Given the  people
n=271
n=244
n=540
n=553
n=6
n=2
n=3
n=16
n=60
n=30
n=27
n=8
n=1
n=122
n=121
n=238
n=230
n=51
n=123
total of 1093
1049 participants
1 Baseline characteristics of participants
1130 patients
20 955 patients
713  patients
1800 patients
n=544
n=586
n=61
n=45
n=504
n=565
total  of 2400
631  patients
631 patients
36 among  patients
total of 631
total of 606
15 476 nulliparous women
56 517 women
69 women
15 476 women
1894 women
320 000 people
N=15 476
N=14 463
N=1013
total of 1894
416 participants
n=42
n=416
total of 597
191 more  specific subjects
total of 9178
8707 patients
100 consecutive consenting  patients
30  consecutive patients
30 patients
1 shows the proportion of patients
12 patients
2 Concordance of patients
10 and CIRS  Proportion of patients
2011 survey of  patients
n=20
n=5777
n=2930
178 participants
12  Control subjects
total of 178
 database of 657
n=539
n=129
n=124
total of 848
163 participants
50 patients
50  patients
n=10
N=163
N=60
N=53
N=50
n=50
n=113
n=99
n=64
n=103
n=60
total of 163
 data from 2005
559 consecutive patients
56 surgical patients
n=  27
n=  41
n=  53
n=  28
n  =8
n  =9
n=  44
n=  12
n=  31
n  =2
n  =7
n  =6
n=  17
n=  47
n=  54
n  =1
n=  34
n=  18
n=  33
n=  56
n=  61
n=  11
n=  57
n=  82
n=  19
n=  10
n=  83
n=  42
n  =3
n=  16
n  =5
n=8
 data  from 1998
525 women
73 114 women
10 000 per family per year for women
19 999  per family per year for women
29 999 per family per year for women
30 000 per family per year for women
61 491  male participants
74 941 female participants
61 491 male participants
1 Characteristics of study participants
2 diabetes  Number of participants
2 diabetes mellitus patients
n=1598
n=3
n=126
n=114
n=1458
n=109
n=1
total of 59 910
study population included 61 491
14  participants
79 participants
n=15
n=12
581 women
21,828 British men and women
n=135
n=106
n=13
428 293 young people
total of  428 293
 data  from 134
n=9
n  =9
n  =7
n  =1
total of 2036
total of 3016
total of 110
total  of 11
31 715 there will be no  people
n=143
n=140
n=136
3 compared patients
266 patients
n=266
n=489
total of 30
152 participants
71 participants
1 Clinical characteristics of participants
55 patients
5 An  understanding of patients
717 patients
247 patients
71 patients
29 patients
20 patients
103 outpatients
N=71
n=44
n=15
n=9
n=6
N = 55
790 persons
48 patients
4 people
1 First Nations  people
13 735 people
N=725
n=554
N=554
N=536 253
N=1 324 241
N=514
N=360 378
N=901 509
total of 790
218 matched patients
297 patients
549 patients
726 patients
428 patients
218 pairs of patients
1256 patients
5 million people
N=218
total of 218
419 eligible and registered participants
2 Basic attributes of participants
200 outpatients
413 patients
n=419
n=103
n=26
n=22
n=13
n=166
N=419
N=413
 data from 413
79 patients
76  Proportion of patients
n=53
n=26
5747  patients
100 patients
597 patients
16 participants
n=16
24 Pregnant women
n=2354
n=0
294 participants
294 patients
294  transplanted patients
45  non-transplanted patients
256  transplanted patients
83  patients
294 trans-  planted patients
142  patients
3 Characteristics of patients
17 remaining patients
45 patients
137 evaluated patients
157 patients
12 remaining patients
38 transplanted patients
54 transplanted patients
83 patients
N=109
N=61
N=31
N=17
N=13
N=2
N=1
N=8
N=5
total of 83
n=356
n=923
n=3992
n=567
34 We also report  women
0 million participants
1199 patients
367 patients
5328 patients
2185 patients
1199  patients
2  ambulatory patients
n=380
n=19
n=26
n=83
n=239
n=678
n=521
n=461
n=178
n=157
n=92
n=63
n=27
n=133
n=1199
n=367
total of 1199
691 women
n=1888
n=1197
n=691
total of 1888
total of 1991
N=2
n=1232
n  =1
n=1130
n=1074
total of 1281
264  women
379 women
742  participants
5292 patients
908 patients
948 patients
1 It is not known why some patients
5292 consecutive patients
908 eligible  patients
527 patients
908 eligible patients
948 eligible  patients
46 patients
1136 patients
46 of the patients
93 416 consecutive patients
985 were women
42 participants
2184  participants
2184 participants
2061 participants
n=2061
n=1076
n=985
total of 140
total of 2061
n=15
n=8
n=17
total of 341
total of 29
76  people
152 people
610 patients
7 A recent study of persons
1003  persons
7 Although most people
n=6979
n=25 167
n=56 634
n=34 707
n=1212
n=3789
n=5358
n=1003
n=518
n=100
n=4260
n=4006
total of 25 167
N=749
N=664
N=244
total of 1601
 data from  2008
928 participants
85 participants
34  participants
13 patients
123 ioflupane on diagnoses of patients
248  patients
610 general practice patients
N=726
N=220
N=102
N=326
N=78
N=202
N=610
N  =7
N  =6
928 participants  were enrolled
928 participants  enrolled
1400 pairs of  pregnant women
1512 participants
15 140 participants
15 140 eligible people
n=5500
n=16 691
n=5442
n=5588
n=3566
n=15 140
n=14 016
n=12 807
n=12 746
n=5026
n=4645
n=4272
n=4266
n=3342
n=3117
n=2747
n=2710
n=5160
n=4775
n=4202
n=4185
n=1785
n=1627
n=1472
n=1465
total of 15 140
32 participants
75 patients
8 patients
32 patients
18 patients
14  patients
14 patients
12 patients
18  patients
n=42
n=3
n=9
n  =3
n  =1
n  =6
n  =9
n  =5
32 were enrolled
866  participants
866 participants
n=2
n = 2
n=575
n=364
n=181
n=30
n=862
n=540
n=282
n=40
2500 women
80 000  participants
n=78 008
n=78 720
n=78 924
n=78 388
n=77 979
n=79 701
n=65 482
n=76 450
n=77 698
n=5143
n=72 865
n=38 783
n=36 063
n=2720
n=30 549
n=28 665
n=1884
n=68 606
n=64 148
n=4458
n=74 931
n=69 960
n=4971
n=55 530
n=52 387
n=3143
n=28 163
n=265 569
n=1594
n=48 516
n=45 770
n=2746
 data of  79 701
2764 patients
13 293 for patients
59 606 310 900 252 858 100 431  Total for all patients
n=2674
n=1457
n=1217
n=1170
n=149
n=138
n=2764
n=12
n=8
n=1
n=22
total of 2764
total of 18
583 deaths among women
total of  15 555
 data came from the 2010
 data from 192
350 000 cancer patients
07 â€˜The percentage of patients
08 â€˜The percentage of patients
2015  Percentage of patients
3721â€”the number of eligible patients
1129 registered patients
0001  Percentage male patients
1000 patients
416  Percentage of patients
777  Percentage of patients
n=215
 data from 2012
N=90
n=16
n=90
10  participants
27  Study populations were patients
232  patients
32 patients
n=22
n=67
n=162
n=34
n=97
n=7
n=8
n=4
n=3
n=44
n=18
n=1795
n=232
n=269
n=183
n=32
n=110
n=81
n=26
n  =7
n  =3
n  =5
n  =2
n  =1
n  =6
n  =8
n  =4
n  =  42
n  =  47
n=1
n=  83
n=  14
n=91 378
n=5
n=19
n=15
n=6
n=12
n=222
total of 293
total of 22
total of 1300
380 395 men and women
101 935 male study participants
n=118 082
n=928
n=11 411
n=7592
n=5266
n=3246
n=30 665
n=8819
n=39 041
n=14 223
n=328
n=6482
n=25 146
n=112 281
n=6042
n=1600
n=14 287
n=29 124
n=0
total of 20 453
225 patients
250 patients
108 patients
147 patients
n=108
n=117
n=119
n=131
n=28
n=80
n=46
n=71
n=97
n=100
80 patients
n=24
n=32
 data of 227
35 and women
3822 participants
1274  patients
3822 adult patients
57 million people
100 000 people
N=1274
N=2548
total of 3822
52 patients
18 patients
60 patients
527 patients
2165 patients
n=24
n=28
n=15
n=0
n=1
n=12
n=11
n=14
n=7
n=5
n=23
n=25
total of 78
20 participants
80  participants
400 patients
80 patients
8  and patients
37 especially  how patients
2,212 newly  diagnosed cancer patients
10,297 patients
527 women
495 women
495  women
266 women
243  women
243 women
266  women
n=243
n=266
30 participants
6  patients
437 patients
271 patients
7 patients
189 patients
177 patients
392 patients
8 Most  studies required patients
60 patients
3 Proportions of patients
5 Proportions of patients
n=136
n=154
n=147
n=92
n=91
n=88
n=114
n=73
n=103
n=71
n=132
n=130
n=30
n  =8
n  =7
n=  49
n=  48
n=  16
n=  15
n=  24
10  since people
total of 389
9327 active patients
14 969  active patients
1564 patients
9327  patients
12 271 patients
400 people
10 707 people
n=9327
n=4056
total of 9
40 participants
n=19
n=20
n=3
N=303
N=547
n=42
n=505
194 adult patients
736 con-  secutive adult patients
10 All patients
217 consecutive patients
194 patients
94 elective ICU patients
26 patients
137 patients
23 Our patients
17 For those patients
625 patients
n=5
n=3
n=2
n=1
n=25
n=169
28,613 elderly women
15 Recruited patients
16  Allopurinol washout  Once patients
2282 patients
5706 patients
2853 patients
total of 456
total of 5706
25 Included participants
177 participants
177 patients
1800 patients
189 patients
n=177
n=75
n=35
n=67
total of 189
33 grouped participants
64 subjects
452 patients
64 patients
57 patients
total of 452
103 657 patients
204 733 patients
103 657  eligible patients
N=89 729
N=204 733
N=103 657
219 patients
139 patients
13  â–¸ â€˜Elderlyâ€™ was defined as patients
309 patients
2 Distribution of the patients
916 patients
12 815 patients
500 patients
n=122
n=9
n=69
N=219
N=143
N=37
N=39
total of 219
total of 309
total of  286
n=9195
n=51
 data from  1987
 data from 1985
1 billion people
n=48
n=169
n=528
n=242
n=4
n=119
n=394
100 persons
100  persons
314 million people
212 million people
total of 23
10 000 people
47 750 people
51 094 people
n=4243
N=9
N=3
N=12
N=11
N=154
total of 191
total of 47 750
total of 51 094
total of 25
12 583 non-pregnant women
n=2
n=6
n=761
n=879
N=712
N=666
N=682
N=645
N  =6
N=650
N=625
n=650
total of 12 583
512 participants
n=940
n=100
n=840
13 000 patients
13 Since  people
N=12 875
n = 12 875
n=11
n=16
n=18
n=14
n=59
n=32
23 Some understanding of  women
1144 British public participants
1 but  directly paying people
1 people
n=1144
N=660
N=697
n=11
n=3
n=44
n=10
n=4
n  =9
n  =6
n  =1
n  =2
n  =5
total of 3820
n=329
n=254
n=129
n=115
n=244
n=142
n=28
n=21
n=33
n=18
n=8
n=31
n=20
n=35
n=13
n=7
n=9
n=102
total of 496
total of 914
  data from a 50
4  women
951 participants
14  million patients
272 patients
402 patients
402  patients
696 patients
4  women and patients
10 codes and identified patients
835 000 people
2 200 000 people
n  =4
n  =5
N  =8
N  =7
N  =9
N  =4
N  =1
n=457
n=454
n=951
n=696
N=272
N=220
15  control participants
15 normal  healthy control participants
15 control participants
16 patients
55 patients
8 patients
14  patients
17 patients
27 In patients
11 patients
12 patients
n=16
n=15
N=11
25  The procedure exposes participants
80 participants
68  participants
72 participants
2  people
326 people
80 people
76 people
n=107
n=108
n=111
n=38
n=31
total  of 10
79 people
29 If people
n=15
n=25
N=27
total  of 27
total of 79
total of 27
28 812  postmenopausal women
761 949 participants
347 million people
26 million people
total of 519
total of 761 949
4  As injured patients
300 consecutive  patients
124 consecutive patients
390 damage control laparotomy patients
700 million people
1885 patients
1887 patients
12  patients
n=334
n=92
n=91
n=158
n=197
n=271
n=246
n=163
n=176
n=37
n=47
n=15
n=8
n=219
n=71
n=181
n=88
n=114
n=32
n=134
n=54
n=21
n=52
n=110
n=20
8 million people
total of 668
4 In many patients
11 These patients
528  symptomatic patients
1,626 patients
1000 people
95âˆ’persons
7879 participants
26  Eligible participants
1183 participants
51 804 patients
835 000  people
n=5544
n=2335
2677 Indigenous persons
14 391  Indigenous persons
2 and Indigenous young people
4338 Indigenous young people
total of  2677
total of 14 391
15 patients
14 participants
1250 participants
11  participants
709 participants
1 The  number of people
6  Older people
136 people
1 criteria among people
25 000 people
33 In large cohorts of people
n=672
n=212
n=743
n=895
n=1372
n=1250
64 women
n=92
total of 92
412 patients
31 000 patients
2 A  substantial number of patients
779 patients
n=427
412 patients have been enrolled
131 participants
262 dizzy  patients
35 In dizzy  patients
105  patients
5D requires patients
26  This item asks patients
57 The scale  measures patients
20 patients
10 000 patients
30 participants
35 participants
105 participants
105 patients
12  patients
total of 105
total  of 105
40 patients
16 In patients
9000 patients
22 patients
14 patients
16 patients
32 patients
2 diabetic patients
n=22
n=14
n=16
n=32
total of 28
total of 27
1 780 977 patients
41 389 of these patients
5 561 368 patients
41 389 patients
1 shows the flow of patients
n=48 090
n=8976
n=1 634 853
n=38 468
n=351 526
n=1 283 327
n=11 283
n=27 185
n=9205
n=20 607
n=76 179
n=44 130
n=297
n=610
n=1994
total of 8397
 data from the 2010
106 patients
1 Clinical characteristics of patients
n=80
n=26
n=204
total of 106
243 women
3 Blood indices of elderly women
16 Elderly women
n=1004
n=1025
 data from the 1992
1 Characteristics of study participants
2254  participants
2254 participants
86 All trials excluded participants
1971 participants
86 included  participants
1802 participants
1577 participants
87 participants
23 participants
24 participants
1635 participants
124 participants
86 included participants
1515 participants
56  participants
1983 participants
167 034 participants
1276 participants
1798 participants
1605 participants
1238 participants
41 068 participants
2091 participants
15 721 participants
69 579 participants
3667 participants
1  diabetic participants
46 the patients
11 patients
52  Four trials included only patients
20985 patients
1 diabetes mellitus patients
n=1971
n=1577
n=2091
n=1635
n=1983
n=1276
n=99
total of 1971
total of 1802
total of 1577
total of 87
total of 1635
total of 1515
total of 56
total of 1276
N=10
N=20
N=50
N=100
5377  unmarried women
3 Many women
7440 women
1884 women
179 women
5377 married women
29 The  age range of women
1 Proportion of women
2533 patients
2735 patients
520  patients
604 patients
n=99
n=418
n=2533
n=1650
n=2154
total of 2533
2533 patients were enrolled
2533 patients  enrolled
1 Cancer staging of recruited subjects
27 patients
13 patients
14  patients
total of 27
total of 13
145 patients
213 patients
145  patients
27  patients
125 patients
4 positive  patients
n=63
n=26
n=119
n=56
n=89
n=27
n=118
80 The number of participants
83 participants
106 The  average number of participants
29 participants
n=116
n=54
n=38
n=17
n=14
n=10
n=2
n=21
total of 63
total of 272
total  of 81
total of 69
58 The type of enrolled
N=250
total of 612
1 Numbers of subjects
4899 patients
166 patients
2640 prospectively  assessed patients
1 shows the proportions of patients
401 patients
total of 6556
300 patients
300 consecutive patients
37 229 patients
101 008 patients
100 000 per month in targeted patients
100 000 per month in non-targeted patients
25 We sought data on  patients
37 229  patients
100 000 patients
3039 outpatients
12  In patients
3039 patients
2497  patients
377 patients
165 patients
182 patients
50 patients
35 patients
9 The majority of the patients
8  In patients
n=182
n=3039
n=2497
n=377
n=165
n=135
n=28
n=19
N=35
total of 3039
total of 69
n  =3
n  =2
45 567 men and women
n=4128
n=4376
n=1183
n=169333
n=45 567
n=536 737 272 320 264 417 260 244 246 817
n=11 940
n=11 750
n=10 995
n=10 882
n  =1
n  =4
10  Number of  participants
329  patients
1500 patients
total of 23
total of 276 000
13 million patients
51 804 patients
3 million people
1336 women
2262 subjects
960 subjects
1710 subjects
1354 subjects
1302 subjects
19 Many DE patients
total of 2600
164  participants
1c levels of the project participants
39 participants
1c values of the project participants
1c of  the FiLDCare Project participants
13 knowledge  of the project participants
2800 patients
203 people
19  of people
549 people
1 Demographics of people
n=53 542
n=21 877
n=83
N=42
N=122
n=  16
n=  42
n=  12
n=  68
n=  96
n  =8
n=  81
n  =5
n  =1
n=  8
n=  44
n=  34
n=  78
total of 203
n=23 438
n=5868
n=3460
n=4447
n=9663
1 521 773 patients
18 862 patients
80 543 patients
1 540 635 patients
12 More AM patients
n=25
n=28
n=26
n=1
n=18 862
 data of  1 540 635
 data from 79
11 patients
N=145
N=49
total of 194
2 diabetic patients
9957 cohort subjects
9470 subjects
9957 adult consecutive inpatients
N=196 814
N=132 728
N=329 542
2022 patients
10 074 consecutive patients
n=1373
n  =2
n  =5
n  =9
n  =4
total of 43
345 participants
1 Characteristics of participants
n=361
n  =3
436 438 persons
n=403 305
n=209 946
n=193 359
n  =2
n  =1
4583  mainstream patients
4583 mainstream patients
30 patients
2587 patients
30 randomly selected patients
12  found homeless people
n=2587
n=4583
n=766
n=1821
n=798
n=1997
n=1199
n=724
n=1058
n=3352
n=2294
n=1772
n=216
n=602
n=386
n=254
n=582
n=1395
n=813
n=470
total of 2587
total of 33
750 000 patients
7 and patients
33 patients
5 of their patients
40 patients
6  million people
3000 people
406 people
total of 256
total of  406
47 million  persons
4 patients
n=260
n=158
n=102
n=57
n=47
n=76
n=35
n=63
n=25
n=45
n=19
n=91
n=38
4145 patients
2 CKD definitions whereby  patients
23 028 registered patients
4145 eligible  patients
4 Characteristics of patients
32 patients
16 and limited number of patients
n=667
n=23 028
n=7657
n=4145
n=1094
n=2859
n=2236
n=1099
n=3046
n=2259
n=642
n=63
n=297
n=141
n  =3
n  =6
n  =1
n  =2
n  =7
n  =5
n  =9
n  =4
181 patients
364 patients
1 Characteristics of the patients
2 Characteristics of the patients
44 patients
n=31
n=150
n=44
n=137
total of 181
78 women
38 women
61 women
228  participants
228 participants
76 among all the participants
22 participants
20 participants
1 Characteristics of the study participants
n=228
5 were  enrolled
n  =2
n  =3
n  =6
n  =1
n  =4
n=298
n=319
n=639
n=1109
n=405
n=2770
total of 2770
163 patients
58 patients
14 patients
17 patients
1 Baseline characteristics of patients
3 Comparison of patients
24 patients
10  patients
122 patients
3035  patients
5000 Japanese patients
n=58
n=105
n=163
n=17
n=146
n=14
n=44
50 participants
100  patients
100 patients
total of 220
2105 men  and women
1500 people
3073 people
N=2318
N=1614
N=1186
N=1069
n=42
N=579
N=1027
 data from the 2008
N=13 477 425
N=13 901 175
total of 14 330
total of 25 534
153 consecutive hospitalised patients
245 patients
92 patients
153 patients
1 Inclusion of the patients
131 patients
1 shows the numbers of patients
22 patients
1c values of patients
10  patients
2,471 patients
1256 patients
N  =2
N  =1
n  =4
n  =8
N=22
N=43
N=88
N=131
N=142
n=8
12 women
2  participants
22  A brief description of the participants
5 patients
n=5
n=4
n=501
n=198
n=88
n=20
n=40
n=21
81 NCPs of whom four were  women
1000 women
42 women
2 Characteristics of women
10 participants
2 diabetesâ€  In men and women
3 million patients
8 million patients
100 patients
3 million  patients
6 758 649 patients
3 177 192 patients
 data were ROC of 0
120 adult patients
38 patients
total of 100
total of 120
1 shows the flow of participants
10 146 participants. These participants
1 Flow of eligible  participants
1 shows the participants
10 146 participants
10 146 people
n=7803
n=2343
n=25 056
n  =7
n  =2
total of 10 146
n=17 929
n=746
n=473
n=1485
n=103
n=862
n=391
n=505
n=624
n=619
n=488
n=555
n=914
n=1712
n=299
n=453
n=497
n=498
n=214
n=276
n=682
n=1446
n=516
n=863
n=200
n=233
n= 699
n=66
n=1241
n=269
n=36
n=12
n=5
n=4
n  =1
n  =7
n  =4
n  =8
n  =3
n  =5
n  =6
n  =9
n  =2
n=  27
  data from the 2006
 datasets from 29
8983  young people
8,983  young people
N=2210
N  =2
4500 people
4001 people
n=754
n=590
n=601
n=4500
n=4004
n=4001
N=754
N=590
N=601
N=660
N=530
N=541
n=14
n=1551
n=584
n=496
n=472
n=39
n=16
n=7
N=1
 data from the 2011
400 women
694  women
6 We followed up all the adult participants
1245 participants
1010 people
30 particu-  larly among young people
n=1245
11  If studies also include participants
93  women
65 women
188 patients
11 All  patients
130  consecutive patients
25  patients
126 patients
130 patients
27 AIP patients
3 patients
84 patients
53 patients
5  patients
58 patients
9 patients
28 patients
128 patients
116 patients
35 patients
31 patients
188  patients
20 patients
158 patients
95 patients
30 patients
162 patients
143 patients
26 patients
11 patients
12 patients
27  patients
6 patients
25 patients
93 patients
14 patients
2 patients
2 criteria and five patients
n=117
n=27
n=188
n=130
n=93
n=95
total of 130
13 627 women
43 participants were women
506 women
16286 pregnant  women
53 370 participants
13 627 participants
549 participants
43 participants
4 participants
16 participants
23  participants
0001  Number of illiterate participants
156  Number of smoking participants
811  Number of participants
18 The patients
n=328
n=201
total of 53 370
65 scores among all-cause patients
16 For patients
514 patients
280 patients
58  patients
126  patients
304 patients
n=8
n=76
n=84
n=153
n=128
n=109
n=80
n=156
n=125
n=111
n=81
n=126
n=82
n=155
n=127
n=110
n=20
n=27
n=59
n=39
160 infertile  women
160 infertile women
160 participants
60 patients
60  Once patients
n=40
n=80
total of 160
1117  people
114 participants
228 trial participants
256 trial participants
34 patients
109 knowlesi malaria patients
73 patients
60 patients
11 patients
20patients
200 patients
18 000 patients
42 If patients
120 patients
100 patients
67 patients
332 patients
400 patients
total of 332
0  Mostly women
300 participants
199 participants
n=175
n=125
280 participants
1 Flow chart of the  participants
3 the patients
180  patients
10 people
n=40
n=280
10 000 participants
20 000 patients
4 inhibitor-treated  patients
10 000 patients
10 000  patients
9200 patients
2 diabetic patients
366 million people
24 million people
total of 20 000
71 300 persons
19 because some persons
n=1480
n=80
n=33 330
n=2160
n=626
n=72
n=281
n=590
n=294
n=689
n=187
n=327
n=34
n=29
n=320
n=179
n=49
n=18
4295 MSM  enrolled
400 participants
200 participants
50 participants
30 inter-  vention participants
n=10
n=15
n=400
total of  400
total of 400
total of 30
1253 participants
1192 participants
25 874 participants
167 590 participants
total of 310
297 participants
1 Flow diagram of participants
n=184
n=297
n=51
n=167
n=79
1500 patients
100 000 patients
3 726 380 people
7  million people
1500 patients  enrolled
 data from  2011
 data from 2004
99 and women
56 865 participants
24 Study participants
297 148 participants
293 488 participants
86 810 participants
n  =4
n  =  15
n  =5
n  =1
total of 56 865
864 consecutive patients
125  patients
300 patients
25 000 patients
847 patients
864  patients
432 patients
528  symptomatic patients
total of 864
total of 847
n=8
n=2
n=10
n=6
n=14
N=28
N=13
N=24
N=31
 data from 661
25 Most patients
49 Since  patients
 data from 10
511 participants
547 participants
511 study participants
total of 547
total of 511
total  of 61
total of 166
9056 participants
9203 participants
1 Proportion of participants
2 Proportion of participants
8983  young people
N=9203
n=19 430
n=1017
n=172
n=11
n=147
N=9056
n=9056
n=4995
n=4208
n=7031
N=40
total of 10 220
total of 20
15  Number of participants
100 000 patients
25 We considered patients
4 Proportion of patients
8 Proportions of patients
5 640 313 participants
90,056 participants
170,000 participants
35 defined as patients
7 million patients
175,000 people
n=0
total of 12
total of 13
  data analysis of 22
 database of 11
 data  from 90,056
 data  from 170,000
 data  from 175,000
1090 women
94 000  women
15  Among postmenopausal women
2 million women
157 997 women
146 338 women
10 689 of these women
92 834 women
1090  women
87 334 women
86 284 women
1 121 women
5508 women
92 834 UKCTOCS participants
total of 157 997
total of 10 689
 data. The HR of 1
N=1221
N=1194
N=553
N  =5
N  =1
total of 1221
total of 553
16 Survey participants
total of 13 896
 data from HSE 2009
702  patients
391 patients
311 patients
702 patients
1 Flow diagram of  patients
3 The proportion of patients
n=391
n=311
2742 patients
1718 patients
475 consecutive outpatients
total of 58
N=3
N=1
N=7
n=37
N=40
N=9
N=160
N  =1
1  Symptomatic participants
97  participants
n=801
n=97
n=34
n=63
n=38
n=59
N=1720
N=801
N=100
N=153
N=34
N=63
N=37
N=59
100 000 persons
100 000  persons
total of 335 609
5036 participants
5209 participants
5036 eligible study participants
n=5036
n=576
74  experimental participants
74 control participants
11 These patients
800 patients
25 000 people
total of 1136
total of  1136
total of  1206
1 Flow of participants
10 000 patients
4701 patients
50 surgical patients
200 patients
2000 patients
6000 patients
22 000 patients
2500 patients
1200 patients
n=13
N=200
N=400
N=50
N=100
N=90
N=80
N=70
1026 patients
878 patients
962 patients
1025 CDI group  patients
101 patients
924 patients
11 patients
102 patients
23 The mortality rate of patients
total of 1026
total of 962
 data from 924
600 study participants
300 participants
10 patients
60 patients
2  The number of patients
2649  postmenopausal women
100  participants
4 Many  patients
400 eligible patients
20  patients
9 A high pro-  portion of people
4200 people
10 persons
32 832 participants
32 832 study participants
4 million people
n=1242
n=3
N=32 832
N=313
n  =3
N  =1
N  =4
N  =8
N  =2
n=313
N=15 279
N=4794
N=8307
N=2480
N=2099
N=8162
total of 32 832
109 patients
17 a group of patients
22 nor did patients
17 no patients
18 included patients
19 included  patients
n=  14
n=  81
n=  8
n=  16
n=  26
n=  10
n=  32
n=  69
n=  19
n=  13
n=  11
n=  21
n=  65
n=  18
total of 266
128  participants
7  The participants
8  Participants  The participants
73 participants
128 participants
128 consecutive patients
92 patients
73 patients
37 patients
4184 LBP and patients
150 eligible patients
128 patients
22 patients
55 patients
65 patients
66 patients
58 patients
35 patients
23 patients
4 patients
27  patients
73  patients
27 patients
5  people
n=36
n=73
n=55
total of 128
total of 4184
20 participants
n=1360
n=140
n=145
n=68
3660 patients
3600  patients
3600 patients
3664 patients
1188 patients
12 and patients
2500 patients
total of 3664
1510 patients
n=16
n=11
n=10
n=3
n=5
n= 4
n=2
n=9
n=1
n=8
1 Baseline Characteristics of participants
n=13983
N=13 983
total of 8420
total of 8610
9  patients
21 studies  and groups of patients
41 of the patients
51 In patients
36 of outpatients
n=10
n=17
n=3
n=4
n=21
n=14
n=6
n=19
n=15
n=56
n=8
n=45
n=27
n=16
n=2
n=1
total of 1491
 data of the 21
41 All  participants
23 participants
4 Baseline characteristics of patients
N=23
n=2
n=0
n=30
total of 66
550 new patients
1000 adult  patients
1000 patients
550  patients
275 patients
102 consecutive  outpatients
104 patients
102  consecutive patients
102 patients
84 patients
13 patients
5 patients
37 patients
15 we examined how women
1000 women
15 These  women
34 additional women
36 women
1 interviews showed women
15  women
50 women
2 participants
15 participants
1 participants
1  participants
17 Trial participants
n=15
n=34
n=13
n=16
n=18
n=6
58  While online access allows patients
76 and patients
97 103 106 112 116 120 121  While patients
n=17
n=13
n=3
n=5
n=16
n=8
total of 143
total of 780
21  RESULTS  participants
9  Manual participants
16 people
n  =2
n  =1
n  =6
25 000 of these patients
1000 patients
1000  patients
3  female patients
n=216
n=165
n=36
n=33
n=30
n=26
n=24
n=21
n=20
n=5
n=4
n=1
total of 10
total of 288
total of 20
100 participants
total of 1000
total of 1300
total of 10
1000 children enrolled
200 children enrolled
228 patients
6  We enrolled patients
253 patients
21  patients
15 patients
6 patients
53 patients
0 velocity than  patients
0 velocity than patients
n=53
6  We enrolled
28 192 pregnant women
75 200 fathers. Pregnant women
34 The women
28 192  nulliparous women
28 192 women
28 192 pregnant  women
2997 women
n=1491
n=2493
n=63 808
n=1475
n=29 111
n=736
n=4294
n=450
n=1976
n=979
n=11
n=584
n=632
17 000 women
10 million eligible  women
1789 women
300 women
5000 women
103 participants
45 participants
40 participants
124 participants
280  participants
321 participants
280 participants
8 patients
64  patients
1 diabetic patients
total of 5
total of 103
total of 321
39 748 patients
40 000 people
63 558 people
39 748 people
31 The majority of people
n=25 961
 data from 2012
 data from 2002
65 women
65 participants
160  participants
42 patients
160 female  patients
26 patients
total of 16 595
total of 160
184 women
21 All women
16 primipar-  ous women
n=0
n=184
n=368
1 required   subjects
2 required subjects
1 Subjects   Fifty-six subjects
900 persons
n = 2
16 adult subjects
16   subjects
16 subjects
 data of the 16
25 people
55   How often do people
13 participants
60   people
25 people
total of 190
36 subjects
n = 17
n = 35
n = 59
n = 3
n = 6
n = 10
36 subjects
3 percent of the subjects
total of 2397
10 people
7 people
total of 415
22 participants
22   participants
4 people
15 people
total of 68
90   subjects
18   control subjects
18   contingency table subjects
18   probability map subjects
18   signal detection curve subjects
18   detection bars subjects
18 subjects
1000 people
101 people
total of   16
8 subjects
7 other subjects
110 subjects
total of 110
   data from 4
 database of 10
42 subjects
total of 42
01 tbm subjects
5812   ABSTRACT   Forty-two subjects
42 subjects
4 summarizes the subjects
N = 42
total of 55
290 persons
n   = 2
n = 1
n =   0
n = 730
n = 947
n = 792
n   = 844
n = 771
n   = 864
n = 921
n = 813
n = 960
n = 847
n = 926
n =   987
n = 1094
3 female   subjects
4 female subjects
15   subjects
34 people
total of 52
total of 48
total of 34
total of 14
1985 the following people
0 allows multiple participants
8 shows two   participants
4 people
n = 13
n =   11
total of 1802
13 participants
7 Such people
6 subjects
1â€™he everyday life of people
28 subjects
 data from 28
total of 21
2 lists the numbers of  participants
0 Percent of participants
0 people
total of 226
total of 102
n = 16
2 video configuration of all  participants
total of  252
1  people
11 subjects
67  N = number of subjects
n = 4
2 participants
15 participants
12 of the  subjects
3 subjects
10 kHz region of the subjects
16 subjects
12 subjects
12 individual subjects
11 of the subjects
8 experienced subjects
8 subjects
16  subjects
total of 18
 data from 6
 data from 18
7 subjects
5 subjects
total of 589
172 confer-  ence participants
14  subjects
2 subjects
1 subjects
N=8
N=5
1992  The subjects
12 subjects
20 subjects
50  most importantly people
50 people
4 people
total of 30
n =  1
n  = 0
n = 1
n = 200
n= 235
n = 152
n = 269
N = 63
N = 42
N= 18
N =25
N  =27
N = 15
N= 22
N = 26
14 women
40 subjects
n = 78
total of 1170
6,000 miles away  with those of people
2k!&& Fourteen subjects
6 as subjects
24 curn?nt participants
total  of 78,240
22 other people
48 participants
8 people
total of 48
total of  47
0  subjects
1992  All participants
12 subjects
6 subjects
12 younger  subjects
6 older subjects
6 older  subjects
40 different people
total of 72
n=5
n=2
15 women
48  subjects
22 people
total of 27
total of 40
135 people
6 shows the number of errors subjects
4 subjects
total of 18
10 participants
total of 6
35 people
60 subjects
26 Novice subjects
total of 26
n  =3
93  Method  Six participants
32  volunteer subjects
14 deaf people
n = 6
n = 9
n = 1
n  = 2
n =  10
n = 5
15 subjects
15  Number of test subjects
N=41
n=9
total of 3000
n= 01
n =  4
n = 20
n = 14
n = 22
n = 6
26 subjects
6 display scores of two subjects
total of 69
total  of 14
300 people
total of 84
2  involved subjects
3D data?  Seven subjects
4  subjects
total of 60
8 people
40  subjects
15 subjects
45 subjects
total of 216
total of 3240
20 participants
27 subjects
200 subjects
24 subjects
4 fully within-subjects
n = 48
  data rate of 38
n = 8
n = 1
n = 2
  database of 10,000
15 subjects
n =  8
n = 0
n =  1
2,000,000 people
n=33
10 subjects
total of 45
total of 10
1 asked subjects
2 required subjects
7 gave  subjects
8 asked subjects
10 required subjects
22 people
50  people
97 other people
20 internal and external people
N= 152
N=142
N= 294
total of 294
total of 55
  data from 5
 database of  249
 database of 249
00001  five subjects
total of 180
 data from  24
12 subjects
12 of the subjects
total of 6794
7 people
12 people
10 subjects
N = 17
N = 14
N =  14
N = 16
total of 1
total of 55
 data from 1993
total of 8
total of 3,013
total of  1,945
17meetingparticipants
30 subjects
17 people
3 users were salespeople
37 people
12people
20 people
290 YO people
total of 7429
10 subjects
n = 19
n = 6
n= 6
17  Formal Recruit and train subjects
0 scroll bar which many subjects
10 women
20 people
23 subjects
11 subjects
12 subjects
n = 1
9 subjects
10 subjects
total of 240
total of 19
total of 23
12  subjects
5 started after the  subjects
7 demonstrates subjects
15 participants
64 elderly  participants
33 subjects
1 Results  Although subjects
44 subjects
66 subjects
48 subjects
5  When people
N = 44
total of 25
total of 15
total of 45
total of 20
49 people
n=15
n=12
total of 50
2 is not aimed solely at people
total of 410
total of 38
90 percent is spent on the participants
200 people
291 participants
291 total participants
 data set   of 55,000
50 people
10 people
2000 people
1000 people
 database from 575
12 subjects
total   of 8
total of 20
total of 296
10 subjects
16 subjects
total of 180
total of 16
50   studies of the way people
141 people
250 people
30 people
4 subjects
72 subjects
total of 72
total of 4
total of 209
total of 131
7   volunteer subjects
3 shows subjects
30 people
24 subjects
1   asked subjects
total of 24
total of 18
4 participants
6   participants
130 people
12   Number   of people
51 subjects
95 MOSAIC OF CREATIVITY   subjects
total of 51
176 subjects
58 subjects
118 subjects
25 people
n = 58
n = 118
1 shows an excerpt of patients
40 people
N = 10
3 the danger of   confusing people
n=64
n=16
Total of 6747
total of 1259
12   participants
3 were aimed at providing participants
4 wc had asked all participants
4 than SS participants
N = 4
N = 8
n = 12
n = 14
10 subjects
10   subjects
2 relatively few of the subjects
total of 38
total of 21
9 participants
20 participants
n = 3
n = 2
157 participants
126 participants
n=48
5 effectively   describe subjects
6 subjects
10 subjects
6 shows the subjects
5 subjects
4 subjects
data from all 10
12 seconds long and participants
total of 29
total of 7
43 subjects
101 participants
n = 117
total of 101
6   participants
16 subjects
total of 540
total of 10
100 subjects
560   subjects
95   involves many people
400   people
50 children of CHI participants
6 except the sighted subjects
18 subjects
N = 17
N = 16
N = 14
1  Description  Five subjects
26 people
50  the changing roles of participants
104 participants
570 of the participants
49 million people
total of 17
3 loudspeakers around the  subjects
3 â€˜Iâ€™he best the meeting participants
1997  brief study of people
12 subjects
total of 12
12 subjects
29 subjects
3 subjects
2 subjects
3 summarizes how the subjects
14 subjects
6  subjects
n=14
n=15
n=29
8 participants
16 subjects
6 subjects
8 female  subjects
N=8
25 people
13 subjects
n = 1
8  participants
N = 8
N = 533
7?ight  conditions where subjects
10 subjects
n  = 45,000
3D movement  required subjects
5 compares subjects
14 subjects
n  = 5376
25 people
5 people
n  =  1
4 of the subjects
5 subjects
total of 64
total of 6
 data  from 23
N= 100
50 people
23 participants
23 subjects
55 subjects
1997  All subjects
24 subjects
16 subjects
1997 PAPERS  Typers and the other subjects
n=5
n=3
n=8
n=6
n=9
18 subjects
8 subjects
N = 9
N= 14
1 Characteristics of the blind subjects
1U bll  subjects
2 late blind people
total of 4
total of 1800
total of  4018
630 million people
6 people
9,000 people
45 people
30 people
81 participants
81 subjects
27 subjects
 data from T5
120 people
1   A between-subjects
2   A between-subjects
N=123
N=23
31   participants
20 subjects
8 All subjects
total of 44
36 subjects
total of 12
n = 100
n = 20
n = 250
n = 500
total of 1801
10 diagrams the subjects
26 subjects
26   subjects
3D   worldlets enabled subjects
15 different people
n=7
total of 8
45   were subjects
total of 45
65 subjects
35 subjects
n = 36
n = 34
2 subjects
15 subjects
9 â€œnon-mobileâ€ subjects
6   of these people
19 subjects
total of 24
12 subjects
total of 12
16 subjects
10,000 people
1,057 people
967 people
126 people
796 people
899 people
118 people
718 people
300 people
31 people
448 people
n = 3
n = 1
N = 742,833
12 participants
total of 19,440
3 people
N = 558
N = 559
N = 515
n=81
n=99
total of 3122
total of 3
330 participants
6 participants
6 people
2 people
N= 179
 data from 179
3 patients
total of 7,588
50 participants
N = 7
6 participants
5000 students enrolled
29 subjects
30 subjects
13 participants
2 shows   the participants
3 subjects
6   subjects
10   women
150   people
15 people
total of 6481
 data consists of 144
total of 43
4 participants
16   participants
N=16
n=16
12 subjects
6 compares subjects
16 people
total of 17
3 subjects
5 subjects
2 subjects
total of 48
1 Conditions Tested  All subjects
15 subjects
400 participants
40 subjects
20,000 people
total of 35,047
total of 314
total of 1
total of 1,275
total of 2,970
total of 3
total of 2125
25 participants
total of 270
total of 720
n = 5
n=5
n=15
11  participants
20 within-subjects
total of 48
24 subjects
20 subjects
20  subjects
15 subjects
3 subjects
total of 250
10 people
15  people
14  people
13 people
 data rate of 500
11 undergraduate participants
total of 108
48   participants
total of 892
2s condition  all eight participants
total of 4,000
98 subjects
5 groups of subjects
2 subjects
3 sites and TopicShop subjects
16 subjects
total of 639
10 participants
2 compares participants
4 compares participants
2 participants
n   = 3200
15 subjects
20  subjects
9 subjects
1 shows the number of subjects
n = 3
24 subjects
12   subjects
12 subjects
N= 12
N=12
N=24
total of 30
24 users who   enrolled
 data from 12
81 Procedure   Sixteen people
N=12
N=6
25 adult participants
200 people
2 within-  subjects
32 unpaid subjects
30 of the subjects
15 of the subjects
19 subjects
15 subjects
N = 32
total of 32
8 participants
4 shows the growth of   participants
25 web sites participants
30 participants
001   model type participants
10   repetition participants
001   simp x rep participants
total of 90
total of 60
15   subjects
10 required subjects
total of 30
   data consists of 1151
1   Five  participants
30 participants
60   people
24 participants
24 subjects
12 participants
n = 99
n = 82
n =   25
n = 17
n = 4
total of 14
6 women
20 participants
N=140
N=139
10 participants
6 participants
N=30
4 female   subjects
8 subjects
4 subjects
2 show evidence of subjects
total of   8640
total of  56
24 subjects
3 shows the   questions and subjects
n = 6
n = 1
n = 0
30 male participants
15 participants
14 participants
4 participants
289 people
total of 289
78 subjects
36 subjects
10 subjects
N=36
N=49
N=22
72   participants
41 of the participants
11 million people
total of 72
8 participants
8   participants
total of 6
13 participants
1 shows how the pilot survey participants
99 panel participants
84 people
20 HCI people
total of 111
total of 134
 data from 134
38   participants
87 subjects
4 subjects
83 subjects
81 subjects
12 of the subjects
N=1555
N=147
N=566
N=216
N=192
N=310
N=307
N=305
N=314
N=319
N=12
total of 1740
total of 19
100 people - and many different people
8 people
1 was the differences   among participants
total of 3
24 participants
1500 people
36 people
60 participants
20 teams of three   people
N = 180
2 subjects
13 subjects
total of  8
total of  96
12 subjects
12 differ-   ent subjects
11 shows the subjects
12 new subjects
total of  48
2,000 non-   research staff. The subjects
1 subjects
22 subjects
150 V-   Chat participants
00   What do people
3D V-Chat Features   Do people
20 other people
3D features had on people
total of 119
total of 1979
90 adult subjects
66 subjects
total of 90
total of   66
67 participants
19 participants
48 participants
69 participants
total of 10
n=3
42 subjects
159 potential subjects
20 people
total of 4
4 university people
12 subjects
3D pointing task where subjects
18 subjects
24 subjects
n=3
 data from 45
N=109
N=77
N=21
total of 184
N =   2
total of 30
17 participants
n=8
n=9
n=6
n=11
n=7
n=10
n=4
n=13
24 participants
8 participants
11   remaining participants
total of 32
total   of 16
9 participants
18 participants
4 people
9 people
11   people
6 people
N = 24
5 percent of the participants
84 percent of   participants
5 participants
3 within subjects
total of 24
total of 6
18 participants
3 shows the participants
6 women
24 participants
10 participants
3 participants
4 of the younger subjects
5 older subjects
24 young   people
total of 24
total of 87
total of 84
total of 42
15   participants
20 people
total of 30
8 participants
12 participants
total of 216
total of 302
20 subjects
3 within-subjects
11   subjects
16 fewer questions than subjects
10   subjects
3 shows the subjects
11 subjects
N=58
N=354
N=20
N=19
total of 106
19 male subjects
100 participants
n=6
n=5
N=24
N=26
n=2
total of 15
15 subjects
12 subjects
10 subjects
2 subjects
9 subjects
12 subjects
1 subjects
total of 39
80 million people
55 percent   more trusting than people
n = 5
n =1
n = 6
n =0
n   = 5
n = 1
n   =1
n =   5
n =   1
n =2
n = 3
n = 4
total of   16
total of 94
31 people
35 people
434 persons
202 participants
20   subjects
n=3047
total of 3,047
5 women
3 participants
13 participants
13  participants
7 participants
n = 1129
n = 952
n = 1160
n = 920
28 subjects
2D Even subjects
28   Even subjects
3D Odd subjects
27   Odd subjects
14 subjects
total of 24
6 shows a histogram of subjects
5 subjects
4   people
12 people
13 people
n = 12
n = 13
18 participants
18 interview participants
7 people
8 participants
N = 8
n=5
n=1
n = 1
14   participants
N = 3
N = 6
N =3
N=6
16 participants
n = 6
N = 2910
100 people
220 people
n=20
n=71
1400 participants
1410 participants
1400 people
20 people
30 people
1441 people
n = 0
13  subjects
13 subjects
41 pairs of people
 data from 13
3 women
40   subjects
3 subjects
3   participants
12 participants
10 within-subjects
total of 15
198 total subjects
N=14
N=16
20 participants
10 feature-  keen participants
19 participants
19   If we consider all participants
13 participants
7 participants
3   participants
17 participants
7   participants
N=19
N=20
10 shows participants
total of 236743
10 people
2 other people
135 different pairs of   participants
28 participants
13 people
32 people
1   Four people
28 people
6 people
3 people
37      pairs of people
 data come from 28
18   participants
13 of   the participants
69 subjects
13 subjects
3D interface   allowed the subjects
01    The subjects
1 concerned how easy the subjects
10 participants
24 participants
24   participants
1 across participants
24   people
4 people
n=19
n=13
n=8
n=6
n=4
n=3
n=67
n=95
n=80
n=78
n=60
n=89
n=83
total of 105
total of 320
6 people
8 subjects
N=12
3 within-participants
total of 4000
total of 1746
n = 25
24 subjects
8 of the subjects
4 of these   subjects
4   subjects
22 participants
4,000 participants
22 subjects
22   people
total of 340
5 women
4 women
100 people
1   and people
13 subjects
16 participants
7 of the participants
12 participants
43 participants
2,222   women
8 participants
5 participants
13 participants
N=66
total of 9
  data consists of 5,346
3 participants
35   patients
009  Meet other Hutch patients
84 people
59     people
11 people
N = 33
N = 13
total of 37
n=18
n=2
total of 55
14  subjects
13 people
n=1
n=6
n=8
462 participants
353 participants
334 participants
2 participants
7 participants
N = 315
total of 462
total   of 353
total of 334
total of 7
 data   from 15
6 experimental participants
23 experimental participants
20 experimental participants
1 participants
20 experimental   participants
 data from 20
10 people
20 people
5 people
3   Number of people
1   Percentage of people
n=102
total of 191
total of 18
12 subjects
14 subjects
3 Three subjects
14   subjects
7 subjects
10 subjects
13 subjects
10 of   these subjects
27 people
total of 400
450   people
250 people
39 people
7 people
90   people
12   people
188 people
30 people
total of 562
3 other people
3 people
24   participants
24 participants
total of 4
115 participants
69   participants
13 participants
110 participants
5 participants
n=115
12 participants
2 participants
60 percent of the   participants
3 percent   of the participants
100 participants
300 participants
200 participants
411 participants
42 people
1,000 people
total of 411
1,000 people enrolled
2 within subjects
10 participants
8 participants
8 people
total of 60
total of 26
total of 720
n = 1
n = 2
3 within-participants
20 participants
12 subjects
21 subjects
total of 12
n=4
n=2
total of 672
total of 56
182 participants
30 randomly chosen participants
N=182
total of 20
68 assertive participants
64 nonassertive participants
130 participants
142 initial participants
72   participants
80   participants
total of 72
total of 80
16 participants
16   participants
total of 32
total of   6
30 subjects
total of 30
32 young participants
2 participants
n=29
n=30
n=12
n=8
n=10
5 participants
46 participants
8 participants
40s and three of the   participants
7 participants
9 participants
11 people
6 participants
n = 6
n=4
13 participants
18 participants
32 participants
n=139
n=21
4 factorial within-subjects
4   people
2 people
13 different  people
4 people
7 people
50 people
20   people
16 subjects
1   on participants
2 participants
12 subjects
11 subjects
6 subjects
85 participants
204   people
total of 40
 data from all 204
244 subjects
1952 sessions   because some subjects
total of   244
total of   8
total of 1386
48 participants
n=6
n=2
n=5
n = 5
30 participants
18 male  participants
total of 536
total of  274
total of 1599
total of 1892
total of 30
75 participants
13 participants
total of 31
1 illustrates the different people
total of 100
20 subjects
19 subjects
18 subjects
14 people
n=30
n=46
n=4
n=1
n=10
n=33
total of 477
2 participants
30 subjects
28 subjects
n = 27
n = 23
n = 13
n = 9
total of   1198
4   participants
2 participants
10 people
total of 10
N = 80
12 participants
3 subjects
10 subjects
total of 15
7,000 people
4 people
4,300 people
7,342 people
480 people
750 people
246 people
153 people
3   Seeing people
2   Seeing people
178 people
148 people
71 people
n = 236
n = 180
N = 245
150 people
0 people
1 people
63 people
n=23
8 participants
8 subjects
8 people
total of 64
3 women
4   women
20 participants
10 participants
4      The participants
n=24
n=88
n=29
n=21
n=84
n=30
n=54
7 participants
N=100
N=0
total of 10
17 different people
8 people
total of 165
total of 17
16 participants
22 additional participants
3 shows the   percentages of participants
n=16
n=22
 data from the 16
34 subjects
15 subjects
1 examined subjects
5 shows subjects
n = 6
N = 0
N = 1
total of 105
15   participants
15 participants
5,000 people
13,630 people
33 people
5,000   people
107,000 people
total of 13,630
n=101
14 participants
2 people
30 participants
10 trials across all participants
12 participants
total of 4
total of 192
8 participants
2 within-participants
04 participants
33 people
n = 1
n = 3
n = 2
n = 5
n = 90
total of 33
N=140
n = 0
total of 563
4 non-aphasic participants
8 male participants
9 participants
3 participants
5 participants
2 There were no participants
1 million   people
100,000 people
15 famous people
N=8
N=9
 databases of 15
5 women
15   participants
4 Two participants
n=23
n=95
12 participants
n=25
total of   30
total of 16
total of 198
total of   116
total of 576
n=63
n=39
n=65
total of 55,158
3   participants
12 participants
total of 1326
n =1
n = 3
n = 1
total   of 14
total of 216
total of 9
total of 1080
23 persons
3   persons
7 participants
4 people
50 people
total of 23
2 within-subjects
65 men and women
N=50
N=52
6 women
total of 6
n=47,474
n=28,277
12 participants
140   people
100,000 subjects
31 participants
8 of the participants
2 we also invited the participants
29 participants
2   participants
31   participants
1 participants
2 participants
21 participants
21 multiple-strategy   participants
10 participants
2    Eight participants
3 participants
2 we also invited participants
n=31
n=8
n=4
12 participants
n = 28
total of 60
total of 44
230 subjects
163 subjects
245   people
29   people
15 people
2 postulated people
3 stated people
6 predicted people
total of 1473
5 participants
total of 81
10 participants
20   participants
40 subjects
total of 741
 database of   840
1 the participants
21 million people
20 withinâ€“subjects
total of 40
4000 people
N=29
n=25
1  participants
12 participants
5   participants
19 participants
14   subjects
5 subjects
19 subjects
8 subjects
total of 8
8 women
12 subjects
3 minute timer reminded   participants
18 participants
2Dâ€  participants
8 participants
8 participants
7   participants
20 people
5 women
5 participants
15 participants
total of 109020
27   subjects
27 subjects
3 subjects
3 of the   subjects
8 subjects
15 subjects
n=788
N=27
total of 27
19 participants
17   participants
17 participants
9   participants
2 over the   seven participants
11 participants
15 participants
n = 0
total of 95
 data of 17
total of 70
117   The people
N=157
N=146
36 participants
25 participants
6 participants
N=36
N=13
N=33
total of 36
1 shows how many subjects
68 subjects
60 subjects
204 subjects
total of 204
1 details the individual participants
20   participants
3 subjects
6 subjects
6  subjects
16  subjects
16 subjects
8 subjects
 data of 3
 data from all 16
total of 50
n=1
8 self-selected  participants
total of 806
13   participants
13 participants
20 participants
12 of the   participants
7 participants
2 participants
39   participants
n=77
n=22
total of 65
total of 39
total of 532
N=8
total of 4420
total of 4307
total of 18
13 participants
24 participants
22   participants
25 participants
4 subjects
500 million people
3 million people
10,000 people
6 shows  the number of subjects
28 subjects
16 subjects
total of 28
total of 5
20 experimental participants
38 experimental participants
23 experimental participants
113 experimental participants
100 new tasks  The subjects
total of 164
total of 64
total of 93
 dataset of 164
N=2246
N=1281
N=1282
2 notified participants
total of 475
total of 54
8   persons
total of 460
total of 26
6 participants
3 participants
4 participants
2 participants
9 participants
5 participants
total of 57
total of 22
10 right-handed   participants
3 within-participants
8 right-handed participants
18 subjects
10   people
2   people
8 people
total   of 72
total of 240
N = 43
N = 36
N = 4
N=21
N=22
N = 321
N = 298
N = 28
N = 29
total of 117
129 total   participants
total of 57
8 participants
10   participants
3 participants
10 participants
5 randomly   selected participants
196,000 people
8 participants
8 subjects
total of 1541
8 participants
total of 28
 database from 1989
2 participants
15 participants
n   =8160
N=64
N=60
15 participants
n=284
n=286
n=1513
5 people
5 women
15 women
24 participants
24   participants
 data from 24
3   participants
12 male participants
24 participants
8 participants
3 shows the responses of the participants
18 people
15 people
total of 18
total of 15
total of 7
3 participants
5 participants
11 participants
total of 11
7 people
total of 34
44  participants
24 participants
36 participants
3 million people
5 million people
N=20
total of 4
total of 90
18 participants
18 participants
18 subjects
n =  9720
total of 9261
3 of the subjects
total of 103
total of 21
40 million people
15 million people
total of 11
10 people
78th floor where hundreds   of people
24   study participants
24 people
total of 52
9 participants
11 participants
11 of the participants
total of 45
121 people
N=581
N=121
total of 581
n = 1286
n = 406
total of 1083
27 participants
n=27
n=7
n=12
n=20
n=35
73   participants
3   participants
23 participants
3 within-subjects
1   Twelve people
total of 384
3   persons
35   participants
21 of the   participants
34 participants
46 user study participants
34 subjects
12 subjects
20 subjects
19 subjects
34   subjects
12   subjects
total of 20
12 subjects
3 of the subjects
23 participants
48 participants
N=48
N=96
16 non-technical participants
16 non-technical   participants
16 participants
16 study participants
12 participants
2 shows a breakdown of where   participants
17 people
14 people
total of   2,015
total of 17
18 women
total of 36
24 female participants
n=26
n=27
n=23
n=24
10 most frequent   participants
33   people
n = 4
total of 2062
110 people
1,532 people
N = 7311
N=44
N=83
N=127
total of 215
11 participants
12 events of other people
25 subjects
5 subjects
n=25
n=8
n=28
n = 9
N=25
32 participants
14 participants
n=13
n=32
n=14
30 participants
n=9
n=47
n=7
n=1
n   = 11
12 participants
12   participants
12 subjects
n=19
n=13
n=6
2,723 subjects
437 subjects
1,982 subjects
2,723  subjects
6 shows subjects
119 people
3 shows people
N = 1
N = 44
N = 357
N = 11
N = 12
total of 2,723
total of  2,755
8   women
25 subjects
4 people
100   participants
100 participants
4 participants
n = 3
n=3
n = 2
total of 100
total of 48
total of   151
24 participants
600 trials  The participants
12 subjects
n=13
total of 79
total of 104
5 women
5   women
9 subjects
12 participants
36 people
40 subjects
42 subjects
N=40
total of   600,000
total of 40
total of 35
14 participants
n=2
n=3
n=5
n =   686
2 women
20 trials and participants
3We asked participants
4 within-subjects
12 people
n = 1
n=1
n = 1517
n = 1755
total of 720
total of 8
total of 48
5 participants
17   were women
8 participants
16 participants
50 disabled people
51 disabled people
50   people
total of 1000
 data from 16
N = 41
N = 97
N = 47
N =   44
N =   47
total of 138
12 individual participants
N=20
96 participants
total of 96
2 people
n=5
n=4
20 subjects
10 subjects
8 people
5 people
total of 253
16 000   participants
10 participants
n=775
48 participants
N = 12
N = 6
total of 48
total of 24
total of 337
24 subjects
n = 1
n = 4
total of 49
7 subjects
4 subjects
total of 25
total of 288
6 participants
26   participants
196 people
885 distinct people
6 people
9 people
N=15
total of 1,843
total of 5,799
total of   101
total of 24
total   of 36
20 participants
20 subjects
5 people
20 people
N=20
total of 158
total of 20
130 participants
N=39
N=26
total of 130
 dataset of 193
N=15
N=8
N=3
4 participants
2 participants
N=16
N=4
total of 519
2 participants
6  participants
37 participants
39 participants
total of 45
total of 20
50 participants
21 participants
N=36
N=20
N=40
225 people
 data from 225
10   women
7 people
10 people
total of 10
12 right-handed   participants
4 within-participants
n = 0
total   of 128
total of 384
total of  4608
3 within-participants
12 participants
total of 4320
8 participants
8   participants
total of 2560
16 participants
16   participants
10 participants
6 participants
n=84
total of 212
34 participants
34 undergraduate participants
3 participants
total of 3808
20 participants
18 participants
10 participants
2 participants
20   participants
8   subjects
20 subjects
12   subjects
3 women
2 women
8 test subjects
13 participants
16 participants
N=32
N=16
total of 6
10   participants
12 participants
N = 2168
total of 47
N=13
14 right-handed participants
2 within-subjects
9 subjects
2 test on subjects
n=13
n = 16
total of 90
5   subjects
48 participants
25 across all participants
8 subjects
40 subjects
48  subjects
26   participants
26 participants
5 participants
25 participants
9 show the number of participants
4 participants
2 of   the participants
14,153 different people
14,153 people
total of 14,153
26 pairs of participants
14 participants
22 participants
10 participants
12 participants
19 participants
8 participants
2 participants
7 participants
11 participants
13 participants
20 participants
17 participants
15 participants
9 participants
5 participants
72 people
n=22
30 subjects
18 subjects
13   subjects
7 subjects
17 subjects
12 subjects
10 subjects
20 subjects
total of 30
total of 12
7 compares the percentage of participants
30 participants
88 people
 data from 88
12 new participants
2 shows the names participants
6 interview participants
13 participants
total of 26
n = 2
n = 1
n = 14
n =   9
n = 3
n =   16
n = 9
n = 28
n =   17
N=1
n = 51
n =   49
n   = 29
n = 30
n = 36
n   = 3
n = 72
n = 64
4 participants
4 trials within subjects
13 participants
13   participants
3   participants
2 participants
n = 1
total of 2
total of    13
16 participants
2   of the participants
73,906   messages from participants
n=22
n=34
n=32
N=337
N=134
total of 360
total   of 337
total of 38
total of 144
267 people
total of 267
19,000 participants
34 subjects
10 subjects
17 people
total of 10
total of 34
 data from   34
8 subjects
total of 8
1 asked participants
129 people
5,000 people
total of 129
55 survey participants
47 survey participants
49 participants
6   participants
146 people
155 participants
10 participants
132 participants
6 shows   the variability of participants
7 shows the variability of participants
2 women
1   The participants
2   The participants
3   The participants
N = 8
total of 2
21 participants
31 participants
900  million people
20 qualified subjects
12 of the   subjects
1 and describe subjects
20 subjects
total of   77
6 women
15 participants
8 participants
9 participants
3 subjects
9 subjects
total of 15
N=10
60 minutes and   participants
N = 148
43 subjects
20 subjects
1 other people
total of 455
 data from the 32
5 genre groups the participants
32 subjects
1 was supportedâ€”subjects
2 was disconfirmedâ€”subjects
3 was  supportedâ€”subjects
4  was supportedâ€”subjects
N = 6,174
N = 2,423
N = 3,751
N= 6172
40   million people
   data from 11
20 participants
20 meeting participants
N=32
N=33
N=23
100 participants
15 people
116 people
10 people
6 subjects
12   subjects
24 lab study   subjects
total of 179
48 participants
total of 48
33 participants
16   participants
n=33
total of 128,887
 data from 11
7 participants
64 participants
7 billion people
total of 6
total of 9
16 participants
16  participants
2 participants
120 participants
15 participants
120   participants
20 participants
45 participants
4 all participants
total of 120
3 participants
16 participants
3 the participants
n = 16
9 participants
7 participants
3 within-  subjects
12 participants
12   participants
12 of the participants
4 participants
3 of the participants
9 of   the participants
4 subjects
16 participants
13 of the subjects
2 within-participants
8 women
5 women
9 persons
5 persons
16 participants
10 other   participants
8 of the subjects
8 subjects
total of 11
12 participants
8 participants
12 participants
n = 18
n = 17
n = 14
n  = 21
12 women
20 subjects
2 random subjects
5   subjects
9 subjects
4 subjects
1   subjects
29 subjects
2 because we did not collect   subjects
1 subjects
2 subjects
29   subjects
3 subjects
10   subjects
total of 344
6 participants
26 people
total of 117
13 participants
N=6152
n = 28,243
n = 7,409
n =   6,234
n = 3,808
n = 10,792
total of   2,416,331
total of 428
N=8
total of 293
total of 33
3 subjects
n = 64
N = 8
N = 16
n=1
3 center dots required participants
N = 32
total of 32
33 subjects
10 participants
16 participants
14 participants
16 people
14 people
4 within-participants
9 participants
8 participants
total of 5280
12 participants
12   participants
3 participants
24 test subjects
18   test subjects
n=25
N=6
N=24
total of 24
total of 126
total of 46
53 participants
76 test participants
4 organizers and   participants
n = 9
n = 6
n = 12
total of 53
total of 76
2 within-  subjects
2 within-subjects
16 subjects
12 subjects
3 participants
6 people
9 women
12 errors and VIO participants
13 of   the participants
20   participants
13 participants
20 practice tasks   participants
20   training tasks aided some participants
n = 4
n = 5
76 participants
8 questions about participants
total of 88
169 participants
3  participants
5 participants
n = 1
9 persons
19   participants
11   people
10 people
19 people
9   people
total   of 121
total of 110
2   The participants
n =  345
n = 345
N=293
N=217
391   participants
277 participants
114 participants
114 people
N = 96
total of 85
14 volunteer participants
22 volunteer participants
1 involved   training participants
3 assessed participants
2 was apparently beyond   participants
n=5
n=10
n=4
n=2
n=5
n = 1
n=1
N=140
N=98
N=238
12 right-handed participants
14 participants
total of 60
total of 20
total of 600
total of 72
total of 14
total of 30
total of 20,713
n = 3
n = 5
n  = 0
2 participants
81   participants
32 participants
32 of the participants
total of 5229
12 enrolled participants
6 participants
3 participants
12 individual participants
total of 24
12 enrolled
6 computer-proficient participants
total of 476
40 participants
total of 40
n = 0
 data from 15
17 participants
12 remaining participants
total of 99
total of 17
44 participants
37 participants
4 participants
n = 19
 data from 44
 data from 37
n=11
n=10
total of 4
20 participants
total of 576
total of 960
16 participants
16   participants
12   participants
N = 3
n = 1,270
N=6
N=3
N=11
N = 5
total of 12
total of 3
total of 135
3  women
12 participants
2 caused two Kodak Culture participants
10   people
40 people
15   participants
350 people
total of 580
5 of   these participants
11 participants
11   participants
total of 173
7 participants
20 participants
n = 4
n = 3
n =   4
n = 2
n =   2
n = 1
2 women
5   participants
2   participants
0   Sighted participants
0   Both blind and sighted   participants
5   Sighted participants
9   Both blind and sighted   participants
N=6
N= 5
total of 7
total of 312
4 participants
18 participants
3 of the subjects
N=12
N=20
total of 26
4 participants
18 participants
n=3
n=6
n=5
n=4
20   able-bodied subjects
4 subjects
3 within subjects
total of 1
N=30,773
29 participants
total of 85
total of 29
40   women
80 participants
75 inches shorter than   participants
4   pounds lighter than participants
N =   71
2D pointing task required participants
5 women
12 participants
8 participants
n = 13
total of 81
3 participants
total of 198
total of 12
22 participants
total of 672
9 pairs of participants
18 participants
18   participants
13 women
29 participants
total of 20
total of 29
400 people
8   participants
8 participants
2 people
total of 3,975
24 participants
24 subjects
15 participants
25 participants
11 participants
31 subjects
222 subjects
3 between-subjects
3 within-  subjects
240 subjects
37 studies the   participants
23 studies the participants
129 participants
N = 19
N = 51
N = 25
 data of 73
12 participants
7 participants
5 participants
n=4
15   within-subjects
6 subjects
14   of the participants
27 people
10 participants
total of 3074
total of 4
14 women
6 suggests this is because   people
220   people
3 people
12 participants
6 participants
n=5
n=4
n=0
n=1
n=2
n=3
n =21
5 women
15 subjects
7 participants
10 of   the original subjects
19 subjects
15 subjects
10 subjects
16 subjects
9 subjects
total of 10
8 women
12 subjects
2 subjects
4 subjects
3  subjects
10 subjects
5 buttons allowed subjects
total of 235
total of 112
4490 survey participants
430 million people
total of 4490
5 participants
32 participants
12 participants
10 female participants
10 other people
20 women
36 participants
36   participants
3 shows the mean time the participants
35 participants
1   and all these allow people
n =   19
n = 27
n = 28
n = 87
n = 88
n = 90
85 participants
57 participants
n = 5
n =   7
n =   11
n = 6
N = 84
N = 54
172 participants
0 participants
total of 172
45 persons
45 married persons
11 de facto persons
12 persons
100,000 a year. Seven participants
37 participants
18 participants
108 people
18 people
11 indigenous people
400   people
30 people
34 people
10 participants
30   participants
3   participants
8 participants
8   participants
3 participants
n = 5
n = 4
n =   5
total of 30
24 women
n=17
total of 400
n = 20
4 participants
3 people
8 people
40 participants
29 participants
20 participants
13 participants
13 interview participants
500 people
50 people
n=172
n = 2
n = 4087
n = 18417
n =   24089
76 subjects
total of 76
50 participants
50 people
total of 40
9 women
16 participants
16   participants
total of 1536
n=1
0 gives people
10 people
1000 people
5   people
107 of the people
273 people
7 people
18 people
3 revealed what people
1  people
601   Finding people
508   Meeting new people
509   Stalking other people
719   Viewing other people
531   Seeing what people
n = 151
n = 16
n = 78
n = 85
n = 61
n = 50
n = 26
n = 22
n = 56
n = 241
n = 4
n = 5
n = 3
n=44
n = 137
total of 46
total of 26
20 participants
10 participants
10   participants
9 subjects
11 subjects
total of 20
20 participants
46 participants
25 of the participants
47 participants
1 depicts the number of participants
311,449 people
N = 670
75 participants
75 people
total of 78
total of 110
N =   193
n =   32
n =   149
n = 634
n =   802
n = 10
n = 5
N = 237
total of 237
11 women
7 women
1 â€“ Profile of participants
900  million people
total  of 15
00      participants
33 participants
N=1260
900   million people
16 participants
10 participants
16 subjects
8 subjects
8=subjects
16 test subjects
16   subjects
3 subjects
16 people
22 participants
9 participants
18 participants
total of 576
10   participants
21 participants
12 people
total of 60
18 participants
24 participants
24   participants
total of 204
total of 1183
total of 428
612,000 people
16 paid participants
1 Three participants
3 shows experimental participants
15 participants
740 people
2 shows the percentage of people
n = 36
n = 170
n = 4
n = 2
n =   4
n = 3
n = 5
8 participants
13 shows the   results of participants
2 within-subjects
total of 58
24 paid participants
15 participants
15 oc-  casions of participants
47 occasions participants
94 participants
N = 47
 data from 47
36 subjects
4 subjects
34 subjects
3 subjects
17 subjects
N = 36
N = 34
N=34
N =34
total of 126
 data of 34
6 able-bodied participants
11 participants
11 motor-impaired  participants
11 motor-impaired participants
n=35
n=24
N=34
n=64
N=763
N=153
N=54
N=99
N=63
N=33
n=26
total of 765
3   participants
7 participants
4 participants
6 participants
11 participants
3 of those participants
2 people
23 participants
16 participants
N=1049
N=87
N=86
N=88
N=44
6 women
5 women
1199   persons
1199 persons
202 persons
2 within-participants
14 participants
total of 13440
10 participants
n=6
46 participants
12 participants
12 participants
12 unpaid subjects
2 within-subjects
total of  11500
total of 380
6 women
12 subjects
3 of the subjects
total of 12
total of 7
11 participants
total of 180
8 of participants
5a during which participants
6 participants
8 participants
n=8
n=12
n=24
n=3
n=5
n=4
 data of the 4
12 subjects
n = 24
n = 29
n = 38
n = 4
n = 1
n =1
n=8
n=9
total of 42
total of 99
total of 11
total of 36
total of 285
60 participants
5 people
3 people
36 participants
18 participants
14 participants
total of 13
total of 24
 data sets of 4000
3 women
16 volunteer participants
n = 26
n = 2
n = 5
n =   4
24 novices who enrolled
n = 33
n = 14
n = 3
n = 2
n = 26
n = 4
n   = 2
n = 55
n = 90
n =47
n = 43
n = 29
n = 18
n = 17
n = 35
total of 90
66 people
108 as the authors and other   participants
17 persons
180 participants
50 people
50   people
116 people
126 people
17 people
6   shows whom people
 data from 285
 data from 9
35 participants
11 participants
12   subjects
total of 12
total of 528
 data from 11
10 women
24 participants
12 participants
n =    9216
n =    18432
3 female participants
12 participants
18 participants
50 rural participants
50 urban participants
50 random rural participants
50 random urban   participants
2,500 people
63 rural people
N  =   3379
N = 2101
N = 3067
N = 1777
N = 2069
N = 1290
16 participants
N = 90
N = 18
N = 180
N=90
total of   12
12 participants
6 new   participants
total of 300
total of 36
total of 270
total of 18
18 participants
total of   5,400
17 of the participants
N=8
36 paid participants
19 participants
17 participants
11   participants
16   participants
9   participants
15 participants
5,000 people
12 groups of three   people
n   = 36
N=32
N=19
N=15
N=33
n=3
n=2
n=1
N=16
N=17
n=4
109 people
204 people
n = 36
n=109
100 participants
total of 100
n=27
12 participants
20 participants
8 participants
8 subjects
total of 12
total of    8
16 participants
14   participants
8 participants
18 participants
1 shows the different ways people
54 people
14 people
7000 people
n = 21
n = 20
n=77
n=39
9 participants
3 Four participants
500 people
n= 26
N=69
total of 128
n = 3
n = 1
n = 15
n = 114
n = 5
n = 0
3D navigation helped participants
35 subjects
11   participants
20  participants
12 participants
3â€”participants
10 participants
n=12
n=75
total of 532
total of 325
total of 70
7 women
26 participants
28 participants
11 participants
15 participants
12 participants
7 participants
6 participants
9 participants
13 participants
5 participants
1 million people
38 participants
18 participants
9 participants
38  participants
38 people
total of 28
total of 38
8  Specific people
31 people
total of 179
46 subjects
26 subjects
n = 0
14 participants
3 Latin-square  within-subjects
total of 504
27 people
n=4
n=3
11 participants
3   people
30 participants
total of 27
60 participants
n=1,472
n=972
total of 3,084
total of 3
12 male participants
n = 23
18 participants
18 right handed participants
30 women
56   participants
total of 35
total of 56
35 participants
22 participants
79   participants
19   participants
17 of the participants
10 participants
21 participants
79 participants
n=79
n=10
30 participants
14   participants
16 participants
N=30
n=16
n=14
total of 58
n=13
 data from the 5
15 participants
12 participants
total of 21
26 students  were enrolled
total of 198
11 participants
34 participants
11   participants
N = 15
N = 8
N = 19
N = 26
36 people
5 people
total of 36
18 participants
7   participants
n = 6
n = 3
20 participants
15 participants
5   participants
17 participants
3 participants
20 people
9 people
3 different people
44 participants
7 shows the character classes participants
1000 new participants
total of 210
20 participants
3 patients
2 patients
11   patients
45 patients
135   # of participants
2 participants
5 participants
n=24
n = 248
n =   198
90 minutes and participants
12 subjects
7 subjects
14 subjects
total of 108
10 women
16 people
15   people
n = 7825
n = 4
 data from the 3
total   of 12
29 study participants
10 participants
6 other participants
total of 244
15 people
8 participants
total of 400
total of 249,555
56   participants
24 participants
8 participants
12 participants
n = 80
n = 68
n = 60
total of 19
64 million persons
1600 persons
9 people
31 participants
30 successful   participants
30 participants
13 participants
28 participants
15 participants
total of 24
total of 15
total of   372
44 participants
41 participants
11 subjects
41 subjects
37 subjects
20 different people
28   participants
n = 7
n= 15
total of 8
total of 22
N=474
total of 117
total of 47
31 study participants
2 such   participants
2 participants
12 participants
total of 62
 database of 298
18 participants
73 participants
73   participants
n=24
n=28
n=20
n=18
n=7
n=3
n=9
n=21
n=1
n=5
n=299
n=359
n=15
n=39
n=12
n=72
n=84
n=13
n=6
n=4
n=27
total of 24
total of 23
 data from 21,600
2 women
91 women
total of 231
27 participants
21 industry participants
170 devices participants
20 participants
17 participants
14 industry   participants
27 people
4 participants
total of 150
total of 450
total of 3
total of 9
18 participants
16 participants
41   women
65 participants
n = 168
n = 114
total of 200
total of 29,120
total of 1872
total of 2031
1,117 people
7 women
15 participants
12 participants
7   participants
15   participants
15 people
total of 1474
31 people
001            itâ€™s the same people
 data from 8
 data from 2
total of   2400
total of 120
67 participants
12 participants
392 participants
16 participants
n = 6
n = 4
n = 3
n = 5
N = 360
N=67
N=360
total of 276
18 participants
66 participants
101 participants
50   female participants
64 participants
8 participants
2 participants
3 between-subjects
66   million people
32   people
 data from   1
30 participants
n = 30
N = 290
total of 290
10 participants
8 participants
N = 100
N = 400
N = 11
N = 5
total of 28
12 subjects
16 test subjects
11 participants
n=8
n=9
total of 607
240 seconds since we   stopped subjects
total of   7
4 are four dual-monitor participants
n=4
24 participants
total of 24,123
2 pools of participants
8 external participants
12 external   participants
2   internal participants
11 participants
12 participants
N=89
N=51
N=88
N=62
N = 89
N=72
N=38
N=37
total of 89
total of 583
14 participants
13 participants
500,000   people
N=13
n=20
total of 63
193 people
24 people
18 people
N=106
22 were women
38 participants
5   participants
12 participants
12 subjects
total of 23
20 participants
20 non-technical participants
20   participants
14 participants
20 new participants
12 people
N=1074
total of   20
12 participants
5 male   participants
12 random layout experiment one participants
12 RSVP layout Experiment Three participants
total of 34
total of 215
12 paid participants
12 participants
8 participants
8   participants
n   = 29
n = 58
n=8
total   of 2
n = 2
n = 93
n = 4
n   = 4
n = 3
n =   3
20 SL participants
20 participants
10 participants
40   participants
40 participants
3 participants
26 participants
54 participants
100 participants
80 of the participants
total of 49,088
total of 512,770
total of 30,237
102 people
170 mixes  participants
52 subjects
n=52
n=20
n=24
n=1
n=3
n=5
n=0
N=29
10 participants
16   participants
 data of   7
18 participants
9 field dependent participants
90 non-solicited participants
90 participants
9 participants
9  participants
9 field indepen-  dent participants
9 field  dependent participants
0 in-  strument also measured participants
5 levels of the  within-subjects
2 levels of the between-  subjects
total of 18
total of 90
49 participants
749 patients
750 patients
30 non-hospitalized people
n=19
n=11
n=23
n=8
n=9
n=10
n=15
total of 30
5 participants
total of 12
441 participants
1   indicated a primarily people
n = 441
24 subjects
N=1546
N=2596
n=12
N=880
N=870
N=676
2 was whether RA-  DAR helps subjects
1 served as subjects
4 assessed whether subjects
46 subjects
N = 713
total of 224
total of 676
 data of 612,000
9 standard forcing participants
total of 4,320
total of 19,440
2 within-subjects
3 within-subjects
16 people
8 people
n = 16
N=48
N=72
13 participants
3 within-subjects
600   participants
277 participants
2 between-subjects
N=422
n=16
N=134
n=19
N=123
n=18
1 a total of six different participants
8 persons
n=   53
total of   11
17   participants
17 participants
12 participants
42   participants
42 participants
1 Eight of the participants
total of 1172
N = 20
N   = 1
total of   10,002
2,500   participants
4 participants
12 participants
2 participants
3 most responsive   participants
112   participants
12   participants
8 participants
total of 20
total of 15
8 participants
6 participants
total of 244
2 women
3   women
39 participants
52 participants
36 participants
10 participants
10 Whyline participants
3 control participants
16   participants
2 participants
7 participants
50 probes were answered   after participants
N = 36
N = 14
N = 83
20 participants
13 participants
3 participants
13 million people
26 participants
20 participants
10 participants
n=26
n = 10
n = 52
n = 231
n = 236
n = 234
total of 26
total of 211
total of 6
n = 296
n = 93
total of 30
 data-sets from 90
 data came from 12
10 persons
24   participants
10 participants
6 participants
9   participants
8 participants
40 test participants
8 shows how the   participants
40 test subjects
N=10
total of 40
total of 46
total of 62
total of 15
total of 29
total of 21
total of 7
2   within-subjects
total   of 160
total of 640
00      The participants
19 participants
N=48
1 lists participants
65 participants
N=71
4 participants
23 participants
11 High accuracy participants
12 Low accuracy participants
3 participants
5 participants
24 new participants
12 participants
N = 23
N=23
N=2
N = 24
total of 48
N=34
N=35
total of 276
18 participants
12 women
8 participants
19 older people
11   people
8 participants
6 participants
8 more participants
total of 14
20 participants
24 participants
3â€™s demonstration of how people
58 participants
20 participants
18   participants
90   subjects
58   subjects
90 subjects
58 subjects
56   subjects
24 of these   subjects
20 subjects
2 male   subjects
13 subjects
59   people
total of 90
total of 58
total of 20
32 women
12 semiliterate   participants
12   participants
10 trials and participants
14 participants
12 participants
3 participants
6 other participants
4 participants
4 Literate participants
3 of the Illiterate participants
4 Illiterate   participants
8 remaining participants
16 semiliterate participants
4   illiterate participants
8 participants
35 million people
10 million people
N = 12
total of 8
total of 100
total of 50
50 per   cent of women
13   all-women
3,020 people
79 people
15 people
20   people
n=22
n=19
2 participants
1 participants
18 participants
8 participants
12   participants
6   participants
23 participants
total of 23
18 participants
100 random   people
N = 18
13 participants
n=36
n=2
n=1
n=53
n=57
n=3
total of 11
150  participants
162 participants
14 blind participants
N=6
N = 161
total of 100
total of 12
total of 42
45 million people
45 million blind  people
 data rate of 44
574 participants
N=1345
N=1039
N=1041
N=1432
N=1434
total of 2473
total of 21
total of 8
17 participants
12 participants
3 participants
9 â€œexploratoryâ€ participants
5 shows the time participants
total of   40
6 of the sessions participants
N=65000
N=144
N=14
total of 1
total of  6
total of  161
total of 161
total  of 58
total of 219
37 people
total   of 184
12 participants
12   participants
n=8
n = 3
16   participants
16 participants
N=85
14 shows participants
15 shows participants
total of   5
26 women
13 women
26 people
3 people
2 other people
9 participants
10 participants
2 within-participants
total of 9
total of 90
total of 120
23 participants
23   participants
8 participants
23 people
1 Do people
total of 23
total of 1822
total of   139
10 external participants
18 participants
5 illustrates the time participants
43 prospective participants
19 participants
9 pairs of participants
total of 118
total of 89
11   participants
3 Potential participants
4   Six participants
N=72
N=22
N=20
N=9
N=8
N=24
N=11
56 participants
3 people
2  people
2 people
6 people
n = 30
n = 26
n = 56
total of 233
600 subjects
1000â€™s of people
total of   30
12 subjects
total of 12
128   participants
197 people
276 people
total of 92
16 test persons
24 test participants
5 participants
total of 22
16 patients
16   patients
32   patients
10 patients
96 participants
2 shows the breakdown of the participants
3 shows participants
37 participants
19 participants
96   participants
41 participants
26 participants
n=96
n=52
3 participants
111 people
130 people
N=549
N=547
N=241
N=308
N=240
N=519
N=487
N=379
N=490
N=353
12 women
N=40
20   participants
20 participants
3 participants
n=10
 data from 2,126
23   women
35 participants
1,261 people
N  = 4368
 dataset of 2,184
200 participants
211 online participants
53 participants
18 participants
39 of the participants
158 participants
37   participants
115 participants
n=31
n=30
n=29
n=37
total of 24
4 participants
18 paid participants
18 participants
18 paid participants
163 people
17 people
23   new people
69 people
82 people
N =   54
N = 54
total of 163
4 people
total   of 10
total of 8
 data from Day 1
8 participants
3 participants
N=32
N = 5
14 participants
8 participants
n = 5
n=3
total of 14
total of 56
5 women
8 women
6 participants
4 participants
n = 16
n = 13
 data from 6
56 participants
N=56
total of 40
19 participants
n = 7
total of 29
12 participants
9 male subjects
n=479
N = 1161
N = 78
15 participants
24 participants
 database of 46000
24 participants
5 participants
3 participants
2 participants
44 participants
11 participants
4 asked participants
n =   4
n = 4
6 shows each individual participants
6 of the participants
3 participants
n = 31
total of 60
3Some participants
108  Thirty test subjects
8 women
15   subjects
3 shows the average time subjects
3 categories based on how many subjects
8 subjects
9 subjects
total of 192
total of 384
n= 1
n=6
n=4
n=5
n=12
36   participants
48 participants
48   participants
48 students as participants
15 participants
N=15
n = 22
n = 1
96 participants
84 participants
70   participants
59 participants
11 participants
233 participants
3 of these participants
3 participants
64 participants
9   participants
70 participants
N = 190
N = 38
N = 5
5 participants
7   participants
16 participants
16 study participants
11   participants
7 participants
total of 131
6 participants
total of 2,304
15 participants
9 mm respectively and women
12      participants
13 participants
13   participants
total of 13
total of 3
total   of 4
3 participants
total of 28
total of 23
total of 18
89 participants
2008 using participants
5  We randomly assigned participants
7We asked participants
total of 89
12 participants
1 shows participants
total of 56
43 deaf participants
43 participants
19 profoundly deaf   participants
43   participants
20 male subjects
21 female   subjects
5 subjects
28 male subjects
15 female   subjects
11 particularly enthusiastic   subjects
41 people
4 illustrate  ired people
1  Profoundly  aired people
10 participants
6 participants
3 participants
25 participants
n=22
n=72
n = 49
n = 44
total of 1
20 people
12 participants
28 participants
n=19
n=13
N=40
8 subjects
48 people
N = 412
total of 86
total of 2
124 participants
20 minutes and the participants
50th  percentile of subjects
75 participants
25   participants
33 participants
16 participants
5 subjects
2  Only one of five subjects
4  Although some subjects
n=1
n=128
4 participants
34   participants
24   participants
34 participants
23 participants
25 participants
29 subjects
N=23
total of 34
total of 21
23 participants
45 participants
38 participants
7  participants
480 million illiterate  people
50 participants
43 participants
N = 132
total of 50
total of 6996
N=124
N=52
N=310
total of 24,002
n=13
n=18
4   women
54 year   old woman   Other participants
22 participants
22 people
n = 27
n = 3
3 women
3 increased people
total of 896
17 participants
48 participants
29 female participants
15   participants
33   participants
16 female participants
36 participants
13 participants
23 participants
2 represent people
n = 1
27 participants
20 participants
7   participants
7 extra   participants
7   more  participants
2Tag encourages   people
n = 96
n =   37
n =0
15 participants
20 people
N=15
N=14
10 participants
total of 118
35   participants
35 participants
27 participants
70   participants
3 participants
7 participants
43 participants
8 participants
90 minutes were spent training participants
n = 12
n = 10
N = 110
total of 70
23   participants
25 participants
total of 16
3 people
n=2
n = 40
n = 11
n=758
n=64
n=12
n=76
41    To make people
6 UX is not about people
N=200
N=235
6 participants
N=71
N=33
N=12
N=21
N=38
N=50
N=113
N=43
N=70
N=18
N=11
N=8
N=130
N=69
N=61
N=23
N=13
n=3
n=5
total of 482
15 women
30 people
total of   1,106
26 participants
 data of 2
10 unpaid participants
10 participants
8   participants
20 unpaid participants
20 participants
20   participants
12   participants
total of 12
10 participants
10   participants
50 people
N=11
100 participants
110 participants
100   participants
69 participants
110 people
total of 110
 data from   100
1,500 people
170  people
70 people
200 people
N=43
N=12
N=19
N=15
N=22
N=4
N=14
N=16
N=25
n=5
n=3
24 participants
13 participants
11 participants
total of 395
12 participants
total of 16
12 participants
n=18
n=22
n=17
n=53
N=50,929
N=89,363
n=9
n=69
n=8
total of 2
total of 220
232 participants
total of 232
104 of the participants
20,000 people
N=260
N=32
N=73
N=72
N=83
N = 25
N = 39
total of 260
1 shows the mashup participants
21 among all participants
4 insurance salespersons
48 participants
16 participants
5  Two participants
4 participants
3 shows the participants
n=28
n=24
1â€™s participants
22 participants
3 shows participants
0 representing  participants
27 participants
5 shows all participants
N=22
N=27
total of 22
total of 132
total of 27
total of 24
27 participants
4 participants
250,000   people
n=05
 data set of 4,592,466
12 participants
12 subjects
total of 60
total of 10
total of 360
21 participants
3 participants
3 shows the accuracy of participants
n = 4
24 participants
1 compares the number of participants
51 participants
23 participants
8 participants
2 participants
n=21
64   pixels of the target and participants
149 tasks where   participants
19 of the participants
18 participants
n=66
n=77
n=0
total of 54
12 participants
24 participants
N = 0
N=0
N=1
N=23
N=24
total of 24
total of   324
33 persons
6 representative  participants
33 participants
5 participants
12 study participants
12 participants
6   participants
12 people
total of 782
total of 30
664 people
762 people
n =   1
8   were regular participants
n=6
n=7
n=2
n=3
15    A few participants
18 patients
n=14
n=0
n=3
n=2
4 participants
11 participants
n = 19
n = 12
n = 51
n = 47
n = 46
n=1
   data from 133
26 participants
24 participants
1 represents parallel playâ€”  participants
4 displays the number   of participants
26      participants
total of 24
N=5
N=3
N=2
7 women
9 participants
1 was defined as   participants
9 violations and audio-visual participants
2   violations than audio participants
2 and participants
4 and audio-visual   participants
30 subjects
30 people
N=10
N=460
N=61
N=1
N=522
N=77
N=40
N=8
N=34
N=9
N=985
N=2905
N=87
N=3977
total   of 43
total of 3977
total of 2905
total of 87
18 participants
18 people
total of 1,620
total of 96
34 young people
6 young people
100 young people
N=100
10 of the participants
14   participants
6 participants
9 participants
20   subjects
20 subjects
total of 320
18   participants
13 female and five male participants
18 participants
8 people
26 participants
total of 24
total of 52
8 of the participants
16 participants
30 participants
30 people
07   Personal home pages of people
total of  4
24 participants
total of 30
 data from 3456
10   subjects
total of 40
916  Results  For all participants
30 participants
10 participants
total of 30
17 participants
16 participants
87 women
44 subjects
39 subjects
5 subjects
108 subjects
40 subjects
30 subjects
n=145
n = 112
n = 121
total of 8
total of 16
 data daily from 22
 data from the 10
48   participants
6 participants
38 total participants
N  = 85
total of 85
44 participants
44   participants
37   participants
n=5
n=3
n=12
25 participants
1 this provoked participants
5 people
16 people
9 participants
total of 52
16 participants
10   participants
10 participants
total of 118
total of 54
total of 12
4 participants
n =  3
20 participants
6 participants
10 participants
16 participants
total of 25
total   of 18
total of 64
10 participants
n=19
n=1
total of 170
n=422
n=423
n=421
n=415
n=425
n=396
n=416
n=411
total of 494
14 total participants
2 asked participants
3 instructed participants
17 participants
6 people
n = 8
n = 12
n = 2
n = 9
n = 5
n = 11
n = 10
n = 6
n = 1
n = 14
n = 3
n = 7
n =  6
total of 17
764 participants
700 participants
25 additional  participants
78  participants
79 layered-format condition participants
N=764
24 participants
n = 7
total of 25
total of 29
N = 15
13   participants
13 participants
10 participants
total of 13
1 All research participants
3   â€œâ€¦people
n=10
n=3
n=13
n=8
total of 97
total of 768
15 women
31 participants
n=1023
total of 1,023
14 participants
n=496,750
n=420,989
n=148,902
n=84253
n=102,355
n=421,005
n=35,656
n=496,766
n=496766
25 people
15 novice participants
15 more expert   participants
5 participants
n=3044
N=7019
total of 7,019
12 partic-  ipant within-subjects
total of 120
3 asked the  participants
3 responses  the participants
4 women
2 women
4 participants
6 Chinese participants
4   required the participants
2   participants
2 participants
1â€™s list of people
20 participants
347 participants
11 participants
249 examples of questions   participants
624 people
242 reasons people
n = 4
n = 1
N = 230
n = 3
N = 234
total of 249
N = 98
N = 88
total of 215
total of 364
175 people
104 people
104   people
53 people
27 people
180 people
115 people
174   people
117 people
total of 206
total of 172
total of 150
70 patients
24 patients
3 million people
total of 260
6 entire   patients
3   patients
total of 57
total of 120
10 people
total of 208
total of 14
8   Some participants
8   For other people
n = 41
n =18
n = 28
n = 40
n = 16
n = 25
n =   11
n = 6
n = 17
n = 11
n = 13
n = 18
14 patients
n=14
5 women
11 participants
total of 11
13 women
13 participants
12 participants
19 participants
total of 19
4 participants
1 billion people
total of 103
6 individual   participants
14 people
total of 41
10 mentioned   people
n = 5
n = 16
total of 12
n=5
1200 trauma patients
60 different   patients
15 people
13 people
60 participants
N=1193
n=155
N=487
N=993
3  million people
n=5
n=4
n=3
n=2
4 participants
15   breast cancer patients
15 patients
126 participants
9   women
19 participants
19   participants
14 participants
14   participants
10 participants
2000 subjects
240 people
total of 327
93 subjects
N=4009
N=1614
900   million people
N = 3571
N = 225
n=41
n=2865
n=33
n=8
total of 509
total of 225
total of 495
15 participants
8 participants
total of 72
15 participants
11 participants
N=100
5 women
24 participants
N=358
N=328
N=386
total of 467
75 participants
20 participants
10 participants
7 people
10 people
15 participants
2005 and none   of the participants
total of 400
91   people
11,000 memory triggers and people
20 people
91 people
33   people
4 shows how people
75 people
17 people
total of 61
total of 120
 data from 91
50 subjects
117 subjects
13 of subjects
N=50
N=24
total of 70
total of 108
total of 72
total of 48
total of 2,880
total of 186
total of  70
4   people
18 participants
total of 8
N=24
N=8
N=1613
N=1
total of 1491
14 participants
total of 106
n=2
n = 1
30 participants
30   participants
22 participants
6 of the observed participants
13 participants
6 participants
2   participants
5 participants
2 participants
16 participants
11 participants
4 subjects
16 subjects
4   people
6 people
3 people
3   people
n =   25
n = 24
n = 28
n = 625
n = 1999
 data rate of 120
10 shows how   participants
5 within-subjects
18 patient participants
18 patients
16 physicians whose patients
7 participants
16 participants
15 participants
total of 16
10   participants
N = 16
n = 155
n = 2
11   participants
n=1
total of 2604
total of 225
12 participants
24   participants
n = 1
n = 2
n = 60
total of 9,200,000
total of 263
total of 31
105   Chinese participants
19   were regular community participants
N=16
745 million   people
1 MEA model of rural people
2 MEA model of rural people
16 participants
total of 16
12 participants
12 subjects
n=   5
n= 4
18 participants
total of 64
3 of the participants
n=30
N=75
N=12
total of   195
N = 9
n = 00010010000010010
N = 0
20 subjects
3 questions subjects
13 subjects
2 subjects
n = 13
n = 5
N   = 92
N = 55
total of 24
total of 51
total of 41
500 participants
441 participants
159 participants
441 overall participants
36}   For many participants
45}   Other participants
28}   For most participants
62 participants
n = 5
 data from 61
total of 24
23 people
10 participants
20 participants
80 participants
10 experimental subjects
2 mixed subjects
N = 200
N = 40
N = 10
total of 200
 data of the 2
30   and women
30 and   women
1,962 participants
1,962   people
n=482
n=76
n=111
n=15
n=36
n=296
n=21
n=187
n=172
n=69
n=123
n=162
n=22
n=114
n=96
n=120
n=98
n=609
total of 1,726
N = 81,920
N = 9,378
N = 36,923
N=11
N=3
N=2
N=1
N=4
N=5
total of 161
180   participants
180 participants
25 participants
6 shows the   number of participants
2 segmented   the participants
n = 5
40 minutes after the subjects
8 participants
73 participants
8   participants
total of 8
total of 73
9 female participants
11 people
8 people
3 people
total   of 11
10 participants
11 participants
5 participants
6 participants
total of 11
total of 5
 data of 10
N=11
N=8
N=7
2 predict   where participants
1,209 of our participants
2,400 of the   participants
N=1209
total of   2
9 participants
total of 17
60 participants
3 participants
45   participants
4 participants
total   of 60
total of 60
total of 215
total of 25
total of 3000
15 people
24   persons
8 subjects
7 subjects
N=56
total of 56
16 participants
total of 7600
 data from 16
   data from 16
 data from 125
20 participants
n=2
n=0
12 women
N=8
N=18
22 women
N=3
N=25
12 participants
39 participants
16 participants
12 people
16 participants
8 participants
6 participants
5 participants
12 participants
n = 25
n=400
n=235
n=104
n=61
n=333
n=399
total of 22,205
1 are the participants
N=134
total of 36
12 participants
12   participants
11 participants
10   participants
10 participants
11   participants
12 people
n = 4
179 participants
23 participants
40 people
64 women
1 All participants
1 shows the variety of participants
n = 12
n=49
n = 51
n = 49
n = 70
n   = 83
11 subjects
37 people
n=12
n=11
n=7
total of 37
487 participants
515 participants
1001 participants
32   participants
4   participants
2 participants
14   participants
15 participants
3 participants
5 non-security   specialist participants
total of 53
48 participants
24 of the participants
2 participants
11 participants
47   participants
n = 13
n = 3
total of 48
n=21
n =68
18 participants
total of 68
total of 31
12  participants
15 participants
28 participants
7 participants
16 participants
16 people
4 displays subjects
8 shows the   distribution of subjects
9 shows the distribution of subjects
15 subjects
23 people
n=106
total of 722
total of 32
13   participants
12 participants
2 participants
12 participants
total of 17012
total of 3572
30,000 paying participants
13,000   people
22 people
total of 22
37 participants
68 people
8 women
10 of the   participants
10 people
3   people
2 people
3 people
12 participants
12 participants
n = 0
12   participants
10 participants
33 participants
27 participants
33 people
5B first said she would trust  people
12 participants
11 participants
3 participants
2 people
3 people
21   participants
107 participants
25 participants
8 participants
5 participants
6 of the participants
17 participants
21 participants
17   participants
10 participants
14 participants
14   participants
11 participants
4 participants
12   participants
7 participants
5   participants
5 more participants
55 of the subjects
23 people
21 people
8 people
6 people
4 people
total of 338
16 participants
 dataset of 400
20   minutes and participants
12   participants
12 participants
3 subjects
12 peopleâ€”seven men and five  women
2 il-  lustrates participants
12 people
N = 26
total of 45
16   participants
14 participants
51 pilot participants
51 participants
17 participants
2Usage data includes these participants
40 non-participants
12  new participants
total of 610
18 participants
2 of the participants
4 participants
5 participants
2   participants
13 participants
n=12
n = 12
total of 180
total of   46
 data from   13
10 participants
10 subjects
2 The small number of female participants
16 participants
88270 people
5149 people
13269 people
total of 728509
10 of the participants were women
10 of the participants
12   participants
17   participants
48 participants
64 participants
N=374
N=371
total of 24
total of 1138
22   participants
22 participants
16 subjects
10 subjects
2 is a within-subjects
6 participants
12 participants
9 within-subjects
2 within-subjects
15 participants
8 participants
40 people
32 people
27 people
2009 survey and people
n=27
total  of 40
total  of 32
total of 20
38 subjects
N=36
11 initial subjects
total of 18
total of 758
6 participants
3 within-  subjects
11 participants
8 participants
total of 33
1 â€“ Contrasting example of two participants
20 participants
11 participants
13 participants
13 patients
N = 2
n = 69
n = 1
n  = 6
N = 11
N= 11
total of 17
5 subjects
27 people
3 people
5 people
7 people
N=14
N=9
30 people
16 participants
16   participants
n=2
n=3
40 participants
18 participants
60   participants
N=60
N=40
N=39
N=38
N=100
N=58
N = 58
total of 713
16 participants
4 participants
17 participants
14 participants
20 participants
3  Four subjects
6These four subjects
1 â€“ How do people
n = 200
N = 204
N = 51
2 presents participants
10 people
4   million people
total of 12
2   groups were comprised of participants
39 participants
n=7
n=12
n=6
n=10
n=60
n=158
total of 202
2   Some participants
total of 24
12 right-handed participants
6 new right-handed participants
15 people
8 shows how participants
131 people
5 million people
5 people
50 people
22 participants
1000  people
70 people
39 people
14 people
11 people
8 people
4 people
10 people
66 participants
6 ask participants
7 asks participants
N = 36
N = 30
N=245,586
 dataset of 245,586
47 subjects
24 women
40 people
5 people
N=44
57 participants
57   participants
114 subjects
22 participants
22 participants
N = 162
1   Method   Pairs of participants
24 participants
4 participants
313 seconds which   meant participants
28 participants
18 participants
6 participants
5 seconds because participants
n=18
24 participants
40 participants
1 shows how the participants
N=20
23 people
10 participants
N=25
N=13
N=15
N=14
N=12
N=16
 data from the 19
19 women
202 elderly people
194 people
38 participants
32   subjects
20 thousand people
n = 45
N=1194
N=96
total of 120
960 participants
50  Next we focused on the participants
48 people
470 people
309 people
181 people
total of 960
total of 121
26 paid participants
2,500 participants
n = 21
total of 1,000
total of 1456
 data set of 1,000
 data   set of 1,000
82 participants
30 participants
41 participants
11 participants
52 participants
4915 people
4984 people
3892 people
7765 people
5050 people
4162 people
4207 people
2281 people
total of 159
8 participants
15 participants
3   within-subjects
10 participants
3 participants
5 participants
3   participants
8 participants
6   participants
2 participants
7 participants
6 participants
N=0
total of 87
total of 80
total of 24
8 persons
13 participants
16 participants
59 participants
6 participants
4 participants
18  participants
16 people
14 people
n   =   60
n   =   29
total of 1280
40  participants
4 depicts the subjects
10   participants
total of 10
8 the subjects
200ms after subjects
9 female subjects
15 subjects
7 subjects
11 of the subjects
11 subjects
45 trials subjects
132 participants
100 related people
16,764 unique people
13,957 people
332 people
132 people
10 people
2 of the people
4 of the people
total of   38,768
1047 participants
247   participants
400 new   participants
200 participants
60   participants
247 participants
60 participants
400 participants
N=160
N=155
total of 1047
500people
120,000   people
15 people
3,000 people
24 participants
10 participants
N=780
28 people
24 participants
33 participants
19 participants
12 shows how much of the time participants
300 subjects
50 subjects
5 people
N=50
N=25
n=0
total of 6
total of   7
total of 7
total of 1500
n = 4
16 participants
40 participants
20 participants
10 participants
n = 800
n=14
n=23
N = 880
 data of H2
15 study participants
total of 16
3 subjects
8 remote subjects
11 statements asked subjects
n=32
n=12
n=14
n=10
n=23
n=17
n=16
n=8
total of 1200
90 minutes and participants
N=30
N=11
3   because the participants
3 we allowed the subjects
12 unpaid participants
12 participants
4 persons
5 participants
5 subjects
total of 5
16 participants
853 over all participants
8 were participants
n= 1
total of 360
total of 17
21   subjects
21 subjects
21 participants
21 subjects
N=72
N=90
N=18
total of 7560
total of 30,240
20   participants
28 participants
11 participants
3 participants
14 participants
3 ratings across all participants
28   participants
12 participants
10 participants
2 participants
8 participants
n =   21
n = 35
n = 10
n = 2
n = 12
n = 4
n = 3
n = 1
5 women
4 women
43 participants
5 additional young   people
total of 50
total of 146
total of   32
total of 8
N=47
N=41
N=39
N=82
N=45
10 participants
10 participants
7,041 patients
4,591 patients
1,016 patients
193 patients
38 patients
181 ICU patients
6  patients
6 patients
2 view and  noted down these patients
12 participants
4 participants
n = 25
22 participants
22   participants
1 participants
10 participants
n=22
total of 1,014
20 participants
total of 20
total of   12,143
total of 18
1   participants
2 participants
2   participants
1 participants
10 percent of the subjects
n=60
n= 23
n = 60
n=2
n=16
n=11
n=6
n= 6
n= 2
  data set of 74,795
20 participants
25 participants
total of 235,707
total of 4,135
49 participants
29 identifiable participants
4 participants
21 participants
32 people
total of 39
total of 1228
total of 711
10 participants
150 people
12 people
21 adult   participants
total of 21
8 of the potential participants
8 initial participants
28  people
300 people
total of 7264
18 participants
17 participants
4 participants
9 participants
n=26
n=2
n=3
n=4
n=1
12 participants
2   subjects
1 shows two people
n=13
n=12
2eC improved participants
total of 28
8 participants
4 participants
5 participants
6 of the participants
20   participants
n = 28
total of 22
12 participants
n = 1
n = 60
n=200
n = 200
n = 0
total of 36
4 participants
20 participants
30 minutes after   participants
2 allowed participants
2 took place after participants
12 participants
6 more participants
4 more participants
18 participants
3 within-subjects
30 participants
11 participants
15 participants
54 participants
18 participants
2 mph depending on   participants
12   participants
10 participants
8 participants
22 participants
7 participants
3 are participants
9 participants
6 participants
15 Type A and Type AB subjects
5 million people
3 considers how well people
3 is a   visualization of how people
9 people
14   people
6 Type AB people
n = 27
n=49
24 participants
24 adult participants
11 participants
11 people
total of 4481
3 million persons
14 cancer patients
47 patients
14 patients
n=6
n=2
n=4
n=1
n=14
N=379
31 people
7   Log people
1 noted people
N=29
24 participants
60 people
total of 19
3 participants
30 participants
30 subjects
N=914
N=502
N=248
N=268
N=99
N=32
N=103
N=28
N= 69
N=62
N= 61
N=70
N=61
N=56
N=75
N=64
N=67
N=63
N=68
N=23
N=4
N=15
N=7
N=14
N=3
N=11
N=16
N=13
N=2
N=20
N=   369
N= 125
N= 244
total of 1628
total of 200
38 subjects
3 subjects
35 subjects
29   subjects
6 subjects
2   subjects
8 subjects
19   subjects
16 subjects
19 subjects
35   subjects
20 people
248   people
total   of 60
N=192
n=51
n=21
n=   41
n=32
n=43
n=47
n=33
n=647
16 subjects
n=24
total of 32
39 participants
n = 4
n = 1
n = 58
n = 7
n =  58
N = 100
n=2
n=161
n=213
n = 51
n =   110
n = 110
n = 107
n   = 106
n = 106
total   of 21
48   participants
36 test participants
8 people
N=333
65 â€“ but only about five people
3 are Not worried about people
1,176 participants
N=1,176
total of 4
3a illustrates   participants
4a illustrates participants
4c illustrates participants
n = 4
total of 90
33 participants
40 participants
73 participants
3  We asked participants
46 participants
22 people
 data from a 2008
40 participants
4 participants
60   people
4   people
40 participants
3D   participants
20 participants
3D Questions   Three people
24 participants
 dataset of 76
22 participants
18 participants
7 participants
11 participants
2  women
18 remaining participants
14 participants
219 participants
45 participants
67 participants
29 participants
83 participants
128 participants
9 participants
3 participants
37 participants
30 participants
50 people
N=6
N=18
N=219
5 participants
total of 10
total of 1092
12 participants
n=9
n=0
n=1
n=4
n=3
n=2
total of 195
total of 20
total of 106
total of   20
total of 122
27 participants
111  people
8 participants
14 participants
4 participants
12 participants
3 participants
N = 20
N = 7
2 â€” The participants
1The participants
3 participants
total of 64
50   people
total of 254
total of 295
total of 164
12 participants
total of 24
12 participants
total of 9
12 participants
9 participants
6 participants
75mm   across participants
30 participants
5 participants
12   participants
2 participants
10 participants
total of 270
52 subjects
26 subjects
36 subjects
16 subjects
5 of these subjects
129 participants
total of 129
n=29
n=3
n=2
n =2
n=1
n=4
n=30
n = 3
n =4
n =3
n =   3
total of 24
2 participants
total of 14
total of 30
10 participants
6 participants
n  = 0
5,000 participants
6,212 participants
5,103 participants
8 participants
1,108 prospective participants
8  participants
16 participants
8survey participants
8 participants than other participants
1,224 participants
total of 6,212
30 participants
20   graduated participants
10 shows the   responses of the participants
14 participants
20 participants
7 participants
103 participants
77 participants
38 participants
n = 9
n = 28
60 women
62 women
32 people
122 people
443 people
36 people
142 reports of people
total of 318
210 participants
210 people
N=192
N=92
N=70
N=42
N=6
N=191
n=2
total of 210
20 participants
11 participants
15   participants
11   participants
n=   011
10 key participants
16   people
16 people
N=14
2 women
10 people
63 people
n=35
n=23
n=230
n=627
total of 330
6  Frustration When people
n = 1254
n = 906
n = 449
n = 348
n = 457
n = 51
n = 398
N = 66
n = 40
n = 22
n = 13
n  = 30
n = 14
n = 30
n = 45
n = 15
n = 27
n = 33
n = 11
n = 35
n = 5
n = 1
n = 16
total of 66
total of 51
total of 45
total of 18
total of 60
16 participants
12 participants
14 participants
8 participants
n = 6
n = 7
n =   6
total of 448
 data captured from 99
N=12
11 volunteer participants
11 participants
8 participants
36 participants
16 participants
15 participants
18 participants
20 participants
12 participants
12 additional participants
N=12
20 participants
1 shows the number of participants
2 shows the   number of participants
10 subjects
5 subjects
19 participants
total of 19
11   participants
11 participants
12 participants
total of 764
 data points from 12
84 participants
28 participants
48 participants
56 percent of the   participants
39   percent of the participants
3   shows the average time participants
32 participants
350 participants
30 participants
182 participants
54 participants
30,000 people
n =5
n=478
n=41
total of 125
total of 61
total   of 97
140,000 people
356 Why arenâ€™t people
n=6
n=2
n=4
total of   300
35 low-income women
35 women
500 women
11 women
28 women
8 women
82 participants
18 were new participants
total of 47
total of 15
total of 82
3   None of the participants
4   Most of the participants
3   Two participants
3   Three participants
16 participants
24 participants
16 manager participants
10 participants
14   participants
28 active participants
16   participants
24   participants
11 participants
13 participants
24 participants
n = 0
total of 34
n = 4
n = 2
n = 91
 dataset of 549
30 participants
3 coders clustered the participants
420 participants
n=473
n=1
n = 420
n = 165
n = 201
n = 39
n = 29
N=66,151
n = 5
7 women
39 participants
21 participants
13 of whom were women
20 participants
24 people
3 shows participants
n=6
n=216
5 participants
11 female participants
17 participants
18   phone participants
7 of the participants
1  Profile of participants
n=20
n=5
n=32
n=28
n=14
n =1
total of 9
7   participants
7 participants
21 Glitch participants
10 participants
23 participants
23   participants
21   participants
1   because participants
2 within-subjects
N=20
total of 43
total of 109
 dataset of 9,364
 dataset of 100
 dataset of 1,580
16  persons
total of 16
3 subjects
11 participants
72   participants
7 participants
7   subjects
n = 401
184 people
183   people
204 people
284 people
N = 230
N = 16
N = 4
n = 62
n =   144
n = 89
total of 34
20 participants
77   participants
N=77
N=30
N=47
total of 6621
10 patients
24 patients
17 patients
900,000 people
n=26
5 within-subjects
3 within-subjects
36 participants
15 participants
21 participants
36   people
N=15
N=21
total of 36
2   women
total of 12
total of 24
total of 20
n=23
n=17
n=16
n=466
total   of 96
total of 889
 data from 36
24 paid participants
12 participants
12 paid participants
n=26
n=25
n=15
n=10
n=4
n=12
n=7
n=2
n=23
n=3082
n=1480
n=3
n=6
total of 123
total of  3,293
total of 12
n=6
n=2
n=9
total of 8,257
total of   1,724
total of 161
10 participants
23 participants
5   participants
4 Five participants
12 of the finishing   participants
N=23
18 participants
21 participants
18 study participants
N = 17
N = 6
N=1000
16 participants
n = 12
n = 9
n = 21
n = 146
n = 183
n = 337
27 participants
18 participants
2   Our participants
1   While participants
2   Some participants
27 people
146   participants
118 participants
62 participants
6 participants
total of 82
total of 72
total of 16
16 participants
30   people
total of 41
4 women
3 women
10 participants
2 participants
2 other participants
4 participants
13   blind and deaf-blind people
3 million legally blind   people
50,000 deaf-blind people
61   deaf-blind people
7 deaf-blind   people
10 blind people
119 participants
2   Thirty-nine percent of the participants
100 participants
N = 21
N = 20
N=20
n = 4
N = 59
N = 60
N = 19
N=69
N=29
N=5
n=48
total of 5
total of 80
16 participants
2 participants
1 participants
32 participants
total of 560
120  A J G E D B C F H I  participants
total of 24
n=16
total of 16
12 women
14 participants
18   participants
18 participants
4 women
9   women
4 people
N=54
24 participants
6 people
8   people
18 paid participants
18 participants
8 shows the number of participants
2 participants
112 participants
3 between-  participants
3 between-participants
136 possible  participants
2  between-subjects
N = 112
N = 10
N = 12
total of 112
2 patients
12 participants
2We divided subjects
2 was a between-participants
N = 12
N   = 50
total of 24
total of 72
32 potential participants
20 interview participants
1  illustrates participants
310 people
total of 20
total of  32
n = 932
n = 388
n = 12
427 participants
97 participants
38 participants
9 billion   people
n = 19
n=10
n=9
total   of 42
total of 38
total of 2,356
32 interview   participants
345 people
16 participants
11 million   people
n =   6
n = 6
n = 7
n = 5
n = 3
n = 1
n =   1
113   women
200 participants
224   people
224 people
10 people
123 paid subjects
 data from 123
1 subjects
11 subjects
3 subjects
21 of these caused subjects
n = 11
N=2
n = 40
n=11
n=5
n=2
total   of 80
total of 30
 data from E1
10 participants
10 subjects
10   subjects
total of 192
11 successful participants
6 of the participants
15 participants
6 of the blind   participants
8 of the blind participants
10 blind participants
9 blind  participants
9 sighted participants
3 sighted  participants
10 participants
2 blind participants
10 sighted people
10 blind people
N=880
N=785
N=2335
N=780
N=1213
N=528
N=233
N=60
N=3624
N=1250
N=1166
total of 20
total of 40
total of 15
total of   2335
26 student subjects
80 different subjects
100 different possible subjects
500,000 people
87   million people
44 participants
13 participants
2  participants
total of 2
 data from 44
4 within subjects
total of 18
total of 20
12 participants
12 participants
4 participants
3   participants
11 participants
6 people
32 participants
18 elder participants
14 younger   participants
total of 4
30   participants
502 people
350 people
25 people
58 participants
48 participants
n=15
total of 104
total of 30
2 important themes of how people
631 participants
16 participants
9 participants
1 Please note all participants
19 participants
N=1193
N=415
total of 574
150 survey participants
150 participants
20 patients
n = 6
n = 51
n = 98
22 items asked participants
3 From a total of ninety-five participants
N = 99
N = 93
total of 22
64 participants
3  All participants
16   subjects
n=6
n=5
total of   45
N = 6
2 two-way between-subjects
2 two-way   between-subjects
11 participants
4 Do you think most people
n=6
n=4
58 participants
N=21
N=20
N=17
n=20
29 women
45 participants
27   participants
14 participants
8 participants
total of 70
1 lists participants
20 people
1   did not want people
12 participants
1129   samples over all participants
n=28
n=94
34 subjects
34   subjects
N=70
N=315
N=711
N=437
N=861
N=308
N=638
N=531
43 participants
7 people
16 people
total of   43
total of 72
12 women
9 women
240 participants
31 participants
27 participants
N= 84
N = 36
n = 12
500 participants
 data from   1,040
total of 127
281 women
252 participants
1,084 participants
 data from 1,040
25   participants
25 participants
total of 25
133 participants
20 items about participants
15 items about participants
N=76
N=57
10 participants
10 people
10 subjects
12 participants
6 participants
4 participants
3 participants
15 participants
16 participants
2 where participants
3 where   participants
16 subjects
total of 19
total of 3
total of 8
18 participants
45  minutes after which participants
10 participants
5 participants
14 subjects
4 new subjects
total of 18
total of 3
4 women
21 participants
12 right-handed participants
11,664 trials in total. All   the participants
1D experiment subjects
1 allowed   participants
12 subjects
5 within-subjects
8 women
n = 0
25 people
200 people
24 participants
32 participants
n=4
n=3
n = 27
n = 4
n = 5
n = 2
n = 28
n = 29
13 people
n=38
23 participants
4 million people
12 participants
18 participants
6 participants
44 participants
10 illustrates participants
11 Comparison of the ratio of subjects
12 Percentage of subjects
n = 20
n = 9
n = 1
n = 14
n = 10
8 participants
total of 37
20 participants
17 participants
9 participants
17 participants  were enrolled
15 participants
12 participants
total of 6
3 participants
77 participants
4 participants
total of 277
total of 254
62 participants
19 participants
n = 6
n = 5
n =  4
2 summarizes participants
 data set of   64,005
 data set of 34
27 participants
11 participants
12 participants
50px  pictures might prime the participants
18 people
N=11
N=12
N=5
N=7
N = 12
 data from 3
12 subjects
74 original participants
74 participants
5 participants
total of 1080
1 between-participants
30 participants
total of 30
176 participants
N=10
N=40
N=200
40 participants
1   where no participants
21 participants
40 participants
n=10
n=11
24   F   participants
24   participants
N = 12
6 participants
9 participants
total of 4
16 people
total of 17
12 participants
5 participants
3   participants
6 participants
5   participants
3 participants
7 participants
1   These two participants
19 participants
19   participants
10 participants
10 volunteer participants
8 factor within subjects
5 factor within subjects
8 factor within   subjects
total of 537
total of 5
total of 96
total of 10
total of 1440
12 participants
12   participants
7   participants
6 participants
4   participants
2 participants
4 participants
12 novel participants
18   random participants
 database of 18
12  participants
6 participants
14 participants
total of 10
 data set of 1,000
15 subjects
N = 40
N = 500
N = 100
12 participants
12  participants
30 locally-based participants
11 local participants
 data came from 40
450 male participants
450 participants
1 If participants
450  participants
1 recorded participants
n =  144
n = 44
n = 36
n = 28
n = 38
n = 66
n =  70
n =  78
n =  93
n = 46
n = 47
total of 450
total of 200
total of 250
28 participants
36 subjects
32 subjects
38 subjects
35 other subjects
N = 36
N = 27
total  of 120
total of 18,554
 data of all 35
 data of 35
total of 1,783
7  million people
total of 33
400 participants
1st group of participants
2nd group of participants
6 participants
6 shows how many participants
8 shows the number of participants
8 participants
248 subjects
22 subjects
15 participants
n=1
total of 100
12 participants
8 participants
9}   Several participants
11}   Five of the participants
5}   Several participants
40 million people
12   people
N=1
N=3
N=4
N=11
25 remaining participants
22 participants
24 participants
9 participants
13 participants
11 participants
5 participants
3 participants
23 participants
25 patients
27 patients
1162 patients
21 patients
15 the patients
12   Six patients
10 patients
11 patients
6 patients
25 emergency department patients
12 people
total of 27
total of 8
total of 106
n=18
n=43
n=45
n=39
n=25
n=0
n=13
n=4
n=5
n=3
n=9
n=2
n=6
n=11
n=17
15,000 young people
n=13
n=11
n=24
total of 48
 data from a 12
29 participants
total of 87
total   of 30
total of 18
N = 5265
N = 5017
N =   6354
   data set of 1
5All participants
70 people
n=37
n=19
703 unique participants
1404 unique participants
95   Number of participants
1934 participants
2 said participants
440,000 people
N=17
n=14
n=3
N=322
N=577
n=4
N=200
N=141
n=8
n=2
n=1
n=7
n=5
n = 18901
n = 17532
total of 112
total of 114
total of 18,901
total of 34,827
500   people
19 people
328 participants
20   participants
20 participants
total of 58
 data set of 53
3We recruited over a hundred participants
 dataset of   15
87 participants
n=5
n=9
n=0
24 participants
7   participants
n=10
39 participants
n = 19
n = 20
total of 48
24 participants
n = 2
total of 28
total of 12
total of 10
total of 20
265 participants
27 participants
13 participants
302 participants
37   participants
3 people
n=3
 data from 265
6   summarizes the full set of participants
12 participants
total of 4
total of 12
1    While the participants
17 participants
20 participants
N = 20
total of 66
total of 9
30 people
n = 0
n = 1
total of 24
21 participants
4 shows a â€œpeople
10   people
100 people
n=21
 data   from 1
2 within-participants
N = 433
661   participants
265,940 people
150 familiar people
0 chose â€˜only people
150 people
200 searched people
total of 1,119,121
90 participants
12 specific elements of people
90 people
10 right-handed participants
90 minutes and participants
10 participants
n = 438
total of 900
48 participants
 data from 59
2 people
10 people
n = 8,772
n   = 8,000
n = 14
n = 72
total of 21,132
32 participants
14 participants
16   participants
   data from 32
11 participants
24 participants
17   participants
n=49
n=48
N=26
N=37
N=27
n=2
N = 28
total of  3275
total of 18
24 participants
8 participants
16 participants
14 participants
n=27
n=26
total of 16
total of 14
12 participants
8 participants
total of 960
total of 800
total of 522
total of 180
N=10
N=5
N=4
7 pairs of participants
4 participants
7= â€œvery highâ€   participants
8 people
5   people
3 people
12 participants
9 participants
10 mousing participants
12 participants
7 participants
23 participants
250 people
4 All names of participants
30 people
100   participants
300   participants
total of 100
total of 300
10 participants
total of 96
15 participants
8 participants
7 participants
4   participants
N=8
N=7
50 participants
100 people
96 people
21 participants
18 participants
24 participants
27 participants
24 counter balanced   participants
n = 2
n = 16
7 participants
7   participants
10 participants
16 new participants
9 participants
3 participants
4 participants
2 participants
9   participants
N=7
n=2
N=16
22 participants
22 right-handed   participants
N=0
total of 55
19 women
31 women
1 participants
98   participants
 data from the 50
n=51
11 participants
10 participants
12 participants
16 participants
48 people
3 patients
3 also shows the number of participants
n=385
n=136
total of 2077
13 were women
30 participants
16 participants
26 participants
n = 10
n = 66
total of 947
53 participants
n=8
n=7
n=6
n=10
n=23
n=19
n=16
n=20
n=21
n=36
n=28
n=45
n=15
n=3
n=13
n=14
n= 1
n=5
n=4
n = 1
n=1
total of 1
total of 29
total of 13
total of 38
total of 40
total of 14
224 people
n=112
n=43
n=141
n=106
n=107
n=41
n=142
n=105
n=102
n=40
n=67
n=38
n=66
n=101
10 participants
11 subjects
3 participants
11 participants
12 subjects
N=6
20 participants
total of 513
total of 618
total of 50
4 participants
4   participants
12 participants
6 pairs of participants
1   All of the participants
n =  5
52 participants
n = 22
total of 52
35 participants
25 of the participants
31 participants
32 of the participants
3 participants
34 participants
8 participants
N=35
N=6
N=4
N=2
N=8
N=7
N=10
N=16
N=9
N=31
N=32
N=34
5 pairs   later we showed the participants
200 as   total participants
433 valid   participants
3   the ip addresses of the participants
4,627 participants
12 people
20 blind participants
89 blind participants
20 participants
10 participants
10 blind participants
10   participants
total of 20
n=4
n=2
24 participants
24   participants
18   participants
21 participants
3   participants
2 within-subjects
3 participants
7 participants
24 participants
8 participants
24 people
8 participants
3 participants
24 participants
27 participants
total of 12
 data from 8
22 participants
7 people
n = 40
n = 0
total of 347
total of   1851
65 participants
5 people
20 people
total of 65
total of   631
20 participants
19 participants
n=15
n=18
N=11
N=651
total of 712
361 participants
361 people
1608   participants
20 participants
N = 20
N=20
3D print the participants
total of 6
470 participants
718 participants
60 people
total of 741
 dataset of 1000
 dataset   of 1000
8 expert participants
total of 110
21 participants
30 people
5 people
N = 21
0 did not match participants
60 undergraduate participants
total of 4979
9,526 people
total of  100
3 participants
6 participants
2 participants
3   participants
n = 10
n=14
n = 1
14 participants
total of 5
total of 9
10 participants
3 factor within-subjects
total of 135
total of 1350
1m apart on a wall behind participants
18 participants
6 participants
24 participants
N=18
N=6
total of 96
total of 464
4 participants
n = 29
n = 24
n = 30
total of 180
27 participants
12 participants
70 participants
15 participants
2 participants
53 participants
N=53
1200 monitor   prompted participants
18 participants
14   participants
total of 10
20 participants
18 participants
5 participants
n=18
total of 20
total of 15
n   = 12
n=3
6   million people
65 and older are people
8 persons
36 participants
N = 36
 data from 36
6 persons
 data from 80,424
 data from  72,945
 data from  26,586
 data from 13,013
 data from  13,013
n = 10
total   of 5 171 840
20 participants
6 new participants
5 participants
1 before participants
6 participants
 data from 20
22 participants
13 of the participants
total of 63
16 participants
16   participants
N=16
total of 1920
 data from 16
20 participants
1 asked participants
3 asked participants
10 control participants
10 Codelet participants
9 participants
8 participants
27 participants
16 p   was randoml  e participants
7 of   participants
n=27
n=6
n=8
n=1
N=3
N=27
N=17
1011 non-contributing participants
13,000 people
300,000 people
1250 people
275 people
135   people
37 people
n=1
total of 701
150K people
16 people
100 people
10,000  people
10,000 people
144,232 unique people
total of 1
26  media people
18 media people
24 participants
N = 23
N = 25
n = 3
n = 96
n = 1
n = 43
n = 5
n = 62
n = 25
n = 9
n = 61
total of 2,080
 data   from 24
29 participants
15 participants
N=29
1 might   also have led people
N=90
total of 18
6 participants
32 participants
2 asked the participants
3 asked the participants
4 asked the participants
5 asked the participants
9 presented participants
10 presented participants
11 presented participants
2,071 US participants
645 Hong Kong and Taiwan   participants
514 participants
500 participants
500   participants
 data from 1,037
31,159 people
8750 people
828   people
n = 18
n =   16
n = 17
n =   11
n = 828
n = 192
n = 190
n = 88
n = 6
n = 1
11 women
23   participants
13 participants
3 of the participants
3 million people
138 persons
5 of the previous participants
12 participants
12 participants
7 subjects
3 subjects
2 subjects
10 subjects
12 participants
12 participants
11 participants
11   participants
 data of 1
22 participants
n = 29
n=4
n=5
total of 1,970
total of 26
total of 45
total of 50
total of 414
total of 148
953 subjects
951 subjects
177 subjects
2 shows how subjects
21 subjects
3 motivations participants
N = 1132
N = 898
21 of   these subjects
total of 14
16 were  women
15 control  subjects
36 subjects
15 con-  trol subjects
13  control subjects
19 test subjects
total of 36
total of 28
 datasets from 13
90 participants
30 participants
20 participants
3 participants
2 participants
2s people
5 people
n=16
289   participants
N=246
N= 43
total of 4,209
24 participants
19 participants
8 participants
14 participants
9 participants
15 participants
10   participants
10 participants
12 participants
n  = 25
n =  25
n = 33
n = 34
n = 3
n = 2
n = 4
total of 240
total of 40
51 participants
19 participants
n=20
n=65
total of 1134
total of 14
total of 88
3 people
56 participants
n = 90
n = 78
total of 161
17 participants
n = 40
n = 14
total  of 17
2 may encourage people
2 will allow more  people
n=2
total of 2
15 participants
total of 94
10 participants
17 participants
14   people
10 people
5 shows how often and how long participants
 data from 8,187
5 women
total of 120
total of 144
18 participants
18  diverse participants
total of 34
total of 7847
total of 68
total of 31
2 persons
250 people
2 within-subjects
4 participants
614 people
n = 15
n = 120
n = 40
n = 1
6 participants
555 participants
86 participants
83  participants
total  of 248,646
36 people
20 people
17 people
total of 17
90s more and more people
18 participants
13 participants
9 participants
8 participants
10 participants
14 participants
152 people
39 people
18 people
10 participants
9 participants
12 participants
n=6
 data consists of 3,433
30 participants
18 participants
10 participants
141 participants
N=141
10 visually impaired participants
2 participants
6 participants
10 participants
5 participants
total of 14
17 participants
n = 39
total of 10
N=20
12 participants
30 participants
26 participants
total of   1920
 data from F4
n=0
65   million people
6 people
n=2
n=3
n=1
n=4
n=5
189 participants
200 participants
N=191
N=81
N=46
N=88
N=189
N=2
N = 189
N=190
N = 157
N = 24
N = 8
N=99
N=90
2 shows how frequently people
 dataset of 15
13   participants
13 participants
total of 13
total of 5,643
428 people
N=13
N=10
N=7
62,332   system participants
30 participants
281   people
9 people
21   people
N=281
total of 9,506
total of 175
30 participants
5 participants
17 participants
18 participants
9 participants
n=25
n=30
45 participants
3  participants
total of 45
 data  from 22,417
N=8
N=16
21 participants
16 participants
37   Two participants
37    Four other participants
100 new people
 data from 21
10 participants
12   participants
43 participants
N=16
3   women
15 participants
8   billion people
25 people
11 people
18 people
3 people
total of 16
total of 61
5 people
n=22
N=10
N=14
21 participants
96 participants
20 participants
n = 28
n = 29
n = 26
n = 24
n=3
n=2
n=1
n= 2
n =2
n = 1
total of 24
total of 30
51 participants
30   participants
32 participants
30 participants
7   Some participants
7   Shared Activities   Seven participants
9   Two participants
4   Several participants
6   Some people
total of 21
n = 61,289
20 participants
20   participants
20 people
total of 20
13 participants
13 people
total of 13
40 participants
22 participants
20 participants
10 participants
n = 20
N = 13
N = 16
N = 11
n =  110
n = 81
n= 106
n = 83
2 billion people
n=19
n=1
n=17
n=7
n=4
n=15
n=3
n=2
n=6
n=5
n=10
n=9
total of 302
total of 120
20 participants
3 within-subjects
12 participants
20 participants
8 participants
5   participants
3 within-subjects
N=36
N=24
N = 16
total of 146
6 women
1,445 responses from the participants
2 shows the distributions of participants
6 provides an overview of the participants
n = 60
n=1184
n=1217
n=1445
n = 1095
23 cases   where participants
6 participants
62 people
n=3
n=5
n=4
8 women
6 women
13 pairs  of participants
1 and now attracts new participants
4 naÃ¯ve participants
457 participants
4 participants
1 million people
total of 457
101 participants
7 people
60 participants
40 participants
51 participants
22,000 new BC   patients
45 rural   BC patients
1,405 patients
21 patients
39 BC   patients
7   patients
10 BC patients
10 patients
15 other patients
39 BC patients
45 BC patients
21   other patients
3   patients
6 patients
29 visits of other   BC patients
30 SMSs patients
43 patients
2 different   classes of people
total of 107
total of 40
501 geriatric patients
total of 16
52 participants
34 participants
18 participants
26 participants
29 participants
28 participants
48 participants
38 participants
34 participants
31 participants
19 participants
31 valid   participants
26 participants
3 participants
3 accuracies of participants
 data of the 31
 data of 26
43 participants
20 participants
10 participants
n=22
n=10
n=5
n=1
n=28
n=9
n=3
n=19
n=20
n=0
n=30
total of 1585
59 participants
20 participants
35 participants
10   participants
13 participants
13 people
total of 13
2 between-participants
48 participants
total of 48
total of 40
5 participants
10 participants
26 people
16 people
10 people
total of 16
5 women
17 women
43 participants
10 participants
6 participants
4 participants
30 participants
38 participants
33   participants
17 Recording group   participants
16 Reflection participants
12 participants
60 participants
20 participants
N = 429
N = 428
N = 169
total of   599
total of 10
15 participants
60   participants
33 participants
18 participants
total of 22
98 lab participants
457    Meeting   new   people
1 There are several people
7 The people
6 The people
8 The people
9 I do not know people
10 The people
7 New people
N=98
N=22
N=76
total of 98
36 subjects
total of 36
total of 10
20 participants
20 participants
9 gesture features   participants
2 we also asked participants
14   participants
14 participants
6 participants
9 participants
13 participants
18 participants
3   participants
N = 17
N=20
N = 238
N = 20
total of 244
15 participants
5 participants
14 new participants
total of 4
3 participants
12 participants
total of 128
total of 16
10 participants
5 participants
17 participants
13   For other participants
15   Several participants
20 people
46 participants
16 participants
4 women
18   participants
561   participants
116   participants
266 participants
16 participants
16 of the participants
14 participants
5  where participants
3 Cerebral Palsy patients
3 Carpal Tunnel Syndrome patients
total of 69
total of 553
12 participants
15 participants
11   participants
12 survey participants
6 people
5 people
N = 60
N = 8
n = 1
N = 187
total of 480
4 participants
3 participants
2 participants
1 shows the   distribution of participants
800,000   people
N=6
N=5
6 participants
4 participants
2 participants
19 participants
12 participants
4 participants
800,000 people
total of   59
28 participants
3 participants
 data from 1959
 data from   1959
total of 20480
total of 375
10 participants
n = 31
n = 5
n = 4
36  unpaid participants
total of 36
28 participants
19    Here participants
n=   4
total of 28
total of 6
total of 4
total of 51
12 participants
11 participants
18 participants
n=969
n=1133
n=1178
n=924
n=964
n=973
n=952
n=999
n=1002
n=0
N=54
N=36
12 participants
3 participants
18 participants
n = 1
10 participants
3 participants
total of 10
30 women
12 participants
3 participants
3 within-  subjects
total of   36
total of   10
total of 45
total of 50
total of 18
total of 25
total of 10
29   participants
29   people
24 participants
24   participants
   data.  Proc. of CHI'12
48 participants
2 shows information on the   participants
5 participants
total of 6
total of 15
27 participants
15   participants
12 participants
27   participants
8 participants
10 less technically adept   participants
61 participants
28 people
n=3
n=2
N=1877
total of 496
16 participants
2 Gathering of   participants
17   participants
4 within-subjects
3 within-subjects
total of 1920
total of 30720
total of 2592
total of   31104
14 participants
4 participants
16 participants
16  participants
3 shows which participants
total of 334
total of 205
14 participants
16Hz participants
250Hz participants
250Hz thus participants
total of 14
total of 247
total of 272
30 participants
50 female participants
10 participants
9 shows the participants
total of 14
total of 21
total   of 600
5 participants
78   participants
3D   d prior exper  e participants
n=16
n=30
n=1
10 participants
233 people
n=32
N=32
N = 924
N=920
total of 1863
20 participants
20 subjects
n=7
14 participants
10 participants
total of 10
205   people
20 people
total of 4
total of 79
total   of 59
100 patients
3 patients
65 patients
409 threads had patients
3    When patients
100   patients
100 randomly selected patients
3   All the dates and names of people
total of 1172
1â€™   represents participants
2â€™ if   the participants
3 participants
total of 164
total of 17
total of 24
total   of 12
17 participants
10 people
3   groups of people
97 people
n = 3
n = 2
9 participants
21 participants
300 asthmatic subjects
300   asthma patients
26 patients
15,000 patients
21   pediatric asthma patients
30 pediatric   patients
1 patients
200 million people
n=118
n=115
total of 2095
1 were enrolled
16 participants
N = 64
N = 16
20 participants
18 participants
2 female participants
8 participants
8   participants
6 participants
total of 4,283
8 participants
n=3
n=4
20 participants
13  participants
7  the participants
36 participants
n=20
7   women
24 people
n = 42
n = 2
n = 1
48 participants
16 participants
16 of the recruited participants
n=2
n=1
n=3
n=5
n=10
n=4
n=6
total of 12
32 participants
24 participants
N=12
N=24
n=7
n=14
2 people
60 people
4 tests   people
total of 80
20  and remote participants
2 told remote  participants
1 introduced the participants
n = 29
total of 58
total of 22
4 participants
20 participants
50 people
8 people
6 people
5 people
total of 240
11 women
2 women
4 billion people
10 people
11 participants
45 people
2012 there were already more persons
1990s where Palestinian   people
200 people
total of 791
5   people
n=64
7,000 participants
n = 226
n = 45
n = 30
n = 151
n = 195
n = 80
N = 300
N   = 300
20 million people
24  local participants
24 local participants
N = 4
total of 206
22  participants
8 participants
184 participants
122 participants
2 across all participants
69 across all participants
500 participants
306  participants
242 participants
n = 21
n = 32
N = 367
  data consist of 184
N=40
N=5
n   =8
n =6
n =2
n =7
n =4
total of 11
total of 366
total of 181
total of 80
total of 56
24 male participants
24 new participants
n =  1
100 participants
14 participants
96 MTurk participants
6 participants
90 participants
92 participants
13 participants
123 MTurk participants
9 MTurk participants
114 participants
283  MTurk participants
35 participants
290 participants
14 subjects
n = 324
 data from 283
 data from 35
500 participants
45 participants
938 participants
15 participants
N = 368
N = 323
n = 30
N = 338
N = 691
N=323
N=368
n = 145
n = 199
N=145
N=199
total of 938
N = 4
total of 6655
n = 273
n = 285
n = 402
n = 389
n = 791
n = 457
n = 60
n = 99
n = 24
n = 17
n = 137
n = 283
N=295
N=270
n = 20
n =  12
1300 participants
1300 formal test  participants
900 participants
total of  900
2 participants
N=27
1  While the number of people
47 people
130 participants
22 participants
10 participants
76 participants
6All iPhone participants
29 participants
82 participants
26 participants
6 participants
1,400 screenshots of our participants
83 subjects
132 people
n = 3
N = 101
 data from 132
48 participants
total of 48
11 women
693   participants
32   participants
15 participants
600   participants
650 participants
1 shows where participants
920 locations participants
28 participants
93 OWork participants
32 participants
31 participants
23 participants
24 participants
29 participants
26 participants
18 participants
13 participants
9 participants
419 people
537 people
N=650
N=693
N=380
N=169
total of 93
 data from 693
 data in-situ from 32
 data from 15
 data from 32
 data from   32
   data from 15
18 participants
21 participants
6   participants
9 participants
15 participants
6 participants
18   participants
7 people
n=121
n=33
n=9
n=5
N=121
14 participants
3 participants
3 within-subjects
N=13
14 participants
total of 386
5 participants
7 were currently enrolled
30 participants
1647 people
12 participants
4 persons
23 participants
28 participants
2 subjects
3 subjects
4 subjects
20 participants
N = 20
959   # of people
106 362   # of people
45 183   # of people
48 164   # of people
47 126   # of people
145 participants
16 participants
n = 2
45 participants
1â€”because   participants
total of 288
total of 10
6   women
17 participants
n=47
84 participants
13 participants
50 participants
39 participants
total of 84
total   of 7
total of 2
n = 3
n = 5
8 participants
3 participants
4 participants
20 participants
5 studying other subjects
total of 20
20 participants
500 patients
28 participants
224   cases participants
87 eligible participants
65 participants
45 participants
14 participants
12 participants
36 participants
38 participants
34 participants
32 participants
65 subjects
250 million  people
250 million people
10 volunteer participants
5   participants
10 participants
 data of hands from 10
47 participants
51 participants
4 participants
40 participants
200 participants
541 participants
763 participants
5We excluded participants
2 PPM  All participants
331 participants
218 participants
37 participants
n = 51
n=15
n=16
n = 541
n = 331
n = 244
total of 541
20 participants
24 participants
21 participants
n = 24
16 participants
20 of those participants
20 participants
13 participants
19 participants
39 people
total of 42
560 participants
252 participants
59 participants
8 participants
2 Between-subjects
110 people
N = 560
N = 308
N = 59
n=3
n=1
n=2
13   Most participants
6    When participants
3   While some participants
11   While the participants
7   Other participants
15   Several participants
17 people
5 people
18 people
7   people
1   In some instances people
903 people
N=588
N=672
N=955
total of 2
 datasets of 217,174
n=180
   database of 32
31 participants
n=7
n=10
n=5
n=6
n=4
total of 710
 data from 3000
10 trial primary participants
2 GB data plan and   charging participants
5 people
total of 155
56 participants
total of 56
total of 70
3 women
8 participants
4 of the participants
31 participants
n = 10
n = 82
n = 79
n = 31
total of   147
15 participants
16 participants
4 participants
1 provides a full list of the participants
10 participants
15 people
total of 16
6 South Asian   women
5 of   the women
3 of the women
1 of the women
total of 109
12 right-handed participants
6 new participants
5min of game play participants
12 new right-handed participants
8 new right-handed participants
3 within-subjects
20 participants
20   participants
10 participants
9 participants
4 participants
5 participants
42 participants
3 people
total of 42
1 consisted of seven  participants
3 included four  participants
17 participants
7 participants
7   participants
10 right-handed participants
10 participants
n=4
n=3
n=1
n=5
n= 3
total of 132
11 participants
 data   from 10
16 participants
4 participants
16 subjects
total of 13
n= 40
N=11
N=13
23 women
44 participants
44 people
N = 44
300 participants
N=291
total of 50
210 participants
109 female participants
20 participants
20 subjects
60 total subjects
total of 40
total of 45
total of 36
10 subjects
total of 393
18 undergraduate student participants
3 participants
15 participants
11 participants
n=60
n=57
n=2
n=1
 data from 3
 data   from 15
10 women
370 million people
total of 11
total of 24
12 women
10 additional   participants
N=6
N=20
total of 5
8 participants
N=40
12 participants
6 participants
12 participants
total of 13,653
total of 12
16 participants
16   participants
6 participants
7 participants
 data from 16
50 participants
1,000   new people
27,000 people
total of 1,023,824
total of 530
total of 23,288
60   participants
60 participants
7 test participants
6   participants
20 participants
25 participants
15 participants
3 between-subjects
800 million people
8 people
n = 60
total of 40
total of 9
28 participants
100 people
10 women
2 women
23 participants
20 participants
4  TGA STGA  Number of participants
0  Female Male  Number of participants
total of 147
total of  23
10 research participants
16 participants
10 eligible participants
28 participants
total of 209
total of 22
total of 641
total of 8
total of 5
12 participants
12   participants
n = 15
n = 7
n = 16
n   =  42
n=1
n=4
n=2
n=5
n=3
total of 12
total of 274
n = 2
n = 10
8 participants
963 participants
10  datasets and allowed participants
40 participants
41 participants
87 participants
13 participants
n = 40
n = 197
total of 9
total of 16
  datasets from 10
16 participants
5 control participants
N=60
N=53
N=62
N=15
total of 42
total of 51
total of 22
48 participants
N=48
N=38
N=27
N=96
N=28
N=25
N=32
N=7
total of 12
30   participants
11 participants
total of 95
total of 837
1 lists the breakdown of   participants
84 participants
2 factorial between-subjects
n = 35
12 participants
12 people
N = 7
N = 4
N=5
N = 5
N = 6
total of 22
total of 12
total of 64
64 participants
18 participants
N=18
total of 12
total of 30
6 participants
N=16
N=513
total of 44
total of 162000
total of 108
total of 80
 data of 6
9 participants
total of 660
33 subjects
N = 1
N = 10
N = 20
total of 480
3 women
total of 80
total of 22
160 different participants
40 participants
total of 1600
total of 79
24   pairs of participants
N=16160
N =10816
N=10816
N=12169
N=11729
N=10712
N=1816
total   of 13
total of 312
total of 16771
total of 216
22 participants
45 participants
26 participants
N=42
N=43
N=6
N = 121
n = 62
n =   56
n = 56
n = 52
14 participants
13   participants
15 participants
n   =   1
total of 56
56   participants
n=14
3  With more participants
550  participants
total of 51
total of 326
total of 73
2 presents participants
9 participants
2â€”participants
N=2
N=8
N=32
total of 285
 dataset of 1335
65 participants
172 university   participants
2 participants
3 participants
36 younger   participants
36 older participants
n = 18
n = 20
n =   18
n = 70
24 participants
24  participants
N = 32
36 participants
total of 31
28 people
N=410
total  of  46
total of 36,948
total of   40,426
32 conversational-regret  participants
350  participants
1127 participants
32 participants
78 participants
49 participants
98 Twitter-  regret participants
1,221 people
3 of participants
96 participants
739   Finding people
817   Stalking other people
833   Viewing other people
n = 159
n = 44
n = 5
n = 90
n = 79
n = 4
n = 2
total of 208
310 participants
2 within-subjects
400 people
40,000 people
N=274
5 women
12 participants
10 participants
12 participants
84 of the participants
4 participants
24 participants
24   participants
total of 24
13 participants
total of 20
8 participants
20 participants
3Given the small numbers of participants
366 MTurk participants
15 participants
125 participants
366 participants
49 people
n=10
n=120
n=123
23 participants
11 participants
15 participants
16   people
255   participants
118 participants
44 participants
12 participants
575 people
200   people
n=94
n=195
n=196
25  participants
25 participants
6  Protocol  All participants
13  participants
6 participants
6  participants
total of 94
total of 13
40 participants
N = 39
N=20
N=19
4 participants
8   participants
8 participants
7 participants
14 participants
14   participants
30 participants
20 people
N=198
N=344
N=33
N=74
N=58
N=145
N=172
N=184
N=309
300 people
200 people
1401 people
150   people
2,000 people
total of 6,125
total of 371
132 people
10 most active people
total of 1463
1 lists the percentages of participants
36 female participants
2 indicate consensus among  participants
3 lists the  percentages of participants
31 participants
001  Once participants
N = 93
N = 82
total of 31
16   participants
48 participants
16 participants
18   participants
n = 48
34 people
1,081 people
268 people
total of 128,845
4 women
2 women
3 million people
10 student subjects
20Also known as a â€œwithin-subjects
N = 432
N = 1296
16 participants
7 participants
8 participants
11 participants
total of 96
50 people
total of 11,806
total of 54
511 people
5 activities of other people
311 people
5 brought   people
26 participants
13   participants
 data from 45
total  of 18,869,566
total of 245
40 participants
40 subjects
8   plots two extreme participants
n   = 7
total of 24058
12 participants
20 participants
18   participants
15 participants
7 participants
n=29
n=28
14 participants
6 participants
6   participants
total of 17
total of 108
300 subjects
50 subjects
N=2
N=6
N=3
N=1000
N  =  142
total of 402
total of 13,379
20 participants
2 participants
n = 10
10 participants
400 people
2 people
20 participants
12 participants
20 people
8 people
12 participants
N=31
15 right-handed  subjects
300 participants
200 matches as some people
300 people
70 people
65 people
 data from 300
20 participants
total of 200
total of 1,282
total of 24
N=4705
 data from our 14
12 participants
20 study participants
100 additional people
   databases of 20
 data-  base of 120
 data from a   1
 data from 12
 data   from 100
23 of the participants
total of 48
N=320
N=384
N=64
total of 64
10 right-handed participants
14 right-handed people
111 study a common  set of subjects
n=516
n=515
n = 516
total of 1031
total of 2620
total of 519
total of 26
total of 22
1031 students enrolled
total of 36
total of 840
N=175
N=111
180 enrolled
137 enrolled
44   patients
800 patients
200 injured patients
200 patients
300,000 injured people
10   participants
932 participants
173 participants
759   participants
759 participants
n=396
n=360
n=380
n=379
n=426
n=101
n=57
n=68
n=226
n=116
n=104
n=159
n=107
n=40
n=53
n=199
n=114
n=96
n=170
n=300
n=86
n=97
n=106
n=25
n=222
n=45
n=0
n=36
n=28
N=1,836
 data from 507
2 women
3D  coordinates of the participants
12 participants
7 participants
15 participants
n = 0
166 participants
n=26
N=384
14 participants
3  shows the participants
total of 168
total of 84
10 participants
N=15
12 participants
11 participants
10 participants
70K subjects
3 between-subjects
25 between-subjects
total of 25
 data from   69,642
12 participants
4 within-subjects
3 within-subjects
n = 480
N=12
total of 240
total of 54
total of 5
total of 60
4 people
n = 3
n = 2
11 people
total of 11
130 total participants
N = 12
 data set of 100
total of 91
2 illustrates how people
31 groups of people
N=19
20   people
100 persons
16 participants
20 participants
35 participants
10 participants
N = 35
N = 662
N = 650
n = 5
n = 6
20 participants
20 subjects
3 people
n=19
n = 20
N = 1
n = 4
n = 5
n  = 45
n = 36
n = 27
n = 33
total of 1,140
total of 16
9 participants
16 participants
12 participants
4 participants
total of 16
total of 2
total of 4
 data from 4
6   participants
2 categorizes participants
N = 17,968
total of 6
total of 648
8 participants
10 participants
 data from 157
36 participants
70 minutes and all participants
22 people
32 people
total of 180
total of  2
total  of 40
40 thousand participants
40,000 participants
22 participants
242 participants
32,222 participants
18,448 participants
n = 32
n = 2
n = 6
N = 220
40 participants
40   participants
10 participants
N = 5
N = 7
N = 8
N = 31
N = 4
138 people
n = 25
n = 10
n = 57
n = 68
n = 27
n = 63
n = 82
n = 79
total of 64
3 items people
n = 8
n=0
n=175
n=2
n=239
n=98
n=1
n=13
n=49
n=21
N = 227,241
N=227,241
8 participants
21 participants
18 participants
18 subjects
10 show subjects
3 people
n=3
n=4
n = 1857
n = 1135
n = 591
n = 749
n = 1
n = 0
n = 2
n = 4
n = 3
18 participants
22 participants
22 people
23   people
33 under-  graduate student participants
33 participants
16 of the participants
8  participants
20 participants
11 participants
23 interviewed participants
total of 191
 data from 33
5 participants
2 participants
187 million people
n = 6
6 persons
36 participants
100 people
6 people
23 people
total of 36
12 participants
4 people
95 participants
N = 15
N = 124
N =  724
total of 904
1 looked at participants
2 looked at participants
24 participants
16 different participants
1 participants
3 paid participants
10 participants
4 participants
12 participants
3 participants
3  participants
3 people
2 as input and asked new   participants
48 participants
48 people
total of 48
n = 1005
65   participants
3 visualize scan   paths of participants
1 Let people
N   = 65
N = 23
N=31
N=33
N=30
n=32
16   participants
2 displays the participants
4 shows participants
5 shows participants
2 a between-subjects
3a shows   participants
13 participants
30 and   under and five people
5,000 live participants
0 as the number of  participants
500 participants
150 people
total of 80
224 people
226 people
2 wondered   what patients
6 also mentioned peer patients
4 was concerned about peer patients
38   participants
n = 35
n=197
n = 3
n = 4
n = 5
n = 6
total of 38
3 women
12 participants
total of 3888
10 participants
3   participants
716   participants
n=2
total of 431
total   of 79
 data from the 1
3 are participants
1  Method  Twelve participants
7 participants
2  Method  Twenty-four participants
12 participants
15 participants
100 persons
30888 people
total of 1297
total of 29
114 participants
50 participants
89 participants
101 participants
10 participants
7 participants
13 participants
9 participants
23 participants
14 participants
116 people
16 native-English-speaking participants
10 participants
total of 16
27 participants
18 participants
n = 6
n = 5
n = 3
32 participants
22 participants
22 subjects
22 of the subjects
N=20
2557395   people
3   women
10 women
03   â€œI have a lot of women
1 These participants
09   Some participants
05   A number of participants
02   Some participants
7 people
21 people
5   â€œI think a lot of people
07   â€œThere were some people
 dataset of 2458
776,000 people
5 million   people
8,175,133 people
N=1
N=2
N=3
total of 26
total of 272
 data from 840
8  We asked participants
2 subjects
1,000 US   participants
11 participants
250 participants
1,013   participants
312   participants
1,000 participants
1000 people
total of 272
 dataset of 33,180
11 female participants
5 participants
15 participants
11 participants
6 participants
3 people
12 participants
12   participants
N=12
10 participants
12 participants
20 recordings of participants
N = 60
N = 70
N=60
N=70
12 participants
10 participants
15 participants
11 rural   participants
15 participants
9 participants
35 participants
10   participants
54 participants
47 participants
14 participants
10 participants
24 participants
35 million   people
4 million people
170,000 people
total of 54
total of 50
total of 216
20 Afro-Caribbean women
20 participants
65 participants
total of 20
100 people
n = 9
n = 1
n = 2
n = 0
n = 5
N=1000
N=974
N=638
N = 638
n = 6
n =   4
11 participants
10 participants
total of 111
33 participants
2 presented participants
6 compares the distribution of participants
137 participants
8 shows how   long it took participants
28 participants
3   participants
10 participants
total of 20
4 participants
3 participants
10 participants
9   people
n = 32
total of 341
total of 26
total of 2400
total of 700
total of 13
total of 27
 data from the 48
11 participants
11 subjects
total of 28
 data set of 28
11 blind people
n=1
n=2
n=3
n=4
n=5
N   =3
total of 168
total of   263
n = 6
11 total participants
19 unique   participants
16 total unique participants
9 of the art and design participants
19   participants
17 participants
19 total participants
total of 19
18 participants
16 participants
2 participants
3 of participants
3  of the participants
3 of  the participants
6 these participants
11 participants
n = 54
20 participants
18 participants
11 participants
5 participants
6 participants
5  participants
1  We setup a simple within-subjects
N = 33
N = 30
N = 18
N =   16
N = 14
N = 16
N = 29
N = 25
0   periods of time than male participants
n = 2
N  = 54
N  = 52
N  = 69
22 voluntary participants
18 participants
3 participants
3 we asked participants
total of 880
7yr girl   Two participants
2 involved the same participants
12 participants
total of 127
9 participants
12 participants
total  of 24
7 non-student participants
62 subjects
total of 5
total of 80
2 women
1718   participants
12 participants
44 participants
N = 44
n = 3
n = 5
15 participants
12 participants
3 within-subjects
n = 3
n = 1
n   = 4
n = 2
total of 600
20 participants
total of 10
total of 4
24 participants
total of 24
15 participants
15 people
15   people
n = 55
36   participants
20 Caucasian   participants
16 East Asian participants
20 Caucasian participants
20 East Asian   participants
8 East   Asian participants
n=8
N = 28
n   = 28
n = 10
n   = 12
n = 14
1 Characteristics of interview participants
N=21
N = 21
n=3
2 women
9 people
15 participants
13 participants
15   participants
2 factor within-subjects
6 ki  ealistic object   e participants
total of 34
20 participants
20   participants
20 subjects
n = 0
 data from the 20
7 women
10 participants
12 participants
total of 3935
total of 16
n = 1
10 participants
3 people
total of 2,700
13  participants
16 participants
42 participants
N = 20
total of 24
30 participants
11 participants
n = 1
n = 2
n = 3
n=1
n=6
n=3
n=5
n=2
13 participants
n = 0
5 persons
33 participants
9 participants
18 participants
20 people
N = 66
n = 33
n = 18
total of 33
 data rate of 60
 data of all 33
40 participants
44 subjects
9 subjects
18 subjects
13 subjects
12 participants
12   subjects
12 subjects
total of 72
26 participants
22 remaining participants
22 participants
25 participants
21 participants
3   Method   Twelve participants
n=29
n=19
n= 30
n=18
22 participants
2  shows a heatmap of where participants
n=22
n=39
n=42
n=13
n=0
60 participants
2 between-participants
10 participants
total of 146
N = 40
n = 31
n = 15
n = 16
total of 35
total of 32
16 participants
15 participants
16 participants
N = 32
N =  32
48 participants
14 participants
14 people
25 participants
12 of these   participants
7 participants
8 of the study participants
total of 8
total of 4
1 where participants
n=1
n=2
n=7061
n=10292
n=4
134 participants
134   participants
14 participants
75 participants
59 participants
5 people
8 subjects
12 participants
12 Study Two participants
15 participants
n = 40
6 participants
4 participants
3 of these participants
12   participants
total of 12
N=589
N=382
N=45
4 female subjects
20 subjects
75 trials subjects
2 female subjects
12 subjects
total of 150
40 participants
14 participants
total of 19
total of 670
 data from 14
2 result shows none of the   subjects
14 subjects
10 subjects
4 subjects
2 subjects
3 subjects
15 test and people
N=28
64 fo  women
28 participants
40 participants
24 participants
10 participants
8 participants
16 participants
28 people
n = 25
n = 22
n =  29
n =  25
n = 1272
n = 4461
 data. Next,  from the 2333
59  participants
24 participants
n = 26
 data from 95
95 participants
8 participants
67 participants
7 participants
4 participants
3 participants
n=11
n=2,579
n=2,471
n=95
n=77
n=45
n=7
n=94
n=61
n=48
n=43
n=22
n=10
n=8
5   women
116 women
n=2
n=1
N=89
total of 272
 data from   2
total of 84
1Most people
n=7
total of 49
10 participants
5 participants
8 participants
12 of the participants
6 of the participants
13 participants
total of 12
total of 84
total of 676
total of   21
total of 752
total of 848
total of 80
9 women
14 participants
33   participants
11 participants
n=1,304
n=165
n=102
27 participants
1      participants
11 participants
16 participants
12 participants
18 participants
17 participants
27 people
18 people
N=27
N=68
17 participants
n =  36
n = 14
n = 21
20 participants
244 English-  speaking participants
2,500  participants
n=17
n=16
n=4
n=5
total of 12
7 participants
9 subjects
4 subjects
N = 34
total of 49,735
22 people
n = 99
n = 98
n = 10
15 participants
2 participants
3 of the participants
4 of the participants
n=1
n=3
n=2
 data from 15
5 participants
18 Parkinsonâ€™s  disease patients
5 additional patients
2557278  A particular problem of PD patients
18 PD patients
5 PD patients
13 PD patients
18 PD  patients
18 patients
5 patients
4 patients
40 PD patients
23 PD patients
1 million people
total of 5
 data from the 18
4 of the participants
5 of the participants
3 and   other participants
4 participants
5 PD patients
4 PD patients
10 million people
5 people
120 people
129 people
16 participants
11 participants
3 participants
2 participants
8 participants
10 participants
187 participants
14 participants
200 participants
2 participants
5 participants
5 shows participants
93 participants
n =   1
n =  1
14   participants
total of 192
n = 100
total  of 8
total of  8
total of 28,800
10 within-participants
16 participants
12 participants
6 participants
12 people
76 participants
2 shows how participants
5 participants
49 participants
n = 36
n=18
n=157
n=175
294 participants
1,501   participants
89 and participants
89 participants
205 participants
89   participants
6 participants
34   participants
23 participants
12 participants
13 participants
294 people
33 people
470 people
20 people
N=89
N=205
N=111
N=94
N=294
N=1501
 data from 1,501
total of 90
22 participants
90 per cent of the participants
600 people
400 people
125 year anniversary and invited people
n=4
n=3
n=12
n=5
n=1
51 women
7 women
11 women
72 participants
618 people
total of 11
total of 618
total of 34
6 women
2 women
5 women
24   participants
24 people
20 participants
14 participants
10 participants
698,989 people
N=20
N=17
N=10
31 participants
184 participants
135 participants
N=3577
76 participants
426 cases where participants
N=1170
N=5,859,592
600 participants
93 participants
507 people
8 participants
4 participants
2 of the participants
7 participants
6 participants
4 of the participants
3 of the participants
3 participants
total of 10
2 included participants
n = 4
n = 5
12 participants
4 shows the average time participants
12 patients
15 patients
14 people
25 people
2 people
30 people
8 people
N=5673
 data of   5673
 data from   5673
9 participants
8 participants
total of 502
52 participants
11 participants
7 people
N=52
N=4
n=5
N=19
N=18
N=7
N=6
N=8
N=9
total of 52
 data from the 10
439   participants
2 asked participants
4 participants
554 participants
439 participants
n = 11
n = 10
n = 6
n = 14
n =   127
n = 27
n = 37
n = 5
n   = 30
n = 32
n = 12
n = 7
n = 296
total of 554
20 participants
16   participants
6 participants
total of 15
total of 27
total of 36
768 participants
20 field study participants
208 participants
20   participants
728 field study participants
13 participants
20 people
242 people
total of 768
total of 899
total of 38
20 participants
18 right-handed participants
5 participants
10 illustrates participants
9 participants
3 POSTURE ID within  subjects
n = 96
n =  100
n = 99
n=126
n=94
n = 7
n = 11
n = 0
n  = 0
n  = 1
n = 3
n = 2572
n = 3330
n = 2416
n = 3062
n = 3373
n = 3433
n = 2469
n = 2319
n =  2619
n = 2824
n = 4041
total of 12
total of 2421
total of 5
 data from 20
10 right-handed participants
10 participants
12 participants
n = 26
n = 24
28 participants
3 participants
N=278
N=186
N=60
N=26
N=6
N=128
N=84
N=47
total of 278
 dataset of 10,000
 dataset of   1101
7 participants
6 new participants
7 independent participants
15   participants
65 participants
100 participants
20   participants
40 subjects
2 subjects
3   subjects
8,143 participants
8,143 on-  line participants
15,108 participants
006  Storage participants
2 lists the per-  centage of participants
8 participants
32 participants
14 participants
28 participants
16 participants
n = 32
total of 140
35 participants
35  participants
34  participants
34 participants
n = 17
16 participants
 data from 11
 data from 16
299 participants
16 questions covering participants
1 participants
3 further   participants
299   participants
N=254
N=214
N=69
N=93
N=61
N=80
N=146
 data from 2013
10   participants
4   participants
10 participants
 dataset of   9495
n=10
n=7
32 participants
1 shows the counts of all participants
5 people
total of 160
 data on each of the 32
9 subjects
7 subjects
20 subjects
12 subjects
30 people
18 people
12 participants
40,191 participants
40,191 people
n=4
n=0
n=16
n=52
n=18
n=14
n=63
99 subjects
total of  1,188
total of 6
N=156
35 participants
3 participants
total of 4
total of 400
 data recall of 0
 data from 20
3 summarizes the participants
1,000 people
18 blind participants
20 participants
18 participants
17   participants
N=18
N=23
total of 18
total of 20
total of 48
total of 40
114 participants
101 sighted participants
10  participants
101  sighted participants
215 participants
145 participants
1 Five participants
32  VI participants
11 VI participants
10 visually impaired  participants
5 participants
3 participants
2 participants
215 people
10  people
N = 114
N = 101
N=103
total of 247
 data from 101
 data  from 145
285 million visually  impaired people
191 blind people
15 blind people
30 participants
20 participants
n = 5
total of 2
total of 12
 dataset  of 32000
2 participants
4 within-participants
10 participants
3 within-participants
12   participants
2 within-participants
8   participants
12 participants
12 subjects
total of 11
2 volunteer participants
32   participants
2557063      virtual traffic participants
26 subjects
N=25
n=10
n=2
12 naÃ¯ve participants
total of 18
total of 72
16 subjects
n = 0
n = 960
total of 25
114 participants
30 participants
100 participants
94 participants
20 participants
5 participants
total of 6
total of 320
13 participants
20 recruited participants
15 most active  participants
20 participants
55 game  participants
30 people
n=276
n=38
n=17
n=46
n=35
n=34
n=30
n=16
n=20
total of 247
13 participants
36 of the participants
N = 563
N = 205
60 pairs of participants
120 people
total of   60
n=14
total of   21
total   of 505
total of 79
84 participants
13 participants
4 participants
24 participants
102 people
n = 4
n =  3
n =  18
n = 6
n = 2
n = 23
n = 9
n = 8
n = 3
n = 18
n = 5
n = 7
total of 6,423
 data from 24
N = 9675
34   percent of people
90 percent of the   people
N=264,934
N=69,269
N=138,166
N= 28,608
N= 40,661
 data of a 3
24 participants
8   participants
6 participants
2 participants
4 untrained people
4 trained   people
total of 12
5350 people
3512 people
8 people
1 many people
1290 people
1,108 participants
5 participants
31   participants
31 participants
n=1,108
n=1,028
n=28
n=99,683
n=954
n=315,217
n=99,608
n=969
n=315,883
n=814
n=337
n=743
n=31
n=618
n=111
total of 1,108
total of 99,683
 data arising from 99,683
18 participants
18   participants
n=7
n=6
23 participants
13 participants
48 participants
N=26
N=27
9 paid participants
21 paid participants
21 participants
40 participants
3700 participants
5 million people
744,313 people
n=718
n=279
n=3829
n= 5139
n=5139
n=24
total of 346
total   of 200
1,000 participants
15 participants
60   participants
77,000 people
24,000   people
15,700 people
229,500   people
627 people
16 participants
30 participants
total of 20
total of 1,785
total of 40
total of 27
75 participants
10,000  combinations of seven participants
36 participants
27 participants
20 participants
10,000 combinations  of N participants
12 participants
N=3
N=25
14 participants
11 participants
5 people
10 pairs of participants
148 participants
134   participants
2 the   participants
3 the   participants
n=26
n=8
total of 67
total of 1080
16 participants
4 participants
6 participants
9 participants
12   participants
8 participants
8 participants
16 participants
12 participants
15 untrained right-  handed participants
3 participants
N = 28
N = 7
N = 3
N = 4
N = 22
N =   22
N = 2
N = 6
N=702
N=2450
n=0
N=28
total of 3152
80 women
6   million people
200 people
8,000 people
total   of 4607
total of 1,047,591
12      participants
1,222,000 persons
16 participants
total of 48
total of 16
total of 32
total of 50
12 people
n = 1
3 lists the percentage of participants
6 on GR were  participants
N = 49
n = 0
10 participants
4   participants
4 participants
3   billion people
total of 16,398
total of 8,280
82 participants
n   = 3
n = 6
n =   6
n = 5
N=22
N=11,014
N=5405
 dataset of 11,014
n = 20
total of 62
14 people
18 participants
10 participants
15 women
30 participants
10 participants
19 of the participants
90mins per participants
11 participants
320 trials per   participants
total of 1200
total of 3520
12 participants
12 subjects
2557230  To keep people
n = 80
n =  80
n = 40
 data from all 16
10 participants
total of 19
3 female participants
7 participants
3D printing process   Most participants
10 participants
n = 20
22 participants
n=21
 data from 1954
22 participants
n=7
n=1
5 older   people
30 participants
30   participants
4 additionally shows how many participants
8 people
7 people
n = 40
n = 55
n = 1
n = 5
n = 4
N = 25
n = 6
n = 8
n = 3
N=156
N=28
N = 202
1 Forty-nine percent of participants
8   participants
1 A few participants
2 Sixteen percent of participants
N = 182
24   participants
12 participants
12 people
n=12
n=6
n=4
n=3
n=2
n=5
total of 24
total of 9
20 patients
21 participants
92 and participants
12 participants
12 study participants
total of 21
total of 2439
total of 8,355
6 older participants
6 young participants
12 participants
16 participants
1    The majority of participants
11 participants
7 participants
22 participants
11   of the participants
6   participants
6 participants
2   participants
4 participants
total of   542
 data from 22
28 male participants
20 participants
13 of the participants
13 participants
99 participants
20 subjects
99 subjects
13 subjects
3,331 people
 data from 20
 data from 99
3 within subjects
16 participants
2 presents the number of participants
3 depicts how many participants
4 depicts the number of participants
8 participants
17 participants
10 unpaid   participants
12 unpaid participants
48 participants
9   participants
19 participants
46 participants
26 people
N=46
n=7
n=1
total of 48
total of 26
 data from 9
 data ranging from 2
9 participants
total of 560
1 because participants
24 people
n=5
6 participants
16 participants
16   participants
12 of the participants
4 within-subjects
n = 19
12 participants
11 summarizes participants
n = 6
n = 12
10   women
20 interview participants
20 participants
20 participants
18 participants
20   participants
6 people
N = 11,701
n = 3,649
n = 5
n = 1
N=40,521
n = 1480
n = 7366
12  participants
12 participants
10 participants
5 within-subjects
8 unpaid participants
2 within-subjects
n = 22
n = 5
n = 3
12 volunteer participants
27   participants
17 participants
27 participants
122 drug-free subjects
27   people
30 participants
15 participants
23 participants
38 participants
17 of the participants
21 participants
21   While some participants
5 unemployed   young people
11 older   people
24 participants
32 participants
96 participants
21 participants
12 participants
118 of the participants
39 participants
15 participants
24   participants
18 participants
6 participants
16   participants
17 participants
15   subjects
14 people
 data from 24
5 million people
14 people
12 participants
N=25
N=12
4 shows the study participants
N = 4
 dataset, out of 28
582 participants
8 participants
64 participants
360 participants
37 addi-  tional participants
total of 44
total  of 582
2  women
11 participants
7 participants
68,000 people
N=16,060
N=303
N=1,230
N = 16,064
N = 306
n = 306
 data come from 11
7 million people
 data   from 8,529
total of 6
 data sets of 100
1   are the seven participants
22 participants
35 examples   of participants
53 occasions participants
3 witnessed only five participants
13 participants
6 participants
49 participants
23 male subjects
24 subjects
total of 100
24 participants
 data from 9
89 participants
87 participants
N=89
13 participants
16 new participants
2   participants
120 million people
N=15
47 participants
17 participants
44 interested participants
n=100
n=1885
n=586
total of 34
total of 25
8   While participants
9   While many participants
8   By providing participants
230,000 people
133,000 people
37 participants
5 participants
7 people
8 people
total of 77
12 participants
16 participants
6 participants
9 participants
6   participants
3 within-subjects
N=16
total of 3
total of 6480
total of 2
total of 14
17   able-bodied participants
17 participants
17 subjects
 data from the 1
 data from the 2
6 participants
total of 1,800
total of 300
total of 900
total of  150
total of 27
total of 77,760
1   Some participants
n=142
n=4393
n=532
n=45
n=42
n=61
777 participants
49 participants
15 participants
3 people
 data from all 55
 data from all 49
19 participants
20 participants
318  MTurk participants
226 participants
163 participants
n = 30
n = 32
total of 1,590
total of 62
total of 77
total of 513
total of 858
390 participants
16 participants
100 Craigslist   participants
390 subjects
8 subjects
N=99
total of 14
 data of 390
10 participants
5 participants
16 participants
23   participants
total of   508
42 participants
28 of the participants
N = 14
total of 42
6 students enrolled
8 undergraduates enrolled
n = 4
total of 90
143 participants
62 participants
34 participants
16 participants
15   participants
20 participants
2   participants
N=186
 dataset   of 73
 dataset of 133
25   participants
13 participants
25 participants
n=25
568 participants
1We asked participants
2Entirely removing these participants
3This question measured participants
102 people
53  people
14 studies participants
10 studies  where only male participants
2 studies let participants
n=49
n=44
n=56
n=52
n=22
n=13
n=12
n=47
n=46
n=82
n=11
n=2
n=75
n=15
n=8
n=29
n=54
n=21
n=5
total of  3
total of 87
12 pla  participants
n=10
Total of 384
256 participants
650 invited participants
N=224
29 participants
n = 870
n = 1
n = 0
N=89
N=4
N=2
total of 27
total  of 20
total  of 40
total of 110
30 participants
16 participants
total of 30
n = 0
n=45
2Such as allowing participants
11  visually  impaired  participants
14  people
n=6
11 adults enrolled
350 participants
91 participants
350 survey participants
142 participants
207 participants
17   participants
58 of the participants
91   participants
70,000 visual questions for blind people
7337 people
14 people
9 people
3 people
89 friends asked about being   people
N=350
N=756
13,000   participants
7   reported being the only people
260 people
80 people
n=4
n=3
n=5
n=1
 data from 841
N=212
total of 446
total of 43
2 other persons
87 participants
123 participants
36 participants
184  people
35 people
N=184
n=5
n=6
n=3
n=22
n=2
n=74
n=110
n=4
n=148
n=36
N = 843
N = 178
N = 96
N = 66
N = 194
N = 116
N = 111
N  = 208
N = 128
N =  128
total of 21
136 were women
165 adult subjects
165   subjects
6 shows the percentage of subjects
n=81
19 participants
10,000 people
350 million people
150 people
1 told people
62 participants
40 participants
21   participants
53 participants
10 participants
34 participants
42 participants
27 participants
2 used between-subjects
N = 62
N =   53
n = 6
n = 275
n =   3
n = 2
n   = 275
n = 3
n = 1
n = 300
8 participants
10 minutes depending on the   participants
3   female participants
total of 720
1,278  participants
1,278 participants
total of 1,278
12 women
4 women
30 subjects
50 subjects
4 Results   All subjects
10 subjects
N = 4
total of 6
13 people
13 women
30   participants
20 participants
8 participants
3 participants
24 participants
12 participants
12   participants
18 participants
16 participants
total of 90
total of 36
total of 37
total of 27
32 participants
120 minutes and all participants
3D did not help people
30 people
17 people
17  people
9 people
15 people
26 people
total of 16
18 participants
16  further participants
34 participants
15 participants
12 participants
47  staff and student participants
21 participants
42 participants
14 participants
300 people
total of 300
4 women
8   participants
1 â€“ Exploration   As the participants
n = 93
10 were the participants
n=50
n=26
7 participants
7 participants
20 participants
20  participants
2 as the number of pairs of participants
1 if the i-th pair of participants
5 participants
10  pairs of participants
2 is the number of pairs of participants
12 participants
18 participants
n =  1
n = 12
n=12
N=840
N=80
N=800
N=160
N=200
N=378
N=36
N=144
2 participants
48 participants
29 female participants
19 male participants
45 right-handed  participants
07  But not all participants
03  Some participants
46  Some participants
700 people
7 people
2,000 people
N=68,000
total of 34
total of 68,000
total of 45
total of 42
6 within-participants
2 within-participants
32 participants
32 feedback participants
16   feedback participants
12 designer participants
12   participants
5 participants
N = 57
N = 71
N = 67
N = 84
N = 59
total of 4
38 persons
19 persons
19 participants
18 participants
11 participants
n=0
n=17
n = 14
total of 372
28 participants
18 participants
16 participants
n = 4
n=3
n=5
n=4
n=1
18 participants
13 participants
36 degrees because  people
383 participants
1 shows the participants
17 participants
1 lists the percentage of participants
158 participants
n = 383
26  participants
10 participants
35 participants
1 summarizes the participants
100 women
100 pregnant women
22 pregnant women
100  women
100 pregnant  women
38 participants
85 participants
34 participants
7 participants
100 participants
97 participants
41 participants
6 people
total of 944
total of 73
total of 50
total of 5028
 data from 100
  data from two 45
67 participants
7  women
40 participants
20 participants
20 people
4 participants
5 participants
4   participants
 data   videos from 8
10 minutes and the participants
250 unique participants
80 unique participants
80 participants
38 of those participants
38 selected participants
40 participants
 data. Out of the 80
15 participants
1,257 participants
19 participants
 data from 56
11 participants
18 participants
15 participants
n = 2
n = 1
n = 5
n = 30
n= 1000
10 gift cards among the participants
158 participants
105 participants
16 participants
13 participants
16   participants
6 participants
5   participants
5 participants
3   participants
4 participants
N=16
n   = 20
40 participants
150,000. Our participants
15 Aware participants
2As participants
40  original participants
19 people
n=12
n=15
n=11
n=5
n=19
n=9
n=21
n=4
n=13
n=24
n=6
n=27
n=3
n=1
n=13
total of 574
 data from 28
25 student participants
n=3
n=13
n=24
n=0
total of 36
6 participants
2 faculty participants
15 participants
3 participants
1 participants
2 participants
8 participants
9   participants
2 women
18 women
10   participants
36 participants
18 pairs   of participants
6 described it as â€œold people
n=35
n=8
n=15
n=13
n=5
n=4
total of 18
8  participants
400  million  people
total of   372
184 participants
216 participants
1 as   groups of people
30 participants
30  research subjects
30 subjects
36 participants
36  participants
1,015 images. We found that people
N=36
N=75
N=186
500 participants
492 participants
98 participants
15 participants
46 participants
81 participants
179 participants
n = 98
n = 28
n = 20
n = 22
n = 94
n = 27
n = 18
n = 44
n = 37
35 people
10 people
9 other people
1,500 participants
2 depicts some of participants
250 participants
1,234  participants
23 participants
n = 304
total of 26
total of 64
total of 162
total of 274
n=36
n=2,181
41 participants
n=20
n=9
n=12
18 participants
9 of the same participants
18   participants
9 participants
8 â€“ Novelty   Presenting people
total of 18
3000 women
total of   1810
total of 109
26 participants
59 participants
1,813 participants
35   Five participants
 data from   59
n=26
n=193
N=341
N=38
N=85
n=341
n=85
n=38
total of 505
60 participants
30 participants
13 participants
12 remaining participants
12 participants
N=12
10 people
10 participants
3D modeling participants
40 participants
38 of  the subjects
N=40
total of 109
14 right-  handed participants
10 participants
15 right-handed participants
n =    9,792
total of 24
total of 8,556
total of 8
total of   11
total of 51
5 women
12 participants
total of 504
total of 6,048
total of 4608
30  participants
30 participants
 data of 30
10 participants
16 participants
25 people
N=16
n=1
66 instances where   participants
14   instances where participants
n=62
n=25
n=34
n=43
total of 212
19   Two participants
n=31
n=30
n=35
n=24
n=10
n=9
n=6
n=19
n=12
n=32
n=0
total of 332
5 images of different  people
14,628 images of women
2,425 images of women
46,392 images of people
8 participants
 dataset of 198
18 people
3   Previously enrolled
total of 631
11 participants
2 participants
n=6
n   = 12
n=45
6   participants
7 participants
2 participants
9 participants
10 participants
10 participants
7 of the participants
4 participants
4   participants
1 presents basic data on the participants
total of 15
total of 25
13 participants
20 participants
 data of a 9
total of 110
16 participants
10 participants
30 participants
5 male participants
n=30
total of 10
total of 30
15 participants
30Â°C   and participants
n   = 22
2   women
10 of these women
20   participants
53 participants
200,000 signa-  tures from people
20   people
10,000 people
3,000,000 people
 data from 21,280
29 participants
12 participants
5 below showed overall the participants
6 participants
262,447 people
14 participants
15 subjects
5 subjects
16 subjects
3   subjects
total of 9
total of 24
total of 16
12 participants
7 people
5 people
n=81
n=76
n=68
n=25
n=27
16 subjects
n = 3
12 participants
total of   180
total of 200
total of 36
total of 20
73 participants
10 participants
6   participants
N=73
6 participants
12 participants
4 participants
1 participants
16 alternating tapsâ€”and   participants
10 participants
3 participants
8   participants
N = 8
N = 2
N = 7
N = 12
N = 5
N = 6
N = 4
N =   3
N = 10
N =   10
total of 8
24 participants
18 participants
15 participants
N = 18
10 participants
98 participants
98   participants
3 participants
237 participants
83 participants
60 participants
N=98
N=237
n=1
n=240
N=177
145 participants
20 participants
5139 participants
12 participants
N=30
n=68
n=80
n=50
n=32
n=55
n=143
n=33
total of 20
20 participants
20,000 or less. Eighteen   participants
16 participants
N=12
N=8
N=13
N=20
N=5
N=4
N=1
N=2
N=18
N=7
N=10
N=14
179 total participants
1 below describes the participants
13 participants
3 depicts the percentage of   participants
43   We anticipated participants
N=119
8 participants
14 participants
6 participants
2 participants
3 participants
8   participants
4 participants
14   participants
9 participants
7 participants
7 all participants
5 participants
11   participants
10 participants
N = 7
n =   7
n = 8
n = 7
N = 10
25 women
2 women
37 participants
31 of the participants
 data from 37
50 participants
70 participants
50 recruited participants
10 participants
15 participants
n = 3
1104 different participants
298 participants
15 participants
n = 298
n=2
n=5
n=1
n=3
n=4
101 participants
83 of the participants
101  participants
total of 101
3 within-subjects
10 blind people
total of 50
total of 30
total of   125
10 pairs of   participants
285 million people
8 million   people
32 participants
32 subjects
12 subjects
20 subjects
4 cells over all subjects
total of 32
12 right-handed participants
2 participants
4 participants
24 participants
60 minutes and all participants
16 of the participants
N = 24
N =  24
n = 24
total of 24
 data from 2,377
24   deaf and hard of hearing participants
4 new participants
4   participants
24 deaf and hard of hearing   participants
19   participants
24 participants
16 participants
18 participants
4 participants
14 participants
3   more participants
2 participants
8 participants
5 participants
9 participants
3   participants
N=9
N=15
N=24
20   people
8 participants
24 people
3 women
5 women
4 women
1 focused on whether   participants
8   participants
8 participants
12 participants
6 participants
2   participants
N = 3
total of 40
total of 15
25 participants
20   participants
8 participants
18 participants
10 participants
40 walking trials we asked participants
9 participants
4 male participants
4 right  turns and took participants
n=25
 data from P4
12 participants
6 participants
5 participants
n=25
7 participants
7 subjects
N=16
2 because participants
N = 23
N = 26
N = 22
total of 81
total of 140
total of 60
11 participants
10 participants
10   participants
total of 240
total of 10
36 participants
12  participants
total of 16
total of 98
N=2803
135 persons
398 persons
69 participants
11 participants
9 women
11 women
19   participants
16 participants
6 participants
3 participants
4   participants
N = 4
n = 21
n = 22
n = 5
n=4
n = 3
n=27
n=6
n = 4
n = 2
N=3
N=5
total of   12
133 participants
16 participants
n=22
N=13
n=21
N=14
N=16
N=15
N=18
N=20
n=19
N=45
n=17
N=51
n=15
N=38
n=20
N=29
n= 94
n=76
n= 75
N=115
n=12
n=1
20 subjects
28 subjects
10 participants
31 valid participants
43 valid   participants
total of 243
43 participants
14   participants
total of 52
18 participants
18  participants
N=14
total of 394
total of 843
total of 535
total of 12
200 diverse participants
40 participants
200   diverse participants
200 participants
50 participants
200   participants
15 other people
200   people
n = 30
total of 25
 data from 200
13 columns giving participants
n = 31
n = 4
n = 3
n = 126
n = 86
N = 1327
N = 145
89 PPI can improve participants
16 participants
4 within-subjects
n = 1
total of 360
6  women
18 participants
total of 10368
12 participants
20 people
4 people
200 participants
15   Some participants
10   On Facebook groups participants
n=12
n=38
total of 45
3D printin  people
n = 6
n = 18
25 participants
38 participants
182 people
n=20
Total of 182
total of 404
30 participants
19 participants
6   participants
11 new participants
total of 30
479 participants
2,184 additional participants
500 new participants
456 participants
80 participants
5 participants
68 participants
500 participants
n  =  6
n =  4
n =  1
total of 503
25   participants
76 participants
total of 13
 data from 76
8 participants
16  participants
total of 10,000
total of 16
100 study participants
total of  7,537
total of 7,537
7,262 participants
6,435 Part One participants
8   of participants
3 shows percentages of participants
9 illustrates participants
2 compares how many errors participants
3,934 participants
8   We asked whether participants
 data from the 3,934
11 participants
400 participants
19 participants
8 p  whom volunt   participants
17 subjects
n  = 62
13 participants
2  arithmetic exercise participants
10 lab study participants
10  field study participants
20 participants
7 participants
5 participants
n=72
n=139
total of 30
total  of 30
  data ratings from 1
12 participants
16 new participants
11 participants
5 items and passive participants
9 participants
total of 200
total of 384
total of 150
total of 4,320
20  subjects
n = 24
n = 175
n = 68
n = 22
n = 150
total of 20
 database of  20
12 participants
11 participants
10 participants
total of 60
20 participants
1    |ð‘ƒð‘ƒ!"| is the number of participants
 data from FSR 402
14 participants
16 participants
N=14
N=1
total of 40
N = 15
2 within-subjects
n = 2
n = 4
n = 5
total of 6
total of 42
27 participants
16 participants
30  participants
1 between-subjects
total of  81
total of 16
14 participants
10 participants
total of 541
total of 260
total of 7
total of 12
total of 8
1 When participants
18 participants
11 participants
27 social media â€œpoint persons
2   participants
15 participants
6 participants
20 people
N=25
N=23
total of 43
n = 833
43,000 people
11 participants
14 participants
21 subjects
8 subjects
16 participants
4  of these participants
12 re-  maining participants
12  remaining participants
n = 0
n = 1
n = 6
n = 4
n = 2
n = 7
n = 5
n = 3
209 participants
219 people
10,000  people
total of  84,255
067 people
N = 191
total  of 2
total of 30
27 participants
14 participants
13 participants
1 contained participants
2 contained   only participants
1  participants
2 participants
257 people
27 people
10 people
total of 27
total of 3569
30 participants
10   people
70 people
10 people
n=9
n=13
n=2
n=7
n=3
17   participants
17 participants
40 minutes and participants
5   participants
40 participants
24 participants
54 participants
N= 91
N=91
total of 108
total of 1038
12 participants
15   participants
12 subjects
4 within-subjects
49 participants
20 participants
4 participants
total of 1540
total of 9
285 million people
5  persons
24  participants
24 participants
7 participants
17 participants
total of 2448
total  of 2448
total  of 24
14 participants
94 participants
5 participants
total of 540
total of 3,834
total of   642,670
total of 9,995
total of 25
 dataset of 300
7 shows participants
14 participants
total of 14
14 participants
20 participants
10 participants
11 participants
total of 20
 data from 20
 data from 11
n = 1
n = 2
n = 4
n = 16
n = 9
n = 8
12 participants
6 female participants
12 people
n = 60
n = 97
n = 58
n =  96
n = 35
n =  78
n = 1
n = 3
n = 8
n = 10
n = 23
n = 25
total of 15
total of 40
12   women
20 people
total of 100
total of 39
15 participants
N = 19
total of 57
50 participants
22 participants
2   plots the proportion of people
N = 26
N = 24
46 participants
16 participants
30 participants
46   participants
N=16
N=30
N=46
total of 23
total of 46
885 participants
885   participants
15 When participants
1220 participants
193   participants
48 participants
9 participants
1 was participants
24    When splitting participants
24 The majority of participants
total of 4
total of 1220
total of 76
12 participants
2 PIM panel participants
2 participants
9 women
14 visually impaired participants
14 participants
8 million people
6 people
4 people
14 vi-  sually impaired people
N=14
N=7
N=5
N=2
N=9
N=4
N=3
N=11
N=6
22 unpaid participants
n=26
total of 65536
26 participants
25 participants
6 participants
24 participants
17   participants
total of 9
20 participants
14 unpaid participants
n = 27
n = 30
total of 8,100
10 participants
32 participants
16 participants
total of 25
3 distinct participants
15 participants
total of 120
total of 1071
39 participants
17 participants
19 participants
1 summarizes the participants
36 participants
n = 20
1  To determine whether people
3  To determine whether people
22 participants
30 participants
40 participants
2 between-participants
001 and intro-  verted participants
total of 17
16 participants
15 participants
n=0
13 participants
10 right-handed participants
4 within-subjects
n = 5
total of 48
 data from  4
7 â€˜expertâ€™ participants
7  participants
14 participants
n = 3
n = 23
n = 28
total of 7
N = 1353
N = 1082
total of 8,748
3 This is all the instruction participants
18 participants
 dataset of 110
14 student   participants
46 participants
97 people
1209 people
25 people
total of 130
   data imported from the 46
20 participants
21 participants
20  people
n=25
n=1
n=3973
n=4888
n=3628
n=4009
n=4209
n=2216
n=3446
n=6
n=5
total of 249
n  = 0
72   participants
72 participants
n = 72
n = 55
16 participants
n=4
n=3
n=5
11   subjects
11 subjects
10 subjects
N = 580,480
N = 3,108,172
N  = 1,955,297
total of 59
4 persons
4 people
10 deformable objects the   participants
12 subjects
n=109
n =53
n = 109
N = 3
N = 2
N = 1
N =   4
8 images of women
77 participants
24 participants
4 women
3 women
20 participants
27 participants
4 shows the participants
8 inter-  vention participants
27 clinical patients
27 alcohol-dependent patients
27  alcohol-dependent patients
27 patients
27 inter-  vened patients
5 intervened patients
 data from 27
 data from 20
36 patient participants
31 patient participants
74,000 patients
36 patients
20 patients
16  patients
36 was not worried about other people
12 participants
6 participants
7 shows how participants
12 shows the participants
24 participants
22 participants
12 participants
total of 3
total of 59
 data from 115
30 novice   touchscreen participants
30 visually impaired participants
total of 150
14 participants
14 people
total of 14
total of 111
total of 123
5   participants
12 participants
17 participants
13   participants
11 participants
8 participants
N=17
N=12
n=26
n=3
n=2
n=4
n=5
n = 20
12   participants
12 participants
n=28
n=9
23 participants
6 participants
total of 23
43 participants
15 participants
6 participants
9   participants
total of 43
total of 2,502
10 older participants
10 participants
45 study participants
45 participants
total of 174
 data from 35
4 participants
30 min   and participants
30 min and participants
2 within subjects
total of 82
20 participants
52 participants
14 participants
285 participants
26 participants
5 factor scale which captures people
19 participants
16 participants
11 participants
n =13,877
n=596
N=9
N=6
total of 17
 data from all of   2013
415 remaining participants
74 people
708  unique people
800 people
134 participants
5 participants
33 participants
1601 participants
869 child participants
100 participants
N=2
total of 33
total of 1601
total of 44
N = 75
total of 75
N=26,885
total of 100
total of 160
total of   27
total of 26,885
8 participants
71 participants
112 participants
33 participants
31 participants
110 participants
110 people
total of 110
4 participants
10,000 people
10,000  people
6 participants
total of 145
 database of 70,000
248   participants
24 fo-  cused on the participants
150 people
14,000 people
40,000 people
8 million people
14 million people
16 participants
14 participants
n = 10
n = 28
20 participants
29 patients
n  =0
n = 5
n = 6
n = 0
11 remaining participants
total of 420
 data of the 11
N = 384
N = 160
1,500 people
73 people
204  people
100 people
11,751 people
N=36
N=21
N=16
N=6
N=4
N=3
N=2
N=25
N=11
N=8
N = 100
N=15
N=7
N=5
N=10
N=9
total of 204
16 participants
12 participants
total of 3,600
4 women
2 women
3 women
16 participants
total of 34
31 participants
8 participants
309 women
1,000 women
3 women
248 unique participants
185 unique participants
175 participants
n=1
N=40
N=120
n=0
total of 9174
1500 people
total of 26
21 participants
5 participants
30 mins and participants
2 suggested supporting older   people
26 participants
30 participants
22 participants
3 participants
8 participants
11 participants
3 we asked participants
N = 26
total of 15
total of 137
30 participants enrolled
8  subjects
n = 1
10 participants
10 local participants
19 remote participants
3 illustrate how people
 data from 15
8   participants
5 million people
 data from 3
6 participants
3 participants
8 participants
1 million people
1 said â€œdifferent people
n=10
n = 49
52   approached people
12 people
6 approached   people
15   approached people
N=58
total of 58
411 pairs of English speaking participants
4 participants
2 asked how the participants
1   Did participants
3      How did participants
N = 76
N= 76
N=76
n = 0
n = 1
n   = 0
n = 6
n = 15
total of 30
1 The  participants
total of 15
total of 30
 data rate of 667
31 participants
5   participants
n=38
n=3
total of 31
19 participants
15 participants
3 participants
total of 31
62 participants
n = 2
n = 39
n = 3
45 participants
24 participants
11 participants
12  participants
12 participants
5 participants
n =  24
n = 28
n = 0
n = 24
n = 25
n = 6
n = 26
n = 21
total of 240
20 participants
12 cases participants
16   participants
16 participants
10 participants
14 participants
n = 25
n = 27
total of 1,008
50 participants
52 participants
32 participants
total of 50
total of 11
total of 1,277
10   participants
20 participants
19   participants
20   participants
n=7
5 people
6 people
1000 people
15   For people
 data transfer of 125
466   adult participants
111 participants
25 participants
n =   9
n = 2
n = 3
total of 33
 data from 466
 data from 55
1,892 women
n=13,030
n=8,535
17 participants
total of 412
total   of 486
total of 5
76 of these participants
n=64
n=41
total of 727
total of 60
3 different subjects
300 people
n=1,174
n=4
n=3
n=29
n=2
n=6
n=11
n=1
N=100
n=0
n=195
n=118
23 participants
22 participants
12  participants
3 positively affected participants
11 participants
n=23
18 participants
14 pilot   participants
5 participants
13 participants
N=14
N=9
N=16
N=11
N=15
N=17
34 participants
61 participants
5 participants
4 participants
3 participants
4These participants
1 billion other people
N = 34
total of 14
n=6
n=11
n=7
n=4
n=3
124 participants
124  participants
224 people
50 people
n = 224
total of 52
6   While the participants
1   While some participants
19   ICD patients
700 ICD patients
14 contacted patients
664 ICD patients
000 people
19   people
14 participants
14 subjects
total of 112
total of 448,000
2 participants
12 subjects
total of 10,398
55 yea  d only women
48 participants
56 participants
20 participants
21 participants
40 participants
3   was also one of the five participants
39 participants
8 compares two   participants
N = 343
total of 76
 data from 629
36 participants
total of 36
total of 34
20 participants
13 participants
7 participants
N = 5
N = 4
N = 2
6 of   these participants
487 participants
N=162
N=158
N=167
 data, both from 1980
   data from 1980
5 subjects
25 subjects
N=3
N = 1
N = 3
total of 52
total of 168
 dataset of 10
10 participants
12 participants
5  number of participants
n= 4
n = 6
n = 5
n = 2
n = 3
n = 4
20   participants
n=5
n=4
13 participants
16   participants
15 of   their participants
4 people
20 people
7 people
15 people
30 people
8   people
20 participants
n=10
n=20
18 participants
 dataset of 1,219
33 participants
n = 17
n = 16
43 participants
24 participants
15 participants
5 participants
N=24
total of 64
total of 24
100 participants
20 of the participants
n = 5
n = 4
n = 10
n = 12
n = 13
n = 27
n = 14
n = 87
n = 21
n = 22
n = 99
n = 33
n = 9
total of 48
17 participants
11 participants
30 participants
total of 1681
total of 2253
12 participants
12 subjects
n = 0
 data from 1
3 plots the averages over participants
6 plot the average over participants
32 participants
n = 21
18 participants
45 participants
210 common cause and chain participants
105 common ef-  fect participants
26 participants
5 ANOVA of  these subjects
3 provided subjects
315 subjects
107  people
N = 18
N = 45
N = 23
n = 3
n = 2
n = 16
n = 4
n = 1
n = 5
n = 12
n = 9
n = 8
n = 13
n = 15
10 subjects
15  The second group of subjects
N = 20
total of 60
total of 40
13 participants
10 participants
53  participants
N=12
n=12
n = 80
N=36
 data of the 11
 data from the 11
2 Two participants
total of 27
total of 196
total of 165
total of 174,792
total of 52
total of 77
171 participants
26  At test participants
5 consisted of high ability participants
total of 171
total of 75
total of 78
68 participants
6 shows the proportions of participants
N = 31
N = 14
N = 17
N = 28
30 younger participants
30 young participants
30 older participants
1  Older and young participants
30 participants
7 s during which participants
2500 ms during which participants
N = 30
N = 320
n = 0
n = 32
n = 8
total of 320
total of  336
total of 288
51  participants
32 participants
1 presents participants
19 subjects
n = 64
n = 36
n = 48
n = 19
n = 51
total of 240
total of 288
19 participants
2 The count of participants
32 participants
12 participants
7 indicating  participants
n = 32
n = 12
N = 62
n = 8
n = 6
N = 57
42 participants
2 signifi-  cantly increased participants
24 participants
n = 6
total of 47
total of 58
total of 26
total of 49
n = 4
n = 2
n = 14
n = 5
n = 12
n = 6
n = 1
N = 12
N = 13
N = 24
total of 21
n = 40
n = 24
n = 960
n = 15
total of 14
20 women
25 women
24 women
26 women
29 women
41 women
36 women
70 participants
70 Mechanical Turk participants
70  Mechanical Turk participants
N = 480
n = 24
n = 2
n = 0
N = 70
 data from our 120
12 subjects
total of 12
total of  118
 data from 12
83  participants
10 participants
174 distinct participants
257 distinct participants
20 participants
56 distinct participants
total of  2
total of 900
total of 9000
total of 174
total of  2000
total of 20,000
total of 257
total of 120
total of 2400
total of 56
1 participants
75 participants
74 participants
40 of the participants
n = 75
 data from 40
3 Both groups of  participants
20 adult participants
140 participants
3  examine how people
3 examine how people
N = 30
 data from 20
total of  40,000
total of 40,000
1  Eye-tracked participants
23 items had animate patients
20 items had human patients
19 items had human patients
n = 30
n = 103
n = 25
4,151 unselected subjects
1 334 consecutive patients
23   patients
1 793 consecutive patients
997 patients
1334 patients
23 patients
2 are the total number of subjects
100 patients
10 participants
108 000 Norwegian-born   persons
4 740 904 persons
95  patients
100 patients
2008 and their patients
23  Actual number of patients
124  Number of patients
7  Number of patients
3  Percentage of patients
55 veiled   women
22 Danish   women
33 patients
49 young   patients
22 patients
49 patients
299 patients
201 patients
1c testing of patients
2 shows the   distribution of patients
1c testing among high risk patients
350 patients
000 people
n = 282 000
n = 30 050
n = 251 950
n = 10 551
n = 241 399
n = 10 201
n = 350
total of 2020
total of 2352
1100 persons
109  nurses selected the patients
81 a   Percentage of patients
72  Percentage of patients
44  Percentage of patients
366 patients
18 820 patients
500 000 patients
n = 571
n = 524
n = 63
n = 43
n = 24
n = 11
n = 5
n = 2
n = 1
n = 20
n = 18
n = 16
total of   63
210 adult patients
1 000 patients
 datasets of 177
1 shows the number of participants
56 participants
196   patients
210 patients
209 patients
56 patients
n = 226
n = 17
n = 4
n = 13
n = 210
n = 105
n = 0
n = 1
n = 104
2 diabetic patients
001  Average number of patients
5 million patients
1 760 223 permanently registered patients
653 patients
1 shows the   demographics of patients
21 096 patients
2 Sc classi-  fi es many fewer patients
20 443 patients
296 patients
79 884   atrial fi brillation patients
total of 17
191   In older persons
10 participants
4 variable MDRD equation  All participants
1304   participants
567 subjects
73 m Â² and   one of four subjects
251 consecutive patients
179 patients
1500 patients
40 patients
72 non-hypertensive patients
179 primary   hypertensive patients
72 normotensive   control patients
58 patients
251 chronically ill primary care patients
559   patients
 data of 179
 data from the 13
2 diabetic subjects
total of 44
41 women
400 persons
860   participants
12 patients
9 895 patients
40 116 diabetic patients
2DM patients
400   patients
30 patients
212 patients
75 patients
27 patients
52   patients
27 patients out of all studied people
total of 254
total of 40
 data of all 233
 data from 70
2 diabetic patients
2 DM patients
396 patients
342 DM   patients
2 DM   patients
371 million people
study population included 342
study population included 2251
31 patients
total of 65
study population included 60
1228 women
153 patients
885 patients
7 patients
1079 patients
22 patients
153   patients
3 patients
20 patients
133 other patients
133 patients
49 patients
33 patients
47 patients
14 patients
74 patients
2 patients
831 patients
59 patients
34   patients
total of 1079
total of 885
total of 150
4DSQ?    METHODS    Design and participants
4DSQ helps   patients
2127 patients
205 English-speaking patients
302 patients
total of 205
total of 302
 data of 2127
414 patients
10   methadone patients
56 women
10 persons
11 476 registered eligible older persons
225 randomly chosen persons
1916 subjects
471 subjects
914 subjects
19 423 patients
221  index patients
139 patients
392   patients
430 deceased cancer patients
532 patients
693 patients
630 people
30 community dwelling older   people
total of 1916
total of 532
N   =   2
N = 550,921
n = 1
n = 0
N = 221
 data from 221
n = 452
n = 30
N   =   2
N = 8,804
N   =   1
N = 1,754
total of 636,484
total of 29
total of 35
31  wherein participants
37  participants
N = 12,915
442 women
48 African   American women
355 persons
235 participants
 data from 495
n = 11
n = 5
n = 153
N = 23,564
total of 664
total of 68
total of 60
N = 772
n = 577
n = 84
n = 111
n = 2
n = 3
n   =   4
n = 423
n = 427
total of   36
total of 427
N = 452
N   =   4
total of 68
total of 608
2014  storylines have positioned women
27 women
2006 Catalyst census of women
N = 112
N   =   1
n   =   0
n   =   1
n = 112
total of 112
N = 114
N = 473
N = 440
N = 129
total of 129
total of 804
N = 206
n = 0
N = 287
 data of 115
N = 267
N = 58
N = 216
N = 685
N = 223
N = 420
N = 344
N = 187
N = 1,725
N = 1,828
N   =   3
0 = subjects
1 = subjects
N = 7,167
n = 3,354
n = 2,211
n = 5,127
n = 638
n = 1,078
n = 2,120
n = 2,567
n = 3,343
n = 2,422
n = 2,528
n = 3,237
n = 4,206
n = 1,559
n = 4,397
n =   1,368
n = 1,402
n = 4,649
n = 1,116
total of 47
2014  women
129 women
961  The average age of women
10  Hours enrolled
1,000 participants
75 participants
46 participants
n = 14
n = 5
N = 100
n = 1
n = 75
1 participants
2 participants
3 participants
4 participants
N = 581
N = 582
total of 13
total of 20
N   =   2
total of 2,064
total of 74
 data from 2001
N   =   7
N   =   2
N = 223
total of 733
total of 286
193 participants
152 subordinate participants
N = 199
N = 156
N = 152
N = 259
total of 400
total of 88
total of 143
total of 193
total of 161
total of 152
2014  participants
1145  all the participants
N = 82
N = 225
total of 125
N = 235
total of 235
168 participants
117 participants
90 participants
86   participants
104 participants
N   =   1
N = 168
total of 1,179
total of 7,205
N = 231
n = 1
n = 4
total of 79
N   =   1
N = 154
 data from 55
136   participants
100 participants
451 participants
N = 136
N = 451
N   =   9
N = 95
 data from 95
10,317 women
n = 0
n = 6
n = 9
n = 12
 data set from 1957
N = 108
N = 54
   data set of 2,102
N = 450
n = 3
N = 543
N   = 543
n = 390
n = 153
N = 217
68 MBA students enrolled
23 million people
165 participants
161 participants
12 participants
149 participants
5 persons
n = 179
n = 92
n = 210
n = 151
N = 179
 data of 179
10 participants
total of 76
total of 80
total of 78
total of 68
n = 204
n = 17
n = 5
n = 100
n = 61
n = 11
n = 44
N = 175
N = 155
total   of 998
62 women
24 women
1 = women
n = 164
n = 111
n   =   2
n   =   1
20 people
5   people
100 people
total of 1,000
5 The participants
6 We did not elicit participants
210 participants
9  Five participants
15 periods since all the participants
210  participants
17 participants
23 only very few participants
29 whereas most participants
35 participants
N = 35
N = 36
n = 47
n = 42
n = 41
n = 37
n = 35
n = 33
n = 1
total of 210
n = 1
n = 0
21 participants
450 German subjects
14 subjects
336 students enrolled
n = 4
4  â€“ I often rely on what people
5  â€“ I usually do what other people
60  I  often rely on what people
75  I  usually do what other people
N = 1648
N = 1518
n = 0
16 Both labs recruit participants
70 subjects
270 subjects
14 We use a standard student subjects
total of 270
20 persons
9 Type-X persons
11 Type-X persons
20 subjects
16 subjects
152 subjects
1 allowed subjects
1 decisions  In each treatment subjects
14 Type-Y subjects
12 instances where Type-X subjects
n = 12
n = 8
n = 14
n = 26
n = 22
n = 20
n = 340
n = 432
n = 288
n = 504
48 subjects
total of 48
total of 20
16 We assign subjects
2 than subjects
68 subjects
50 than subjects
70 subjects
200  persons
40 participants
240 different subjects
16 Even if subjects
total of 240
70 participants
84 sender participants
4 After the subjects
2  Number of subjects
60 subjects
total of 59,389
 data from the 2003
290 subjects
3  the demographics of the subjects
total of 13
total of 290
116  subjects
1  Aggregate data of subjects
total of 116
1 participants
20 participants
200 participants
174 participants
13  Experimental subjects
32  subjects
26 subjects
total of 10
3 persons
n = 2
n = 1
n = 25
total of 63
n = 1
50 subjects
22  More subjects
total of 12
n=1
  data consists of 52
  data from  52
 data from 52
n = 63
n = 8607
N = 1
N = 2
240 individual participants
66 participants
N = 90
N = 30
N = 45
N = 15
N = 105
N = 35
n = 6
N = 80
total of 100
160 participants
16 subjects
4 subjects
total of 160
58 people
98,000 people
N = 167
N = 13
N = 180
4 The subjects
380 subjects
9 NTU subjects
N = 20,745
N = 15,197
N = 15,701
 data from 1977
  data from the 16
 data from 1990
21 If subjects
1 as obscene may  cause people
N = 600
N = 1974
n=1
total of 645
45 percent of Jewish survey participants
11 percent of Muslim survey participants
31 more than half of the  participants
13 All subjects
N = 10
N = 6
N  = 20
24 subjects
12 subjects
5 if  subjects
15 Clearly not all subjects
5  Number of subjects
total of 502
n = 1
 data is taken from the 2006
2011 on the application of patients
1 âˆ’  of the  patients
1 cannot turn down patients
1 of treating patients
n = 9
n = 1006
n = 1060
n = 429
n = 216
n = 258
 data from 2004
12 participants
12 subjects
8 subjects
6 All subjects
n = 4
2 percent were women
40 percent representation of women
5 percent of women
n = 25
n = 0
24 subjects
5 and  subjects
n = 4
n = 20
n = 80
n = 9
n = 1
n = 44
94 subjects
total of 94
10 subjects
1 does not directly enter into subjects
10 individual human subjects
60 subjects
30  subjects
30 subjects
2 we also provided subjects
N = 10
 data  from 3
N = 1000
 data from the 19
n = 2
n=2
n = 0
n =  1
n = 1
total of 119,217
 data  from 2001
total of 2400
12 three-digit numbers and participants
total of 89
N = 4
N = 5
N = 64
N = 77
total of 6
total of 150
107 participants
n = 40
n = 28
n = 18
n = 21
n = 0
N = 40
N = 28
N = 18
N = 21
11,200 persons
25,000 persons
 data from the 1992
 data from 1987
 data from 1996
10 subjects
136 subjects
14 Some subjects
10 patients
10 distinct patients
total of 10
total of 171
total of 136
17 We did not tell subjects
26 Only three subjects
158 active subjects
35 passive subjects
total of 158
total of 7
102 subjects
34 subjects
231 217 224  Excludes subjects
40 subjects
32  For subjects
576 576 576 576  Excludes subjects
total of 102
total of 34
n = 0
47 subjects
32 subjects
5  For  most people
 data set of 1
 data from 2006
 data from 2007
6 persons
36 persons
19 people
80 million people
24 participants
231 subjects
80  subjects
N = 120
N = 111
n = 120
n = 111
n = 231
288 million people
364 million people
total of 2,914,313
12 subjects
n = 14
n = 8
n = 12
N = 2000
N = 1062
N = 787
N = 294
N = 768
N = 233
N = 556
N = 1056
N = 786
1 subjects
343 subjects
29  subjects
2 subjects
43 subjects
132 subjects
5 forms more frequently than subjects
30 subjects
10 people
11 people
9 people
N = 78
N = 30
N = 61
N = 29
n = 135,044
n = 74,417
n = 132,167
n = 57,435
n = 50,176
total of 14
n = 567
total of 15
n = 1
n = 0
5 Five subjects
N = 83
N = 42
N = 19
N = 11
N = 41
N = 21
N = 12
N = 9
N = 16
N = 17
N = 15
N = 5
N = 22
4  Dedication towards patients
N = 67
n = 578
n = 6
n = 2
n = 1
n = 368
n = 299
n = 5
n = 39
n = 20
N = 144
N = 36
N = 27
total of 377
total of 343
205 participants
6 female participants
5 male participants
194 participants
194  participants
59 participants
51 subjects
22  Number of subjects
97 108  Number of subjects
37 The subjects
total of 253
90  Percent of participants
80  Percent of participants
10  The next nine decisions let subjects
13 One reason why subjects
562 subjects
76 subjects
24 All subjects
110 subjects
15 subjects
737 subjects
57  Number  of subjects
8  Number of subjects
84  Number of subjects
150 and people
n = 5
 data of 15
 data of 2008
 data consist of 1996
3000 people
1500  people
N = 10,044
N = 9985
N = 61,556
N = 30,757
total of 1000
83 women
168 participants
10 time series where subjects
168 subjects
17 All subjects
19 All subjects
1530 790 740 790 740  No.  of subjects
790 790 740 740 790 790 790 740 740 740  No.  of subjects
total of  21
total of 120
150 professional market participants
13 Many of the subjects
total of 36
 data from 24
31 participants
15,170 Wave I participants
N = 12,369
N = 117
6 All subjects
n = 1
7 subjects
9 subjects
13 These averages include two subjects
14 subjects
total of 60
0â€™  participants
24 market participants
2 subjects
4 subjects
20 None of the subjects
192 subjects
24 subjects
68 condition subjects
n = 6
n = 12
total of 192
total of 239
10  In state SAMPLING subjects
4 percent of subjects
N = 9
total of 270
45 percent more than women
 data of 1200
 data from 56
total of 32,613,045
39  participants
32 participants
37 participants
2 types of within-subjects
3 between-subjects
2 between-subjects
n = 24
n = 20
n = 25
n = 0
total of 7
20 subjects
19 subjects
5 The subjects
n = 115
n = 25
138 additional participants
1 participants
n = 119
n = 12
n = 319
n = 292
n = 178
n = 155
n = 141
n = 124
n = 97
n = 113
total of 19,251
20,750 subjects
167 subjects
N = 167
N  = 167
N = 77
N = 52
N = 38
n = 1
n = 0
n     =   1
n = 63
 data and that of the 972
 data from the 1960
 data from 49
 data from 2000
total of 19,251
 data set is from 617
n = 1
n = 0
total of 2687
120 subjects
60 subjects
20 In Slonim and Roth subjects
154 participants
158 subjects
79 German subjects
3 subjects
308 subjects
154 German subjects
n = 27
n = 23
n = 24
n = 29
n = 26
n = 12
n = 32
18 subjects
1 â€“ subjects
1 choices of subjects
2 of those  subjects
2 compares choices within subjects
141 subjects
N = 141
9 The instructions tell the subjects
10 For self-interested subjects
192 undergraduate student subjects
8 subjects
16 subjects
288 subjects
16  people
total of 288
100  participants
n = 4
n = 6
94 participants
78 participants
27 participants
9 participants
6 of the high  cost participants
20  #  participants
16 participants
20 participants
N = 80
N = 36
N = 84
N = 100
4 This test has participants
90 participants
30 participants
n=1
N = 4
N = 72
32 participants
18 This should also stimulate participants
400,000 women
n =1
total of 30
total of 60
26  women
20  women
20  women
52 women
28 women
41 women
3 women
25 women
1 While the participants
143 participants
138 participants
21 participants
57 female participants
69 male participants
3  Numbers of participants
17 male participants
15 female participants
22 male participants
34 male participants
20 female participants
35 male participants
20 female  participants
78 male participants
44 among all male  participants
8 male participants
67 male participants
2 male participants
52 female participants
5 female participants
65 female participants
4 female participants
4  Average payoff basis among participants
60 periods the  proportion of participants
61 female participants
62 male participants
10 The allocation of participants
7 female participants
8 female participants
9  female participants
14 female participants
105 participants
60 participants
18 participants
16 Recruitment of participants
4 could have anchored participants
11 participants
43  participants
6 participants
35 participants
24 participants
20 participants
34 participants
57 participants
3 participants
n = 0
N = 29
N = 10
total of 143
total of 86
total of 46
total of 5000
total of 138
total of 23
total of 60
total of 20
total of 200
n = 20
n = 10
N = 1
N = 7
48 participants
total of 300
n=0
n = 1
4 We  invited participants
50 participants
48 participants
47 participants
3 shows the percentage of participants
N = 50
N = 47
N = 48
N=50
N=47
N = 10
32 subjects
 data from 91
58 subjects
125 people
  data  are from the 1949
 data are from 1943
 data from the 1949
700 people
n = 221
total of 700
total of 1536
3 persons
1   We  thank the participants
30 cases  participants
6 The participants
3 of the participants
22 Six participants
29 female participants
5 participants
3 where subjects
N = 75
N = 73
N = 33
N = 30
N = 0
N = 13
N = 15
N = 9
N = 10
N = 8
N = 12
N = 11
N = 14
N = 29
N = 44
N = 60
N = 36
258  subjects
160 participants
10 participants
 data from 80
385 participants
24 subjects
96 subjects
8 subjects
24 indicates a group of four subjects
n = 4
total of 40
total of 96
total of 12
12 subjects
3000 subjects
24 subjects
2 â€“ description of subjects
5  High costs  Number of subjects
7 presents all the subjects
78 subjects
N = 180
N = 108
n = 3
382 women
3 required some participants
5 percent of participants
47 percent of participants
22 participants
4 includes only the first  participants
1 I have many people
9 poorer people
100 participants
300 subjects
n = 2
20 participants
20 senior  subjects
20 senior subjects
N = 200
N = 160
1950 are women
2 million ABP participants
007  We  find inexperienced participants
6  Providing the participants
6 We provide participants
30 participants
12 The program enables  participants
10 We did not invite participants
50 suggesting the participants
63 FULL participants
62 AGGR participants
70 142  Between-participants
60 154  Between-participants
14  Between-participants
6 shows the AGGR participants
10 percent of the subjects
13 subjects
N = 16
N = 4
total of 16
80 subjects
60 subjects
3 subjects
0  #  subjects
6 more than subjects
1 subjects
360 360 240 240  No.  of subjects
120 300  No.  of subjects
720 720 600 600  No.  of subjects
total of 300
96 subjects
18 subjects
48 subjects
48  subjects
320 subjects
2 between-subjects
32 subjects
20 subjects
4 For experienced subjects
10 people
12 participants
13  We  randomly pair subjects
1 subjects
108 subjects
n = 4
n =  4
480 subjects
60 min  and subjects
192 subjects
96 subjects
3 displays the percentage of subjects
24 subjects
12 subjects
5 subjects
1 both subjects
total of 480
total of 90
13  Before dismissing subjects
65 student  subjects
total of 65
3901 women
total of 13,969
 data from 2003
170 participants
N = 170
total of 80
total of 10,080
total of 8
total of 30
 data from 8
 data from 16
30 subjects
278 subjects
32 subjects
10 Even though subjects
27 Some subjects
1 be the sum of other participants
22 subjects
N = 0
N = 2
N = 4
N = 9
N = 2 351 339 287 331 250
N  = 4 277 377 254 300 188
N  = 9 380 251 348 326
N = 4 293
N=2
N=9
N=4
total of 9
n  = 1
017  men  and women
44 women
3 The experimental subjects
10 people
N = 75
N = 135
N = 144
N = 150
N = 81
N = 107
N = 44
N  = 219
N = 94
N = 125
total of 22
N = 3908
N = 2262
total of 38
total of 1,346,770
n = 16
n = 2955
n = 5228
total of 5228
n = 1
4 subjects
20 subjects
108 subjects
4 include only periods where subjects
N = 32
N = 40
N = 20
total of 45
total of 108
n = 3
n = 42
n = 43
n  = 1
n = 4
n = 2
n = 7
180 participants
24 participants
15 periods  after participants
15 periods after participants
168 participants
117 participants
90 participants
86   participants
104 participants
N   =   1
N = 168
total of 1,179
total of 7,205
N = 772
n = 577
n = 84
n = 111
n = 2
n = 3
n = 3
2014  women
129 women
961  The average age of women
10  Hours enrolled
total of 636,484
N = 543
N   = 543
n = 390
n = 153
N = 217
68 MBA students enrolled
N   =   2
N = 550,921
442 women
48 African   American women
355 persons
235 participants
n   =   4
n = 423
n = 427
total of   36
total of 427
23 million people
N = 452
N   =   4
total of 68
total of 608
n = 1
n = 0
total of 29
total of 35
165 participants
161 participants
12 participants
149 participants
5 persons
n = 179
n = 92
n = 210
n = 151
N = 179
 data of 179
1,000 participants
75 participants
46 participants
n = 14
n = 5
N = 100
n = 1
n = 75
N = 231
n = 1
n = 4
total of 79
 data from 495
31  wherein participants
37  participants
N   =   1
N = 154
 data from 55
2014  storylines have positioned women
27 women
2006 Catalyst census of women
N = 112
N   =   1
n   =   0
n   =   1
n = 112
total of 112
1 participants
2 participants
3 participants
4 participants
N = 581
N = 582
total of 13
total of 20
N = 221
 data from 221
10 participants
total of 76
total of 80
total of 78
total of 68
N   =   2
total of 2,064
total of 74
 data from 2001
N = 114
N = 473
N = 440
N = 129
total of 129
136   participants
100 participants
451 participants
N = 136
N = 451
n = 11
n = 5
n = 153
N = 23,564
total of 664
total of 68
N   =   9
N = 95
 data from 95
N   =   7
N   =   2
N = 223
total of 733
total of 286
n = 204
n = 17
n = 5
n = 100
n = 61
n = 11
n = 44
total of 60
10,317 women
n = 0
n = 6
n = 9
n = 12
 data set from 1957
193 participants
152 subordinate participants
N = 199
N = 156
N = 152
N = 259
total of 400
total of 88
total of 143
total of 193
total of 161
total of 152
total of 804
N = 175
N = 155
total   of 998
N = 206
n = 0
N = 287
 data of 115
62 women
24 women
1 = women
n = 164
n = 111
n   =   2
n   =   1
2014  participants
1145  all the participants
N = 82
N = 225
total of 125
n = 452
n = 30
N = 108
N = 54
N   =   2
N = 8,804
N = 235
total of 235
   data set of 2,102
N = 267
N = 58
N = 216
N = 685
N = 223
N = 420
N = 344
N = 187
N = 1,725
N = 1,828
N   =   3
N = 12,915
N = 450
20 people
5   people
100 people
total of 1,000
0 = subjects
1 = subjects
N = 7,167
n = 3,354
n = 2,211
n = 5,127
n = 638
n = 1,078
n = 2,120
n = 2,567
n = 3,343
n = 2,422
n = 2,528
n = 3,237
n = 4,206
n = 1,559
n = 4,397
n =   1,368
n = 1,402
n = 4,649
n = 1,116
total of 47
N   =   1
N = 1,754
37 participants
200 participants
5803 participants
5285 participants
201 participants
243 participants
N=2279
N=2263
N=743
N=5285
200 participants enrolled
5803 participants enrolled
 data from 459 000
1007 participants
5 The   of patients
13 a substantial number of patients
7303 patients
7067 patients
478 patients
450 patients
123 patients
115 patients
145 patients
146 patients
305 patients
355 patients
335 patients
12 510 patients
928 patients
333 patients
n=450
n=478
n=1007
n=928
5001 people
 data from the 2009
 data from   1998
n=227
n=118
n=119
n=220
514 enrolled
74 babies not enrolled
514 babies enrolled
69 women
4082 participants
68 500 patients
n=1791
n=2294
n=871
n=1181
n=610
n=1860
n=243
n=739
n=125
n=1648
26 For women
218 patients
2  The largest group of patients
19  We tested whether patients
60 assessable patients
70 patients
196 patients
22 more patients
2484 screened patients
23 other  Articles  Most patients
271 eligible patients
68 patients
15 patients
34  Very large numbers of patients
n=4
n=8
n=13
n=68
n=70
n=80
total of 60
32 patients Premenopausal women
50 patients Premenopausal women
5191 patients
66 patients
134 patients
57 patients
20 patients
25 patients
28 patients
32 patients
50 patients
27 patients
63 patients
694 patients Female patients
183 patients
127 patients Female patients
54 patients
1791 patients
150 patients
122 patients
17 patients
62 patients
427 patients
191 patients
67 patients
181 patients
62 patients Female patients
23 patients
498 patients Female patients
11 patients
15 patients Female patients
5381 patients
22 patients Female patients
72 patients Female patients
64 patients Female patients
40 patients
1184 patients
408 patients
776 patients
3052 patients
1517 patients
1535 patients
386 patients
90 patients
282 patients
111 patients
80 patients
4000 patients
1007 participants
450 dyads of patients
928 patients
800 community-based patients
n=18
355 patients
3 In patients
17 patients
459 patients
278 patients
615 patients
36 patients
315 patients
348 patients
2 shows the numbers of   patients
n=238
n=117
n=236
n=115
 data cutoff , 278
 data cutoff , 222
68 500 patients
308 patients
608 patients
400 patients
536 patients
721 patients
152 patients
9 patients
119 patients
270 patients
40 A higher   proportion of patients
n=147
n=161
n=119
n=113
n=145
n=159
n=8
135 participants
54 patients
55 patients
242 patients
727 patients
127 patients
57 patients
99   Data are number of patients
n=80
n=82
n=58
n=65
n=46
total of 73
149 participants
171 participants
177 participants
17 participants
79 participants
60 participants
65 patients
6 and many patients
79 patients
30 patients
2 million   people
668 people
17 people
n=79
n=98
n=171
n=149
n=54
n=38
n=12
n=16
n=92
177 participants enrolled
460 participants
1636 patients
466 patients
460 patients
926 patients
10 We excluded patients
1032 patients
26  The proportions of patients
110  The proportions of patients
11  patients
n=71
n=73
n=5
n=6
n=3
n=102
n=105
n=259
n=112
n=348
n=513
n=508
n=331
n=1
n=4
n=2
1032 patients were enrolled
40 patients
13  All patients
7 In patients
12  In patients
36 patients
22 patients
12 patients
18 patients
n=40
n=26
n=14
n=15
n=24
n=10
218 patients
60 000 participants
300 000 persons
8 million participants
8 million   participants
1 million participants
4 million participants
0 million participants
310 000 participants
170 000 participants
7 million participants
 data from 97
 data from   170 000
25 participants
16 participants
11 participants
19 other participants
5  All participants
10 000 people
n=25
n=5
n=3
n=23
11 million people
8 million people
154 women
166 women
320 women
410 patients
26 patients
4012 patients
364 patients
800 patients
803 patients
803 were outpatients
764 patients
33 patients
17 patients
16 patients
38 patients
48 patients
574 patients
345 patients
336 patients
31 Most patients
194 patients
180 patients
138 patients
n=409
n=394
n=478
n=317
n=210
n=303
n=282
n=132
n=435
n=228
n=307
n=488
n=795
total of   574
26 patients were enrolled
12 patients
219 participants
205 participants
28 991 patients
122 patients
152 patients
466 patients
445 patients
444 patients
15 patients
194 patients
n=219
n=225
n=172
n=170
170 000 participants
80 people
 data from   170 000
40 patients
18 patients
40   patients
177 participants
32 participants
34  Methods  Study design and participants
32 eligible participants
90 056 participants
18 686 people
n=3
n=6
n=24
n=8
n=7
n=5
 data from 90 056
15 patients
11 patients
3 patients
17 patients
12 patients
5 million people
n=15
n=14
n=3
n=6
25 were enrolled
17 patients were   enrolled
242 patients
78â€”by which time patients
1000 patients
9 For many patients
n=517
n=515
218 patients
6 women
10 801 women
2232   participants
1721 patients
3451 patients
1200   additional patients
2232 patients
1140 patients
2020 patients
1222 patients
2298 patients
17 patients
15 patients
12 patients
27 patients
1153 patients
1222 of these patients
0400   Prepathologyâ€   All patients
0091  Postpathologyâ€¡  All patients
n=2298
n=1153
n=3451
n=2232
n=1222
n=3375
n=2234
n=1141
n=1450
n=817
n=782
n=405
n=1300
n=1143
600 participants
45 participants
626 patients
16 patients
21 patients
60 patients
40 patients
357 patients
12 patients
618 patients
11 patients
23 patients
311 patients
315 patients
226 patients
218 patients
37 patients
15 patients
14 patients
300 patients
303 patients
24 patients
921 patients
1200 patients
n=311
n=315
n=603
626 enrolled
1 year after we   enrolled
2000 among persons
7 million   participants
4 million participants
0 million participants
1 million participants
100 000 people
35 the pro portion of young people
 databases from 1990
253 women
21 We included women
445 women
2093 women
222 women
138 women
26 On average women
109 women
33  Articles  women
447 eligible patients
n=225
n=222
N=225
N=222
n=214
n=210
n=223
n=217
n=196
n=201
n=224
n=218
n=216
n=188
n=189
n=145
n=139
n=168
n=171
n=138
n=187
n=128
n=124
n=123
n=183
n=181
n=126
n=70
153 patients
101 patients
94 patients
50 million people
5191 patients
578 patients
 data of 5191
56 fewer patients
n=56
12,903 institutionalised subjects
247 people
244 people
58 people
189 people
30  The number of deaths of people
1 Clear identifi cation of people
n=6962
n=8543
N=247
N=480 467
N=56
N=482 164
n=58
175 000 women
1810 remaining trial participants
1811 eligible all-comer patients
906 patients
1810 patients
905 patients
10   all-comer patients
3954 patients
721 patients
703 patients
903 patients
902 patients
900 patients
1788 patients
1811 eligible   all-comer patients
1811 patients
1062 patients
899 patients
29 The proportions of   patients
29  Very few patients
11 which enrolled   patients
150 patients
2938 patients
n=906
n=905
n=1205
n=1166
n=1810
1811 enrolled
1413 not enrolled
11 which enrolled
 data from 900
5   The study participants
224 patients
227 patients
451 patients
210 patients
191 patients
9 Eligible patients
11 patients
13 patients
7 patients
3 patients
382 patients
185 patients
175 patients
N=227
N=224
n=1
n=2
n=7
n=4
n=5
308 patients
9018 participants
42 149 patients
32 843 patients
9306 patients
n=343
n=547
N=1099
N=1068
N=1097
N=1081
N=4345
n=93
n=969
9306 patients who were enrolled
170 participants
222 patients
108 patients
109 patients
16 We pretreated all   patients
91 patients
50 patients
16 no patients
3311 patients
1 shows the number of patients
19 patients
208 patients
201 patients
202 patients
124 patients
30  Not all patients
201 people
n=27
n=55
n=56
n=110
n=112
n=111
total of 174
56 patients
42 patients
15  High-risk patients
58 patients
56 eligible patients
34 patients
13 patients
21 patients
45 patients
29 patients
24 patients
44 patients
12 patients
16 treated ten patients
15 patients
368 patients
n=11
n=19
n=3
n=1
n=2
n=21
n=36
n=20
n=35
58 patients enrolled
58 patients were enrolled
119 786 patients
30 randomly selected   patients
20 randomly selected   patients
739 828  Study population of AMI patients
129 patients
n=119 786
n=391 077
758 patients
1502 eligible patients
63 culture-positive patients
153 patients
170 patients
550 patients
345 culture-positive patients
182 culture-  positive patients
185 culture-  positive patients
60 patients
124 HIV-  infected patients
181 culture-positive  patients
185 culture-positive  patients
1502 patients
39  Culture-positive patients
333 patients
54 patients
28 culture-positive patients
154 patients
0004  In culture-positive patients
0001  In culture-negative patients
12  In patients
98 patients
N=758
N=744
25 participants
25 adult   patients
1 Even   patients
8 million   participants
2000 among persons
 data from 56
200 participants
100 participants
314 participants
199 patients
16 patients
153 patients
10 million people
n=90
n=95
n=94
n=104
30 patients
28 000 patients
14 people
15 patients
3090 patients
10 million people
 data from 56
45 million people
13 participants
15 participants
1501 participants
2008  Male participants
1 shows the fl ow of participants
50  Male participants Female participants
733 participants
1  Male participants Female participants
n=898
n=1727
n=1697
n=1628
n=1575
n=1530
n=1601
n=1520
n=1501
n=821
n=929
4967 women
n=26 510
n=36 784
n=47 853
n=32 920
n=13 447
n=183 707
n=3189
n=11 011
n=20 369
n=21 104
n=18 712
n=15 553
n=15 274
n=4967
n=5406
100 adult patients
40 patients
20 patients
21 patients
19 patients
25 treatment-naive patients
116 patients
60   patients
37 patients
22 patients
13 patients
100 patients
97 patients
33 patients
60 treatment-naive patients
40 previously treated patients
1900 patients
444040 trial did not include patients
1 patients
n=20
n=21
n=19
100 patients   enrolled
626 patients
37 patients
921 patients
56 patients
368 patients
n=56
40 participants
100 participants
7 And if such participants
100 patients
n=60
n=40
n=20
n=19
n=21
199 patients
4 enrolled
367 251 participants
14 cohorts including all participants
n=0
 data from 22
2385 patients
2381 patients
1778 patients
2326 patients
1913 patients
1283 patients
2359 patients
2198 patients
2171 patients
2288 patients
198 patients
90 patients
106 patients
528 similar patients
n=15
n=14
n=12
 data   from 15
 data from 15
451 patients
13 patients
227 patients
224 patients
2143 patients
153 patients
88 patients
111 patients
150 patients
13 patients
80 patients
28 patients
15 patients
29  patients
18 patients
1 billion   people
n=150
n=88
n=80
n=85
n=82
n=141
n=144
n=132
n=105
n=10
n=118
n=9
n=92
n=6
n=78
n=98
n=34
n=27
n=65
n=23
n=86
153 patients enrolled
1   Those patients
25â€”  zero deaths of patients
176 464 women
1 women
19 We included all randomised   women
44,102 women
total of 1 214 415
176 464 women were   enrolled
 data of 44,102
140 participants
134 participants
91 participants
70 participants
13  Initial clinical studies of patients
408 patients
54 patients
70 patients
49 patients
52 patients
130 patients
n=70
n=307
14 women
20 participants
30 participants
143 participants
22 participants
37 participants
n=37
n=5
n=34
n=30
n=26
n=25
n=28
n=24
n=23
n=19
n=22
n=18
n=21
n=16
n=17
n=15
n=13
n=27
n=14
n=11
n=20
total of 18
 data   rates of 29
41 738 women
72 500 women
782 women
1000 persons
12 000 participants
151 811 participants
151 000 participants
n=5435
n=1066
n=321
n=57 361
n=12 278
 data from 210 002
1920 women
40 women
3864 women
1000 women
4000 women
3500 women
1803 women
326 women
5  Hazard ratio  Number of women
19 399 women
979 women
357 women
36 women
n=1920
n=1944
39 participants
31 participants
76 participants
21 participants
19 We excluded participants
104 participants
52 participants
35 waiting list group participants
n=46
n=39
n=20
n=19
total of 26
10 801 women
1305 patients
2234 patients
654 patients
4004 patients
223 patients
n=2298
n=1153
119 786 patients
457 participants
300 participants
20 We could not mask participants
400 participants
489 participants
103 participants
2954 people
3411 people
3411Â people
n=230
n=224
n=454
1â€”aff ects men and women
5039 women
4505 women
626 patients
 data from 2
356 programme participants
34 271 participants
n=374
n=373
n=747
1231 men enrolled
200 patients
11 955 patients
13 856 patients
11 869 patients
11 807 patients
12   patients
1989 patients
7328 patients
2000 patients
n=668
n=1355
n=1554
n=2131
n=2598
n=1856
n=907
n=1495
n=2072
n=285
n=334
n=1523
n=2411
n=733
n=217
n=785
n=7328
n=2493
n=781
n=482
n=6320
n=5487
n=8567
n=1221
n=475
n=426
n=4392
n=3217
n=1986
n=630
n=385
n=701
n=364
n=471
n=1157
13 856 patients enrolled
 data from 12
1 million participants
172 female   patients
3864 postmenopausal   women
1920 women
3 All   the women
200 additional women
329 patients
45 patients
35 million people
600 people
10 million   people
15 persons
7 million people
6 million people
200 million additional people
848 million people
n=635
n=815
3090 patients
10 million people
187 participants
1021 participants
187 eligible patients
n=187
n=95
n=0
n=246
n=162
n=84
140 patients
0  Data are number of patients
39 OIT participants
46 participants
119 786 patients
459 participants
1789 white participants
339 unrelated white patients
1789 white patients
14 These   patients
n=635
n=395
n=241
n=238
n=339
n=1789
n=239
n=220
n=123 791
n=123 847
107 patients
56 patients
44 patients
17 patients
12 patients
45 patients
22 patients
8 patients
107   of these patients
91 patients
39 patients
52 patients
21 patients
68 patients
29 patients
19 patients
79 patients
11 patients
63 patients
100 patients
2 patients
4 patients
35 patients
12  patients
n=107
n=44
n=63
n=56
n=19
n=26
n=68
n=22
n=17
n=39
n=21
228 patients
2000 among persons
2007 Who Counts?   â€œTo make people
2007 Who Counts?   â€œTo make people
215 eligible   patients
215 eligible   patients
5 million people
5 million people
5 million people
800 million   people
2 million people
n=0
800 million   people
2 million people
n=0
274 women
1 139 patients
13  Methods  Study design and participants
18  All participants
240 patients
260 patients
120 patients
23 patients
52 patients
n=120
240 patients were enrolled
1 million participants
172 female   patients
39 OIT participants
 data   from 22
180 million   people
60 million people
25 000 children and people
180 million   people
60 million people
25 000 children and people
10 million people
10 million people
10 million people
10 million people
2926 patients
64 patients
2926 patients
64 patients
10 801 women
223 patients
35 patients
11 patients
153 patients
101 patients
94 patients
n=109
n=114
n=30
n=31
n=17
8447 patients
4584 patients
13 patients
45 852 patients
250 million people
88 000 patients
88 000 patients
 data from 2007
 data from 2007
 data from 2007
total of 168
total of 168
50 000 people
24 people
9 All patients
12 000 women
45 patients
35 million people
600 people
10 million   people
7 million participants
347 million people
 data   from 55
41 patients
102 patients
65 patients
35 Some patients
35 In the motor imagery task patients
35 The patients
126 patients
81 patients
50 patients
13 patients
130 people
89 people
107 South African patients
49 patients
12 patients
45 patients
6 nearly half the   patients
6 Although patients
 data from   26 746
1â€”aff ects men and women
5039 women
4505 women
564 patients
 data from 564
564 patients
 data from 564
1 366 862 participants
9 million participants
1 305 965 participants
7 million people
N=4
 data from 192
1â€“infected women
595 patients
484 patients
234 evaluable patients
242 patients
61 patients
10 patients
24 than did patients
0  Data are number of patients
31 No patients
n=242
n=214
n=206
n=192
n=211
n=200
n=212
n=201
n=202
n=190
n=210
n=199
n=204
37 patients
184 million   people
19th-century doctors and their patients
2364 patients
16  Intensive care patients
386 people
total of 2364
2364 patients
16  Intensive care patients
386 people
total of 2364
2364 patients
16  Intensive care patients
386 people
total of 2364
3 HIV-positive women
3 HIV-positive women
3 HIV-positive women
1 eight patients
1 eight patients
1 eight patients
42 412   patients
11 799 patients
23 838 patients
8694 patients
9512 patients
2010â€”with patients
9 patients
120 patients
240 patients
52 patients
211 261 people
n=4
n=8646
n=350
 data   from the 1999
446 women
18 women
450 women
139 women
154 women
215 women
231 women
404 women
51 women
43 women
164 women
201 women
649 women
276 women
29 women
n=215
n=231
total of 649
 data   from the 1999
446 women
5 For women
172 patients
1224 patients
607 patients
1185 patients
3   because people
196 participants
2 Most   patients
n=98
 data from   26 746
40 participants
100 participants
100 patients
6 million people
n=60
n=40
n=20
n=19
n=21
25 million people
9 million   people
100 000 people
215 people
100 000 people
69 000 people
2 of patients
2 of patients
2 of patients
14 participants
14 patients
11 patients
12 patients
2 patients
13 patients
16 and the other two patients
30 patients
n=2
n=12
1228 women
242 women
293Â women
24   women
8 women
1212 women
9364 pregnant women
1600 participants
1600Â  recruited participants
1078 participants
364Â participants
849 participants
189 participants
2653 participants
1119 participants
6403 participants
6 of non-IVF patients
n=615
n=613
n=1078
n=535
n=543
n=242
n=250
n=293
n=24
n=8
n=364
n=1228
n=275
n=274
n=340
n=339
211 261 people
 data from 64
5 million people
1329 participants
1 year after participants
1369 participants
478 participants
95 participants
34 participants
12 and   three participants
2138 patients
n=662
n=667
n=1329
n=602
n=657
n=1100
1369 participants were enrolled
18th-century   Johnstones are people
9 000 patients
9 000 patients
9 000 patients
42 572 participants
20 330 patients
3680 patients
42 572 participants
20 330 patients
3680 patients
42 572 participants
20 330 patients
3680 patients
420 000 patients
3 patients
2011 on the application of patients
4 billion people
10 801 women
8135 women
300 000 women
193 no data on patients
 data   from the 151
210 eligible participants
67 participants
78 participants
65 participants
29 participants
16 participants
51 participants
64 participants
192 participants
67 eligible participants
65 eligible participants
78 eligible participants
13 participants
3 shows the proportion of participants
914 patients
n=67
n=78
n=65
N=210
n=210
n=96
100 patients
n=197
n=194
874 patients
171 patients
n=120 707
n=2031
n=20 055
n=74 326
n=26 326
1 million participants
71 683 patients
16 billion overweight   people
 data from 27
 data from 27
 data from 27
128 standard ised patients
n=64
 data from 27
128 standard ised patients
n=64
24 participants
5 month   follow-up than were participants
4  generally recommended once patients
7 For patients
425 patients
28 patients
24 patients
60 patients
30 patients
98 patients
n=7
n=9
n=8
n=6
126 patients
36 clinically unresponsive patients
n=24
n=13
10 Treatment of patients
8447 patients
4584 patients
1185 participants
1224 patients
375 patients
6310 patients
750 randomised   patients
1200 patients
607 patients
617 patients
1185 patients
913 patients
587 patients
1011 patients
838 patients
989 patients
3020 patients
385 patients
270 patients
25 patients
10 patients
44 patients
141 patients
75 patients
16 patients
17 patients
20 patients
34 patients
108 patients
21 patients
5 patients
24 patients
66 patients
12 patients
38 patients
72 patients
45 patients
39 patients
53 patients
n=587
n=598
n=583
n=602
total of   3020
1224 patients had been enrolled
1224 enrolled
1200 patients were enrolled
7 million people
5 million people
5 million people
24 people
41 710 women
1 858 984 women
604 women
403 participants
82 647 patients
19 In patients
9382 patients
73 261 patients
82 627 patients
8405 inpatients
30 We initially   included all people
n=20 700
n=40 937
n=41 710
18 patients
10 patients
50 000 people
n=8
n=2
n=10
n=12
 data from a 6
11 million people
11 million people
30 patients
30 patients
30 patients
n=6
1 patients
n=6
4   LGBT persons
1 patients
4   LGBT persons
4   LGBT persons
2332 eligible adult patients
1162 patients
2332 patients
9221 patients
1170 patients
4 patients
n=1985
n=2236
n=1162
n=1170
2332 enrolled
50 000 patients
30 people
2 million people
56 million people
453 participants
900 patients
447 patients
445 patients
449 patients
3 million patients
4 We excluded patients
300 patients
600 patients
14 patients
34 patients
437 patients
n=445
n=449
n=5
n=3
n=14
n=10
n=2
535 patients
90 patients
9 patients
526 patients
78 patients
76 patients
43 patients
150 assessable patients
525 patients
0  Fatigue  Proportion of patients
391 patients
68 patients
n=388
n=138
n=90
n=135
n=199
n=192
n=391
n=196
535 patients enrolled
16 Patients were enrolled
196 patients
78 patients
73 patients
90 patients
88 patients
87 patients
98 patients
175 randomly assigned patients
169 patients
156 patients
173 patients
68 surviving patients
69 patients
83 patients
85 patients
1 month than patients
36 patients
11 patients
165 patients
663 patients
n=15
n=3
n=2
n=1
n=87
n=88
n=76
n=79
n=75
n=74
n=49
n=53
n=71
n=70
n=63
n=55
n=56
n=33
n=36
n=98
n=78
n=73
101 330 matched patients
100 patients
9  A large proportion of patients
76 074 patients
102 patients
1217 patients
n=1
total of 341 749
417 patients
416Â  patients
420 enrolled and randomised patients
419 patients
416 patients
556 patients
444 patients
n=209
n=210
n=207
420 enrolled
556 patients enrolled
 data cutoff  of Aug 31
3864 postmenopausal   women
1920 women
3 All   the women
4 Other   patients
56 million people
30 million   people
2   How many more people
3 million people
3 million   people
450 000 people
1 million people
23 000 participants
1 the people
5 million women
062  Estimates of   women
1_molestation-cases-  stranded-women
5 million women
062  Estimates of   women
1_molestation-cases-  stranded-women
3 As older people
78 million   people
3 As older people
78 million   people
3 As older people
78 million   people
202 million elderly   people
3   among elderly people
202 million elderly   people
3   among elderly people
0  Data are number of patients
8 million   participants
120 million women
n=368
n=364
n=383
n=374
n=84
n=83
n=81
n=757
n=732
n=738
n=751
n=134
n=80
n=108
n=106
n=696
n=701
n=661
n=680
n=658
n=676
n=699
n= 705
n=748
n=725
n=741
n=687
n=659
n=650
n=686
n=642
n=652
n=667
n=693
total of 3550
368 infants were enrolled
374 infants enrolled
383 infants enrolled
364 infants enrolled
368 infants enrolled
172 participants
157 participants
809 participants
1 This group of people
n=86
n=50
n=4
n=3
n=1
n=85
n=81
n=76
n=74
n=71
310 000 participants
8 million participants
1000 people
n=1769
n=19 244
 data from   369
1162 patients
1170 patients
n=1162
n=1170
800 000 people
2012  Pregnant women
2012  Pregnant women
n=666
n=462
n=664
total of 666
 data from 1970
8135 women
3786 women
700 women
1314 women
1772 women
400 women
5424 women
3831 women
0 women
3131 women
45 women
1594 women
870 women
5821 women
3 women
813 women
1133 women
318 women
173 unirradiated women
365 women
542 women
431 women
2304 women
1494 women
1029 women
2000 women
12 The women
10 801 women
100 000 women
total of   2304
67 participants
600 people
2 million people
260 000 people
783 million   people
100 000 people
394 patients
150 million chronically infected patients
481 patients
125 patients
264 patients
202 patients
247 patients
28 patients
60 simeprevir-treated   patients
38 patients
86 patients
117 patients
12 data   are the number of patients
20 patients
16 patients
12 patients
99 patients
1 HCV infected patients
1   patients
n=264
n=130
n=263
n=259
n=128
n=71
100 outpatients
16 000 patients
3 million people
3 million   people
16 000 patients
3 million people
3 million   people
1250 participants
49 participants
13 participants
562 participants
568 participants
16 participants
n=627
n=623
n=9
n=4
n=1
n=2
n=624
n=1247
n=562
n=568
n=1130
1250 enrolled
11   Allocation of participants
124 patients
41 patients
2 million people
30 patients
444 patients
2   Increasing numbers of people
580 000 persons
 data   from 2010
257 patients
125 patients
474 patients
391 patients
1 shows the patients
134 patients
255 patients
77 patients
80 patients
100 patients
179 patients
17 patients
15 patients
27   In patients
40 patients
103 patients
24 patients
52 patients
12 data are the number of patients
30 patients
21 patients
1 HCV infected patients
1 patients
n=257
n=134
n=77
n=45
n=122
n=80
n=43
n=123
1183 patients
6433 patients
20078 and patients
10 000 patients
n=0
total of 45
52 patients
30 patients
48 patients
20 patients
17 patients
11 patients
63 patients
n=18
n=2
n=24
4 All patients
182 patients
2 million patients
n=4
n=1
5 million people
10 000 people
5 million people
36 million people
10 000 people
5 million people
36 million people
n=98
1 Most patients
67 participants
1224 patients
607 patients
1185 patients
7102 patients
434 patients
7547 women
497 women
9661 women
4677 women
3885 women
314 623 women
22 women
29 women
23 women
842 women
10 781 women
286 137 women
229 women
4906 women
2612 women
303 842 women
17 705 women
1957 women
274 women
n=346
n=497
n=7547
n=9661
n=17 705
N=94 740
n=3900
n=3373
N=131 835
N=16 611
N=36 460
N=24 196
n=3836
n=7273
n=4677
 data from   314 623
183 patients
6756 participants
3721 participants
3035 participants
270 participants
6756 patients
787 patients
3035 patients
244 patients
3 patients
198 patients
3391 patients
3â€”older patients
22  All patients
1729 patients
1700 patients
3 and patients
n=0
n=3391
n=3365
 data from 6756
 data from IST-3
778 people
528 people
23 392 people
778 people
528 people
23 392 people
2011  Number of participants
3909 people
1859 people
n=155
n=38
n=35
n=26
n=3909
n=256
n=788
n=862
n=718
n=658
n=627
2 In patients
1620 patients
528 patients
632 patients
460 patients
n=199
n=192
n=135
total of 1620
831 million people
10 251 men and women
n=5128
n=5123
2440 patients
1259 eligible patients
23 All   patients
21 We excluded   patients
43 patients
51 patients
1492 patients
1181 patients
1259 patients
181 patients
20 we randomly allocated patients
12 536 enrolled patients
n=635
n=624
n=671
n=253
n=201
n=29
n=27
total of   12 536
2440 patients enrolled
1286 enrolled
1259 were enrolled
12 536 enrolled
 databases from Jan 1
500 participants
3750 participants
11 000 participants
11,000 participants
4161 patients
1 For patients
8 patients
13 250 patients
n=277
n=555
n=554
n=52
n=110
n=107
n=105
total of 11 000
8 million   participants
4 million participants
7 million   participants
1 million participants
8 million participants
0 million participants
4161 patients
1 billion people
185 million people
2 million people
185 million people
2 million people
4   Many Chinese people
95 mentally   ill people
375 older men and women
300 older women
4 whereas   more than half the participants
4   Many Chinese people
95 mentally   ill people
n=2201
375 older men and women
300 older women
4 whereas   more than half the participants
n=2201
375 older men and women
300 older women
4 whereas   more than half the participants
n=2201
375 older men and women
300 older women
4 whereas   more than half the participants
n=2201
19 patients
19 patients
19 patients
6 We follow   up the patients
6 We follow   up the patients
24 participants
44 participants
2 diabetic patients
5 million people
124 patients
39 patients
41 patients
40 patients
43 patients
120 patients
187 patients
124 randomly   assigned patients
16 patients
12 patients
22 patients
81 patients
80 All patients
11  All patients
10 than were   patients
n=41
n=40
n=43
n=34
n=38
n=39
n=390
n=20
n=15
n=18
n=21
n=24
n=210
n=17
n=14
n=26
n=22
n=25
n=16
n=12
n=250
n=8
n=6
n=9
n=33
n=30
n=19
n=5
n=10
n=2
n=13
n=11
n=4
n=7
10 even why women
6756 patients
10 251 patients
417 patients
30 patients
55 patients
0 patients
19 patients
15 patients
444 patients
748 million people
5 billion   people
1 billion people
 data from 90
500 million people
500 million people
1 million patients
1 000 000 people
1 000 000 people
28 few participants
1620 patients
632 patients
460 patients
528 patients
300 patients
1500 patients
1272 patients
16 patients
333 patients
203 patients
5247 patients
3525 patients
100 000 people
1620 people
n=1058
n=348
n=214
n=528
n=878
n=459
N=460
n=91
2694 Framingham   participants
1000 participants
25 million patients
1 258 006 patients
25 million people
n=10 349
n=4139
n=11 029
n=3661
n=10 437
n=2355
n=8767
n=4329
n=830
n=1639
n=8414
n=2261
n=83 098
n=3949
n=5422
n=4486
n=861
n=1245
n=954
n=2094
n=937
n=533
n=434
n=2695
n=310
n=5688
n=6110
n=5316
n=1940
n=5798
n=1261
n=4874
n=2452
n=254
n=879
n=4697
n=1567
n=712
n=817
n=1227
n=860
n=3394
n=140
n=1799
n=940
n=43
n=326
n=1022
n=384
n=2146
n=1717
n=276
n=14 139
n=14 329
26 684 women
638 women
241 women
9 The proportion   of women
n=76
n=12
n=2
n=90
n=62
2579 women
2292 women
3 Among patients
4540 people
n=8
n=19
n=154
n=618
n=772
n=350
n=277
n=112
n=33
 data from the 2011
350 participants
39 participants
396 patients
1594 eligible patients
390 patients
11 patients
16 patients
1620 patients
n=196
n=200
396 were enrolled
10 Treatment of patients
41 710 women
9 of   the patients
total   of 21
 data coverage of   97
 data from 180
3885 women
60 000 women
1218 infants enrolled
29 234 patients
6 million people
100 000 people
100 000 people
3 million people
3 million people
5 million people
770 people
470 people
218 people
37 people
10 people
5 million people
5   Although the number of people
4 more   children than women
580,000 subjects
 data from 183
1259 PCI-treated patients
20 000 patients
n=624
n=635
46 000 people
670 people
40 000 people
46 000 people
670 people
40 000 people
580 000 persons
3â€”of ARUBAâ€™s   participants
6 Treated   participants
20 patients
 data   from 2010
3â€”of ARUBAâ€™s   participants
6 Treated   participants
20 patients
18 surgical patients
18 surgical patients
18 surgical patients
109 patients
1012 treated   patients
109 patients
1012 treated   patients
109 patients
1012 treated   patients
748 million people
1 billion   people
292 women
146 women
3022 women
143 women
141 women
469 eligible women
26 women
289 randomised women
34 women
15 participants
11 participants
143 patients
36 centres screened patients
14 patients
12 patients
3 patients
6 patients
146 patients
n=146
n=143
n=148
n=144
n=141
n=2
50 patients
183 patients
318 patients
n=196
n=175
326 patients
219 patients
32 patients
600 patients
320 patients
326 randomised patients
28 the proportions of patients
84  Number of patients
1  Number of patients
353 patients
25 As patients
n=126
n=133
n=67
n=3
n=1
n=4
n=6
n=5
n=7
n=2
n=11
n=37
n=89
n=94
n=49
n=45
n=100
n=53
n=47
10 were enrolled
550 participants
25 participants
1643 participants
1594 participants
1650 patients
4606 patients
550 patients
1652 patients
549 patients
553 patients
12 patients
3 patients
13 patients
546 patients
547 patients
230 patients
196 patients
229 patients
0  Number of patients
N=550
N=546
N=547
N=545
N=543
N=544
N=548
N=542
N=491
N=478
N=474
N=455
N=456
N=450
N=342
N=343
N=330
N=308
N=313
N=296
N=532
N=528
N=529
N=490
N=473
N=472
N=453
N=454
N=448
N=340
N=328
N=306
N=312
N=449
N=416
n=46
n=309
n=745
391 previously   untreated patients
264 patients
130 patients
257 patients
236 patients
80 patients
200 million people
1 enrolled
2 enrolled
25 000 women
4540 people
100 million patients
100 million patients
20 000 patients
20 patients
20 patients
10 801 women
20 patients
3451 patients
10 801 women
3451 patients
10 801 women
3451 patients
1665 patients
1261 patients
n=6
1665 patients
1261 patients
n=6
1665 patients
1261 patients
26 patients
1222 patients
n=6
total of 37
26 patients
1222 patients
2232 patients
n=1222
total of 37
2232 patients
1222 patients
n=1222
4161 patients
n=805
172 patients
3   because people
4 T cells of persons
54 participants
156 participants
165 participants
343 participants
173 participants
146 participants
10 participants
151 participants
159 participants
14 participants
161 participants
198 participants
490 participants
508 patients
n=165
n=175
n=168
n=343
2954 participants
600 participants
14 enrolled participants
2968 participants
2968 subjects
N=979
N=988
N=987
N=2968
n=977
n=2966
n=973
n=985
n=986
n=2950
n=974
n=987
n=2953
n=826
n=156
n=319
n=263
n=121
n=255
n=501
n=308
n=206
n=13
N=974
N=984
N=981
n=100
N=2489
N=2576
n=185
n=176
n=182
N=3520
N=3504
2968 subjects enrolled
2 inappropriately enrolled
1 inappropriately enrolled
11 inappropriately enrolled
600 participants enrolled
14 enrolled
2968 individuals were enrolled
2968 participants enrolled
 data from 46
1825 patients
1253 patients
628 patients
625 patients
627 patients
618 patients
306 patients
3 and some patients
10 Treatment of patients
18 Eligible patients
1242 patients
621 control group patients
624 ramucirumab group patients
143 patients
63 patients
48 patients
31 patients
884 patients
320 patients
54 patients
30 patients
16 patients
14 patients
18 patients
53 patients
43 patients
22 patients
13 patients
75 patients
32 patients
11 patients
33 patients
1825 consented   patients
13 the ineligibility of   many patients
50,000 patients
n=628
n=625
n=627
n=618
 data cutoff  611
 data cutoff  613
50 000 patients
292 women
146 women
138 patients
total of 572
500 patients
3 enabling matching of women
2013 survey of   women
224 929 women
138 624   women
254 women
553 women
4 Were   study participants
224 929 women
138 624   women
254 women
553 women
4 Were   study participants
224 929 women
138 624   women
254 women
553 women
4 Were   study participants
10 251 patients
160 patients
n=3967
n=11 140
n=1791
n=160
7 For patients
1183 patients
7000 patients
101 330 matched patients
90 000 people
6 but people
1 million Norwegian women
25,157 women
4808 EPIC-Oxford participants
3790 additional annual UK patients
3790 extra patients
3790 additional patients
 data from 2003
10 102 eligible patients
7112 patients
3483 patients
506 patients
378 patients
2050 patients
12 140 patients
10 102 patients
7000 patients
5000 patients
7011 patients
6992 patients
283 patients
91 patients
640 patients
230 million people
n=3495
n=3516
n=29
n=28
n=3483
n=3509
n=3052
n=3069
n=421
n=439
n=20
n=579
7112 patients enrolled
8 previously enrolled
7112 patients   were enrolled
900 patients
445 patients
449 patients
29 343 patients
1 Most patients
118 patients
133 patients
33 patients
251 patients
21167 patients
25 million people
4540 people
2 billion people
4   It has deprived many patients
4   It has deprived many patients
4   It has deprived many patients
18 patients
28 patients
45 patients
18 patients
28 patients
45 patients
18 patients
28 patients
45 patients
3   patients
5752 women
2881 women
16   especially among women
5777 women
5400 women
3200 women
143 initially   seronegative women
132  Number of women
133  Number of women
18  Initially seronegative women
11 All women
40 and HPV vaccination of   women
1 million women
30 000 trial participants
n=2881
n=2871
n=2264
n=2241
n=1138
n=4505
n=4985
n=5752
n=345
n=360
5777 women enrolled
47 participants
1917 patients
905 patients
907 patients
122 patients
140 patients
751 patients
740 patients
900 patients
1800 patients
1829 patients
17 surviving patients
47 participants remained inpatients
1595 patients
95 patients
748 patients
733 patients
728 patients
n=905
n=907
59 137 pregnant women
52 171 women
7929 women
1027 women
46  The women
n=1595
n=3551
n=2493
n=2358
n=3702
n=2821
n=2939
n=1027
n=20 486
59 137 pregnant women enrolled
n=224
n=222
n=221
total of   7
450 children were enrolled
450 children enrolled
508 patients
8  Indigenous Australian people
382 million people
340 people
340 people
600 patients
70 000 people
70 000 people
70 000 people
9 Deaths of women
20 More women
6000 people
10 million   people
1000 people
 data from the 2001
14 participants
14 patients
112 842 Chinese patients
1   the number of people
173 patients
81 patients
135 patients
48 patients
60 patients
100 patients
178 patients
80 ipilimumab-refractory patients
84 patients
170 patients
131 patients
26 patients
58 patients
27 patients
31 patients
16 A high percentage of patients
n=89
n=84
n=173
n=81
n=76
n=91
n=87
n=21
n=20
n=24
n=27
200 participants
1620 patients
528 patients
632 patients
460 patients
3090 patients
total of 1620
100 000 women
70 000 people
8 million people
269 participants
599 patients
299 patients
300 patients
24   The proportion of patients
296 randomly   assigned patients
814 patients
599 eligible patients
19 patients
252 patients
26  Only patients
812 patients
19   whereas patients
n=299
n=300
14 participants
n=33
n=15
1652 patients
1 represent a large group   of patients
314 million people
8 million people
140,000   observations in men and women
14 patients
46 participants
46 participants
584 participants
8 million participants
584 participants
8 million participants
584 participants
8 million participants
5  An analysis of participants
220 000 participants
5 million   people
400 000 people
5  An analysis of participants
8 million participants
220 000 participants
7 million   participants
1 million participants
5 million   people
400 000 people
7 million   participants
1 million participants
60 patients
60 patients
60 patients
7 If most of the patients
326 patients
126 patients
133 patients
67 patients
47 patients
275 patients
138 patients
1101 patients
335 patients
300 000 people
5 million   people
50 million people
100 000 people
100 000   people
300 000 people
5 million   people
50 million people
100 000 people
100 000   people
22 women
39 women
22 women
39 women
185 million people
185 million people
185 million people
14 patients
60 patients
16 patients
60 exposed patients
43 patients
43 exposed patients
8 perhaps advising patients
n=18
n=25
n=4
n=13
168 patients
54 patients
31 patients
30 patients
167 of patients
108 patients
40 treatment-naive patients
24 patients
20 patients
1b patients
12 even though patients
100804020  Observed proportion of patients
1 treatment-  experienced patients
150   million people
n=80
n=87
n=72
n=82
n=52
n=33
n=26
n=22
n=167
n=24
n=15
n=27
n=14
n=30
n=16
n=54
n=31
n=28
n=1
168 patients were enrolled
320 participants
2 diabetes   enrolled few participants
590 screened patients
1 Many patients
114 patients
590 patients
23 patients
158 patients
8 of patients
21 patients
2 diabetic patients
102 patients
2   diabetic patients
n=168
n=163
2 diabetes   enrolled
2119 patients
1063 patients
1056 patients
2060 patients
2129 patients
1066 patients
1050 patients
4  Articles  patients
n=0
n=1063
n=1056
n=1008
n=995
n=852
n=845
n=1594
n=1545
n=1560
n=1523
n=1575
n=1540
n=1517
n=1483
N=1063
N=1056
25 participants
326 patients
126 patients
133 patients
67 patients
47 patients
275 patients
138 patients
1101 patients
335 patients
54 patients
25 patients
12   Four patients
15   All patients
n=5
n=10
1829 patients
905 patients
1829 patients
18 065 patients
905 patients
8 million people
800 000 people
total of 13
20 990 patients
7000 patients
20 patients
3500 patients
8000 patients
3751 patients
500 patients
550 patients
7017 patients
7525 patients
7719 patients
6695 patients
6032 patients
6598 patients
5984 patients
7012 patients
7283 patients
502 patients
551 patients
520 patients
22 261 patients
16 279 patients
4113 patients
3837 patients
4182 patients
5171 patients
5468 patients
1000 patients
n=13
n=15
n=14
n=6695
n=5171
n  =2
n  =1
n=7012
n=7283
N=5171
N=5468
N=5572
307 treatment-naive patients
200 patients
100 treatment-naive patients
293 patients
453 patients
12 status of patients
596 patients
27 patients
75 patients
521 patients
78 patients
39 patients
13 patients
150 million people
n=205
n=102
n=235
n=203
n=599
n=634
n=630
n=8
N=203
18 participants
10 278 participants
10 632 participants
575 participants
100 million people
96 million people
n=6851
n=3424
n=6852
n=3426
n=5
n=3
n=1
N=6851
N=3424
N=6848
total of 5
7000 patients
101 330 matched patients
283 patients
296 patients
8 additional people
100 000 people
44 million people
653 adult patients
2 664 patients
333 patients
238 patients
600 million people
500 million people
852 participants
426 participants
164 participants
171 participants
43 participants
852 patients
800 patients
829 patients
n=426
599 patients
11 and patients
1 More than a third of   patients
1257 patients
6 but not all patients
331 patients
2 diabetic patients
4   patients
4   patients
60 participants
60 participants
60 participants
2143 patients
3 a substantial number of   patients
114 intention-to-treat   patients
600 000 people
150 000 people
170 000 participants
9795 people
 data from   170 000
74 patients
8 million people
100 peopleâ€”most were women
1  The death of innocent women
100 people
8 million   people
3   The people
100 peopleâ€”most were women
1  The death of innocent women
100 people
8 million   people
7 For patients
1183 patients
90 000 people
10 million women
34 million women
3 billion people
510 million people
n=2531
n=1 013 363
n=10 202
n=5642
n=5
n=1 029 207
n=970 725
n=58 482
 data from 1995
173 patients
7 Although patients
n=31
5000 patients
5000 patients
260 000 people
260 000 people
206 participants
143 study participants
805 patients
940 patients
400 assessable   patients
61 patients
11 patients
14 patients
52  Total number of patients
15  PDVF patients
9  No PDVF patients
401 patients
250 patients
n=401
n=404
n=378
n=389
n=4
n=3
n=46
n=484
n=77
n=198
805 patients enrolled
805 enrolled
24 million persons
580,000 subjects
166 000 people
16 211 patients
1218 infants enrolled
292 women
31 patients
68 patients
153 patients
44 patients
n=426
18   Most patients
3000 patients
716 patients
333 patients
27 patients
10 Consenting patients
620 patients
720 patients
664 patients
238 patients
29 patients
35 patients
143 patients
131 patients
190 patients
15 patients
280 patients
63 patients
18 patients
10 272 patients
2710 patients
1570 patients
8323 patients
30 Both studies enrolled   patients
710 patients
n=333
n=331
n=908
n=431
716 patients enrolled
716 patients were   enrolled
30 Both studies enrolled
7579 people
3   The people
4 T cells of persons
12 patients
25 participants
89 participants
n=5
n=10
n=25
25 participants were enrolled
25 enrolled
8 million people
200 000 people
8 million people
200 000 people
37 male patients
1 Partners   of these women
4   Many women
5   Many women
1 Partners   of these women
4   Many women
5   Many women
1000 patients
1 the number of treated patients
51 917 patients
50 000 patients
2 diabetic patients
14 224 people
n=691
n=991
n=51 917
n=25 480
n=12 544
n=8287
n=5606
n=52 035
n=48 198
 data from   27
33 958 patients
27 and seven enrolled patients
2422 patients
1406 patients
31 748 patients
n=4
n=3
total of   33 958
27 and seven enrolled
 data from 16
1 represent a large group   of patients
11 patients
645 patients
205 treatment-naive   patients
235 patients
75 patients
167 patients
28 patients
80 patients
20 non-cirrhotic patients
1 patients
1 treatment   naÃ¯ve patients
29 patients
4348 participants
2881 patients
2871 patients
24 patients
n=2881
n=2871
500 participants
231 participants
250 participants
217 participants
1428 patients
500 patients
28   and monitor patients
483 patients
500 people
4 million   people
n=253
n=247
n=249
n=244
n=252
n=246
n=251
n=231
n=217
n=218
n=228
n=227
500 participants were enrolled
23  We enrolled
 data, ranging from 217
 data from 462
3 For   non-STEMI patients
150 000 people
3 For   non-STEMI patients
3 For   non-STEMI patients
2 These missing patients
2 These missing patients
9   million women
2 These missing patients
25 million people
9   million women
25 million people
3 billion people
510 million people
10 million women
34 million women
3 million people
9 million people
74 patients
17 final participants
17 final participants
4000 pregnant women
2 billion people
25 participants
n=5
n=10
51 917 participants
2 664 patients
333 patients
238 patients
1650 patients
1000 patients
1   the number of people
181 Palestinian women
1160 women
8 million people
166 women
60 elderly   people
166 women
60 elderly   people
166 women
60 elderly   people
166 women
60 elderly   people
100 000 people
112 842 Chinese patients
100 patients
5 million people
1603 people
100 patients
5 million people
1603 people
900 patients
445 patients
449 patients
41 behaviourally   unresponsive patients
41 behaviourally   unresponsive patients
4 more   children than women
170 000 participants
4444 patients
9795 people
 data from   170 000
34 000 patients
n=4
n=3
n=9
n=5
 data from 27
51 917 participants
1000 patients
591  Comment  only the patients
9 most studies enrolled patients
9 most studies enrolled
 data from 27
4348 participants
1136 participants
3356 participants
28 three trials compared   patients
N=4348
N=3356
N=3941
142 participants
500 patients
173 patients
20 000 people
11 million people
8 million patients
650 million people
8 million patients
650 million people
13 000 people
33 patients
251 patients
18 254 patients
18 000 patients
300 patients
844 patients
13 946 individual patients
13 084 patients
76 patients
6722 patients
27 recruited patients
n=13 946
n=3066
n=2237
n=633
n=13 645
n=3002
n=0
6756 patients
 data from 6756
6756 patients
 data from 6756
500 participants
14 patients
14 patients
6912 patients
3483 patients
3977 patients
7012 patients
10 187 patients
4153 patients
276 patients
2759 patients
6912 patients
3483 patients
3977 patients
7012 patients
10 187 patients
4153 patients
276 patients
2759 patients
90 more   patients
1000 patients
90 more   patients
1000 patients
total of 76 621
total of 76 621
508 patients
508 randomised   patients
82 patients
500 patients
8  Indigenous Australian people
20 000 people
4348 participants
24 patients
2 diabetes patients
18 254 patients
18 254 patients enrolled
 data from   18 254
20 patients
total of 20
20 patients will be enrolled
508 randomised   patients
82 patients
500 patients
20 000 people
140,000   observations in men and women
2129 patients
250 000 patients
n=6439
250 000 patients were enrolled
4000 pregnant women
4 For   women
51 million patients
2 In patients
1 billion people
100 million people
total of 51
6000 patients
6000 patients
5388 patients
5388 patients
100 patients
100 patients
100 patients
39 patients
100 outpatients
 data from 316
39 patients
100 outpatients
 data from 316
35 000 indigenous Inuit people
422 730 patients
422 730 patients
422 730 patients
13 108 women
13  We scanned women
4000 women
500 pregnant women
13 108 pregnant women
3976 women
4500 women
4607 women
8501 women
10  Methods  Study design and participants
8501 ineligible patients
n=4321
4607 women enrolled
26 of south Asian women
125 million women
80 patients
57  The Lancet Commissions  patients
89  only a third of patients
138 If you leave people
260   The ill nesses of poor people
2014  through it the people
2014  through it the people
1000 people
42 000 younger people
670 000 unpaid carers of people
42 000 younger people
670 000 unpaid carers of people
342 patients
1000 patients
2   diabetic patients
3040 randomly assigned patients
342 patients
1000 patients
2   diabetic patients
3040 randomly assigned patients
12 900 people
 data from the 10
12 900 people
 data from the 10
50 patients
1 More than a third of   patients
1257 patients
6 but not all patients
8 additional people
3 Most treated patients
22 million   people
22 million   people
3 Of patients
3 Of patients
142 patients
142 patients
300 000 people
30 000 people
1 billion   people
80 people
60 people
2000 people
3 Most treated patients
4452 patients
3675 patients
3564 patients
n=15
n=3
n=12
4452 patients
3675 patients
3564 patients
3 Many patients
n=15
n=3
n=12
n=29 234
3 Many patients
n=29 234
3 Many patients
n=29 234
3302 patients
3293 patients
97 patients
50 patients
6378 participants
18  A third of patients
33 of patients
100 critical care units admit patients
3300 patients
831 patients
2 Triage of patients
3 Referral of patients
404 patients
102 of patients
28 000 patients
23 targeting patients
2533 patients
12 368 patients
920 patients
400 patients
7000 patients
59 995 for   patients
600 000 people
60 000 people
5000 people
2 million people
15 278 people
98 160 000 people
200 000 people
1000 people
7000 new people
95 000 people
12 people
34 347 people
26 million people
35 million people
5 million people
1   placing patients
9 million people
36 people
260 000 people
190 000 people
4 million people
410 patients
856 patients
1185 patients
3 856 patients
5   To defi ne a subset of patients
410 patients
856 patients
1185 patients
3 856 patients
5   To defi ne a subset of patients
2 million people
2 million people
234 233 Syrian   patients
280 Syrian   patients
80 trauma   patients
2 million people
4  The Turkish people
n=44
234 233 Syrian   patients
280 Syrian   patients
80 trauma   patients
4  The Turkish people
n=44
1000 participants
230 HCM   patients
22 patients
51 million people
7 million of these   people
90 000 people
1 Some people
400 participants
1   placing patients
9 million people
36 people
260 000 people
300 patients
 data from 2013
300 patients
 data from 2013
1 million   people
1 million   people
51 million people
7 million of these   people
3 Giving patients
1000 people
1000 people
20 million   people
1000 people
 data from   54
 data from   54
 data from   54
4 the   percentage of patients
1 such patients
4 the   percentage of patients
1 such patients
4 the   percentage of patients
1 such patients
1503 patients
1503 patients
1503 patients
N=23
N=24
N=79
N=80
20 million people
20 million people
76 women
441 patients
445 patients
265 patients
441 patients
445 patients
265 patients
3 659 patients
3 659 patients
12 some participants
5 million people
6 million   people
225 million women
125 million women
43 million   women
21 million women
805 million people
2 billion   people
400 million women
400 million women
5000 people
5 Can we ethically watch   patients
 data   from 11
 data   from 11
 data   from 11
 data from 27
N=23
N=24
N=79
N=80
 data from 27
17 people
1000 people
60 000 women
1 million people
372 000 people
1 million people
372 000 people
8135 women
100 000 women
1133 women
8135 women
100 000 women
1133 women
8135 women
1 patients
8135 women
10 801 women
1 patients
8135 women
10 801 women
8135 women
7000 patients
20 patients
800 000 women
101 330 matched patients
5000 people
7521 participants
15 and   participants
6756 patients
77 million people
77 million people
2 but the proportion of people
2 but the proportion of people
2 but the proportion of people
8 million people
n=2
n=1
n=2
n=1
2 diabetes patients
18 254 patients
3066 patients
8 Although the number of patients
17 people
18 254 patients enrolled
 data from   18 254
220 000 people
8 million people
19 000 people
170 000 people
300 people
6 million people
800 000 women
5000 people
101 330 matched patients
800 transgender   patients
800 transgender   patients
6 million women
800 transgender   patients
6 million women
300 million people
3500 participants
10 000 people
5 mortality and women
5 mortality and women
541 patients
67 patients
364 Asian patients
18 patients
1513 patients
274 patients
829 patients
410 patients
1024 patients
477 patients
24 patients
1322 patients
274 excluded patients
1200 patients
1239 patients
531 patients
177 patients
97 patients
806 patients
433 patients
0  Data are number of patients
N=829
N=410
n=538
n=291
n=268
n=142
n=487
n=752
n=321
n=475
n=443
n=396
n=843
n=806
n=433
N=806
n=521
n=285
n=537
n=269
n=737
n=67
n=358
n=442
n=310
n=496
n=365
n=131
n=762
n=44
N=538
N=268
n=0
N=291
N=142
N=433
n=277
n=156
n=309
n=124
n=406
n=27
n=207
n=224
n=84
n=402
n=31
N=409
N=1024
N=477
1513 patients were   enrolled
281 patients
258 patients
129 patients
116 patients
12 patients
14 patients
76 patients
88 censored patients
257 patients
84 censored patients
175 patients
129 eligible patients
128 patients
0 129  Data were missing for some patients
17 patients
26 patients
19 Optimum care of   patients
n=129
n=281
281 patients were enrolled
281 patients enrolled
258 enrolled
58 participants
50 patients
61 patients
41 patients
58 patients
29 patients
611 patients
46 people
n=15
n=50
n=14
n=26
n=13
n=27
n=20
n=45
n=6
n=10
n=22
n=36
n=58
61 patients   were enrolled
29 patients
31 patients
56 patients
50 assessable patients
21 All patients
24 patients
36 patients
27 patients
22 patients
13 patients
12 patients
11 patients
13 of these   patients
20 patients
23 patients
142 patients
N=31
n=21
n=4
n=19
n=20
n=23
n=22
n=26
n=16
n=18
n=25
501 participants
213 participants
188 participants
249 participants
13  Eligible participants
947 participants
18 participants
229 participants
211 patients
14 We excluded   patients
16 patients
213 patients
188 patients
202 patients
187 patients
150 patients
117 patients
109 patients
160 imiquimod   treated patients
166 surgery patients
195 patients
174 patients
242 patients
201 patients
249 patients
347 patients
n=254
n=247
n=220
n=249
n=229
total of   6
40 Older English   women
10 million   patients
22 million records of patients
10 million patients
370 000 cancer patients
 data.  Eight of the 29
 data from 107
 data from   107
 data from 99
35 women
168 patients
50 patients
154 patients
10 Eligible patients
320 patients
164 patients
84 patients
65 patients
16 patients
80 patients
56 patients
242 patients
40 patients
133 patients
69 patients
355 patients
12 We also included patients
n=3
n=5
n=84
n=81
n=74
total of 164
total of 57
32 patients
14 patients
13 patients
29 patients
9 In patients
25 patients
30 patients
30 treated patients
22 All patients
18 patients
191 patients
n=30
total of   12
   dataset of 191
831 women
100 000 women
831 participants
828 patients
404 patients
408 patients
406 patients
812 patients
200 patients
400 patients
831 patients
27 patients
107 patients
750 patients
191 patients
812 eligible patients
828 eligible patients
410 patients
409 patients
413 patients
110 patients
819 patients
141 patients
671 patients
1414 patients
1596 patients
314 patients
276 patients
6377 patients
1327 patients
187 patients
662 patients
911 patients
36 663 patients
94 such patients
37 280 patients
n=828
n=413
n=415
n=414
n=404
n=408
n=406
107 patients enrolled
 data from 1414
22 million patients
85 patients
31 patients
532 patients
29 enrolled patients
3 Although patients
29 enrolled
1 but more than half   of patients
40 pretreated patients
202 Korean patients
168 patients
n=84
850 patients
425 patients
258 patients
263 patients
n=0
 data from 36
213 participants
281 Japanese patients
404 patients
408 patients
406 patients
6377 patients
655 patients
206 patients
199 patients
322 patients
35 patients
1 Most patients
60 patients
1300 patients
1773 patients
1314 randomised patients
658 patients
555 patients
1314 patients
336 patients
279 patients
659 patients
10 The   frequency of patients
n=655
n=659
n=322
n=336
n=206
n=199
n=652
 data cutoff 646
 data cutoff 650
3469 participants
13 of these participants
119 participants
28 The proportion of participants
5 shows   the distribution of participants
38 Many   participants
6 Selection of patients
8 The percentage of patients
n=3469
n=0
49 patients
37 patients
12 patients
11  Proportion of patients
1 shows patients
49 enrolled patients
39 patients
0  Data are number of patients
18 patients
751,871 in patients
n=37
n=12
n=49
49 patients were enrolled
37 patients were enrolled
37 patients enrolled
49 patients   were enrolled
49 enrolled
1011 patients
0 patients
505 patients
506 patients
501 patients
980 patients
37 patients
252 patients
253 patients
355 patients
787 patients
31 patients
11 patients
19 patients
526 patients
3 More than a quarter of patients
665 patients
470 patients
787 eligible patients
n=0
N=252
N=253
910 patients
239 patients
113 patients
330 patients
364 eligible patients
364 patients
6 included   patients
n=242
n=122
n=239
n=113
n=364
n=345
 data cutoff 0
 data from 36
32 465 patients
5 and we judged   patients
16 595 patients
1187 patients
3533 patients
17 845 patients
n=839
N=15 870
N=16 595
 data from 22
400 000 people
502 patients
127 patients
280 patients
7 and more female than male   patients
3469 participants
50 patients
1310 patients
17,845 patients
404 patients
408 patients
406 patients
23 recruited patients
17 patients
23 patients
21 patients
14 patients
19 patients
60 adult patients
22 patients
20 lymphoma patients
680 000   people
284 patients
280 patients
4 Nearly all patients
2 study have shown   patients
764 patients
570 patients
550 patients
194 patients
570 randomly assigned patients
265 patients
230 evaluable patients
241 evaluable patients
48 patients
170 patients
85 patients
66 patients
281 patients
28 patients
2 trial of patients
n=284
n=286
n=70
n=280
n=230
n=241
total of 411
194 not enrolled
282 patients
96 patients
226 patients
4 Gy  All patients
94 patients
12 patients
134 patients
n=299
n=315
680 000 people
212 patients
16  Methods   Study design and participants
391 patients
421 patients
422 patients
18 All patients
800 patients
1 shows characteristics of the patients
831 patients
12 patients
838 enrolled patients
833 patients
843 patients
117 patients
221 patients
170 patients
91 patients
224 435  N=number of patients
N=421
N=422
N=126
838 enrolled
675 patients
57 patients
600K mutations enrolled
367 patients
13 patients
4  Number of patients
217 patients
101 patients
38 patients
11 patients
59 patients
18 patients
392 patients
25 patients
2 stage patients
6 and   includes the patients
240 patients
23 selected   patients
22 patients
n=217
n=101
n=38
n=11
n=367
n=104
n=24
n=369
n=23
n=40
n=41
 data derived from   367
15 participants
3226 patients
675 patients
384 patients
843 participants
N=1006
N=473
3  Not all patients
4519 additional   patients
1944 patients and   these patients
455 patients
5   and because patients
3  Not all patients
2 wild-type patients
117 patients
2   wild-type patients
364 patients
621 patients
272 patients
22 patients
52 patients
340Â  patients
268 patients
349 patients
235 patients
14 patients
128 patients
129 patients
73 patients
119 patients
222 patients
98 patients
24 patients
110 patients
112 patients
29 The analysis of only the   patients
n=128
n=129
n=134
n=104
n=137
n=105
401 patients
64 patients
77 patients
92 patients
119 patients
282 patients
158 patients
226 patients
78 KRAS wild-type patients
24 patients
169 patients
13 patients
78 patients
42 patients
107 patients
n=78
n=91
n=112
n=114
n=169
n=29
n=17
n=1630
n=978
226 of whom were enrolled
226 patients were enrolled
119 patients were enrolled
 data from CR06
5 But what about patients
436 patients
3394 participants
1343 patients
1343 enrolled patients
671 patients
672 patients
1320 patients
660 patients
368 patients
38 patients
652 patients
645 assessed patients
354 patients
n=671
n=672
N=1343
1343 enrolled
541 patients
67 patients
5   and because patients
4519 additional   patients
47 participants
60 participants
62 patients
67 patients
63 patients
26 patients
16 patients
61 patients
24 patients
n=24
n=23
n=13
n=12
n=67
n=41
n=26
67 men were enrolled
148 participants
160 patients
73 patients
4 Most   patients
27 patients
26 patients
170 patients
12 patients
148 patients
130 patients
119 patients
n=80
n=73
n=75
n=59
n=89
   data from 148
569 women
639 patients
1 Median survival of patients
4   For patients
569 women
569 patients
280 patients
282 patients
572 patients
284 patients
285 patients
48 patients
189 patients
29 patients
24 patients
n=284
n=285
n=0
n=280
n=282
569 women were enrolled
275 million people
20 million people
1210 patients
552 operated patients
339 patients
82 patients
2012 and collected data on patients
2 patients
563 patients
647 patients
563 of the   patients
313 patients
563Â  patients
11 patients
95 patients
552 patients
438 patients
257 patients
54 patients
28 patients
23 patients
34 patients
15 patients
114 patients
1023 patients
83 patients
187 of these patients
460 patients
385 patients
30 centres contributed   patients
n=563
652 patients
90 patients
89 patients
20 patients
221 patients
225 patients
376 patients
22 centres enrolled
1071 patients
680,000 people
2012 patients
1 In patients
34 252 patients
19 This cohort includes all patients
86 patients
100 patients
896 patients
817 patients
127,805 unselected patients
n=3672
n=2012
 data from a   1
340 patients
1408 patients
1044 patients
135 patients
n=170
90 patients
89 patients
20 patients
221 patients
225 patients
376 patients
690 patients
201 patients
n=104
n=39
n=0
22 centres enrolled
1482 patients
1 of   patients
614 patients
307 patients
2096 patients
2559 patients
785 patients
15  In patients
2 wild-type   patients
450 patients
1407 patients
18   patients
805 patients
2 subgroup of patients
n=984
n=742
n=791
n=811
n=368
n=374
N=785
N=805
N=364
N=374
n=2096
n=957
N=791
N=811
N=492
N=368
N=79
N=67
2   mutated tumours enrolled
2559 patients   were enrolled
2012 unselected older   women
49 patients
45 patients
32 patients
16 patients
3184 patients
76 patients
74 patients
2 it was the   proportion of patients
24 patients
1 patients
124 patients
38 patients
1 Most patients
35 patients
201 patients
134 patients
32 patients
169 patients
21 patients
31 evaluable patients
17i-naive  Number of evaluable patients
17i  Number of evaluable patients
17 inhibitior-naive patients
17 inhibitor-naive patients
5 at baseline  Number of patients
11   Data are number of patients
140 patients
800 patients
n=38
n=37
n=35
n=24
n=3
n=7
n=124
n=15
n=16
n=32
n=55
n=111
1 were enrolled
24 patients were enrolled
136 enrolled
24 were enrolled
24 patients   enrolled
280 patients
282 patients
75,000 women
533 MRD high-risk patients
2 Continuing therapy  Female patients
112  Male patients
164  Clinical intermediate-risk patients
117  Male patients
3207 patients
52 patients
450 randomised patients
3126 eligible patients
808 eligible MRD high-risk patients
267 patients
3184 patients
n=266
n=267
n=3126
n=808
n=275
n=533
total of 12 000
3 study recruited patients
297 patients
174 patients
293 patients
83 patients
84 patients
297 eligible patients
3 patients
174 eligible and willing patients
89 patients
12 patients
166 patients
70 patients
123 patients
110 patients
26 patients
85 patients
17 patients
22 patients
2 patients
7 patients
30 patients
57 patients
25 patients
68 patients
16 patients
279 patients
6 patients
460 patients
297 registered   patients
297 registered patients
297   patients
174 randomly assigned patients
29 patients
32 patients
167 patients
174 overall because not all patients
30 The proportion   of patients
266 patients
200 patients
n=89
n=85
n=297
n=174
n=22
n=54
n=84
n=6
n=112
n=47
n=75
n=13
n=293
n=110
n=167
n=83
 data cutoff , 125
2559 patients
1602 patients
3 if more patients
3184 patients
3325 participants
3324 participants
3325 patients
142 patients
5 and   older patients
295 patients
14 patients
6 included patients
2728 patients
785 patients
1110 patients
1488 patients
197 patients
23  In identifying patients
788 patients
5876 younger adult patients
1 mutations on older patients
1312 patients
n=133
n=565
n=196
n=205
n=72
n=283
n=67
n=173
n=33
n=576
n=264
n=242
n=0
n=224
n=14
n=9
n=179
n=57
n=186
total of 5
3325 patients who were enrolled
1480 patients
9 EUROCARE Survival of cancer patients
 data from 1992
   data from 1992
2 resection patients
9 and   east Asian patients
256 women
47 697 patients
263 000   patients
39 patients
63 patients
66 patients
n=66
n=63
14 as are women
410 female patients
410 patients
13 patients
20 patients
20 assessable patients
14 assessable patients
376 patients
42 patients
34 patients
14 patients
20 assessable   patients
410 female cancer patients
n=98
n=14
n=6
n=141
n=20
40 patients
15 patients
85 patients
34 patients
15  In patients
34 evaluable patients
31 patients
39 patients
20 patients
38 patients
24 patients
174 patients
116 patients
1482 patients
n=40
n=33
n=39
n=36
n=10
n=13
n=15
n=7
n=11
n=2
n=35
n=5
n=37
n=4
n=30
n=32
40 patients were   enrolled
174 patients
83 patients
98 patients
58 patients
16 did not consist of human patients
28 patients
18 patients
13 patients
2 Few   patients
n=174
n=126
n=40
n=18
n=98
n=58
n=22
n=15
n=7
3 a far higher proportion of   patients
10 000 people
295 patients
1137 patients
247 pilot study participants
429 recruited participants
130 recruited participants
46 recruited participants
279 recruited participants
1643 participants
2664 participants
82 429 participants
46 patients
24 patients
4 and PIVOT   treatment trial patients
32  a UK cohort of patients
n=79 208
n=2896
n=82 429
n=8566
n=7414
n=545
n=553
n=1643
n=997
47 patients
44 patients
21 patients
46 patients
85 patients
0  Data are number of patients
26 patients
15 The proportion of patients
44 assessable patients
n=47
n=21
n=7
n=13
n=42
n=9
47 patients were enrolled
 data cut-  off , 24
321 patients
149 patients
146 patients
322 patients
320 patients
26 patients
295 patients
161 patients
160 patients
0  Data are number of patients
1,864 patients
n=161
n=160
n=149
n=146
n=102
n=96
n=58
n=65
 data cutoff , 21
141 assessable patients
455 patients
24  Methods  Study design and participants
3471 patients
926 patients
52 patients
411 patients
2134 patients
382 ineligble patients
545 eligible patients
504 patients
252 patients
382 patients
545 patients
272 patients
152 patients
3500 patients
n=272
n=273
n=545
n=136
n=409
n=291
n=254
n=419
n=90
n=65
n=368
n=112
n=86
n=453
n=307
n=237
n=106
n=432
n=216
n=329
n=269
n=274
n=111
n=220
n=213
n=157
n=153
n=263
n=258
total of 60
154 patients
75 patients
1 Most patients
2 In this subgroup of patients
12 patients
150 patients
152 patients
77 patients
77   patients
11 patients
n=75
n=77
154 patients were enrolled
154 patients   were enrolled
 data from   152
15 822 participants
7155 participants
7155 screened participants
7915 participants
7438 Dutch participants
7907 participants
477 Belgian participants
283 participants
477 participants
7438 participants
187 participants
19 participants
34 participants
15 participants
34 patients
n=15 822
n=7155
n=8667
n=61
n=25
n=110
n=42
n=1
n=54
n=79
n=145
n=94
n=3
n=7915
n=7907
n=5
n=7
n=12
n=19
n=34
n=6934
n=187
n=66
n=56
n=74
n=4
n=196
n=16
n=35
n=231
total of 196
total of 35
15 822 participants were enrolled
15 822 participants enrolled
n=40
7438 participants were   women
7155 participants
14  Methods  Study design and participants
15 822 participants
7907 participants
477 participants
283 participants
7438 participants
283 Dutch participants
27 Dutch participants
239 Dutch   participants
935 Belgian participants
14 887 Dutch participants
7449 participants
0001  All participants
n=3
n=16
n=5
n=61
n=25
n=110
n=42
n=1
n=7135
n=66
total of 15 822
15 822 participants were enrolled
15 822 participants enrolled
1071 patients
44 patients
64 patients
21 patients
8 In ALK inhibitor-naive   patients
12 patients
10   patients
141 assessable patients
n=17
46 women
47 women
43 women
22 women
24 women
2 trial is no longer accruing patients
12 patients
90 patients
46 patients
44 patients
19 patients
90 enrolled patients
n=46
n=44
90 patients were   enrolled
90 enrolled
127 patients
20 patients
3 used the proportion of patients
40 patients
3 used the proportion of patients
1139 patients
419 patients
416 patients
411 patients
1220 randomised patients
1139 eligible patients
571 patients
305 patients
568 patients
831 patients
835 patients
13 randomised only   patients
138 patients
81 patients
n=571
n=568
n=0
n=308
n=297
n=314
n=220
n=1139
n=831
n=770
n=369
n=910
n=229
n=906
n=233
n=320
n=576
n=243
n=263
n=683
n=148
n=660
n=171
n=247
n=470
n=114
total of 831
31 000 screening participants
665 patients
663 patients
794 screened patients
794 patients
327 patients
329 patients
656 patients
5  Any patients
17 patients
n=330
n=335
N=330
N=335
n=398
n=44
n=223
n=327
n=329
44 patients
494 patients
245 patients
238 patients
6   In patients
76 patients
488 patients
247 patients
50 patients
102 patients
98 patients
483 patients
n=247
n=494
n=238
n=245
n=483
 data cut-off , 102
3 trial of patients
768 patients
381 patients
377 patients
1062 patients
n=387
n=381
n=768
n=499
n=232
n=37
n=407
n=361
n=445
n=323
n=308
n=359
n=249
n=514
n=352
n=416
n=432
n=336
n=329
n=439
n=283
n=485
n=570
n=198
n=122
n=378
n=195
n=73
n=275
n=482
n=167
n=377
n=2
n=7
n=1
n=4
768 patients were enrolled
294 not enrolled
2 was enrolled
   data cutoff , 286
100 000 persons
4 In individual   patients
127 patients
768 patients
758 patients
284 patients
91 patients
92 patients
230 patients
331 patients
360 patients
287 patients
94 patients
0  Data are number of patients
3 trials of patients
3 trial of patients
n=99
n=185
n=92
n=91
n=94
n=284
287 enrolled
287 patients were enrolled
20 patients
110 patients
103 evaluable patients
28 patients
46 evaluable patients
27 evaluable patients
30 evaluable patients
30 patients
50 patients
32 All patients
33 Seven patients
103 patients
45 patients
18 patients
13 patients
27 patients
n=50
n=30
n=5
n=1
n=2
110 patients enrolled
100 000 women
15 women
67 women
180 participants
87 participants
174 participants
89 patients
84 patients
0  Data are number of patients
180 patients
91 patients
87 patients
72 patients
69 patients
91   patients
87   patients
23 patients
83 patients
201â€   Data are number of patients
62 patients
32 patients
33 patients
3322 published patients
n=89
n=91
n=84
n=72
n=69
total of   174
180 participants were enrolled
182 enrolled
total of   5
100 000 persons
4 In individual   patients
4823 patients
2402 patients
1425 patients
672 patients
744 patients
17 patients
4806 patients
132 patients
41 patients
12 patients
3131 patients
1265 patients
655 patients
586 patients
26 When those patients
72 patients
34  Articles  patients
19 although the population of   patients
n=744
n=681
4823 patients were enrolled
4823 patients   were enrolled
 data cutoff  of Oct 31
89 patients
121 patients
0  Proportion of patients
20 and defi ned patients
80 patients
89 enrolled patients
45 patients
31 patients
16 patients
21 mutations   showing patients
23 patients
1 study all patients
155 patients
n=25
n=20
n=89
n=45
n=8
n=14
n=22
89 patients   were enrolled
89 enrolled
 data cutoff , 61
 data   cutoff , 24
 data of 10
2314 patients
791 patients
214 participants
35 study   participants
16  Methods  Study design  and participants
1035 participants
1035 patients
103 patients
141 patients
16 Eligible patients
512 patients
973 patients
62 patients
520 patients
515 patients
52 patients
20 Most patients
3838 patients
15 patients
n=188
n=118
n=520
n=515
n=203
n=139
1035 patients   were enrolled
921 randomly assigned   patients
518 patients
383 patients
347 patients
171 patients
253 patients
130 patients
8 Although the proportion of patients
3 trial studied patients
18 patients
599 patients
302 patients
921 patients
900 patients
347 vs no patients
352 patients
600 patients
600   patients
19 which included patients
n=352
n=174
n=262
n=133
n=307
n=151
n=236
n=120
n=290
n=139
n=   236
n=119
n=347
n=171
n=253
n=130
921 patients enrolled
152 women
40 women
29 women
30 women
98   women
152 patients
142 patients
15 patients
67 patients
47 patients
25 patients
52 patients
26 patients
14 increasing the proportion of patients
48 patients
135 patients
176 patients
24 patients
12 patients
73 patients
69 patients
60 patients
1206 patients
3â€”this table includes only patients
2447 patients
2 positive breast cancer   patients
n=48
n=25
n=139
n=69
n=67
n=47
152 patients enrolled
 data from 2447
8734 patients
8734 total patients
1982 patients
2867 patients
1881 patients
2004 patients
982 patients
942 patients
1000 patients
5819 patients
1942 patients
952   patients
3829 patients
1927 patients
757 patients
659 patients
1222 patients
n=1921
n=2898
n=3877
n=1942
n=1000
n=942
N=744
N=757
N=1222
N=659
n=322
n=584
n=3829
n=1927
N=8734
n=744
n=499
n=964
n=659
n=380
n=279
total of 5819
total of 1942
total of 757
89 patients
45 patients
110 patients
18 patients
47 women
28 women
52 women
117 randomly assigned patients
105 patients
104 patients
76 patients
29 patients
78 patients
18 patients
117 patients
111 patients
41 patients
34 patients
110 patients
79 patients
12 patients
1 million people
N=111
n=4
n=106
n=105
n=104
n=76
n=29
n=75
n=19
total of 25
117 patients were enrolled
263 patients
16 A subgroup of   patients
196 patients
240 patients
254 patients
253 patients
97 patients
94 patients
91 patients
105 patients
103 remaining patients
103 patients
12 patients
93 patients
98 patients
51 patients
64 patients
72 patients
24 we compared the outcome of   patients
11 we selected patients
0  Unfav-BEP=patients
n=98
n=105
n=51
total of 240
263 patients were enrolled
263 patients   were enrolled
89 patients
91 patients
84 patients
15 patients
3322 published patients
48 eligible patients
48 patients
48 eligible   patients
45 assessable patients
47 surviving patients
40 surviving patients
11 patients
48 treated patients
15 patients
44 patients
30 patients
40 patients
39 patients
53 untreated patients
n=48
n=27
n=26
1 patients
1 specifi cally excluded those patients
110 patients
18 patients
335   Japanese lung cancer patients
142 patients
73 patients
48 patients
3  Low-risk patients
126 patients
1 patients
3 patients
2 patients
250 patients
108 MSKCC patients
110 Cambridge   patients
108 MSKCC   patients
39 patients
1000 patients
144 patients
n=210
n=271
n=336
335   Japanese lung cancer patients
142 patients
73 patients
260 women
77 women
73 women
1008 women
310 women
342 women
149 women
46 women
60 women
12 Eligible women
237 women
257 women
85 women
68 women
3864 women
500 women
1410 postmenopausal women
358 women
55 women
13 of these women
1410 women
866 women
65 women
20 women
23 women
109 women
44 women
51 women
14 women
711 women
n=257
n=237
n=85
n=68
n=73
n=77
n=60
n=46
n=147
n=142
n=70
n=58
n=69
n=67
n=43
n=31
100 000 people
28 women
105 patients
76 patients
1 million people
1 The number of women
5 Although most patients
1 only six patients
48 patients
1008 patients
1008 patients
212 patients
333 patients
2317 conservatively treated   patients
1 ratio of patients
49 patients
48 patients
256 patients
545 patients
960 patients
1000 patients
n=545
n=212
n=333
n=232
n=183
n=75
n=157
n=49
n=134
n=9
n=39
n=48
n=463
n=  4
n  =2
n=  12
n=  9
n=  3
n  =1
n=  20
n=  2
n=  5
n=  1
n  =5
n  =4
n=  10
n=  7
n=  29
n  =3
n=  13
n  =9
n=  8
n=  15
n  =6
n=960
n=44
n=37
n=68
n=230
1 The number of women
2 Studies of patients
10 000 patients
205 women
196 women
5 Although most patients
130 men had accepted patients
1008 patients
65 patients
11 patients
64 response-evaluable patients
25 patients
40 patients
22 patients
13 patients
64 patients
24 evaluable patients
14 patients
50 patients
20 patients
52 response-evaluable patients
100  Individual patients
n=15
n=50
n=65
n=53
n=25
n=42
n=49
n=52
n=64
n=9
n=21
n=29
65 patients were enrolled
15 were enrolled
50 were enrolled
13 140 people
371 participants
13 participants
144 participants
29 participants
872 participants
72 participants
52 participants
27 participants
101 participants
954 participants
17 participants
200 000 patients
n=185
n=186
n=0
468 participants
22   Eligible participants
120 participants
460 participants
99 participants
50 participants
12 and renders most patients
1215 patients
n=117
n=115
n=113
n=116
27 patients
1 most patients
9000 patients
6PD-defi cient patients
6749 participants
11 950 patients
101 patients
153 patients
13 498 to allow for other patients
17 412 patients
12 829 adult patients
12 099 patients
11 patients
29 patients
87 people
n=11 950
n=11 722
n=1107
n=1781
709 patients
1334 patients
960 patients
14 390 patients
8519 patients
8976 patients
8184 patients
500 patients
n=2043
n=2072
n=2348
n=2513
n=3215
n=1962
n=1688
n=3345
n=1926
n=1681
n=3710
n=2280
n=2029
n=4120
n=2351
n=2007
n=979
n=1020
n=983
n=906
2036 participants
821 participants
1015 participants
1019 participants
25 participants
849 participants
842 participants
1800 participants
2034 participants
1644 participants
417 LT-  vaccinated participants
59 participants
14 The proportion of participants
304 participants
n=821
n=823
n=140
n=125
n=809
n=814
n=788
n=804
n=5
n=268
n=272
n=259
n=264
n=279
n=286
n=321
n=50 227
n=799
n=1528
56 patients
n=14
n=4
total of 940
9000 patients
n=1966
n=346
n=508
400 patients
100 million people
n=16
n=4
n=2
n=1
n=12
n=5
n=9
n=14
n=6
n=3
 data from A76
1075 patients
77 people
100 000 people
4 million people
15 876 participants
15 368 participants
15878 participants
7675 participants
8442 participants
14 865 participants
7559 participants
7674 participants
45 974 participants
20 327 participants
10 200 participants
n=651
n=11
n=20 327
n=10 200
47 000 children were enrolled
47 366 children enrolled
82486 patients
n=425
n=25
n=7 200 092
n=2457
n=267 942
n=6 932 150
345 participants
136 participants
20 participants
100 participants
4x treated   participants
137 participants
135 of   these participants
135 participants
4x participants Placebo participants
43 placebo participants
39 placebo participants
32 placebo participants
25 placebo participants
18 placebo participants
4x group two participants
30 participants
4x participants
63 participants
4x and placebo participants
52  Number of participants
12  Articles  participants
174 patients
22 patients
1 infected patients
n=7
n=15
n=16
n=32
20 participants   enrolled
100 participants were enrolled
137 enrolled
21 000 participants
821   participants
17 participants
17 participants
13 000 adult patients
133 patients
3   Using the number of people
21 000 participants
133 patients
3   Using the number of people
21 000 participants
400 patients
100 000 people
total of 17
40 participants
1 infected participants
14 participants
51 participants
34 patients
38 patients
12 patients
61 patients
13 patients
1763 people
77 people
26 people
40 people
20 people
n=886
n=875
n=162
n=120
n=54
n=35
n=21
n=921
2 enrolled
15 individuals enrolled
n=114
n=26
13 000 adult patients
700   treatment-naive patients
708   treatment-naive patients
801 participants
1 uninfected   participants
695 participants
1 infected   participants
3000 participants
100 participants
458 of these participants
463 participants
22 Male   participants
1 vaccine trials should inform participants
n=0
627 not enrolled
3000 participants were enrolled
463 participants enrolled
204 patients
12 patients
n=40
n=149
n=186
n=185
n=116
n=173
total of 22
total of 13
2499 MSM and transgender women
12 uninfected participants
32 participants
1248 participants
28   most participants
1248 patients
n=1248
n=83
n=1165
31 The   iPrEx trial enrolled
700   treatment-naive patients
708   treatment-naive patients
6 patients
n=29
n=50
79 people
85 people
50 people
46 people
100 000 people
 dataset from 1963
 data from 2000
2 billion people
1 The   unmasking of Phambili participants
204 patients
108 patients
22 patients
77 patients
1371 participants
691 female participants
200 million people
n=158
n=144
n=5
n=20
n=159
total of 171
1371 residents enrolled
1371 participants were enrolled
1371 enrolled
 database of   3464
15 patients
11 patients
64 patients
total of   64
2 million people
649 patients
50 million people
n=2014
204 patients
2 103 patients
 data   from the 12
2 103 patients
108 patients
22 patients
2 A study of patients
133 patients
39 patients
40 patients
32 patients
49 patients
50 patients
179 patients
153 patients
75 patients
46 patients
38 patients
33 patients
34 patients
806 patients
15 two patients
16 eight patients
N=51
N=153
499 people
264 neonates   enrolled
284 new villagers enrolled
776 villagers enrolled
650 participants
24 participants
16 For participants
624 participants
257 participants
89 participants
113 participants
096  All treated participants
13 participants
70 participants
300 mg and   ten participants
259 participants
212 participants
212 patients
201 patients
211 patients
13  We recruited patients
59 patients
73 patients
63 patients
0  Data are number of patients
650 people
n=212
n=201
n=211
n=16
n=89
n=79
n=41
n=39
total of   545
212 patients enrolled
624 enrolled
624 participants enrolled
257 participants enrolled
624 participants   enrolled
8000 people
284 000 people
702 participants
15 patients
11 patients
64 patients
total of   64
69 patients
600 patients
12 patients
25 patients
32 patients
14 patients
100  All patients
17 To   identify patients
5  Number of patients
1 non responder patients
n=24
n=26
n=11
n=21
n=13
n=5
n=50
702 participants
15 patients
11 patients
64 patients
total of   64
1538 patients were women
13 588 patients
767 patients
331 patients
834 patients
3 million patients
900 patients
1675 patients
1538 patients
69 patients
834Â patients
841 patients
18 included patients
100 patients
51 patients
n=767
n=771
n=834
n=841
13 588 patients and enrolled
1675 enrolled
1 million people
22 participants
217 patients
198 patients
189 patients
543 patients
410 patients
175  Number of patients
71  Number of patients
416 patients
214 patients
22 patients
23   patients
007  Total number of patients
n=10
n=1
n=214
n=202
n=416
n=180
n=373
n=11
22  Methods  Study design and participants
666 patients
331 patients
327 patients
329 patients
17 patients
12 patients
293 patients
314 patients
305 patients
299 patients
200 patients
n=332
n=334
n=5
n=331
n=327
n=1
n=2
n=197
n=202
2 enrolled
155 patients
51 patients
51   patients
2 million people
702 participants
54 participants
31 Eligible participants
301 participants
50 participants
224 participants
n=61
n=60
5  We enrolled
1   RNA-suppressed participants
10 patients
476 patients
433 patients
290 of patients
434 patients
76 participants
40 participants
39 participants
426 treatment-naive patients
189 patients
187 336 patients
N=175
N=457
N=187 336
n=78
n=20
n=94
n=113
n=35
n=16
n=23
n=26
n=79
n=70
n=61
n=114
n=175
n=13
n=1
n=8
n=9
n=5
n=4
 databases from Jan 1
 data from 48
1538 African patients
331 patients
35 million people
24 patients
4 billion people
2 A study of patients
1   RNA-suppressed participants
67 women
48 were women
124 patients
39 patients
41 patients
38 patients
5 Antiparasitic   treatment of patients
167 consenting patients
167 patients
43 patients
63 patients
118 patients
18 patients
58 patients
18 714 patients
31 273 patients
6960 patients
7200 patients
11 762 patients
24 073 patients
203 patients
n=240
n=41
n=43
n=40
n=39
n=38
n=14
n=2
1000 people
433 participants
139 participants
290 participants
632 participants
420 participants
267 participants
1 RNA-suppressed participants
12 Virologically suppressed   patients
469 patients
707 virologically suppressed patients
273 virologically suppressed   patients
1 infected   patients
n=293
n=140
n=290
n=139
n=1
2C shows patients
298 other people
300 people
439 participants
290 participants
143 participants
291 participants
420 participants
571 participants
434 participants
96 participants
269 participants
9 Whether patients
3 studies of treatment-  naive patients
15 Most patients
1 infected   patients
n=291
n=143
n=290
n=57
n=16
n=23
n=2
n=15
332 patients
4 billion people
study population included 259 944
 data from 22
data from   18
100 000 people
100 000   people
14 410 participants
n=748
n=216
n=192
n=1999
n=319
n=275
n=517
n=175
n=127
 data from 1960
n=34
40 participants
39 participants
79 participants
67 participants
76 participants
40 vaccine participants
8 placebo participants
36 vaccine participants
7 placebo participants
3 vaccine participants
2 placebo participants
21 participants
18 participants
3 shows   the number of participants
11 participants
96 patients
112 patients
173 patients
n=24
n=25
n=23
n=19
n=5
n=21
n=3
n=4
n=18
n=79
n=17
n=126
n=237
n=100
85 patients
332 patients
269 patients
170 million people
170 million people
269 patients
240 patients
15 patients
60 000 people
240 patients
15 patients
85 patients
60 000 people
202 women
404 women
15 included women
14 These   women
268 unvaccinated women
1340 women
4  Articles  Of women
1058 women
518 fully   vaccinated women
518 women
25 year-  old women
1058 participants
n=202
n=1058
n=149
n=391
n=518
n=515
n=7
n=161
n=20
n=37
n=804
n=29
n= 391
404 women   enrolled
15 patients
60 000 people
76 participants
40 participants
39 participants
24 enrolled participants
22 participants
24 participants
20 participants
12 participants
38 people
n=12
24 enrolled
24 participants enrolled
 data   from 1
2 and   hetero sexual men and women
27 Transgender women
14   All participants
2499 participants
279 participants
68 participants
814 eligible iPrEx participants
30 participants
1603 participants
1573 asymptomatic seronegative participants
63   participants
92 participants
1573 eligible HIV-negative   participants
365 participants
309  Number of   participants
1603   seronegative patients
72  Number of  patients
48  Number of patients
1603 HIV-negative people
10   including among people
30 people
446 people
1603 people
41 people
60 people
n=305
n=851
n=33
n=1
n=2
total   of 72
279 originally enrolled
2009 and enrolled
1603 who   enrolled
706 patients
657 patients
123 patients
35 reported the proportion of patients
37 no TBM patients
17 no patients
5 patients
15 did not follow up   patients
3 patients
2 patients
63 patients
184 patients
74 treated patients
34 million people
2 billion people
100 000 people
21 694 patients
54 patients
197 studies enrolled patients
198 clinical trials enrolling patients
15 455 patients
1132 patients
1092 patients
377 patients
222 patients
583 patients
1595 patients
48  Origin of patients
14 studies included patients
28 than did patients
18 patients
24 patients
197 studies enrolled
2 million people
50 million   people
2000 people
3   In healthy people
147 people
100 000 people
1 million people
n=0
583 patients
185 patients
397 patients
139 patients
245 patients
582 patients
n=582
n=185
n=397
700 000   people
1511 patients
500 patients
700 000   people
n=1177
n=24
n=723
1511 patients
500 patients
n=1177
n=24
n=723
165 patients
153 patients
40 patients
157 patients
113 patients
117 people
165 people
131 people
10 000 people
n=165
N=99
N=18
27 MFI   All patients
27 MFI ratios than did control patients
n=63
n=113
n=18
n=8
n=12
n=3
n=1
n=23
n=50
n=290
11 000 patients
521 patients
165 patients
10 000 people
2 It reduces   both patients
5932 patients
157 patients
100 000 people
56 567 800 people
2 billion people
100 000 people
582 patients
521 patients
165 patients
160 women
14 We included all   patients
n=1075
n=474
 data from 1987
20 patients
6 The management of patients
19 patients
13 patients
22 patients
44 patients
18 patients
n=20
n=24
10 000 people
2 It reduces   both patients
5932 patients
157 patients
100 000 people
56 567 800 people
21 elderly   people
n=13
 data from 21
77 pregnant   and breastfeeding women
3  All participants
1 RNA PCR and   participants
15 Masked follow-up   of participants
n=1584
n=631
n=2215
n=1579
n=633
n=2212
n=0
4747 couples were enrolled
9 of pregnant women
44 patients
24 control patients
9 patients
44 patients
24 control patients
9 patients
538 patients
0001  Number of people
n=540
n=1434
n=370
n=1024
n=1069
n=230
n=76
n=64
n=42
n=38
n=28
n=45
n=15
2054 participants
166 participants
23 991 participants
33 861 patients
195 cells per Î¼L and most   patients
25 303 patients
714 patients
45 patients
9 million   people
400 million people
14 As the life expectancy of people
70 694 people
700 000 people
n=33 861
n=1114
n=6149
n=2958
n=23 640
n=33 695
n=35 855
n=978
6812 inpatients
1200 randomly selected   patients
9  In a cohort of inpatients
6812 patients
4119 patients
730 patients
59 patients
50 of those patients
84  Baseline is patients
n=13
n=730
n=282
n=90
n=98
n=272
n=105
n=115
n=91
n=82
n=65
n=88
n=485
n=157
352 people
34 million people
N=36
N=40
N=44
N=49
N=13
10â· pfu  Number of participants
n=9
n=10
n=5
n=7
n=6
n=1
n=2
27 volunteers   were enrolled
7  The number of people
232 million people
100 000 people
N=70125393
total of   14
352 people
400 participants
5 of adult inpatients
400 participants
5 of adult inpatients
40 000 inpatients
2  Data are number of patients
119 patients
34 patients
74 inpatients
148 undiagnosed patients
493 patients
237 patients
n=641
n=969
n=7297
n=4582
n=458
n=396
n=44
 data   from 2008
1700 patients
10 000 people
75 000 people
23 people
total of 170 996
total of 27 378
400 participants
13 540 people
300 000 people
100 000   people
8382 participants
230 patients
5 In patients
111 patients
1691 patients
142 patients
20 Information about all patients
374 patients
50 patients
703 patients
102 patients
419 patients
93 patients
5720 patients
57 patients
8382 patients
220 patients
n=17
n=40
n=220
n=8162
n=7776
 data from 8382
17 enrolled
1691 patients
93 patients
35 million people
100 control participants
250 patients
27 patients
24 patients
100 control participants
45 patients
23 patients
250 patients
35 patients
20 patients
2 Only patients
100 consecutive patients
74 patients
100 control patients
11 patients
459 patients
8 patients
4 patients
571 patients
49 patients
648 patients
14 patients
577 patients
38 patients
n=96
n=16
n=47
n=10
n=23
71 patients
20 participants
31 participants
71 participants
35 patients
31 patients
37 patients
34 patients
36 patients
33 patients
71 patients
n=37
n=34
n=35
n=31
n=71
34 patients were enrolled
140 patients
416 patients
416 control patients
12 patients
15 patients
13 In some   patients
1134   patients
1134 patients
41 seronegative patients
238 patients
35 patients
143 patients
19 patients
18 patients
20 patients
100 participants
49 participants
50 participants
38 participants
46 participants
30 participants
15 participants
79 participants
82 participants
90 participants
99 participants
40 participants
64 participants
176 participants
33 patients
67 patients
400 patients
n=15
n=50
n=43
n=60
n=174
n=760
n=9
n=33
30 participants
617 patients
100 patients
80 participants
44 participants
25 participants
30 participants
34 participants
73 participants
38 patients
600 patients
100 patients
240 patients
20 patients
27 patients
275 patients
63   patients
13 patients
15 patients
2 million people
n=38
n=35
103 participants
560 participants
300 subjects
121 patients
13 A small number of patients
30 patients
80 patients
20 patients
663 patients
97 Italian and French   patients
97 patients
74 patients
39 patients
11 patients
54 patients
28 patients
51 patients
n=2
n=1
n=4
n=62
n=59
n=10
1169 patients
370 patients
385 patients
409 patients
371 patients
2 patients
14 female patients
404 patients
367 patients
382 patients
14 mg group and no   patients
0001  Proportion of patients
n=389
n=408
n=372
n=388
n=407
n=370
n=385
n=409
n=371
n=384
3 study enrolled
total of 114
4 621 patients
n=522
n=259
300 subjects
6 was the inclusion of patients
663 screened patients
38 patients
903 participants
616 patients
32 patients
30 patients
18 patients
600 patients
617 patients
204 patients
206 patients
25 patients
3 studies excluded such patients
24 patients
34 patients
n=204
n=206
N=616
n=3
n=1
n=2
n=193
n=190
n=154
n=155
n=292
n=176
n=243
n=238
n=175
n=171
617 patients were enrolled
140 patients
416 patients
20 patients
7  Methods  Study design and participants
2839 participants
1381 participants
20 which included patients
2839 adult patients
400 consecutive patients
2839 patients
959 patients
36 of patients
1000 patients
117 patients
1 million   people
n=2645
n=2347
2 enrolled
1000 patients enrolled
420 patients
35 patients
23 patients
n=458
n=37
n=55
n=22
30 participants
100 patients
285 patients
100 eligible patients
140 patients
416 patients
13 women
14 women
55 eligible participants
1 shows the fl ow diagram of participants
19 participants
11 participants
15 participants
13  Procedures  All subjects
600 patients
n=17
n=3
n=4
n=13
n=10
n=8
n=11
n=19
n=21
n=6
n=2
40 enrolled
255 patients
9 In patients
73 patients
324 patients
52 patients
254 patients
184 patients
n=165
n=63
n=64
n=65
n=25
n=34
n=35
n=33
653 consecutive eligible patients
33  All patients
14 patients
653 patients
523 patients
113 patients
229 patients
113Â patients
65 patients
111 patients
248 patients
N=523
N=113
n=734
800 patients
567 patients
11 patients
621 patients
18 patients
6 Numbers of patients
517 patients
115 patients
114 patients
12 patients
n=3
n=86
n=87
n=84
n=88
n=79
n=65
n=64
n=68
n=129
n=163
n=132
11 Both trials have included patients
6 In patients
total of 114
21 participants
19 participants
263 patients
1083 patients
0 patients
358 patients
355 patients
113 switched   patients
1555 patients
1080 randomised patients
360 patients
24  Number of patients
0002  Percentage of patients
227  Percentage of patients
0001  Percentage of patients
24â€   Number of patients
6  Number of patients
12  Number of patients
370 patients
25 mg group and no patients
27 patients
369 patients
354 patients
350 patients
7 A high proportion of patients
N=370
N=358
N=355
n=366
n=353
n=350
n=360
n=351
n=346
n=330
n=315
n=326
3 patients
n=63
n=64
n=65
298 patients
4 Some patients
7 and patients
30  Two patients
522 patients
521 patients
27 patients
69 patients
517 patients
500 patients
250 patients
100 suvorexant-treated patients
1076 patients
484 patients
397 patients
196 patients
N=521
N=258
n=26
n=12
n=464
n=228
N=517
N=254
N=492
N=245
N=298
N=147
421 patients
2 but many patients
50 patients
420 patients
1129 patients
211 patients
411 patients
15 patients
11 patients
200 patients
24 patients
n=211
n=200
n=51
n=58
n=111
n=95
n=100
n=105
n=411
n=421
n=398
n=152
n=259
n=205
n=206
n=136
n=138
n=135
191 patients
124 patients
43 patients
192 patients
1658 patients
622 patients
374 patients
244 patients
3 patients
67 patients
10 patients
4 patients
121 patients
57 patients
122 patients
63 patients
61 patients
2 patients
191 eligible patients
n=124
n=67
n=4
n=10
n=83
4 621 patients
total of 24
3526 patients
2154 patients
1372 patients
515 patients
2621   patients
3500 patients
240 patients
656 patients
182 patients
426 patients
35 patients
12 patients
58 patients
434 patients
222 patients
83 patients
118 patients
623 patients
n=54
n=83
n=182
n=58
656 patients enrolled
191 patients
500 participants
18 participants
1512 participants
1936 patients
0114  Proportion of patients
1512 patients
500 patients
1000 patients
n=500
n=512
n=2
n=4
1936 patients and enrolled
1516 enrolled
3526 patients
5 increasing the number   of patients
191 patients
182 patients
73 patients
345 patients
 data from 182
803 patients
271 patients
600 000 patients
7000 patients
3500 patients
3640 patients
800 randomised   patients
391 patients
412 patients
289 patients
803   patients
44 patients
18 patients
64 patients
62 patients
16 patients
28 patients
340 patients
32 patients
2143 patients
n=391
n=412
n=70
n=74
n=496
182 patients
73 patients
345 patients
2 patients
35 patients
n=78
n=26
n=34
n=30
 data from 182
313 participants
10 All   participants
17 participants
23 participants
21 participants
8 and   therefore patients
360 patients
n=157
n=156
n=151
n=153
n=304
n=21
n=12
n=118
n=123
n=241
n=106
n=111
n=217
n=108
n=219
n=10
n=22
n=11
n=23
n=13
n=6
n=19
n=7
n=5
n=20
n=37
n=312
21 participants enrolled
8382 patients
60 000 patients
1691 patients
6513 patients
90,056 participants
100 patients
200 patients
100 000 people
 data from   90,056
5 In patients
3 In other patients
2 lesions and proportion of patients
8 of healthy people
90,056 participants
7 Trial participants
200 patients
313 patients
3526 patients
5 increasing the number   of patients
100 000 people
 data from   90,056
10 women
6 women
92 women
9  Methods  Study design and participants
n=10
n=6
n=607
n=8
n=58
n=252
n=255
n=355
n=69
N=49
N=9
total of 25
 data from 64
98 patients
104 patients
48 patients
28 patients
217 of patients   were women
218 patients
482 patients
13 patients
190 patients
160 patients
107 patients
110 patients
217 of patients
217 patients
98 patients
20 patients
n=108
n=110
n=107
 data from 23
119 men enrolled
12 women
57 clinic-based   patients
25 patients
50 of the clinic-based patients
15 patients
12 patients
57 patients
176 patients
53 patients
22 patients
286 multiple sclerosis patients
50 clinic-based patients
286 patients
11 patients
397 patients
50 patients
5000 patients
77 patients
177 patients
32 That patients
n=90
n=9
n=50
n=8
n=99
n=77
n=32
n=53
n=176
n=57
n=286
n=208
21  All patients
16 patients
21 patients
62 patients
32 patients
30 patients
404 patients
85 patients
51 patients
10 patients
390   per million people
n=32
n=30
n=62
total of 51
62 patients enrolled
1 Although patients
420 randomised patients
84 patients
601 patients
80 patients
70 patients
420 patients
73 patients
0 patients vs fi ve patients
0 patients
n=84
n=85
n=82
n=420
n=336
397 patients
329 patients
19 patients
268 patients
268 people
65 patients
2 patients
420 patients
65 patients
397 patients
329 patients
19 patients
186 patients
656 patients
40 789 participants
3445 patients
1018 patients
1493 patients
10 064 people
n=8696
n=2606
n=5310
n=26 157
total of 34 853
 data from 12
 data taken from the 1000
100 000   people
183 cases per million people
total   of 6
66 patients
21 patients
23 patients
22 patients
514 patients
278 patients
500 patients
150 000 people
total   of 514
780 participants
846 screened participants
618 patients
214 patients
216 patients
846 patients
260 patients
199 patients
614 patients
197 patients
14 mg group and two patients
23 Few patients
n=216
n=205
n=197
n=214
n=203
n=249
n=207
n=191
total of 454
618 patients were enrolled
985 eligible participants
133 participants
n=985
n=503
n=213
n=130
n=139
53 patients
14 patients
15 patients
16 patients
12 patients
0  Data are number of patients
8  Whereas patients
35 patients
18 patients
n=18
n=17
n=15
n=16
n=186
79 patients
88 patients
30 of   these patients
303 patients
79 patients
88 patients
30 of   these patients
303 patients
278 patients
132 patients
25 patients
16 patients
135 patients
145 patients
133 patients
13 patients
27 patients
15 The excess withdrawal of patients
0  Data are number of patients
742457 versus patients
n=133
n=145
n=38
7 068 334 patients
2 372 223 patients
7 068 334 patients
2 372 223 patients
205 patients
216 patients
197 patients
10 About half of patients
1 Although patients
79 patients
88 patients
30 of   these patients
303 patients
174 patients
81 patients
1 Few patients
160 randomly assigned patients
360   patients
163 patients
143 patients
81   patients
n=81
n=82
n=80
n=76
n=78
n=73
17 All participants
34 million   people
66 participants
448 new participants
340 participants
41 participants
0 participants
600 participants
500 participants
22 participants
513 participants
184 participants
102 participants
15 participants
296 participants
3 participants
200 participants
732 patients
173 patients
337 patients
333 patients
732 people
n=53
n=45
n=340
n=173
3 enrolled
3 participants
3020   participants
104 participants
2916 participants
1586 participants
1304 participants
9954 participants
3020 participants
180 patients
721 patients
692 patients
713 patients
700 patients
2668 patients
376 patients
275 patients
20 332 patients
n=2472
n=1968
n=1521
n=1135
n=803
n=1468
n=1448
n=1452
n=1464
n=0
n=752
n=1689
n=475
n=1632
n=120
n=109
n=693
n=362
n=1457
n=1459
n=1586
n=1303
n=2611
n=300
n=1710
n=1126
n=1437
n=804
n=625
n=6105
3 participants were enrolled
656 patients
218 patients
163 patients
7 885 patients
100 000   people
n=81
n=82
656 patients
278 patients
500 patients
930 patients
684 patients
342 patients
218 patients
163 patients
n=81
n=82
14  Control participants
206 control participants
1078 gene-  expanded participants
260 control participants
225 participants
n=853
n=225
n=1078
293 people
total of   293
2876 patients
110 000 patients
2800 patients
2 shows the outcomes of patients
1438 patients
2799 patients
151 patients
26 patients
n=1438
n=2799
1 participants
1 participants
44 million people
886 patients
14 In patients
1 week run-in period patients
150 patients
35 patients
148 144 149 142  Number of patients
148 144 149 141  Number of patients
130 135 136 127  Number of patients
n=19
n=20
n=11
n=13
n=153
n=149
n=151
n=46
n=17
602 were enrolled
873 123 recorded COPD deaths   in women
298 participants
328 million people
N=5993
30 patients
5 All patients
n=30
n=217
259 participants
129 participants
23 and all trial   participants
288 participants
216 participants
137 participants
139 participants
61 participants
276 participants
192 participants
276 patients
137 patients
339 patients
297 eligible patients
259 patients
13  In patients
n=137
n=139
n=6
n=2
n=3
n=5
n=1
n=4
n=99
n=93
n=84
n=85
n=133
n=136
n=120
n=125
n=117
n=122
n=22
n=39
16Gly   participants
9000 participants
7376 patients
5125 patients
2 genotypes among patients
16Gly patients
16Arg patients
2357 patients
2768 patients
2866 patients
3444 patients
n=960
n=946
n=1170
n=1200
n=434
n=415
n=528
n=514
n=1173
n=1218
n=863
n=829
150 patients
59 patients
37 patients
1  patients
200 000 critically ill patients
150 eligible patients
41 patients
18 patients
36 treated patients
22 patients
37 treated patients
23 patients
14 patients
19 control patients
59 control   patients
51 control patients
1201 treated patients
n=4
n=37
n=26
n=23
n=22
37 were enrolled
5125 COPD patients
5125 COPD patients
251 patients
503 patients
660 consecutive outpatients
59 patients
201 patients
89 patients
19 In   unselected patients
n=252
n=45
n=157
n=57
n=251
n=89
n=503
n=2
total of 503
n=16 147
n=6270
n=11 080
n=7895
N=4579
N=8366
N=1587
N=3423
22 patients
26 patients
59 patients
98  Comment  treated patients
30 patients
100 participants
1297 patients
482 patients
495 patients
286 patients
1250 patients
1006 patients
33 patients
36 patients
221 patients
218 patients
44 patients
523 patients
120 Chinese patients
13 286 patients
120 patients
n=504
n=502
n=495
355 participants
1022 participants
73 Puerto Rican participants
772 control participants
176 participants
8018 participants
62 748 participants
46 800 participants
46 800 patients
73 Puerto Rican patients
1165 patients
659 non-Hispanic white patients
34 patients
553 patients
176 white patients
1626 patients
659 non-  Hispanic white patients
952 non-Hispanic white patients
191 non-Hispanic white patients
213 African American patients
316 African American patients
1209 patients
587 LABA-treated patients
418 non-LABA-treated patients
164Ile   Non-Hispanic white patients
81 patients
155 patients
46 African American patients
164Ile patients
13 non-Hispanic white patients
13 non-Hispanic white   patients
251 patients
37 In African   American patients
150 non-Hispanic white people
1300 people
n=73
n=707
n=260
n=176
n=1143
n=315
n=95
n=410
n=236
n=1626
n=75
n=1134
n=18
n=553
n=6
n=181
n=179
n=119
n=5
n=13
n=384
n=218
n=10
n=446
n=430
n=1300
5 The vast majority of patients
total of 1
1000 patients
482 patients
10 The large number of   patients
30 patients
5 The vast majority of patients
1 uninfected people
200 patients
565 patients
500 patients
675 patients
46 patients
14 patients
110 non-COPD patients
n=565
n=147
n=84
n=164
n=64
n=51
2859 ICGN participants
1000 non-Hispanic   white participants
3500 participants
1000 non-Hispanic white participants
15 patients
56 and   people
n=2812
n=2534
n=821
n=1749
n=1764
n=178
n=373
n=435
n=863
n=808
n=999
n=383
n=1390
n=352
 data from 2859
38 859 patients
842 patients
6897 patients
25 All patients
1 122 787 patients
22 821 patients
2 million   people
18 Identifi cation of people
46 Because   people
n=38 859
n=22 821
n=22 286
n=9351
n=1167
total of   1 122 787
 data from Jan 1
1087 participants
1087 consecutive participants
120 participants
1087 consecutively screened patients
111 patients
84 patients
120 patients
1087 patients
494 patients
315 patients
9 patients
11 patients
98 patients
976 patients
135 patients
21 patients
102 patients
n=111
n=84
n=120
n=388
n=102
n=171
60 participants
1908 participants
11 Almost all the participants
120 patients
60 patients
19 patients
104 patients
89 patients
25 patients
113 patients
64 patients
n=60
n=56
n=57
n=88
n=23
n=26
n=58
n=73
n=120
2 Although patients
33 participants
92 patients
2 patients
433 patients
47 patients
45 patients
26   Inclusion of patients
36 patients
n=47
n=45
N=84
N=129
n=41
n=36
n=3
n=2
n=0
n=4
n=12
384 patients
3 the role of these patients
390 patients
12 patients
269 patients
247 patients
380 patients
380 evaluable patients
261 evaluable patients
46 patients
13 UK-born patients
254 patients
125 patients
255 patients
62 patients
25 By genomically linking patients
n=43 000
n=62 000
n=47 000
38 859 patients
500 patients
4 although patients
3  Many patients
315 patients
84 patients
102 patients
 data of   38 859
135 participants
3  Many patients
315 patients
84 patients
102 patients
100 000 people
   data from 2005
327 participants
1742 participants
567 participants
1730 participants
8172 registered patients
1371 registered patients
379 PCR-confirmable registered patients
24 medically attended patients
96 patients
93 people
459 people
n=102
n=35
n=10
n=385
n=189
n=147
n=195
n=70
120   patients
8 If excluded   patients
28  Pregnant women
07  Pregnant women
59  Pregnant women
36  Pregnant women
29 234 patients
78 studies of patients
168 117 potentially eligible patients
24 416 patients
143 701 patients
106 138 outpatients
34 970 inpatients
5736 patients
168 117 patients
106 138 were outpatients
0215  Critical care patients
0026  Critical care patients
0118  Critical care patients
51  Critical care patients
4233 patients
n=29 226
n=29 034
n=22 527
n=19 066
n=29 234
n=28 672
n=20 518
n=17 081
n=17 853
n=18 419
n=19 860
n=12 264
n=9803
n=13 598
n=24 764
n=25 268
n=4382
n=23 769
n=13 254
n=12 284
n=20 362
n=9982
n=22 366
n=16 551
n=24 435
n=25 001
n=19 816
n=9218
n=2166
n=5103
n=1725
n=12 992
n=9270
n=3899
n=917
n=3385
n=683
n=16 425
n=13 200
n=10 607
n=5696
n=1303
n=1608
n=572
n=17 670
n=14 409
n=12 269
n=5282
n=1302
n=2977
n=644
 data from the 2009
5 million patients
19 million patients
10 069 critically ill patients
734  patients
7 million people
82 patients
30 patients
750 patients
24 patients
29 patients
26 patients
0  Two patients
26   studied patients
501 patients
n=1
n=30
n=24
n=29
800 subjects
821 patients
448 patients
382 patients
406 patients
347 patients
255 patients
428 patients
2 For these patients
21 We   regarded patients
21 We regarded patients
285 patients
826 patients
569 surviving   patients
59 patients
5210 patients
84 patients
137 patients
115 patients
217 patients
117 patients
25 patients
149 patients
116 patients
19 patients
467 patients
404 patients
346 patients
251 patients
231 patients
34 patients
10 we relied on patients
n=821
n=467
n=448
n=382
n=110
n=156
n=142
n=112
n=164
n=152
n=161
n=149
n=100
n=148
n=126
n=147
n=125
n=113
n=141
n=93
821 patients enrolled
46 previously enrolled
826 enrolled
2 Although patients
n=30
2 Although patients
n=325
n=316
n=1219
n=24
total of   316
325 cases enrolled
10 069 patients
5445 patients
2973 patients
6356  Number of patients
546 patients
24 patients
10 000 patients
n=10 069
n=1209
n=2504
n=6356
n=730
n=62
n=237
n=431
data missing from 70
1141 participants
1191 participants
212 patients
217 patients
94 assessable patients
146 assessable patients
208 patients
1141 patients
20 patients
1191 patients
n=208
n=209
n=214
n=212
n=215
n=222
n=217
n=206
n=211
n=221
n=216
n=203
n=205
n=219
n=202
n=210
n=213
n=207
n=201
n=204
1141 participants enrolled
1191 participants enrolled
1141 patients enrolled
1191 patients   were enrolled
71 available patients
55 patients
16 patients
35 patients
3 shows the distribution of patients
18 patients
22 patients
20 patients
n=55
total of 200
n=30
448 participants
382 participants
821 critically ill patients
6 In patients
5 million patients
19 million patients
10 069 critically ill patients
50 patients
734  patients
4 and patients
433 patients
55 patients
1 These patients
800 participants
n=800
n=236
n=564
46 participants
1022 patients
18 Some   patients
194 patients
41 additional patients
861 patients
41 patients
549 patients
202 patients
74 patients
71 patients
2299 patients
717 patients
n=429
n=473
n=549
n=318
n=155
n=404
n=145
n=202
n=71
n=74
194 patients were   enrolled
18 Patients were enrolled
861 patients enrolled
41 patients enrolled
549 patients enrolled
50 patients
1 These patients
3 study enrolled patients
238 patients
118 patients
120 patients
77 patients
3 trial recruited patients
232 patients
118   patients
114 patients
111 patients
100 patients
103 patients
116 patients
0  Data are number of patients
n=120
n=118
n=116
n=72
n=74
n=44
n=42
3 study enrolled
100 000 people for   women
23 315 patients
15 259 patients
12 066 patients
3195 patients
100 000 people
3 716 485 people
2 The exclusion of   younger people
n=12 066
n=5197
n=3195
 data from 1997
 data   from 1
 data from 2001
508del homozygous   patients
508del homozygous patients
232 patients
34 970   patients
2000 patients
4 patients
1022 patients
N=1022
100 000 people
370 patients
149 patients
221 patients
139 patients
54 patients
38 patients
149 Dallas patients
22 the worse survival of   patients
24   The telomere lengths of patients
n=139
n=54
n=221
n=149
n=148
n=147
n=137
n=211
n=122
n=187
n=136
n=123
n=49
n=195
n=46
n=106
n=126
n=17
n=30
n=10
n=22
n=16
n=135
n=143
n=124
n=50
n=307
n=317
370 patients were enrolled
34 970   patients
2000 patients
4 patients
 datasets from   37
 datasets from   37
64 participants
97 participants
1 Mean age of all participants
508del   CFTR homozygous patients
508del CFTR homozygous patients
508del CFTR heterozygous   patients
508del CFTR   homozygous patients
508del CFTR heterozygous patients
20 patients
2 assessed patients
28 pooled placebo patients
62 patients
64 patients
111 patients
15 patients
109 patients
27 patients
21 patients
97 patients
508del CFTR patients
508del CFTR hetero-  zygous patients
508del CFTR hetero zygous patients
n=20
n=21
n=23
n=17
n=6
n=11
n=4
n=27
n=18
320 patients
158 patients
139 patients
788 patients
151 patients
160 patients
352 patients
n=160
n=158
n=157
n=150
n=144
total of 320
508del homozygous   patients
508del homozygous patients
27 541 patients
 datasets from   37
 data from 27 541
45 974 participants
15 878 participants
15 368 participants
8442 participants
7675 participants
15 876 participants
14 865 participants
7559 participants
7674 participants
N=651
N=264
N=55
N=32
N=87
N=46
N=44
47 366 children were enrolled
47 366 children enrolled
n=16
n=174
n=67
168 participants
336 patients
165 patients
653 patients
121 patients
326 patients
220 patients
32  Tracheostomy  Number of patients
271 patients
247 patients
163 patients
125 patients
132 patients
38 patients
31 patients
29 involving patients
32 and many patients
499 brain-injured patients
n=165
n=163
n=125
n=132
n=38
n=31
N=38
N=31
n=138
n=190
n=0
14 not enrolled
33 enrolled
336 enrolled
336 were enrolled
1066 patients
100 000 people
545 394 women
4 In susceptible people
n=7733
n=13 619
n=43 722
195 patients
102 patients
93 patients
3  In patients
15  Methods  Study design and patients
150 patients
352 patients
12 patients
11 patients
85 patients
70 patients
48 patients
111 patients
52 patients
80 patients
13 included patients
13 patients
252 patients
n=102
n=93
n=144
1050 randomised women
1050 participants
1036 participants
13 Within those participants
26 participants
990 participants
n=521
n=529
n=448
n=452
n= 445
n=446
n=606
n=294
n=150
n=602
n=289
n=119
n=12
n=14
n=18
n=118
n=1010
n=2
n=1
n=4
n=6
1 Index-case patients
226 people
179 people
201 patients
3 participants
3 In patients
3 patients
3   patients
348 patients
404 patients
266 patients
218 treated patients
274 patients
242 treated patients
134 patients
132 patients
136 patients
138 patients
2 patients
131 patients
4 points placebo-treated patients
97  All patients
135 patients
137 patients
134 AZLI-  treated patients
132 placebo-treated   patients
27 patients
137 placebo-treated patients
29 patients
5 of stable patients
1 enables selection of patients
n=134
n=132
n=266
n=136
n=138
n=274
n=102
n=90
n=97
n=99
n=94
n=70
n=78
n=76
n=91
n=104
n=101
n=100
n=85
n=95
n=80
n=135
n=137
n=118
n=126
n=129
n=130
6 patients
n=262
n=183
n=368
n=342
n=385
n=331
n=294
n=773
n=1279
n=1274
n=1615
6 patients
278 patients
140 patients
138 patients
116 patients
122 patients
5 270 patients
1614 patients
1073 ineligible patients
48 patients
117 patients
102 patients
12 patients
13 patients
1073 patients
n=113
n=118
N=138
N=140
total of 24
6 million people
2 million people
3 billion people
266 patients
274 patients
5 not benefi t patients
3 In patients
3 patients
266 patients
274 patients
5 not benefi t patients
3 billion people
3 estimated the number   of people
600 000 people
2   and more people
 data from 13
3 billion people
9986 patients were women
4661 women
10 364 patients
9986 patients
4439 patients
1238 patients
2493 patients
n=9986
n=453
n=9533
n=198
n=4241
n=255
n=5292
10 364 patients enrolled
n=669
n=677
n=0
n=26
n=652
n=656
90 participants
95 participants
101 patients
82 patients
50 patients
14 vs nine patients
421 patients
80 patients
15 patients
19 patients
14 patients
12 In people
n=50
n=51
n=40
n=42
n=21
n=20
n=34
n=7
n=37
n=17
n=25
n=12
192 patients
100 patients
4613 participants
2142 participants
2471 participants
1054 participants
1238 participants
7785 participants
28 and a third   of participants
938 participants
818 participants
1216 participants
1088 participants
1233 participants
1069 participants
1223 participants
319 participants
359 participants
204 participants
12 423 participants
4922   participants
4370   participants
n=2321
n=2292
N=2142
N=2471
N=4613
n=1088
n=1054
n=1233
n=1238
n=1
n=3
n=2
n=4
n=237
n=1687
n=260
n=68
n=54
n=378
2   and more people
 data from 13
201 patients
93 patients
102 patients
201 patients
385 participants
280 eosinophilic participants
242 non-  eosinophilic participants
324 participants
290 participants
1 shows participants
12 participants
324 patients
282 patients
609 patients
964 patients
355 patients
1  Number of patients
6 scoreâ€¡  Number of patients
1â€¡  Number of patients
6 scoreâ€¡Â§  Number of patients
147  AQLQ scoreâ€¡Â§  Number of patients
281 patients
n=80
n=81
n=82
n=142
n=143
n=70
n=97
n=83
n=140
n=65
n=139
n=16
n=11
n=124
n=221
n=223
n=385
216 patients
105 patients
117 participants
86 randomly assigned patients
1 Adult patients
24 patients
n=44
n=42
4613 participants
2292 participants
1054   participants
1238 participants
93 patients
102 patients
78 participants
83 participants
26 participants
17 participants
4 participants
192 patients
551Asp-CFTR patients
N=67
N=77
N=22
N=26
n=18
n=17
N=89
N=103
total of 144
48 children enrolled
192 patients enrolled
4613 participants
2292 participants
1054   participants
1238 participants
216 patients
105 patients
n=138
n=140
324 patients
101 patients
105 consenting patients
20 patients
34 patients
110 patients
216 eligible patients
13 patients
105 patients
42 patients
42 control patients
30 patients
75 million people
65 million people
n=105
n=53
n=52
n=42
n=40
n=21
n=84
30 patients enrolled
10 In patients
3365 patients
28 and the number of patients
4 non-surgical patients
n=3
n=2
n=6
n=1
n=3365
n=3150
n=123
n=0
 data from 12
86 patients
86 patients
n=138
n=140
1007  In patients
3365 patients
1600 patients
200 000 people
37 000 people
788 patients
784 patients
6 All patients
1099 patients
295 patients
590 patients
738 patients
369 patients
2 diabetic patients
2 diabetic   patients
78,945 patients
n=361
n=350
n=360
n=335
n=317
n=130
n=122
n=108
n=124
n=125
n=116
n=100
n=89
n=103
n=93
n=148
n=139
n=134
n=123
n=212
n=196
n=216
n=194
n=371
n=366
total of 590
total of   738
2300 patients
690 patients
436 patients
438 patients
129 patients
252 patients
226 patients
n=690
n=276
n=113
401 patients
7 For   patients
203 patients
1008 patients
201 patients
371 million people
n=201
n=200
n=401
n=397
27 779 participants
455 569 participants
366 million people
n=18 497
788 Chinese   patients
690 patients
788 Chinese   patients
n=389
7 and people
2   Illness perceptions of patients
5 In patients
2057 family members of people
703 participants
1 diabetic subjects
1 diabetes   mellitus patients
1 diabetic patients
282 429 patients
2 diabetes patients
n=1003
n=4012
 dataset of 282 429
51 participants
322 patients
55 patients
54 patients
52 patients
51 patients
4 In patients
384 patients
200 mg  Number of patients
306 patients
2DM patients
472 could provide clinicians and patients
38  Number of patients
3  Number of patients
0  Data are number of patients
n=55
n=54
n=52
n=51
total of   306
384 patients enrolled
16  All participants
180 participants
115 participants
3000 potential participants
12 participants
101 participants
64 participants
60 participants
11 participants
18 participants
13 110 participants
173 participants
170 000 participants
356 patients
64 patients
60 patients
390 patients
1 shows number of patients
11 385 patients
12 000 people
n=86
n=87
n=60
n=161
n=19
n=10
n=6
n=140
n=5
n=8
173 were enrolled
 data   from 170 000
7 For lactating women
64 study participants
n=26
n=10
n=8
12 participants
16 During the procedure   participants
12 South Asian participants
12 Caucasian   participants
23 assessable participants
2 diabetic patients
n=12
12 000 patients
20 000 participants
14  Androgensâ€”women
11 women
26 participants
40 evaluable participants
2 participants
21 participants
2   diabetic subjects
41 patients
35 patients
12 patients
229 patients
74 patients
0916Â inÂ overweight and obese patients
n=35
n=34
N=40
N=39
N=35
173 patients
40 patients
118 patients
500 patients
950 patients
10 of   patients
12 000 patients
n=29
50 000 patients
total of 1003
 data from 65 870
382 million people
114 million people
2 diabetic patients
1 In patients
5653 participants
502 were non-white participants
10 308 participants
5653 people
5183 people
n=8637
n=5183
n=7870
n=6967
n=5653
n=6761
n=502
n=4703
n=648
n=115
n=187
n =0
n=0
15 000 participants
14 348 participants
10 946 participants
9445 participants
12 081 participants
5  Among people
10 000 people
N=12 081
N=10 946
N=12 306
5037 of these participants
31 040 participants
25 580 participants
80 404 participants
5460 participants
9765 participants
6254 participants
84 526 participants
n=12 489
n=13 091
n=5460
690 patients
136 patients
N=690
N=136
85 participants
86 participants
171 participants
84 participants
83 participants
171 entered the trial as participants
140 south Asian participants
2 diabetes of people
1319 people
150 people
2089 people
2 included people
N=84
N=83
N=81
N=82
83 patients
156 patients
1317 patients
74 patients
2 CKD  Number of patients
3 CKD  Number of patients
4 CKD  Number of patients
85 patients
167 patients
30 patients
682 patients
375 patients
51 of the treated patients
18 patients
23 patients
15 patients
2 diabetic patients
2642 patients
3 million people
n=290
n=374
n=95
n=98
n=97
n=89
n=94
n=91
n=63
n=74
n=187
n=178
n=175
n=132
n=133
n=37
total of 682
540 participants
171 participants
6   although participants
171 participants were enrolled
198 outpatients
114 patients
198 non-surgical patients
23 patients
2 shows the characteristics of patients
103 patients
61 patients
224 patients
81 patients
27 patients
125 patients
118 patients
3 million people
n=129
n=59
n=10
n=114
n=61
n=23
n=14
n=1
50 000 participants
130 000 participants
200 000 participants
350 000 participants
48 647 patients
46 431 patients
48 167 patients
76 497 patients
27 834 patients
3853 patients
46 237 patients
N=48 687
N=46 431
N=48 167
N=76 497
N=27 834
N=50 090
N=81 173
 data from 44
2 diabetic patients
841 adult participants
402 participants
25 participants
422 patients
404 patients
400 patients
728 patients
320 patients
9  For patients
18 patients
58 patients
346 patients
2 patients
402 patients
419 patients
11 patients
408 patients
68 patients
340 patients
5 patients
403 patients
841 patients
12 patients
n=643
n=33
n=67
n=25
n=35
n=10
n=16
n=12
n=404
n=408
n=402
n=403
2 diabetes were enrolled
7 For these   patients
9 Some patients
444 patients
70,528 patients
400 million patients
534   patients
2 diabetes patients
1 diabetes patients
1  In healthy people
2 studies of patients
236 patients
69 patients
17 All patients
43 patients
26 patients
564 patients
21 patients
17 patients
22 patients
23 patients
47 eprotirome-treated patients
22 placebo-  treated patients
156 patients
109 patients
175 patients
7000 people
100 000 people
n=1
N=23
N=24
N=22
n=2
n=4
4776 patients
60 patients
1022 women
25 participants
2 000 000 people
60 patients
1044 patients
1 But such   patients
24 patients
169 patients
236 patients
69 patients
2 diabetes should allow most patients
456 patients
n=80
n=79
n=77
n=2
1524 outpatients
1 In patients
n=35
n=39
223 participants
456 patients
233 patients
36 patients
4 patients
4 Eligible patients
205 patients
287 patients
659 patients
223 patients
24 antibody-positive patients
2 diabetic   patients
2 diabetic patients
n=233
n=223
n=140
n=147
n=228
n=220
n=216
n=209
n=230
n=222
n=116
n=117
n=96
n=127
n=1
n=4
n=163
n=70
n=156
n=67
n=213
n=202
n=188
n=164
n=139
n=161
n=49
n=15
89 eligible patients
45 patients
89 patients
255 unselected   outpatients
43 patients
39 patients
45   patients
2 diabetic patients
2   diabetic patients
n=45
n=160
48 enrolled
444 patients
3 For these patients
400 patients
50 new patients
1 diabetes patients
1   diabetic patients
7 All participants
2 diabetic subjects
2 diabetes should allow most patients
456 patients
233 patients
223 patients
12 patients
22 patients
116 patients
47 patients
27 patients
2 diabetic patients
1 participants
7 million participants
1 million participants
4 million participants
0 million participants
1273 participants
11 of hospital treat ment of patients
300 older women
300 older women
22 critically ill patients
22 critically ill patients
18 705   participants
10 000 patients
4134 patients
3499 patients
6992 patients
2085 patients
1465 patients
1942 because   some patients
4450 patients
5600 patients
n=1465
n=620
 data from 2085
113 800 participants
40 162 participants
370 patients
280 patients
1044 patients
113 800 participants
40 162 participants
370 patients
280 patients
3   Studies of people
576 participants
174 participants
148 participants
155 participants
136 participants
577 study participants
20 participants
542 participants
563 participants
78 participants
35 participants
577 patients
577 people
439 people
138 people
10,532 people
n=430
n=138
n=59
n=200
n=79
n=230
total of   439
577 patients enrolled
3392 ORIGIN participants
2000 participants
3714 participants
12 537 people
11 685 people
12 484 people
2833 people
n=0
n=11 685
n=5811
n=5874
n=5855
n=5830
n=3392
n=1683
n=1709
n=1699
n=1693
n=6264
n=6273
n=6281
n=6255
438 patients
9 of patients
23 participants
25 participants
12 079 participants
14 normal and dysglycaemia participants
51 patients
17  For all patients
12 patients
2 diabetes mellitus   patients
2 diabetic patients
23 people
n=25
n=26
n=23
2 diabetic patients
366 million people
68 500 patients
n=29 535
n=22 291
n=9919
N=29 535
N=22 291
N=9919
 data from 20
3   Studies of people
370 participants
159 patients
18 patients
141 patients
6112 patients
3861 patients
27 patients
114 patients
15 patients
28 patients
159 randomly assigned patients
159 randomised patients
119 patients
135 patients
64 patients
33 patients
1 diabetic patients
1076 adult patients
n=159
n=114
n=41
n=32
2 diabetic subjects
2 diabetic patients
438 patients
9 of patients
2 diabetic patients
30 000 participants
n=0
620 patients
271 patients
1240 patients
0 Â·Â·         Articles  patients
4444 patients
n=306
n=314
n=272
n=129
n=119
n=100
n=30
n=10
n=271
n=285
100 people
100 000 for women
100 000 women
310 000 participants
7 million   participants
1 million participants
4 million participants
0 million participants
8 million participants
560 352 participants
90 056 participants
 data were from the 2000
 data, were from the 2000
 data from 61
 data   from 90 056
2   diabetes among adult women
300 000 persons
2856 participants
26  The prolonged follow-up of participants
17 participants
1152 patients
1270 patients
1 billion people
300 million people
13 people
1082 people
n=191
n=425
n=553
n=292
n=285
n=100
n=183
n=145
n=211
n=158
30 000 participants
2 Since almost all patients
n=0
370 patients
159 eligible patients
6000 patients
1 diabetic patients
1 participants
11 of hospital treat ment of patients
7 million participants
1 million participants
4 million participants
0 million participants
1273 participants
366 million people
1 and   patients
40 000 people
n=26
2 diabetic   patients
2218 women
1320 women
1166 women
3627 women
0 women
2977 women
7703 women
285 women
2203 women
1769 women
1684 women
447 women
1307 women
1334 women
384 women
569 women
459 women
4985 women
1349 women
991 women
3601 women
994 women
1370 women
2755 women
670 women
497 women
728 women
421 women
2691 women
18 000 participants
101 patients
n=49 363
n=146 581
n=142 255
n=36 282
n=99 582
n=8591
n=29 136
n=34 433
n=51 122
n=7152
n=1684
n=1998
n=8199
n=5654
n=868
n=1554
n=2906
n=1210
n=3287
n=2911
n=4488
n=995
n=9467
n=2392
n=1129
n=2443
n=58 337
n=49 346
n=901
n=941
n=1842
n=1776
n=907
n=5054
n=1465
n=1728
n=13 235
n=1717
n=2771
n=2674
n=718
n=3649
n=498
n=782
n=5146
n=41 245
n=5460
n=1289
n=69 395
n=108 173
n=6877
 data from   35
25 participants
24 participants
25 eligible participants
24 patients
28 patients
n=24
N=112
27 enrolled
8 Why all treated   participants
2 In healthy people
4607 women
59 137 women
15 Eligible women
20 486 women
4500 women
8501 women
13 108 women
500 pregnant women
13 108 pregnant women
36 women
4422 women
31 685 ineligible women
16 Most women
60 000 pregnant   women
n=8406
n  =  41
n  =1
n  =  60
n  =3
n  =   62
n  =2
n  =  50
n  =  61
n  =  59
n  =  64
n  =  31
N  =  43
N  =  20
n  =4
n  =6
n  =5
N  =4
N  =2
N=4265
N=4237
N=20 166
N=4217
15 879 were   enrolled
4607 women enrolled
59 137 women enrolled
15 consented and were enrolled
4607 enrolled
68 500 patients
100 people
25 people
57 000 people
68 500 patients
100 people
25 people
57 000 people
2 diabetic   patients
27 of women
41 029 patients
7481 patients
2114 Chinese patients
8054 patients
9505 patients
27 In Asian patients
382 million people
26 million people
n=33 548
n=748
n=106
n=2650
n=1195
n=41 029
n=107
n=275
n=385
n=705
n=1751
n=7712
n=9107
n=5646
n=15 341
4 Among patients
4 Among patients
340 234 European participants
2 diabetes and subcohort participants
27 779 participants
15 919 subcohort   participants
16 835 participants
340 234 EPIC participants
27 296 participants
2 diabetes and subcohort   participants
12 403 people
340 234 people
16 835 people
15 919 people
755 people
15 809 people
2348 people
723 people
n=15 919
n=15 164
n=12 132
n=1524
n=10 919
n=3476
n=6002
n=9917
n=7052
n=6255
n=2502
n=1048
 data from a 7
309 patients
14 593 pregnant women
17 186 pregnant women
6,587 patients
20 patients
1441 participants
726 participants
715 participants
1415 participants
1220 participants
N=1441
N=1415
N=1220
n=711
n=730
n=698
n=717
n=622
n=598
N=711
N=730
1 diabetes   were enrolled
5145 participants
n=2575
n=2570
n=0
total of 296
4607 pregnant women
7 million   participants
30 million children and young   people
 data from 2001
4 Among patients
340 234 people
1288 subjects
198 patients
358 patients
176 patients
182 patients
62 patients
354 patients
27 patients
12 patients
125 patients
60 mg pasireotide-LAR than did patients
110 acromegalic patients
n=65
n=68
n=1
n=63
n=62
n=66
198 patients were enrolled
15 Patients   enrolled
7 million participants
198 patients
347 million people
66 women
2866 patients
19 246 patients
2978 patients
2985 patients
213 974 people
162 people
5963 people
n=15 679
n=47 037
n=272 994
n=90 998
n=30
n=133
825 participants
825 patients
4 For many patients
3004 patients
833   patients
412 patients
16 patients
15 patients
1   diabetic patients
n=833
n=413
n=414
n=825
n=412
7 million participants
198 patients
2978 patients
60 000 patients
5963 people
2978 patients
60 000 patients
   data from 0
500 million people
170 patients
166 patients
158 patients
146 patients
169 patients
340 patients
550 patients
214 patients
336 patients
332 patients
13 patients
314 patients
16 â€ Six patients
304 patients
289 patients
163 patients
15 patients
0001  Number of patients
70  Number of patients
n=162
n=152
n=137
n=122
n=159
n=151
n=158
n=143
n=127
n=169
n=163
153 women
204 participants
200 participants
40 sequential participants
13 200 participants
525 potential participants
66 participants
3 participants
47 participants
76 participants
51 participants
61 participants
43 participants
34 participants
36 participants
75 participants
57 participants
40 patients
17 patients
n=103
n=97
n=43
n=61
n=200
n=127
n=76
n=51
n=45
n=15
n=18
n=20
n=16
n=19
n=11
n=9
n=55
n=34
n=24
   data from 0
796 participants
1658 participants
300 participants
2167 patients
1658 patients
103 502 obese patients
4793 obese   patients
401 patients
2167 obese patients
14 people
878 people
0001  Data are number of people
n=1053
n=2167
309 patients
825 patients
14 593 pregnant women
17 186 pregnant women
5 In a study   of patients
6,587 patients
9 High-level panel of eminent persons
3 Cohorts of patients
300 participants
298 participants
36 participants
299 participants
300 patients
296 patients
594 patients
324 patients
300 enrolled patients
n=175
n=125
n=300
300 enrolled
24 not enrolled
129 664 participants
41 We   included only participants
126 263 patients
15 270 patients
3500 patients
201 822 patients
100 000 adult patients
18 000 records for patients
16 635 patients
1144 patients
924 patients
295 patients
14 272 patients
12 606 patients
102 713 patients
10  For patients
5911 patients
8384 patients
975 patients
37 patients
3 patients
6 patients
7 patients
126 263 adult patients
100 000   previously ART-naive adult patients
126 263 adult patients enrolled
N=95 101
n=123
N=106 557
n=135
N=104 851
n=141
N=122 919
n=156
N=187 013
n=167
N=104 872
n=137
N=41 378
n=121
N=157 266
n=140
N=65 761
N=268 030
n=158
N=95 066
n=134
N=422 642
n=159
N=106 199
n=126
N=684 584
n=155
N=142 986
7 million   people
n=15
1 billion people
1 billion   people
2 of long intervention Reach women
2000 people
1857 people
N=173
N=175
 data from the 6
4 million people
191 million people
196 million people
6 and workshop   participants
3 during which many patients
n=1310
n=904
6   Young people
9 Reasons include women
700 people
126 000 patients
123 000 patients
14 million people
249 women
30 million   people
16 million women
n=185
n=65
n=25
n=54
 data for each of the 144
 data from 144
140 patients
200 000. That deaths in patients
15 000 patients
1 If participants
2 If participants
900 million people
8 million people
22 million people
64 307 people
4000 people
65 million people
n=21
n=6
n=10
800 women
52 per thousand   women
100 000 pregnancies   currently in women
264 695 Danish women
 data from   144
 data from 22
26 million people
6 million   people
75 000 people
87 000 people
 data from   7657
90 participants
90 case participants
17 participants
73 participants
35 case participants
216 patients
73   patients
3117 people
90 people
216 people
17 people
1000 people
n=42
n=19
n=12
90 people were enrolled
3885 women
1003 women
536 women
118 women
total of   3885
400 patients
5 Other   patients
1899 patients
1 diabetic patients
260 000 people
44 the people
 data from 18 712
 data from 22
 data from 54
n=328
n=520
 data from 121
 data from 63
 data   from 121
 data   from 40
500 assessment participants
900 assessment participants
1430 assessment participants
60 000 potentially eligible participants
7366 participants
315 participants
292 participants
23 participants
39 012 HIV-negative participants
7361 HIV-positive   participants
46 378 study participants
864 651 participants
n=14 567
n=56 683
N=7
N=4
N=5
n=3787
n=3832
n=5923
n=5957
n=4684
n=4357
n=5913
n=5929
n=6846
n=6769
n=23 366
n=23 012
50 communities were enrolled
 data from   39 012
4 million participants
N=4
N=8
N=12
N=24
N=176
N=92
N=67
N=34
N=68
N=150
N=83
 database of 33
20 million people
7 million   people
16 million people
n=2
 data from a   2012
20 million people
n=535
n=89
n=250
n=196
n=106
n=429
1053 children enrolled
16 All children enrolled
549 women
21  Methods  Study design and participants
1271 participants
747 baseline rural participants
1022 people
n=1022
n=860
n=162
n=851
n=171
1271 participants enrolled
n=42
n=12
1 Whether patients
 data from 121
681 patients
1632 patients
100 patients
729 patients
1879 patients
2021 patients
681 febrile patients
1669 patients
53  Febrile patients
n=9
n=18
n=19
n=681
n=1632
n=1669
n=39
n=95
n=103
50 participants
131 participants
363 participants
135 patients
64 patients
106 patients
14 patients
 database.   of 33
n=250
n=196
n=157
n=192
212 participants
93 enrolled participants
93 enrolled
14 patients
3 In some patients
2598 patients
300 patients
1511 patients
186 male patients
187 female patients
n=427
n=158
2031 participants
10 among   participants
260 000 people
n=2031
n=2
n=3
n=506
n=511
n=504
n=510
total of 872
500 individuals were enrolled
2031 participants were enrolled
6 million people
 datasets from 115
 datapoints from 79
 datapoints from 32
 datapoints from 11
 datapoints from 115
 data from 79
703 participants
504 participants
707 eligible participants
182 participants
579 people
n=282
n=45
n=41
n=31
n=28
n=38
n=55
n=30
n=12
n=2
707 children were enrolled
507 enrolled
200 enrolled
208 enrolled
1006 patients
100 000 per   year in people
n=34
n=46
n=133
n=1
n=3
n=42
n=20
n=5
n=10
n=22
n=23
n=27
n=6
n=8
n=12
 data from 179
100 000 people
3   and older people
2 million   women
2 patients
11 million people
2 million women
8   and among women
4 million pregnant women
4 million women
total of 27
118 women
536 women
204 women
139 women
682 women
575 women
886 women
40 million women
9â€”that young women
100 women
n=878
n=879
n=0
n=12 119
n=7642
n=4589
n=5640
n=3663
n=2279
 data from 1999
 data from all 182
 data from the 100
 data from BHP,10
total of 79
100 000 people
100 000   people
 data from the 2003
 data from 2003
 data from 2011
 data from 2008
2 million people
500 000 people
08  Number of people
2218 people
4471 participants
n=456
n=1081
n=3418
58 922 pregnant women
30 pregnant women
496 women
1,020 patients
 data from   54
7 Consenting   women
49 women
5236 people
3 289 000 people
7 people
19 025 people
n=2187
n=99
n=98
n=298
n=249
n=100
n=1343
n=2170
n=97
n=295
n=1333
n=242
n=246
n=718
n=86
n=155
n=235
n=612
n=253
n=234
n=125
n=187
n=3225
n=5230
n=147
n=92
n=39
1 tests   all patients
185 million people
513  Comment  women
1 billion people
 data from 192
total of 182 088
11  Mean nets-to-people
10  Proportion of people
n=1
 data from 29
529 patients
7415 cases of patients
14 we counted people
100 000 people
n=25
581  Comment  HIV-uninfected people
162 participants
19  Methods  Study design and participants
20 Masking   of participants
5 billion people
n=1961
n=650
n=637
 data from   112
12 which ask women
n=50 396
n=122 757
n=392 300
 data from 206
 data from 1986
1,900 patients
1000 people
100 000 people
5 Many women
1200 women
1985 women
14 women
n=422
n=419
n=69
n=290
1643 women
2773 women
0001  All women
0001  HIV-infected women
0001  HIV-uninfected women
115 women
103 women
00 Â·Â· Â·Â· Â·Â· Â·Â·  All women
25 All   participants
25 All participants
n=2946
n=1770
n=1575
n=1371
n=574
n=1196
n=4682
n=1759
n=2923
n=4696
n=2935
n=1761
n=0
n=4389
n=1645
n=2744
n=4416
n=2773
n=1643
1 million people
400 000 people
n=70
36 million people
n=87
n=98
n=46
n=45
n=88
n=48
18 were enrolled
67 500 cases in pregnant women
4 For pregnant women
1000   pregnant women
1000 pregnant women
200 000 pregnant   women
1000 people
100 000 people
3 million women
103 patients
125 million girls and women
7 Many carers   of people
260 participants
6  Eligible participants
173 participants
84 patients
n=200
n=260
n=183
n=87
n=172
n=173
n=86
n=171
n=84
n=165
n=242
n=232
n=67
n=64
n=138
n=132
n=209
n=192
n=61
n=55
n=121
n=113
n=189
n=53
n=49
n=114
n=95
n=174
n=168
n=47
n=176
n=163
n=161
n=157
n=147
n=145
n=141
n=140
n=134
n=131
n=129
n=127
n=208
n=199
n=247
n=206
n=197
n=213
n=204
n=190
n=184
n=179
260 enrolled
8692 patients
918 patients
10 million   patients
17 All patients
48  Number of active patients
1 685 430 334 250  Number of patients
26 Eligible patients
8692 registered patients
918   registered patients
5256 patients
771 patients
2034 patients
9610 patients
n=4645
n=611
n=1119
n=325
n=659
n=112
 data, from 2009
2058 women
9676 women
24 297 patients
1 we have included both outpatients
24 297 people
24 827 people
n=485 940
n=26 357
n=7 238 800
n=14 621
n=9676
n=24 297
n=8003
n=280
n=590
n=0
 datapoints from 1979
n=911
n=1822
n=946
n=1707
n=937
n=2013
5   among people
n=1897
n=1729
n=1703
n=1751
n=1745
n=1741
n=1717
n=1727
 data from the 2003
1448 eligible participants
n=497
n=509
n=442
n=268
N=489
N=472
N=401
n=489
n=449
n=472
n=436
n=401
n=372
45 schools were enrolled
45 schools enrolled
45 schools were   enrolled
26 million people
197 participants
85 participants
676 participants
98 participants
197   participants
136 participants
86 participants
676 patients
n=98
n=99
n=119
n=34
n=42
n=11
n=5
n=9
n=14
n=26
n=197
n=178
n=191
n=95
n=96
n=195
n=97
n=194
n=196
n=193
n= 197
n=87
n=85
n=75
n=81
n=86
n=76
n=82
n=84
n=89
n=83
n=77
n=88
n=78
n=80
n=79
n= 86
n=74
n=73
118 women
26 adult   psychiatric patients
1200 patients
102 young people
n=78
n=38
n=116
n=256
n=118
n=374
45 unmedicated participants
15 of these   patients
45 unmedicated people
10 In people
n=5
n=1
n= 22
n=23
n=15
21 151 patients
1538 patients
26 570 patients
5510 patients
21 151 screened patients
1599 patients
26 Of the patients
10 071 patients
33   some patients
3 million people
4 million people
N=21 151
N=4316
N=3010
N=8461
N=3355
N=2009
n  =4
n  =8
n  =2
n  =3
n=701
n=1130
n=408
13 164 participants
14 229 participants
839 participants
156 participants
23   and participants
30 people
125 people
n=29
n=20
n=2
n=1
n=64
n=28
n=7
n=148
n=4043
n=999
n=3312
100 trials and thousands   of patients
1866 women
1012 women
n=1190
n=645
n=164
n=481
3273 women
3273 women were   enrolled
5112 HIV-diagnosed men and   women
3258 patients
n=68
n=503
n=540
N=1138
N=353
n=388
N=1527
12  Whether HIV positive people
6 Drug use might make people
2 Most people
3258 of participants
8503 participants
3258 participants
3258 people
8503 people
n=170
n=3151
n=7424
 data from 2009
total of 17
252 participants
6 subjects
 data from  236
N = 8
N = 8401151 411
n = 51101
n = 101151
n= 5
n= 5011001
n= 4
n =  3141
total of 900
total  of 11,700
n = 20
n = 21
N = 71
n = 10
n= 20
n = 48
N = 639
total of 306
total of 639
total of 97,226
57 participants
28 participants
112 participants
N = 6
N = 22
N = 52
N = 82
N = 99
N = 117
10 The subjects
15 To avoid subjects
17 The  subjects
101 subjects
0 subjectsa subjects
6 subjects
19 subjects
8 subjects
7 subjects
5 subjects
2 subjects
24 subjects
16 subjects
40 subjects
48 subjects
00  aNumber of subjects
64 subjects
47 subjects
97 subjects
90 subjectsb subjects
11 subjects
90 subjects
total of 47
 data from 445
0  the participants
n= 2
total of 120
total of 3,671
total of 134
total of 949
266 subjects
 data from C0
1,000 people
10,000 people
5 people
N = 23,422
N = 328,351
N = 84,982
N = 167,241
N = 475
N = 477
N = 483
N = 373
N = 410
N = 455
N = 370
n = 41270
n = 507
n = 803
total of  18
 data for each of the 445
 data from 445
 data from 451
n = 2
9 The participants
16  Ninety-six participants
928 subjects
N = 104
n = 64
n = 40
N = 136
n = 44
n = 52
N = 140
n = 60
n = 24
n = 56
N = 92
n = 48
N = 80
N = 96
n = 32
N = 84
N = 116
n = 80
total of 3,601
total of 20
61 female salespeople
10 salespeople
3 salespeople
6 compensating salespeople
00202 on outside TC salespeople
600 and two low-ability salespeople
26 salespeople
2005  classes linking subjects
10 subjects
7 subjects
16 subjects
5 subjects
36 subjects
53 subjects
n = 607
n = 303
total of 40
n = 291
total of 651
n=110001
n = 8
n= 11
n=1
n=161
n = 5
n = 5
n= 1
N = 54
n = 30
n = 0013
20  Unframed men  Unframed women
33 women
66 subjects
 data from 19
n = 0017
 data from 2005
 data from 1964
500 people
total of 344
226 participants
4  We provided participants
82 novels and required participants
215 participants
5 Two participants
1 averages exclude participants
212 participants
211 participants
137 participants
n = 75
n= 75
n= 76
n = 0
N = 226
N = 76
N = 75
N = 215
N = 89
N = 72
N = 66
N = 71
N = 70
N = 65
N = 695
n= 1
n = 114
n= 4
n = 1
n = 4
N = 1,944
 data from 2006
n = 111777
n = 111175
n = 91431
n =  71196
n= 355
n = 45
n= 202
n = 8
n = 4
n = 2
n = 0
n = 1
n = 1121
N = 50
n= 2
N = 2
N = 10
n =  1
n =  4
2304  Unemployed persons
15404  Unemployed persons
31 and unemployed persons
4002465  Unemployed persons
4001315  Unemployed persons
n = 1
N = 2
total of 105
2014 INFORMS  participants
585 participants
1 leads  people
N = 21806
total of 585
n = 2
N = 12,842
N = 4,631
n = 1
n=1
n= 05
n = 0
n = 8
n= 011121
n = 4
n = 0001
n = 05
N = 10
N  =  1
n = 8
N = 14
n = 0
N = 61002
35 subjects
1 subjects
70 subjects
22 subjects
33 subjects
46 subjects
50 subjects
total of  900
total of 969,033
total of 25
total of 56
23 people
 data starting from 2002
n = 3801982
n = 131536
total of 13,536
N = 104
N = 101
N = 108
total of  11
75 women
15 participants
50â€”participants
14 We generate participants
21 different scenarios where participants
104 participants
1,000 people
10 people
N = 17
N = 10
N = 12
total of 21
total of 500
total of 6,000
total of 3,500
total of 74
n = 215
n = 441
n= 215
n = 1
n = 5110120
n= 011121
total of 143
n = 00256
n = 00536
n = 00214
 data consist of 11
n = 8
n = 1
n = 0
n = 2
n = 3
n = 4
n = 15
n  =  40
n=1
total of 40,000
total of 2,000
 data from 7,730
n=1
n= 0
n = 31709
N = 1081257
n = 11457
N = 421887
n = 286
N = 81342
n = 0
n = 005
n = 009
130 subjects
total of 210
total of 83
total  of 79
3 on which participants
5 Website participants
N = 11692
N = 118
N = 298
N = 92
N = 11184
N = 392
N = 31
N = 11116
N = 153
total of 39
N = 81121
total of  2,500
total of 64
N = 0
N = 009
N = 4
N = 01
N  = 41
N =01
N  =2
 data set of 100
11 across rounds  and participants
93 subjects
87 subjects
20 subjects
n = 0
n = 01
n =  41
N =  1
N = 41
2 would not cut down on the participants
120 subjects
5 106 subjects
118 subjects
110 subjects
112 subjects
534 subjects
312 subjects
n = 222
n = 117
n = 165
n = 60
n = 53
n = 59
n = 55
n = 68
n = 47
n = 51
n = 29
n = 35
n = 115
n = 219
total of 534
total of 312
18 participants
36 subjects
38 subjects
N = 1
N = 0
total of 146
total of 36
total of 38
total of 16
1 What people
n = 3
N = 48
N = 49
N = 30
total of 98
N = 2
N = 8
N = 4
N = 0
n=1
n = 30
n = 9
n = 0
n = 1
N = 236
N = 520
N = 40
N = 2,800
N = 7,120
N = 21800
N = 85
N = 321
n= 7
n = 8
n = 7
310 subjects
269 of these  subjects
41 subjects
total of 310
 data from the 2005
27 participants
N = 737
n = 123
n = 51152
n= 15
n= 11559
n = 33
n =  640
n = 49
n = 11458
n = 8
n = 346
100 subjects
98,278 subjects
79,680 subjects
128,690 individual-wave subjects
3,493 subjects
1,283 informed-  of-reward subjects
24 Among subjects
1 million people
N = 3,516
N = 89,206
N = 79,317
N = 92,722
N = 2,939
N = 12
N = 108
11 Using subjects
23 The potential subjects
40 independent pairs of subjects
1 If people
n = 007
total  of 32
n = 741262
n = 441550
n = 601657
n = 81087
n = 241502
  data set of 212,058
  database of 697,456
N = 8
N = 3
n= 256
n= 10
147 subjects
2821  potential demand than subjects
n = 19
total of 276
total of 40
N = 43
40 participants
29  participants
30 participants
344 subjects
N = 42
N = 40
N = 29
total of 344
N  =  1
N  =  4
N = 12
N  = 4
n= 5
n= 1
n= 2
N = 4
n= 25
n= 2
total of 43
6 For four subjects
N = 00
N =00
N = 20
N = 0
total of 50
3 Their patients
n= 0
N = 87
 data from 35
52 participants
53 participants
49 participants
1 examines people
2014 INFORMS  help people
n = 1
N = 0
N = 811
N = 8112139
n= 15
n= 30
total of 12
N  =  44
total of 9,734
N = 81121
7 The  participants
79  aAll participants
2455  participants
12 pairs of participants
N = 1
2014 INFORMS  patients
 data  only from 1986
 database of 13
N = 11810
N = 11469
  database from 2002
 data from 1967
 data from 1997
 data from 1962
n = 15
n = 7
n = 25
n = 55
n = 12
N =  112,857
N = 576,640
N = 90
total of 158
total  of 39
total of 16
45 students enrolled
2014 INFORMS  currently enrolled
12 million people
total of 85,168
N = 585
n = 45
total of 466,830
5 evolves as people
n = 41
n =  61
n =  41
10 To allow subjects
36 subjects
32 subjects
17 When subjects
16 Three subjects
9,681  Number of subjects
19 as well as the percent of subjects
4 we show the fraction of subjects
6 reports the  fraction of subjects
12,120  Number of subjects
5  Call type  To test whether subjects
3,957  Number of subjects
77 subjects
20 Calls among subjects
88  Number of subjects
54  Number of subjects
total of 104
total of 36
total of 17
252 participants
6 subjects
 data from  236
N = 8
N = 8401151 411
n = 51101
n = 101151
n= 5
n= 5011001
n= 4
n =  3141
total of 900
total  of 11,700
n = 20
n = 21
N = 71
n = 10
n= 20
n = 48
N = 639
total of 306
total of 639
total of 97,226
57 participants
28 participants
112 participants
N = 6
N = 22
N = 52
N = 82
N = 99
N = 117
10 The subjects
15 To avoid subjects
17 The  subjects
101 subjects
0 subjectsa subjects
6 subjects
19 subjects
8 subjects
7 subjects
5 subjects
2 subjects
24 subjects
16 subjects
40 subjects
48 subjects
00  aNumber of subjects
64 subjects
47 subjects
97 subjects
90 subjectsb subjects
11 subjects
90 subjects
total of 47
 data from 445
0  the participants
n= 2
total of 120
total of 3,671
total of 134
total of 949
266 subjects
 data from C0
1,000 people
10,000 people
5 people
N = 23,422
N = 328,351
N = 84,982
N = 167,241
N = 475
N = 477
N = 483
N = 373
N = 410
N = 455
N = 370
n = 41270
n = 507
n = 803
total of  18
 data for each of the 445
 data from 445
 data from 451
n = 2
9 The participants
16  Ninety-six participants
928 subjects
N = 104
n = 64
n = 40
N = 136
n = 44
n = 52
N = 140
n = 60
n = 24
n = 56
N = 92
n = 48
N = 80
N = 96
n = 32
N = 84
N = 116
n = 80
total of 3,601
total of 20
61 female salespeople
10 salespeople
3 salespeople
6 compensating salespeople
00202 on outside TC salespeople
600 and two low-ability salespeople
26 salespeople
2005  classes linking subjects
10 subjects
7 subjects
16 subjects
5 subjects
36 subjects
53 subjects
n = 607
n = 303
total of 40
n = 291
total of 651
n=110001
n = 8
n= 11
n=1
n=161
n = 5
n = 5
n= 1
N = 54
n = 30
n = 0013
20  Unframed men  Unframed women
33 women
66 subjects
 data from 19
n = 0017
 data from 2005
 data from 1964
500 people
total of 344
226 participants
4  We provided participants
82 novels and required participants
215 participants
5 Two participants
1 averages exclude participants
212 participants
211 participants
137 participants
n = 75
n= 75
n= 76
n = 0
N = 226
N = 76
N = 75
N = 215
N = 89
N = 72
N = 66
N = 71
N = 70
N = 65
N = 695
n= 1
n = 114
n= 4
n = 1
n = 4
N = 1,944
 data from 2006
n = 111777
n = 111175
n = 91431
n =  71196
n= 355
n = 45
n= 202
n = 8
n = 4
n = 2
n = 0
n = 1
n = 1121
N = 50
n= 2
N = 2
N = 10
n =  1
n =  4
2304  Unemployed persons
15404  Unemployed persons
31 and unemployed persons
4002465  Unemployed persons
4001315  Unemployed persons
n = 1
N = 2
total of 105
2014 INFORMS  participants
585 participants
1 leads  people
N = 21806
total of 585
n = 2
N = 12,842
N = 4,631
n = 1
n=1
n= 05
n = 0
n = 8
n= 011121
n = 4
n = 0001
n = 05
N = 10
N  =  1
n = 8
N = 14
n = 0
N = 61002
35 subjects
1 subjects
70 subjects
22 subjects
33 subjects
46 subjects
50 subjects
total of  900
total of 969,033
total of 25
total of 56
23 people
 data starting from 2002
n = 3801982
n = 131536
total of 13,536
N = 104
N = 101
N = 108
total of  11
75 women
15 participants
50â€”participants
14 We generate participants
21 different scenarios where participants
104 participants
1,000 people
10 people
N = 17
N = 10
N = 12
total of 21
total of 500
total of 6,000
total of 3,500
total of 74
n = 215
n = 441
n= 215
n = 1
n = 5110120
n= 011121
total of 143
n = 00256
n = 00536
n = 00214
 data consist of 11
n = 8
n = 1
n = 0
n = 2
n = 3
n = 4
n = 15
n  =  40
n=1
total of 40,000
total of 2,000
 data from 7,730
n=1
n= 0
n = 31709
N = 1081257
n = 11457
N = 421887
n = 286
N = 81342
n = 0
n = 005
n = 009
130 subjects
total of 210
total of 83
total  of 79
3 on which participants
5 Website participants
N = 11692
N = 118
N = 298
N = 92
N = 11184
N = 392
N = 31
N = 11116
N = 153
total of 39
N = 81121
total of  2,500
total of 64
N = 0
N = 009
N = 4
N = 01
N  = 41
N =01
N  =2
 data set of 100
11 across rounds  and participants
93 subjects
87 subjects
20 subjects
n = 0
n = 01
n =  41
N =  1
N = 41
2 would not cut down on the participants
120 subjects
5 106 subjects
118 subjects
110 subjects
112 subjects
534 subjects
312 subjects
n = 222
n = 117
n = 165
n = 60
n = 53
n = 59
n = 55
n = 68
n = 47
n = 51
n = 29
n = 35
n = 115
n = 219
total of 534
total of 312
18 participants
36 subjects
38 subjects
N = 1
N = 0
total of 146
total of 36
total of 38
total of 16
1 What people
n = 3
N = 48
N = 49
N = 30
total of 98
N = 2
N = 8
N = 4
N = 0
n=1
n = 30
n = 9
n = 0
n = 1
N = 236
N = 520
N = 40
N = 2,800
N = 7,120
N = 21800
N = 85
N = 321
n= 7
n = 8
n = 7
310 subjects
269 of these  subjects
41 subjects
total of 310
 data from the 2005
27 participants
N = 737
n = 123
n = 51152
n= 15
n= 11559
n = 33
n =  640
n = 49
n = 11458
n = 8
n = 346
100 subjects
98,278 subjects
79,680 subjects
128,690 individual-wave subjects
3,493 subjects
1,283 informed-  of-reward subjects
24 Among subjects
1 million people
N = 3,516
N = 89,206
N = 79,317
N = 92,722
N = 2,939
N = 12
N = 108
11 Using subjects
23 The potential subjects
40 independent pairs of subjects
1 If people
n = 007
total  of 32
n = 741262
n = 441550
n = 601657
n = 81087
n = 241502
  data set of 212,058
  database of 697,456
N = 8
N = 3
n= 256
n= 10
147 subjects
2821  potential demand than subjects
n = 19
total of 276
total of 40
N = 43
40 participants
29  participants
30 participants
344 subjects
N = 42
N = 40
N = 29
total of 344
N  =  1
N  =  4
N = 12
N  = 4
n= 5
n= 1
n= 2
N = 4
n= 25
n= 2
total of 43
6 For four subjects
N = 00
N =00
N = 20
N = 0
total of 50
3 Their patients
n= 0
N = 87
 data from 35
52 participants
53 participants
49 participants
1 examines people
2014 INFORMS  help people
n = 1
N = 0
N = 811
N = 8112139
n= 15
n= 30
total of 12
N  =  44
total of 9,734
N = 81121
7 The  participants
79  aAll participants
2455  participants
12 pairs of participants
N = 1
2014 INFORMS  patients
 data  only from 1986
 database of 13
N = 11810
N = 11469
  database from 2002
 data from 1967
 data from 1997
 data from 1962
n = 15
n = 7
n = 25
n = 55
n = 12
N =  112,857
N = 576,640
N = 90
total of 158
total  of 39
total of 16
45 students enrolled
2014 INFORMS  currently enrolled
12 million people
total of 85,168
N = 585
n = 45
total of 466,830
5 evolves as people
n = 41
n =  61
n =  41
10 To allow subjects
36 subjects
32 subjects
17 When subjects
16 Three subjects
9,681  Number of subjects
19 as well as the percent of subjects
4 we show the fraction of subjects
6 reports the  fraction of subjects
12,120  Number of subjects
5  Call type  To test whether subjects
3,957  Number of subjects
77 subjects
20 Calls among subjects
88  Number of subjects
54  Number of subjects
total of 104
total of 36
190  Young women
34 000   participants
1123 patients
2200 mostly   young people
total of 76
3281 vaccinated patients
2342 patients
11166  Of the patients
374 patients
510  patients
184 adult  patients
3281 patients
n = 302
n = 1000
n = 1053
n = 2228
n = 53
n = 698
n = 2
n = 643
n = 210
n = 7
n = 85
n = 582
n = 1644
n = 211
n = 4
n = 1429
n = 300
n = 37
n = 245
n = 2226
total of 3281
5 The population of patients
6 The needs   of these older patients
1135 potential participants
1135   potential participants
n = 259
n = 250
n = 108
n   = 1
n   = 2
n = 143
n   = 3
n = 114
n = 145
1172  patients
3369  patients
187 patients
10435  patients
172 LiN  patients
2 Number of patients
1 Characteristics of patients
16 Data on the number  of patients
187 people
9370   patients
291,413 patients
n = 14
n = 23
3 The prevalence of   patients
1150 people
214 826 adult  patients
74 181 patients
17 772 deaths among  ICU patients
10 000 patients
108 171 people
90 399 older people
78   patients
n = 7
total of 99
total of 10
total of 198
total of 245
9 Patients were then enrolled
3055 survey participants
147 patients
n = 27
n = 25
n = 13
n = 147
n = 21
n = 14
n = 7
n = 5
n = 4
n = 3
n = 149
2010 of all   patients
1175 patients
62 splenectomy patients
536   patients
30 P  Number of patients
65 patients
1304 people
1304 people   enrolled
557 patients
45 people
n = 625 147
n = 5845
n = 619 302
n = 1296
n = 4549
n = 83
n = 1213
n = 3
n = 80
total of   557
190  Young women
34 000   participants
1123 patients
2200 mostly   young people
total of 76
53   patients
24   patients
10982  Twenty-five patients
14 patients
53 patients
24 patients
 database from   1
14 For patients
25 and excludes patients
10   people
200 people
1000   people
3000 people
2 million   people
7000 people
8 million people
10 people
200   people
1000 people
284 participants
482 participants
95 participants
121 participants
68 participants
n = 51
n = 37
n = 14
n = 28
n = 22
n = 3
n = 20
n = 17
n = 61
n = 44
n = 1
n = 16
n = 45
n = 141
n = 109
n = 127
n = 70
n = 49
n = 21
n = 82
n = 39
n = 2
n = 0
n = 4
n = 12
n = 48
n = 150
n = 98
n = 306
total of 482
total of 284
1192 women
6 We further cat-  egorised women
283 women
149 of these women
1  Numbers and proportions of women
461 patients
300 000 patients
1775 patients
1414 patients
5195 patients
235 patients
2  Characteristics of patients
10 vaccinated patients
n = 74
n = 8
n = 32
n = 3
n = 16
n = 7
n = 5
total of 275
17 remaining patients
13 patients
218 000   people
3   Colonisation disrupted people
129 patients
41 patients
6890 people
n = 98
n = 91
n = 42
n = 39
 data from 6
n = 313
n = 153
n = 220
n = 122
total of  242
1260 participants
n = 9922
n = 1 321 950
1260 participants
n = 9922
n = 1 321 950
41   women
65 participants
68 participants
49,364 obese participants
47   patients
2  Proportions of patients
4  Number of patients
total of 288
1  Characteristics of study participants
n = 852
n = 200
n = 1
n = 5
n =1
n =2
981 children enrolled
total of 246 665
total of 8750
3 The prevalence of   patients
1150 people
398 patients
3147 patients
191 patients
26  The subgroup of patients
27 Among patients
2  Characteristics of patients
1200 ma-  jor trauma patients
n = 201
n = 197
60 potential participants
22 participants
60 people
 data from 2003
n = 9345
n = 9145
n = 9243
n = 9126
n = 8989
n = 8963
n = 8988
n = 8877
n = 8903
n = 8593
n = 8759
n = 8775
n = 7977
n = 8112
n = 8126
n = 7912
n = 8044
n = 8059
19  NSTEACS  All patients
16 Some patients
7 patients
22  patients
1495 patients
764 patients
83 patients
123 patients
7 â€  Data are number of patients
22 patients
n = 764
n = 83
n = 56
n = 708
n = 123
total of 141
104 patients
12 patients
3  Number of patients
17,600 melanoma   patients
n = 11
n = 8
n = 79
n = 104
1861 participants
143 participants
66 patients
31   people
n = 1718
n = 143
3040 patients
255 â€œlow surgical riskâ€ patients
24 patients
29 patients
255 patients
3211 resected patients
n = 3040
3   Young Aboriginal people
908 patients
1621 patients
9618 people
2008 on people
1000 people
n = 908
n = 1621
n = 467
n = 441
n = 737
n = 884
total of 42
total of 84
478 patients
1000 patients
3 The prevalence of   patients
1150 people
103 participants
100 Indigenous   people
   data from 24
17 445 patients
n = 2392
n = 2405
1 In  women
6 In  men and women
3027 women
2813 women
1,844 women
657 control women
4284 participants
13 participants
1 Study participants
100 patients
4284 patients
500 people
n = 6147
n = 4233
n = 1914
N = 4284
n = 1130
n = 2814
n = 3409
n = 528
n = 1061
n = 2807
n = 3336
n = 525
n = 1129
n = 2761
n = 3357
n = 526
n = 1091
n = 2530
n = 3124
n = 490
n = 910
n = 2477
n = 2939
n = 443
n = 1175
n = 2867
n = 3499
n = 535
total of 134
total of 4284
total of 699
100 patients were enrolled
4 dying patients
35 general medical   patients
170,000 participants
169 138 subjects
39 612 patients
129 526 patients
 data from 170,000
36 More vulnerable patients
38  Engaging patients
1000   people
8000 people
31  Most people
1000 women
17 Most women
19 â€” all women
319 patients
n = 319
24 018 Victorian women
1235 of   these women
83 000   women
22 171 patients
 data from   53
total of 101
3 The prevalence of   patients
1150 people
n = 3377
n = 1143
5 Of those patients
total of 70 000
3 The prevalence of   patients
1150 people
99s-  children-and-young-people
n = 557
n = 311
n = 107
n = 116
n = 23
n = 42
n = 7
n = 19
n = 48
329 women
572 women
865 Aboriginal patients
13 For   patients
17 180 patients
865 patients
2959 people
total of 2959
total of   865
total of 17 180
total of 983
total of 572
001  IHCA patients
2011   Indigenous women
168 729 new patients
179 276 patients
437 patients
168 729   patients
1  Proportion of fi rst-time patients
5   Indigenous people
3   Indigenous people
25   Indigenous people
n = 3158
n = 3945
n = 479
n = 5219
n = 427
n = 7043
n = 168 729
total of 179 276
 data from 1
1 For women
222   Victorian women
1272 young vaccinated   women
1655 women
9229 women
17 763 women
10 548 women
n = 4245
n = 167 746
n = 130 026
total of 12 683
 data from 2008
n   =   14
n   =   2
n   =   8
n   =   13
n   =   3
n   =   9
n   =   14
n   =   21
n   =   8
n   =   13
n   =   3
n   =   9
3 The prevalence of   patients
1150 people
100 women
23 316 women
13 Of these women
23 316 women enrolled
 data from 23 316
2  Target population  All women
9  Young women
20  Case study  All women
total of 101
5 The rate among   Indigenous women
250 798 to non-Indigenous   women
13 582 to Indigenous   women
241 270 to non-Indige-  nous women
n = 13 582
n = 241 270
n = 6987
n = 5926
n = 1271
20 people
total of   20
426,344 pregnant women
4  When women
10 patients
1260 participants
n = 9922
n = 1 321 950
2308 adult inpatients
2308 inpatients
388 patients
583 patients
323 patients
1354 patients
474 patients
404 patients
82 patients
388   patients
270 patients
158 patients
51 patients
227 patients
20 patients
189 patients
495 patients
424 patients
437 patients
449   patients
451 patients
483 patients
290 patients
278 patients
346 patients
527   patients
500 patients
490 patients
473 patients
401   patients
276 patients
8   inpatients
2000 patients
2 diabetes among acute inpatients
5963 people
n = 583
n = 334
13 Most participants were   women
221 participants
100 participants
13 Most participants
755 survey   participants
755 people
total of 755
2011 were  of patients
1 Characteristics of patients
001  Medical patients
1115  patients
89  patients
n = 58 158
n = 47 124
n = 11 034
21 Refugees and people
938 participants
1860 participants
10 Another study of cancer patients
n = 1860
n = 938
n = 2325
n = 1165
total of 2103
34 172  admissions of patients
4549 patients
5630 patients
64  million people
600 000 people
15 000  people
12 360 consecutive patients
12 360 con-  secutive patients
8 patients
1  Characteristics of patients
436   patients
n = 1897
n = 944
N = 12 360
n = 8090
n = 4270
14 184 patients
234 800 people
2 Indigenous people
6 Indigenous people
n = 1421
n = 1892
n = 772
n = 119
n = 63
n = 18
n = 278
n = 393
n = 50
n = 1024
n = 1436
n = 704
total of 14 184
13 the number of Aboriginal patients
4000 people
7 Many   patients
11 These are patients
16 Many patients
1394 participants
415 participants
1271 participants
50 000 people
141 participants
15 participants
129 study   participants
n = 129
total of 17
141 participants enrolled
  data from all 4
35 000 people
total of 164
 data drawn from the 2006
n = 2626
n = 1072
n = 3698
n = 2187
n = 439
891 enrolled
2187 domestic students  enrolled
2047 medical students enrolled
31 682 tests in   women
2011 significantly among women
31 682 chlamydia tests among women
498 women
10 teenage young women
2011 among heterosexual people
3 Percentage of people
10 Most patients
727 contacts of patients
13  MDR-TB patients
21 All nine patients
9,153 patients
n = 1352
n = 16
n = 48
total of 196
5000 patients
400 000 people
2766 patients
3 The prevalence of   patients
1150 people
3 The prevalence of   patients
1150 people
100 000 patients
143 207 women
55 777 participants
196 464   participants
196 464 included participants
196 464 people
n = 103 977
n = 92 487
n = 196 464
n = 454
n = 240
n = 349
total of 196 464
total of 267 113
total of 1096
19 019 patients
403 patients
100   patients
1  Characteristics of patients
18 The   number of older patients
total of 19 019
 data from 1
90   patients
3 The prevalence of   patients
1150 people
11 Pregnant women
400  patients
11 patients
33  patients
400 patients
115 patients
356 patients
345 patients
293 patients
284 patients
24 patients were inpatients
800 million  people
n = 2858
30 patients
3 The prevalence of   patients
1150 people
12 patients
7 patients
2005  All patients
230 000 people
9477 women
6348 women
10  Among women
7162 women
2532   women
1742 women
986 women
10 women
n = 18 983
n = 5518
n = 5407
n = 8058
n = 254
n = 7417
2072 male patients
1132 female   patients
n = 350
total of   3205
3 The prevalence of   patients
1150 people
n = 258
n = 759
n = 1017
total of 67
9 The second situation is patients
6 people
100 000 women
1000 women
8 Of Australian women
n = 304
n = 847
n = 135
n = 6987
n = 5926
n = 1271
n = 6725
n = 6728
n = 6720
n = 21 690
30 000 patients
23 million people
300 000 people
Match
99   patients
54   patients
63 patients
213 patients
total of 87
6503 persons
250 patients
30 patients
18 of these patients
2 patients
total of 30
total of 16
69 Chinese women
41 patients
192 Chinese patients
99 patients
54 patients
3414 patients
25,673 patients
N = 1718
N = 1696
299 Korean persons
365 unaffected Korean persons
788 persons
1900 persons
600 unaffected persons
2 patients
1016 patients
11 patients
 data from 11
3 involving patients
756 patients
20 patients
1016 patients
11 patients
1 Approximately   half the patients
59 patients
316 patients
196   patients
2 and all patients
77 patients
 data from 11
132 medical in-  patients
1 patients
total of 45
76 patients
7 patients
total of 263
77 patients
2 patients
10 patients
13 patients
25 patients
1 patients
2 In   ICU patients
3 Although some patients
36 patients
11,000 patients
36 patients
76 patients
7 patients
total of 263
1 recruited women
150 patients
354 patients
800 patients
1   an increased proportion of patients
30 large trials involving patients
100   patients
192 Chinese patients
1680 patients
258 patients
40 such patients
2216 patients
13 patients
162 patients
680,000 persons
7 million people
680,000 persons
7 million people
7244   patients
2216 patients
4950 patients
6503 persons
2685 Euro-  pean persons
1,000 participants
250 patients
30 patients
18 of these patients
2 patients
2000 patients
total of 30
total of 16
2  Contraceptive use among women
2 and   women
70,000 women
30 patients
2 On-  cologists may not refer patients
2 and   women
70,000 women
35 patients
3 patients
4 new patients
7 patients
22 patients
13 patients
9 patients
4 patients
total of 11
108 patients
3 In such   patients
30 patients
 data from the 1962
2 On-  cologists may not refer patients
108 patients
3 In such   patients
1 two of us described three patients
3 patients
20 patients
853   patients
2 patients
23 geno-  typed patients
650 patients
557 patients
151 patients
152 patients
322 patients
328 patients
67 patients
52 patients
23 patients
554 patients
548   patients
548 patients
306 patients
299 patients
total   of 334
650 patients
557 patients
151 patients
152 patients
322 patients
328 patients
total   of 334
19,540 patients
5 patients
6 patients
17 patients
N=5
N=6
N=17
total   of 61,482
total of 19
3 Although some patients
205 patients
275 participants
939 participants
4 Because patients
138 patients
939 patients
3438 patients
total of 3438
220 patients
88 patients
69 patients
837 patients
6910 patients
989 patients
total of 163
10 patients
N = 222
2  In women
109 patients
394   study patients
N = 63
N = 109
N = 73
N = 154
144,165 persons
1 million persons
269,179 patients
260,048 of these patients
2 patients
N = 162,385
N = 97,663
0  Total participants
138 patients
939 patients
 data from the 1970
213 patients
total of 87
989 patients
516   patients
9 persons
13 persons
5 persons
11 persons
44 case patients
5   of patients
1   In patients
67 patients
67 patients enrolled
837 patients
6910 patients
989 patients
total of 163
4300 persons
2203 persons
113 persons
49 persons
701 patients
334 patients
150 patients
N = 239
N = 245
3 These   patients
17   patients
80 reliably identifies patients
2915 women
3694 women
9 persons
13 persons
5 persons
11 persons
44 case patients
1 two of us described three patients
3 patients
20 patients
853   patients
2  In women
2915 women
3694 women
3 clinical trial involving patients
180 patients
178   patients
182 patients
700 patients
77 patients
50 patients
N=70
N=7
N=22
N=24
50 volunteers enrolled
5 Anything less exposes patients
3 clinical trial involving patients
50â€   of the human-subjects
2 Other patients
5342 women
172 patients
   data from 2008
10 patients
700 patients
5557 black patients
200,000 or more  No data  Number of patients
2 Other patients
200,000 patients
2 Among patients
 data from   101
1 involving critically ill patients
70 kDa autoantibody   positive patients
N = 60
N = 58
4 six of seven   patients
2700 patients
 data from   101
1989 participants
4 six of seven   patients
2700 patients
33 severely malnourished   patients
46 patients
total of 112
4   Since the median age of patients
1121 patients
42 patients
10 patients
3 additional patients
N = 42
N = 10
N = 32
70 kDa autoantibody   positive patients
118 patients
58 patients
37 patients
N = 60
N = 58
total of 4
10,000 persons
792 persons
296 persons
2235   participants
142 patients
4   Early access can benefit patients
total of 30
2275 preg-  nant women
5010 women
5010   pregnant women
759 pregnant women
736 patients
N=6195
N=1771
N=59
8025 Were enrolled
1121 patients
4   Early access can benefit patients
5 million persons
1 million persons
32,225 diabetic   and nondiabetic patients
4 T cells of persons
1â€“infected   patients
10,000 persons
2 diabetic   patients
190 female patients
12 Dutch breast-cancer patients
675 fe-  male patients
1 patients
total of 675
123 patients
303 patients
80 among patients
344 patients
335 patients
162 patients
164 patients
2 The patients
1 the patients
1341 patients
2275 preg-  nant women
5010 women
131 patients
80,000 women
192 participants
173 participants
30 patients
80,000 women
18 patients
11 patients
1 Nearly half the patients
2 diabetic patients
220 patients
109 patients
5342 women
172 patients
   data from 2008
total of 3
290   patients
18 patients
5 patients
7800   Geisinger MyCode Project participants
178   patients
82 patients
96 patients
484 patients
154 patients
57,030 eligible patients
N = 1157
N = 14,751
N = 27,491
N = 43,399
6 patients
N = 6015
N = 6076
N = 6022
35 patients
651 patients
127 patients
13 patients
2000 European patients
606 patients
581 patients
1995 patients
402 patients
186 patients
total of 10
total of 2
total of 17
1359 patients
7800   Geisinger MyCode Project participants
4 patients
1359 patients
N = 2080
N = 3633
795 patients
1000 patients
605 participants
total   of 1183
24 participants
1 The article de-  scribes two patients
3018 patients
32 patients
378 patients
70 patients
45 patients
5000 patients
186 patients
total of 56
total of 24
24 participants
1 infected patients
71 patients
65 patients
4 Many women
total of 56
total of 24
total of 3
18F-FDG PET-CT evaluated patients
567 women
1996   patients
378 patients
70 patients
45 patients
6 patients
N = 6015
N = 6076
N = 6022
1 The article de-  scribes two patients
3018 patients
567 women
18F-FDG PET-CT evaluated patients
36 critically ill adult patients
1277 patients
total of 2
251 patients
3 Among patients
251 patients
9699   patients
36 critically ill adult patients
132 patients
12 additional patients
2 negative Chinese women
100 Asian   patients
78 patients
100 Asian   patients enrolled
12 additional patients
170,000 participants
3 in-  cluded patients
57,030 eligible patients
 data from 170,000
132 patients
88 patients
170,000 participants
3 in-  cluded patients
 data from 170,000
1277 patients
3CA of healthy persons
3CA of healthy persons
20 consecutive patients
20 patients
2 patients
3   patients
7 patients
20   patients
N = 20
3 vaccination of pregnant   women
3 vaccination of   pregnant women
2275 persons
270,000 persons
131 participants
1439 French patients
101,945 people
370,000 people
3   Most patients
N=91
N=189
45 patients
38 patients
7â€“negative patients
1  If these patients
906 patients
952 patients
30 patients
19 patients
1200 patients
45 patients
6  In many patients
38 In patients
4 T cells of persons
12 patients
3 million   people
3 Many patients
1000 persons
500 patients
50 people
 data   from 27
total of 88
32 In a study involving patients
5  Black women
11 Among women
19  For symptomatic patients
100,000 persons
638 participants
77 subjects
764 patients
998 patients
112 patients
5 In the   majority of patients
total of 998
total of 638
6 even among young people
7  In sensitized persons
324 subjects
7 For patients
103 patients
6 The   study participants
total of 12
3 Even though patients
4 Many patients
99 patients
15 patients
60 patients
50 patients
30  Some persons
46 patients
41 patients
100,000 persons
24 Asplenic   persons
4   In patients
7 In some patients
8  Most patients
23 The proportion   of patients
180 patients
140 patients
39   Anxious patients
43 In patients
48 In most of these patients
50 people
15,000   patients
47  patients
20,536 people
75 subjects
42  For patients
42 In   the case of patients
118 patients
350 participants
1000 persons
1272 participants
566 patients
total of 1272
12 In a small number of patients
12 Most patients
9 these patients
10 involv-  ing patients
21 In patients
20  Most patients
300 patients
50,000 persons
1000   persons
1000 persons
50,000 persons enrolled
34   A minority of patients
443 patients
66 patients
231 patients
49 patients
 data from   242
1 Some patients
17 consecutive out-  patients
147 patients
5   and among patients
186 patients
593 patients
300 patients
113 patients
108 patients
80 patients
287 patients
total of 6
10 patients
5 patients
49 patients
18 Many patients
5000 new   patients
87 trauma patients
390   damage control laparotomy patients
20 people
 data   from 2001
100,000 patients
177 consecutive patients
1 million patients
183 patients
1570 patients
111 patients
4   Among those patients
11   patients
301 pediatric patients
111   patients
10 patients
3 patients
50 patients
250 patients
101 patients
9 HIV-   infected women
10 than do women
19  Although the majority of women
25 Among patients
22 Although some patients
total of 2
47 con-  secutive patients
324 consecutive patients
128 patients
33 patients
9 patients
4  and patients
21 In patients
111 patients
121 patients
248   patients
9  Approximately half the patients
18 patients
1 million persons
1 million   patients
2 Although men and women
2 Among patients
total of 1691
126 patients
112 patients
1   RNA-suppressed participants
6321 patients
202 patients
7000 patients
1 patients
5295 people
700 million people
719   patients
290 patients
1 Among patients
2313 patients
2300   cardiac surgical patients
3 many patients
93 patients
total of 70
4 Treatment of patients
114 patients
689   participants
34 participants
154 participants
4 T cells of persons
59 persons
57 patients
46 patients
32 patients
7 patients
85 patients
200,000 patients
1006 patients
506 patients
499 patients
500   patients
3 The care of   such patients
3445   patients
59 persons
57 patients
46 patients
32 patients
7 patients
85 patients
18 addi-  tional patients
20 patients
56 patients
539 patients
1952 patients
2 patients
4â€   Low-target group  All patients
2  High-target group  All patients
32 patients
40 patients
20 patients
25 patients
200,000 patients
1006 patients
10,010 patients
4382 patients
3 The study involving patients
8 million people
2 In some patients
49,000 women
5 In postmenopausal   women
6 Further studies in-  volving patients
3414 patients
8 In patients
11 patients
5 patients
10 patients
2   In patients
3317 participants
05 among patients
13 involving patients
998 critically   ill patients
838 critically ill patients
6264 patients
1341 patients
1600 patients
3426 patients
2488 of these patients
05 among patients
1400 patients
6505 patients
12,049 patients
12,000 patients
1 more patients
2  Who were the patients
115 patients
50 patients
998 critically   ill patients
838 critically ill patients
2800 people
6 The needs of people
96 patients
1 studied hospitalizations of patients
1 enrolled patients
2 enrolled patients
1 studied hospitalizations of patients
1 enrolled
2 enrolled
3  Two patients
28 patients
 data from 233
50 patients
9961 patients
467 patients
total of 28
100,000   patients
104 patients
59 How will   patients
total of 22
4 Another app allows patients
25 million people
4 million people
5 million people
500,000   people
5 million uninsured   people
6 million   people
46 million   people
total   of 38
total of 24
total of 21
100,000 U.S. patients
2 A survey of patients
4 These groups are patients
66 patients
8   An understanding of how patients
5 So women
779 patients
16 patients
15 patients
31 patients
148 patients
68 patients
3 patients
109 patients
93 patients
54 patients
18 patients
86 patients
79 patients
161 patients
N = 462
N = 317
19 patients
15 patients
4 patients
11 patients
13   patients
17 patients
total of 19
total of 21
268 patients
107 patients
14 We screened   patients
64 patients
25 patients
3 status   among patients
14 patients
15 patients
21 patients
4 patients
5 patients
12 patients
2 patients
N = 51
N = 217
N=60
N=208
N=71
N=197
N=53
N=137
N=37
N=23
N=110
N=80
N=170
N = 268
N = 330
1761 patients
294 patients
100 patients
24 patients
94 patients
17 We excluded patients
1647 patients
114 patients
14 patients
19 For patients
100   patients
394 study patients
394 patients
418 patients
N = 294
N = 100
N = 394
N = 6397
N = 7561
N = 13,958
N = 6263
N = 4646
total   of 12
total of 166
total of 4646
1005 patients
439 patients
186 patients
32 patients
133 severely ill patients
105 patients
625 patients
103 patients
120 patients
2 patients
N = 507
N = 498
total of 70
total of 1010
total of 160
total of 227
total of 105
507 children enrolled
758 participants
376 participants
72 participants
2 participants
100 participant-years among participants
1012 participants
758   participants
754   participants
38 participants
22 participants
1145 participants
5 participants
3 participants
22   participants
14 participants
77 participants
39 participants
57 participants
38   participants
55 participants
10 participants
N = 376
N = 382
total of 758
total of   2
total of 1012
total of 384
total of 38
total of 96
total of 2
total of 21
total of 72
total of 252
total of 5
59 patients
10 patients
4 patients
3 patients
4 and patients
22 patients
34 patients
20 patients
5 patients
2 patients
17 patients
36 patients
4 other patients
32 patients
57 patients
56 patients
39 patients
18 patients
12 patients
6 patients
15 patients
24 patients
N = 46
N = 13
7 participants
11 participants
12 patients
6 patients
12   patients
2 patients
total of   30
20,000 participants
25,000 participants
25,673 participants
1696 participants
1758 participants
2203 participants
2159 participants
798 participants
8299 participants
17,374 participants
1000  participants
10,000 participants
1000 participants
674 participants
59 participants
174 participants
170,000 participants
1000 patients
37 patients
139 patients
51,698 people
N = 12,838
N = 12,835
N = 25,673
N=12,838
N=12,835
total of 2
total of 25,673
 data from   170,000
2â€“positive persons
4 In immunocompromised   persons
261 persons
147 participants
4 participants
3 participants
2 participants
155 participants
18 participants
1 among participants
N = 30
N = 33
N = 32
N = 29
N = 31
N = 155
total of 147
total of 4180
N = 76
N = 77
N = 230
N   =   7
total of 1133
total of 230
total of 16
300 morbidly obese white patients
95 participants
1 billion people
N = 119
N = 121
N = 120
N = 480
total of 380
total of 4
total of 18
total of 84
total of 443
total of 349
1006 patients
6 patients
32 patients
12 patients
10 patients
16 patients
9 These patients
1000 patients
1005 patients
5 patients
9 patients
303 patients
13 patients
28   patients
8 patients
25 patients
18 patients
3 patients
14 patients
15 patients
58 patients
10 of these patients
59 patients
15,520 patients
N = 506
N = 499
N=506
N=499
total of 6
total of 12
total   of 1006
1006 patients were enrolled
1369 patients
694 patients
675 patients
135 patients
799 patients
570 patients
N = 694
N = 675
total of 1369
total of 19,924
total of 60
total of 135
total of 11
5600 participants
12,000 eligible participants
5481 participants
12,000 participants
514 participants
1 of the participants
1000   participants
41 participants
2 patients
N = 6000
N = 549
N = 550
total of 12,000
total of 14,445
total of   514
total of 594
total of 202
total of   68
719 participants
8  In patients
750 patients
731 patients
235 patients
225 patients
176 patients
167 patients
178 patients
37 patients
5 events   among patients
179 patients
138 patients
N = 182
N = 178
N = 180
N = 179
N = 59
N = 61
total of 719
total of 731
157 patients
189 patients
14 patients
44 patients
8 patients
64 randomly selected patients
9 patients
35 patients
55 patients
5 patients
19 patients
17 patients
N   =   2
N   =   1
N   =   3
total of 1599
N = 882
total of 102
total of 444
9 Newborns were enrolled
6970 persons
1 million persons
38 million participants
4 million   participants
total of 1
 data from   24
 data from 66
20 women
8970 participants
2457 participants
59 HPFS participants
123 HPFS participants
11,427 participants
2457 HPFS participants
15   Among participants
179,081 for all participants
2 diabetic patients
total of 3083
total of 227
total of 20
total   of 20
139 persons
131 persons
137 persons
47 persons
9 virus infection   among persons
47   persons
30 persons
2 patients
2675 close contacts of case patients
9 case patients
104 patients
108 patients
79 case patients
9 Nine of the patients
139 patients
103 patients
2 critically ill   patients
107 patients
8 patients
23 patients
79 patients
32 patients
107 case patients
45 patients
139 case patients
137 patients
109 of the patients
83 patients
47 patients
1953 close contacts of the patients
87 patients
9 case   patients
1   case patients
48 case patients
9   patients
47 deaths among hospitalized patients
9 virus among poultry and people
N = 139
total of 137
total of 47
total of 139
total of   47
total of 79
total of 87
 data from H7
1000 participants
1300 participants
141 participants
3 trials involv-  ing patients
2   clinical studies involving patients
1121   patients
1331 patients
1090 patients
1114 patients
141 patients
75 patients
12 patients
432 patients
493 patients
47 patients
352 patients
169 patients
337 patients
329 patients
20 patients
448 patients
524 patients
7 patients
N = 1090
N = 1114
N = 432
N = 658
N = 493
N = 314
N = 307
total of   1090
total of 6
total   of 5
 data from the 2
 data from 448
 data from 524
5000 participants
9165 participants
119 participants
150 participants
158 participants
1291 participants
11 participants
N = 5044
N = 5033
total of 10,077
total of 5041
total of   9165
total of 119
total   of 1950
total of 150
10,077 children were   enrolled
419 postmenopausal women
419 postmenopausal   women
419 participants
367 of the participants
52 participants
50 participants
36 participants
N=55
N=51
N=52
N=53
N=54
N=22
N=30
N = 52
N = 51
N = 55
N = 261
N = 50
N = 49
N = 53
N = 48
N = 54
N = 255
total of 367
total of 419
419 participants were enrolled
1818 patients
895 patients
888 patients
700 patients
1800 patients
841 patients
910 patients
579 patients
8 patients
2 patients
903 patients
888   patients
1121 patients
582 patients
N = 903
N = 907
total   of 1818
total   of 8
 data from the 1121
544 persons
146 participants
181 participants
10 participants
136 participants
90 participants
181 patients
N = 61
N = 58
N = 62
total of 10
total of 544
total of 136
44 previously untreated   patients
44 patients
123 additional patients
82 previously untreated patients
41 patients
211 patients
126 previously untreated patients
26 patients
18 patients
12   were observed among patients
82 untreated patients
40 patients
14 patients
20 patients
126 untreated patients
167 patients
85 patients
82   patients
3 patients
132 patients
35 patients
61 patients
150 patients
175 patients
10 patients
90 patients
121 patients
126 patients
6 patients
123 untreated patients
23 patients
30 Most patients
193 patients
27 patients
5 patients
1b patients
170 mil-lion people
N   =   1
N   =   4
N   =   2
N = 16
N = 14
N = 44
N = 15
N = 41
N = 126
N = 21
N = 20
N = 31
N = 28
N = 29
total of 92
total of 211
total of 44
571 patients
11 Because   patients
1013 patients
438 previously untreated patients
166 patients
79 patients
80 patients
41 patients
0  SAFETY  A total of eight patients
11 patients
5 patients
7 patients
4 patients
24 patients
25 pre-  viously untreated patients
10 patients
1B patients
1 patients
N = 438
N = 133
N=80
N=41
N=79
N=45
N=43
N   =   8
N   =   4
N   =   7
total of 1013
total of 571
total of 11
total of 5
318 participants
301   participants
301 participants
37 participants
318 patients
31 Eligible patients
36  Since patients
N = 97
N = 90
N = 94
N = 93
N = 95
total of 301
846 Were enrolled
11,282 patients
648,000 patients
100 patients
11,290 patients
4504 patients
494 patients
452 patients
436 patients
109 patients
27 patients
25 in-  patients
N = 11,282
N = 10,830
N = 452
N = 504
N = 110
N = 86
N = 65
N = 50
total of 183
total of 504
total of 481
total of 43
total of 44
total of 42
110,970 persons
150 persons
3734 persons
6823 persons
13 persons
3734 participants
41,671 participants
3238 fasting participants
2082 participants
34,432 participants
7239 participants
110,970 study participants
110,970 participants
3061 participants
27 participants
3237 participants
34,002 patients
794 patients
N = 34,432
N = 7239
N = 41,671
N=2913
N=2722
N=2485
N=1390
total of 3061
total of   1
11   In all five patients
12   These patients
94 patients
46 patients
3 affected persons
4 persons
19 persons
19 Georgian Jewish participants
19 patients
16 patients
14 unrelated Turkish   patients
15 patients
3 patients
4 patients
13 patients
2 of the patients
20 patients
2 patients
22 In the   patients
115 patients
total of 4
total of 20
16 Affected   persons
N=5
N  =1
N  =9
75,725 participants
10,797 participants
10,333 consecu-  tive participants
65,392 consecutive participants
7980 participants
7557 of these   participants
10,333 participants
41 participants
250 participants
251,000 participants
N = 19,924
N = 35,122
N = 12,699
N = 4419
N = 3561
N=75,465
N=260
N=75,692
N=33
N=75,516
N=209
N=75,707
N=18
total of 75,725
total of 13
total of 41
 data from 75,725
18 patients
458 patients
463 patients
921 patients
911 patients
10 patients
43 patients
354 patients
387 patients
284 patients
27 patients
7 patients
339 patients
333 patients
20 patients
12 patients
122 patients
61 patients
8 patients
6 patients
N = 458
N = 463
N = 461
N = 450
total of 458
total   of 921
total   of 911
total of 741
total of 284
total of 21
921 patients were enrolled
978 patients
612 eligible patients
320 patients
621 patients
20 patients
312 patients
309 patients
57 patients
268 patients
274 patients
88 patients
45 patients
317 patients
155 patients
178 patients
39 patients
512 patients
500 patients
303 patients
75 patients
4  number of patients
416 patients
N = 303
N = 300
N = 260
N = 233
total of 978
total of 12
total of 637
29 This design filtered   out persons
126 participants
23 participants
25  Qualified participants
46 consecutive   participants
108 participants
40 participants
46 consecutive participants
32   Screening potential participants
929 participants
598 participants
56 of these participants
222 participants
30 These patients
N = 126
N=23
total of 124
total of 33
total of 18
total of 126
929 Patients were enrolled
929 participants enrolled
4 million   people
1 and those of the af-  fected women
394 people
11 patients
15   patients
4 ad-  ditional patients
2 patients
69 patients
223,842 patients
331,164 Total colonoscopies in patients
223,842   patients
41,882 Were performed in patients
3 million people
N = 314,872
N = 712
10 participants
02  Average of all subjects
N = 159
N = 160
N = 121
N = 127
N = 150
N = 154
N = 109
N = 116
total of 319
22 con-  secutive patients
44 patients
33 patients
11 patients
167 screened patients
2 patients
98 patients
31 patients
9 patients
5 patients
20 patients
15 patients
4 patients
7 patients
N = 33
N = 31
N = 34
N = 98
total of 131
357 con-  secutive patients
452 women
452 patients
450 patients
173 patients
6 patients
219 patients
7 patients
220 patients
15 patients
21 patients
17 patients
9 patients
11 patients
N  =  22
N  =  11
N = 219
N = 220
total of   452
total of 15
452 women were enrolled
425 Patients were enrolled
7738 participants
N   =   6
N   =   5
N   =   1
total of 45
total of 31
8 The study enrolled
124 pregnant women
123 women
61 women
62 women
4 Identification of pregnant women
60   women
338 pregnant women
157 eli-  gible women
124 women
338 Pregnant women
181 women
89 women
45 women
13 women
14 women
27 women
59   women
16 women
10 women
4 women
53 women
51 women
104 women
N = 61
N = 62
N = 10
N = 38
N = 17
N = 30
total of 124
total of 123
total of 271
total of 18
total of 20
124 women enrolled
652 participants
700 participants
1  Among patients
11 patients
4 patients
04 and two patients
N = 214
N = 213
N = 232
N=214
N=213
N=232
N=117
N=115
N=118
N=124
N=125
N=121
N = 211
N = 212
N = 231
N = 228
N = 226
N = 230
 data from the 4
2000 persons
44 subjects
10 patients
171 patients
35 patients
40 patients
82 patients
139 patients
42 patients
181   patients
26 of these patients
14 patients
19 patients
6 patients
5 patients
59 patients
20 patients
N   =   2
N   =   4
N   =   5
475 patients
479 patients
120 patients
250 patients
960 patients
1 shows the numbers of patients
204 patients
500 patients
N = 475
N = 479
N = 244
N = 242
N = 473
N = 481
2001 patients
900 patients
1200 patients
1270 patients
290 patients
232 patients
500 patients
117 patients
770 patients
643 patients
765 patients
173 patients
116 patients
17   Among patients
28   The number of patients
1134 patients
2,313 patients
N=31
N=87
N=12
N=44
N=122
N=57
6   Study participants
958 patients
956 patients
770 patients
186 patients
5 patients
19 and the pro-  portion of patients
373 patients
397 patients
13 patients
26 patients
130 patients
371 patients
395 patients
369 patients
393 patients
184 patients
24   among patients
106 patients
105 patients
2 patients
6 patients
11 patients
3 study involving   patients
N = 373
N = 397
N = 186
N   =   3
N   =   1
total of 31
 data   from 346
 data from 369
 data from 166
659 patients
1086 patients
556 patients
1312 patients
1303   patients
652 patients
288 patients
23 patients
9 patients
4 patients
N   =   2
N   =   3
N   =   6
N = 652
N = 651
total of 608
947 participants
1080 participants
16 participants
5322 Potential participants
931 trial participants
19 patients
5322 patients
467 patients
480 patients
472 patients
459 patients
11 patients
N = 459
N = 472
total of 5322
total of 12
4375 Were not enrolled
10,000 persons
1914 women
1741 pregnant women
2052 women
39 patients
18 patients
1909 patients
1905 patients
57 patients
10 patients
6 patients
3 patients
1914 patients
9 patients
899 patients
1015 patients
17 patients
27 patients
13 patients
1912 patients
1909 unaffected patients
1906 patients
1905 unaffected   patients
1952 patients
1947 unaffected patients
1950 unaffected patients
N = 1909
N = 1905
N = 1365
N = 1361
N = 899
total of 12
total of 2052
100 persons
120 Han Chinese   persons
90 persons
120 Han Chinese persons
90   persons
120 Han   Chinese persons
345 Japanese patients
11 patients
29 patients
2 patients
12 patients
11 Japanese patients
7 patients
27 patients
9 other Japanese patients
345 Japa nese patients
total of 97,942
59 patients
71 patients
130 patients
114 patients
80 patients
18   Approximately one third of patients
8 patients
81 patients
32 patients
12 patients
11 patients
78 patients
122 patients
50 patients
34 patients
66 patients
43 patients
18   patients
64 patients
19 patients
7 patients
321 patients
N = 130
N = 10
N = 14
N = 5
N = 81
total of 59
total of 130
total of 83
total   of 66
total of   114
total of 19
59 patients were enrolled
3 was enrolled
2 shows the number of persons
55 persons
48 persons
180 persons
220 persons
248 persons
10,000 persons
9989 participants
12,000 participants
12,776 participants
9989 of these participants
65 participants
757 participants
65   participants
60   participants
39 participants
9167 participants
4457 participants
10,000 participants
2840 participants
3271 participants
N = 9989
N=29
N=21
N=10
N=4
N=60
N=39
N=99
N  =1
N  =5
N  =7
N  =3
N  =4
N = 1611
N = 8389
N = 696
N = 9304
total of 12,776
total of 65
total of 757
total of 69
12,776 participants were enrolled
426 patients
433 patients
418 patients
255 patients
400 patients
1277 patients
232 patients
381   patients
379 patients
194 patients
43 patients
22 patients
10 patients
9 patients
2 patients
3 patients
48 patients
6 patients
1268 patients
1247 patients
1238 patients
N = 426
N = 433
N = 418
N = 1277
N   =   4
total of 6
total of 48
112 patients
11 patients
82   patients
40 patients
42 patients
30 additional patients
9 patients
21 patients
49 patients
63 patients
47 patients
62 patients
2 shows the percent-  ages of patients
75 and no patients
N = 49
N = 63
N=49
N=63
N=62
N=47
total of   112
total of 30
 data from 11
1,687,930 women
1015 women
N = 1015
N = 1,686,915
23 patients
7 patients
N = 347
N = 348
N   =   3
total of 347
total of 294
total of 447
total of 63
695 men enrolled
total of 7
 data from 18
101,945 persons
156,424   persons
3317 participants
23 Selection of the participants
101,945 participants
448 participants
1976 participants
21,220 participants
57,988 participants and excluded participants
305 participants
397 participants
58 participants
101,887   participants
397   participants
101,887 participants
57,954 participants and excluded participants
101,945 people
N   =   1
N   =   2
N   =   4
N = 10,810
N = 21,131
N = 46,663
N = 12,324
N = 11,017
N = 14,262
N = 31,466
N = 30,956
N = 17,171
N = 8032
 data from   61
156,424 persons
156,424   persons
388,796 persons
156,424 of the eligible persons
152,606 participants
1163   participants
4646 participants
N   =   7
N   =   8
N   =   4
N   =   6
N   =   1
total of 200,905
218 persons
482 persons
235 persons
112 persons
412 persons
102,216 participants
448 participants
8637 participants
43,042 participants
1083 people
N = 102,216
N = 157,543
 data from 61
776 patients
388 patients
600 patients
64 patients
40 patients
14 patients
26 patients
11 patients
18 Among patients
N = 388
258 Were enrolled
53,452   persons
53,302 participants
49,338 participants
11,696   participants
53,302   participants
18,840 participants
37 All participants
150 NLST participants
47 of these participants
53,452 patients
3964 patients
total of 53,452
53,452   persons were enrolled
   data from 5133
2 We   studied six patients
4 patients
11 patients
5 patients
3 patients
40 case patients
90 case patients
239 patients
40 patients
36 case patients
43 case patients
48 patients
70  â€  Only patients
N = 160
N = 40
total of   239
160 controls were enrolled
251 patients
8 million patients
447 of these patients
11 patients
1 year   among patients
30 The patients
4000 patients
N = 126
N = 125
949,504 pregnant women
64,389 women
46,144 women
14,040 women
06 among   women
38   Medicaid-eligible pregnant women
N = 46,144
N = 885,115
N = 36,778
N = 180,564
total of 64,389
total of 200
1040 patients
1012 patients
25 patients
20 patients
32 patients
169 patients
97 patients
19 deaths among   patients
N = 506
N = 519
N = 521
N = 325
N = 322
N = 1027
N = 1025
total of 1012
total of 169
1012 patients were enrolled
1040 patients were enrolled
10 patients
27 untreated patients
5   In patients
74 patients
37 patients
4 patients
12 patients
6 In the patients
26 patients
56 of these patients
27 patients
N = 10
N = 12
N = 45
N = 25
N = 20
N = 74
N = 37
N = 27
total   of 1359
47 were   women
78 patients
2 patients
5 patients
4 patients
10 randomly selected patients
26 patients
79 patients
51   of the patients
7 patients
16 patients
17 patients
N = 26
total of 79
total of 51
total of 7
400 randomly as-  signed participants
400 patients
2224   patients
200 patients
282 patients
N = 200
total of 2224
total of 282
837 patients
66 patients
11 patients
40 patients
280 patients
287 patients
19 patients
2 patients
38 patients
66   patients
148 patients
total of 72
total of 895
total of 11
total of 21
 data from 837
750 women
750 infertile women
158 women
001  Fecundity among women
300 patients
750 patients
320 patients
N = 376
N = 374
N=750
N=250
N=249
N=251
total of 750
total   of 158
300 patients
152 patients
148 patients
220 patients
80   patients
136 patients
164 patients
150 patients
539 patients
208 patients
202 patients
52 patients
4 patients
56 patients
51 patients
3 patients
54 patients
152   patients
154 patients
300   patients
14 patients
31 patients
80 patients
37 patients
12 patients
25 patients
20 patients
5 patients
17 patients
79 patients
221 patients
140   patients
133   patients
908 patients
6336 patients
N = 152
N = 148
N  =3
N  =2
N  =8
N  =1
N=300
N=152
N=148
551 participants
630 participants
18  All randomly assigned participants
3445 participants
1151 participants
311 participants
65 participants
590 participants
671 participants
3445 patients
1722 patients
1723 patients
206 patients
245 patients
4 Such patients
12  Among patients
3515 patients
981 patients
113 patients
229 patients
239 patients
203 patients
197 patients
160 patients
176 patients
3 patients
5 patients
242 patients
280 patients
78   patients
71 patients
N = 1722
N = 1723
total   of 22
total   of 3445
total of 2464
total of 311
total of 671
981 patients enrolled
160 patients
75 patients
282 patients
79 patients
132 patients
60 patients
66   patients
66 patients
28 patients
9 patients
7 patients
3 patients
4 patients
8 patients
25 patients
37 patients
39 patients
46 patients
15 patients
12 patients
18 patients
26 patients
38 patients
2 patients
16 patients
5 patients
81 patients
6 patients
9153 patients
233   patients
9,153 patients
N = 66
N = 132
N = 79
N = 81
N=66
total of 28
1 diabetes were enrolled
781 patients
21 Previously untreated patients
189 centers enrolled patients
118 patients
15 patients
N = 238
N = 118
N = 233
N = 333
N = 330
N = 241
N = 116
N = 225
N = 336
N = 321
N=238
N=118
N=233
N=333
N=329
total of 781
189 centers enrolled
781 patients were enrolled
827 participants
827 patients
514 patients
17 patients
4 patients
42 patients
158 patients
219 patients
436 patients
38 patients
25 patients
8 patients
6 of these patients
N = 188
N = 193
N = 212
N = 593
total of 827
total of 97
total of 593
total of 45
827 patients were enrolled
738 patients
1306 patients
700 patients
737 patients
1305 patients
7 patients
22 patients
4 patients
9 patients
980   secukinumab-treated patients
19 patients
7 of these patients
2 patients
702 patients
N = 245
N = 248
N = 327
N = 326
N=323
N=327
N=245
N=244
N=243
N=246
N=324
N   =   3
N   =   4
total of 700
total of 737
total   of 1305
158 persons
30 persons
27 persons
50 persons
52 patients
20 patients
32 patients
9 patients
11 patients
12 of the patients
N   =   2
N   =   3
total of 52
125 patients
72 patients
125   patients
1 studies in-  volving patients
100 patients
75,000 per cubic millimeter. Of the patients
73 patients
111 patients
81 patients
60 patients
50 patients
36 patients
124   patients
108 patients
99 patients
112 patients
7 patients
63 patients
28 patients
68 patients
40 patients
122 patients
110 patients
25 patients
5 patients
4 patients
3 patients
2 patients
42 patients
13 patients
9 patients
20 patients
8 patients
16 patients
31 comprising patients
20,000 people
N = 125
N=125
N=72
N=28
N=15
N=10
N=71
total   of 99
total of 7
total of 28
 data cutoff, 108
6 patients
8 patients
10 patients
14 patients
13 patients
109 patients
54 patients
50 patients
18 patients
80 patients
127 patients
7 patients
5 patients
127 dupilumab-  treated patients
3 patients
471 patients
N = 16
N = 51
N = 54
N = 55
N = 10
N = 21
total of 109
total of 10
total of 5
total of 17
1952 patients
50 patients
60   patients
14 patients
18,865 patients
1241 patients
125 patients
48 patients
47 patients
39 patients
2 patients
3 patients
total of   18,865
total of 12
8 women
11 women
1 case per   million persons
31 persons
31 patients
43 patients
31   patients
12   patients
15 patients
4 of the patients
14 patients
43 control patients
30 patients
25 patients
5 patients
17 For four of the patients
N  =3
N  =1
N  =2
220 patients
2 For these   patients
110 patients
3 patients
2 patients
63 patients
12 patients
53 patients
4 patients
176 patients
88 patients
169 patients
44 patients
37 patients
9 patients
11 patients
N = 110
N = 107
total of 8
total of 78
total of 110
total of 63
total of 169
168 patients
156 patients
45 patients
199 patients
22 patients
21 patients
55 patients
53 patients
40 patients
31 patients
10 patients
24 Two   patients
N = 55
N = 57
N = 56
N = 113
N = 112
52   women
3 women
49 women
31     non-Amish persons
2738 Amish participants
2 study participants
24   Old Order Amish study participants
2738 study participants
9 100  Body-mass indexÂ§  No. of participants
2 diabetes among participants
7 study participants
total of 7
2738 study participants enrolled
100 participants
36 participants
3773 participants
2135 participants
599 participants
552 participants
3773 NHANES   participants
N = 3773
N = 1583
N = 2135
N = 599
N = 115
N = 43
N = 56
N = 14
 data from 3773
 data from 2005
631 patients
600 patients
450 patients
855 patients
473 patients
464 patients
322 patients
31 patients
363 patients
463 patients
3 patients
10 patients
1bâ€“infected patients
12 among patients
13 patients
469 patients
4 patients
12 were similar among patients
1 patients
184 million people
350,000   people
N=473
N=158
N = 473
N = 158
total of 631
total of 855
total of 7
total of 2
31,989 participants
228 participants
301 participants
30,000 participants
14,500 participants
3745 participants
3827 participants
529 participants
1323   participants
1442 participants
99 participants
103 participants
N = 15,990
N = 15,993
N   =   1
N   =   2
N   =   5
N  =5
total of 31,989
total of 14,500
total of 99
31,989 participants were enrolled
14,500 participants were enrolled
7645 reenrolled
N = 145
N = 135
N = 280
N = 45
N = 163
N = 162
N = 98
N = 86
total of 75
total of 45
total of 86
7 status of the participants
62 participants
31 enzalutamide-treated patients
31 abiraterone-treated patients
7â€“positive patients
7â€“negative patients
9 Among patients
30 patients
30   patients
62 patients
31 patients
7â€“positive   patients
7â€“  negative patients
20 patients
11 patients
4 patients
27 patients
6 abiraterone-treated patients
12 enzalutamide-treated patients
7â€“negative   patients
31   abiraterone-treated patients
10 patients
5 patients
6 patients
16 patients
7  In all patients
14   Studies involving patients
total of 31
total of 35
total of 39
total of 55
total of 50
30 patients had been enrolled
1836 patients
1356 patients
697 patients
138 patients
41 patients
63 patients
2 patients
140 patients
77 patients
20 patients
57   patients
43 patients
694 patients
33 patients
9 patients
791 patients
794 patients
16 patients
6 patients
3 patients
5 patients
N = 848
N = 844
total of 1836
total of   1836
total of 1356
total of 2
total of 16
1836 patients were enrolled
138 patients enrolled
10 patients
5076 patients
14 patients
12 In patients
3202 patients
206 patients
21 patients
2 patients
N = 10
N = 11
N=11
N=10
N = 21
N = 9
total of 21
21 patients were   enrolled
40,826 patients
1273 patients
22 patients
457 patients
20 Data on all patients
20,423 patients
442 patients
220 patients
383 patients
total of 398
total of 20,423
total of 1273
79,036 participants
15,828 patients
7924 patients
7904 patients
7924   patients
737   patients
814 patients
2650 patients
7322 patients
7498 patients
N = 7904
N = 7924
N = 7890
N = 7912
total of 7924
306 patients
28 patients
3 patients
55 patients
165 patients
300   patients
306   enrolled patients
198 patients
63 patients
131 patients
305 patients
157 patients
302 patients
193 patients
132 patients
61 patients
37 which   included patients
N   =   6
N   =   5
N   =   4
N   =   3
N = 63
N = 65
N = 53
N = 46
N = 32
total of 198
total of 131
total of 79
306 patients enrolled
306   enrolled
91 patients
419 patients
73 patients
3 trials involving patients
320 patients
80 patients
475 patients
68 patients
250 patients
213 patients
334 patients
6 patients
47 patients
1 patients
N = 85
N = 73
N = 11
N = 250
N = 84
total of 475
419 patients who were enrolled
101 patients
103 patients
1 Since many of   these patients
85 patients
200 patients
100 patients
204 patients
53 patients
26 patients
30 patients
120 mg and patients
5 patients
2 patients
10 patients
4 patients
3 patients
57 patients
95 patients
98 patients
64 patients
1 tumors and few patients
100,000 people
N = 101
N = 103
total of 204
total of 57
901 patients
1104 patients
2120 patients
302 patients
33 patients
13 patients
3 patients
34 patients
15 patients
7 patients
24 patients
9 patients
5 patients
16  More patients
1300   patients
N   =   3
N   =   7
N   =   1
N   =   2
N   =   6
N   =   5
N = 302
N = 599
440 patients
1 The   treatment of patients
100 patients
551 patients
109 patients
11 patients
427 patients
439 patients
228 patients
163 patients
7 patients
4 patients
1 patients
170 million people
N = 109
N = 111
total of 20
total of   10
9 Few patients
15 We evaluated patients
24 To determine   whether such patients
32 In patients
3 Nearly all patients
25  Because patients
391 patients
57 patients
5 patients
15 patients
17 patients
4  number of patients
10 patients
N = 195
N = 196
N=195
N=196
N = 191
311 women
58,209 women
101,986 women
75 Nordic patients
total of 63
 data from 154
 data from 52
1404 teenage girls and women
1404 teenage   participants
2 participants
N = 1404
N = 484
N = 920
1404 adolescents   who enrolled
795 patients
2 many   patients
1 year   among patients
790   patients
995 patients
747 patients
323 patients
5 patients
3,519 patients
663 patients
N = 394
N = 401
N = 390
N = 357
total of 795
total of 355
total of 995
871 Were enrolled
707 participants
125 patients
5 patients
N = 297
N = 256
N = 117
N = 93
N = 436
total of 26
 data from all 553
798 participants
6592 participants
13 participants
5 participants
3 participants
779 patients
19  For patients
N = 210
N = 286
N = 289
total of 13
390,652 patients
10,010 patients
5628 patients
4382 patients
4998 patients
5012 patients
230 patients
188 patients
110,000 patients
16 Among patients
5012   patients
309 patients
315 patients
16 patients
19 patients
1000 patients
13,356 patients
31  For patients
N = 4998
N = 5012
total of 10,010
10,010 patients were enrolled
10,010 patients
329 patients
295 patients
2385 patients
1854 patients
16 patients
5 patients
5009 patients
600 patients
403 patients
12 trials in-  volving patients
605 patients
300 patients
8351 patients
9841 patients
N = 5009
N = 5001
N = 10,010
N = 624
total of 10,010
total of 81
total of 88
23 countries were   enrolled
34   For selected patients
30 patients
90 patients
121 patients
N = 240
N = 32
N = 138
N = 8
N = 62
total of 23
 data   from 240
54 participants
100   participants
372 screened participants
87 participants
53 participants
39 participants
5 participants
4 participants
27 participants
3 participants
13 participants
11 participants
61 participants
2 participants
2 of   these participants
12 and elderly   patients
N = 39
N = 17
N = 14
N = 87
N = 53
N = 27
N = 13
N = 10
N = 11
N = 30
total of 5
total of 3
total of 69
N=589
N=475
N=15
N=99
N=107,016
N=106,988
N=28
total of 8,187,737
total of 475
 data set of 10,196,620
150 obese patients
150 obese   patients
150 patients
9 patients
8 patients
4 patients
137 patients
49 patients
13 patients
10 patients
43 patients
N = 40
N = 48
N = 49
N = 43
N = 50
total of 91
total of 9
1691 surviving patients
854 patients
1820   patients
1820 patients
1818 patients
2010 and   included all surviving patients
1818   patients
16 patients
8 patients
N = 327
N = 527
total of 854
total of 40
1820 patients who were enrolled
1818 Patients were enrolled
758 Were not enrolled
2116 pregnant women
194 pregnant women
19  The vaccination of pregnant women
2116 black African pregnant women
183 HIV-infected   women
796 women
789 women
180 participants
376 participants
N   =   1
N   =   8
N   =   9
1000 patients
60 enrolled patients
344 enrolled   patients
225 patients
81 patients
105 patients
250 patients
745 patients
7 patients
171 patients
339 patients
109 patients
13 patients
12 patients
508 patients
237 patients
16 patients
650 patients
60 patients
N = 379
N = 366
N = 54
N = 55
total of 339
60 enrolled
344 enrolled
225 patients were enrolled
250 patients enrolled
508 patients had been enrolled
237 patients   enrolled
394 patients
297 patients
86 patients
65 patients
146 patients
2b study involving patients
400 patients
12 and all patients
562 patients
12   among patients
286 patients
173 patients
123 patients
293 patients
5 patients
2 patients
4 patients
3 patients
78 patients
12 among all patients
50 patients
36 patients
87 patients
59 patients
3 trial involving   patients
18 In patients
N = 297
N = 97
total of 394
total of 562
total of 286
total of 166
1341 patients
1 Most patients
1950 patients
650 patients
1300 patients
1350 patients
1351 patients
404 patients
435 patients
439 patients
10 patients
4 patients
252 patients
264 patients
346 patients
18 patients
16 patients
411 patients
92 patients
885 patients
N = 439
N = 446
N = 456
total of 1350
total of 92
1300 patients had been enrolled
100,000 persons
204 participants
196 participants
9 participants
90 participants
6 participants
97 participants
99   participants
11 participants
1 of these participants
2 participants
31 participants
N = 97
N = 99
total of 196
total of 3236
total of 31
total of 9
131 patients
105 patients
130 patients
264 patients
133 patients
6 patients
3 patients
N = 133
N = 131
N = 81
N = 78
N = 52
N = 53
total of 139
total of 34
131 patients were enrolled
N = 302
N = 305
N = 607
total of   484
total of 25
total of 98
total of 21
total of 37
20 We enrolled
2 mil-  lion persons
2012 were observed   among persons
100,000 people
total of 35,192
2 study involving patients
419 patients
305 patients
12 and among patients
25 patients
436 screened   patients
629 patients
95 patients
100 patients
205   patients
18 patients
3 patients
16 patients
18   patients
210 patients
209 patients
6 patients
2 of   these patients
N=100
N=205
N=210
N=209
N = 100
N = 205
N = 210
N = 209
total of 629
total of 18
1a study were enrolled
1a study   were enrolled
1b study were   enrolled
647 previously untreated   patients
200 patients
831 patients
215 patients
647 patients
23 patients
11 patients
15 patients
10 patients
2 patients
3 patients
25 patients
3 million people
N = 215
N = 216
total of 10
total of   2
total of 11
total of 3
865 patients
200 patients
665 patients
1015 patients
5 patients
4 patients
214 patients
2 patients
861   patients
1b included four patients
861 patients
3 patients
10 of   these patients
33 patients
18 patients
11,241 patients
N = 214
N = 217
total of 5
total of 19
total of 1
total of 2
1623 patients
535 patients
541 patients
547 patients
1590 patients
535   patients
173 patients
16 Six patients
17 patients
15 patients
26 The   proportion of patients
25 and more   patients
26   We enrolled patients
21 patients
1175 patients
N = 535
N = 541
N = 547
N=535
N=541
N=547
N=402
N=397
N=341
N = 532
N = 540
total of 1623
total of 39
26   We enrolled
 data cutoff of May 24
   data from 6
555 patients
275 patients
779 patients
522 patients
261 patients
55 patients
39 patients
237 patients
46 patients
88 patients
63 patients
27 patients
99 patients
81 patients
100 patients
20 patients
3 patients
7 patients
1247 patients
15 patients
4 patients
5 patients
69 patients
52 patients
56 patients
40 patients
30 patients
N = 278
N = 277
N=278
N=277
total of   555
total of 522
555 patients were enrolled
1066 patients
432 patients
194 patients
291 patients
515 patients
551 patients
513 patients
78 patients
36 patients
65 patients
548 patients
44 patients
62 patients
218 patients
298 patients
202 patients
326 patients
217 patients
14 patients
15 patients
17 patients
2 patients
5 patients
N = 309
N = 204
N = 329
N = 219
N  =3
N  =2
N   =   3
N   =   2
total of 1066
total   of 1066
total of 513
total of 78
total of 548
total of 15
total of 17
535 patients
316 patients
158 patients
530 patients
1441 patients
31   patients
4,121 patients
N = 364
N = 171
N=364
N=171
N=353
N=360
N=167
N=329
N=162
total of 535
total of 530
total of 1441
466 participants
548 participants
1156 screened participants
423 participants
1156 participants
N = 273
N = 285
N = 284
N = 274
485 participants
435 participants
486 patients
1156 patients
244 patients
208 patients
25 involving patients
N   = 244
N = 242
N = 244
380 patients
208 patients
172 patients
10  Among patients
3   studies involving patients
24 and   patients
26 Previously treated patients
671 patients
42 patients
50 patients
203 patients
12 patients
17   patients
2 patients
15 patients
19 patients
34 patients
25 For patients
184 million people
N = 208
N = 172
N = 380
total of 191
total of 165
total of 15
381 were   enrolled
273 patients
251 patients
400 patients
240 patients
402 patients
237 patients
45 patients
24 patients
156 patients
399 patients
N = 399
N = 141
N = 132
N = 116
N = 115
total of 402
402 Patients were enrolled
402 patients were enrolled
31 patients
15 patients
28   patients
33   the patients
N = 15
N = 16
total of 28
885 participants
878 participants
877 participants
28 A small number of   participants
36 participants
27 Before patients
911 patients
1002 patients
1126 patients
430 patients
447 patients
155 patients
12 mo  All patients
30 patients
17 patients
4444 patients
5963 people
N = 433
N = 452
N = 430
N = 447
total of 885
total of 44
total of 1982
total of 296
total of 36
1725 patients
154 patients
2013 patients
136 patients
7 patients
160 patients
264 patients
45 patients
61 patients
17 patients
30 patients
124   patients
11 patients
4 patients
31   patients
8 patients
34 patients
22 of these   patients
10 patients
12 patients
total of 154
total of 123
508 patients
450 patients
508   patients
256 patients
407 patients
406 patients
23 patients
12 patients
139 patients
142 patients
114 patients
130 patients
252 patients
173   patients
166 patients
3825 patients
N = 256
N = 252
N = 254
N = 250
total of 508
total of 139
total of 142
19 patients
617Fâ€“negative patients
617Fâ€“positive patients
11 Enrollment of   patients
13 patients
102 core genes   segregated the patients
30 patients
617Fâ€“  negative patients
338 patients
N = 8
N = 11
N = 7
N = 12
total of 16
540 patients
259 patients
524 patients
5926 patients
8 patients
5 patients
2 patients
258 patients
N = 259
N = 280
total of 540
total of 8
total of 5
103 Were enrolled
576 patients
180 patients
802 patients
19 patients
N = 191
N = 194
total of 449
135 patients
20 patients
120 patients
185 patients
6 patients
12   These patients
N = 66
N = 69
N=66
N=69
126 unrelated   patients
2359 premenopausal women
4690 women
1803   premenopausal women
1996 women
4690 patients
325 patients
194 patients
7 patients
383 patients
3 patients
186 patients
N = 4690
N = 1053
N = 943
N = 1607
N = 1087
N   =   2
total of 42
total of 60
total of 1803
total of 73
 data from 4690
475 participants
483 participants
69 participants
N = 475
N = 469
total of 963
total of 25
total of 19
total of 99
total of 141
total of 59
total of 101
total of 75
115 enrolled patients
58 patients
57 patients
17 patients
2 patients
3 patients
118 patients
115 patients
17   patients
4 patients
20 patients
8 patients
11 patients
25 patients
445 patients
N = 58
N = 57
N = 115
total   of 118
total of   118
total of 6
total of 25
115 enrolled
118 patients were enrolled
118 Patients were enrolled
1600 enrolled patients
1600 patients
9 patients
793 patients
798 patients
2 patients
1588 patients
555 patients
365 patients
714   patients
494 patients
5 patients
3 patients
792 patients
796 patients
56 patients
42 patients
N = 793
N = 798
N   =   7
1600 enrolled
208 patients
101 patients
72 patients
4 Most patients
348 patients
25 patients
867 patients
102 patients
3 patients
2 patients
104 patients
30 patients
32 patients
46 In nine patients
167 patients
N = 101
N = 104
total of 208
total of   867
total of 101
total of 5
total of 18
208 patients were enrolled
2000 persons
238 persons
10 persons
8 Although the num-  ber of patients
14 patients
4 patients
50 patients
68 patients
3 patients
10 patients
10 different patients
30,000 people
2759 patients
2500 patients
3638 patients
2776 patients
17 of those   patients
908 patients
113 patients
11 patients
6 patients
316 patients
17 patients
3 patients
579 patients
569 patients
615 patients
623 patients
633 patients
680 patients
650 patients
709 patients
777 patients
766 patients
680,000 people
N = 908
N = 893
N = 958
total of 2759
total of 2776
total of 113
total of 466
20 patients
5 patients
14 patients
total of 111
20 patients
8 patients
7 patients
19 Our patients
1 patients
4 patients
total of   2
total of 125
20 patients enrolled
8 patients enrolled
608 participants
604   participants
36 participants
303 participants
543 participants
5 participants
3 participants
535 participants
268 participants
5000 people
N = 303
N = 305
total of 21
total of 535
total of 543
21 clinical centers enrolled
1717 patients
626 patients
532 patients
9  In most patients
1680   patients
1715 patients
832 patients
801 patients
872 patients
845 patients
278 patients
309 patients
21 many   patients
3  number of patients
N = 872
N = 845
N = 871
N = 844
total of 626
total of 1717
1717 patients were enrolled
25,000 initially healthy American women
650 persons
22,092 participants
91,002 participants
2836 participants
1951 participants
34 participants
650 participants
22,590 participants
13,626 participants
43,628 study   participants
11 participants
113,094 study participants
170,000 participants
7364 patients
22,590 patients
29,954 patients
28,223 patients
total of 91,002
total of 34
 data from 170,000
224 patients
111 patients
113 patients
30,000 patients
2 patients
110 patients
220 patients
16   Because patients
102 patients
N = 111
N = 113
N = 108
N = 112
total of 224
total   of 111
total of 201
16   Because patients enrolled
7244 patients
3621 patients
1071 patients
11,956 patients
15 additional patients
3623   patients
1498 patients
10,700 patients
N = 3623
N = 3621
N = 3543
N = 1169
total of 15
total of 66
7244 were enrolled
   data from 1498
3024 participants
26 index patients
17 of the patients
total of 59
total of 6
total of 44
423 previously untreated patients
947 patients
423 of these patients
423 patients
211 patients
212 patients
245 patients
6 patients
18 patients
40 patients
55 patients
77 patients
71 patients
133 patients
140 patients
22 patients
210 patients
3  number of patients
209 patients
52 patients
28 patients
103 patients
67 patients
27 patients
5 patients
3 patients
107 patients
30 patients
79 patients
30 The edu-  cation of patients
N = 211
N = 212
N = 423
N=211
N=212
N=77
N=71
N = 210
N = 179
N = 180
N = 31
N = 30
N = 209
19,102 patients
12,049 patients
16,850   patients
1972 patients
1384 patients
272 patients
1446 patients
3588 patients
1 In patients
N = 9550
N = 9552
N = 9539
N = 9544
total of 19,102
total of 73
64 patients
11 patients
14 patients
39 patients
25 ipilimumab-treated patients
101 shared exclusively among   patients
25 patients
35 In the patients
N = 11
N = 14
N = 25
N=8
N=17
N=23
N=16
N=15
N=10
1005 patients
502 patients
13 including among patients
500 patients
15 patients
5 additional patients
14 patients
1000   patients
5 patients
4 patients
2 patients
998 patients
488 patients
176 patients
216 patients
77 patients
51 patients
28   An important exception is patients
21 patients
53  All patients
N = 502
N         = 496
total of 15
total of 5
total of 29
total of 1545
total of 176
total of 7
total of 21
total   of 1
 data from 998
50 patients
25 patients
30 patients
27 of these patients
3 patients
14 patients
20   patients
49 patients
50 study patients
33 patients
9 patients
36 patients
4 patients
1 cohort of patients
27 patients
143 patients
3  All   Grades  number of patients
50 study   patients
N = 50
total of   30
 data cutoff, 23
1862 patients
1875 patients
909 patients
953 patients
37 patients
906   patients
30 patients
82 patients
51 patients
18 patients
N = 909
N = 953
N = 906
N = 952
total of 12
total of 1875
total of 30
1875 Patients were enrolled
1875 patients were enrolled
2485 patients
2456 patients
2234 patients
17 patients
44 patients
N = 1243
N = 1242
N = 2485
total of 2485
total of 82
3426 Patients were enrolled
25 were participants
30 were participants
27 patients
2 patients
30 patients
25 patients
5 older patients
22 patients
3 patients
15 patients
4 patients
18 patients
019  Five patients
8 All the patients
8 patients
6 than did patients
19 patients
16 adult patients
3 This study included patients
18   patients
N = 25
N = 5
N = 30
total of 30
total of 25
6 patients
2 patients
4 additional patients
10 patients
9 The next four   patients
10  P P  P  P  All the patients
10 study patients
total of 10
total of 128
1371 participants
1223 participants
1400 patients
1250 patients
44 patients
240 patients
940 patients
N = 706
N = 694
N = 625
N   =   7
N   =   6
total of 1400
total of 1250
total of 44
1400 patients were enrolled
1250 patients were enrolled
1400 patients enrolled
1931 patients
127 patients
633 patients
2763 patients
436 patients
467 patients
419 patients
436   patients
46 patients
12 patients
24 patients
27 patients
148 patients
17 patients
122 patients
111 patients
173   patients
50 patients
600 patients
N = 510
N = 514
N = 524
N = 1548
N = 555
N = 568
N = 551
N = 1674
N = 639
N = 655
N = 636
N = 1930
total of 2763
 data from 24
204 participants
134 participants
1 month we also asked participants
134   participants
107 participants
88 participants
348 participants
1 month participants
1410 participants
171 participants
1310 people
3001 people
N = 655
N=655
N =655
96 patients
9 patients
4 patients
17 The patients
10,261 participants
11,140 patients
8494 patients
2 Among patients
10,082 patients
7279 patients
879 patients
1000 patients
1386   patients
1166 patients
1031 patients
1147 patients
1234   patients
1019 patients
N   =   5
N   =   4
total of   10
43 patients
13 patients
248 patients
9 and two patients
3 patients
12 patients
4 patients
43   patients
2 patients
11 patients
8 patients
15 additional patients
N = 14
N = 29
8 Among persons
33,915 patients
33,915   patients
2701   patients
912 patients
132 patients
84 patients
82 patients
613 patients
70 patients
176 patients
2455   patients
28  Unlike patients
23,000 patients
1 diabetic patients
20,985 patients
7,454 patients
1 diabetic   patients
N   =   1
N   =   3
N   =   6
N   =   7
N   =   8
N   =   5
N   =   4
343 patients
3 trial involving   patients
340 patients
171   patients
91 patients
25 patients
26   patients
171 patients
172 patients
89 patients
21 patients
79   patients
62 patients
24 patients
4 patients
4  number of patients
N = 172
N = 171
N = 169
total of   343
total of 21
 data cutoff, 79
1220 patients
816 patients
447 patients
441 patients
332 registry patients
888 patients
36 patients
86 patients
15 patients
18 patients
72 patients
90 patients
28 patients
44 patients
179 patients
166 registry patients
151 patients
232 patients
110 patients
204 patients
N = 447
N = 441
n=0
total of   888
1220 patients who were enrolled
495 patients
63 patients
1049 patients
495   patients
247 patients
0  All patients
111 167  Percent of patients
493 patients
4  number of patients
85 patients
N = 248
N = 247
N=247
N=248
N = 239
N = 254
total of 1049
total of 493
total of 85
34 study participants
34 patients
29 patients
34   patients
5 patients
19 patients
9 patients
5 of these patients
8 patients
35 The   patients
170 million people
N = 34
2971 persons
2924 participants
2416 participants
132 participants
N = 2924
N = 731
N = 2416
N = 602
N = 605
N = 607
total of 2971
total of 57
total of 132
8442 patients
914 patients
1117 patients
711 patients
835   patients
8 patients
8000 patients
2410 patients
20 patients
45 patients
10,521 patients
43 patients
4187 patients
746 patients
833 patients
9 patients
2670 patients
2638 patients
696 Better  All patients
658 patients
835 patients
84   patients
83 patients
94 patients
108 patients
19 patients
10 patients
12,440   patients
N = 4187
N = 4212
total of 711
total of 10,521
total of 2670
total of 558
total of   94
9961 patients
5009 patients
9800   patients
9960   patients
25,682 patients
N = 5020
N = 4941
N = 4710
N = 4649
total of 9961
total of 6594
11 countries   were enrolled
2 All study   participants
44 patients
110 patients
74 patients
76 patients
154 patients
6   The remaining patients
65 patients
4 patients
152 patients
365 patients
10 additional patients
12 Three of these patients
7A-seropositive patients
7Aâ€“positive patients
7A-pos-  itive patients
15 patients
total of 7
103 patients
total of 13,042
2400 patients
1188 patients
1195 patients
44 patients
74 patients
100 patients
194 patients
1184 patients
1200 patients
11,108 patients
12   patients
2388 patients
37 patients
81 patients
18 patients
58 patients
4 patients
5 patients
29 patients
1552 patients
24 patients
262 patients
253 patients
6 patients
4 and patients
31 sites involving patients
N = 1191
N = 1197
total of 25
total of 48
84 Were previously enrolled
2400 were enrolled
301 patients
10   Many patients
300 patients
725 patients
102 patients
73 patients
103 patients
N = 151
N = 150
total of 725
69   patients
3 patients
28 patients
69 patients
21 male   patients
28 female patients
28 paired contacts of patients
49 patients
29 patients
2 patients
30 patients
11 patients
1121 contacts of the patients
N = 60
N = 28
N = 38
total of 69
total of   5
total of 1121
total of   830
995 patients
1737   patients
30   patients
103 patients
20 million people
1 million people
total of 4507
total of 718
total of 318
total of 67
total of 70
106 patients
78 patients
213 patients
59   patients
87 patients
19 patients
65 patients
43 patients
20 patients
5 patients
44 patients
106   patients
N=23
N=47
N=16
N=15
N=30
N=18
N=36
N=8
N=25
N=6
N=29
N=39
N=17
total of 213
total of 27
20,000 of their patients
20,000 of their patients
1 million people
6 million people
7 million people
2 In   one study assessing women
200 women
1  Preventing women
150   incarcerated women
62,000 women
1  But pregnant women
8 million people
700 million people
300 persons
702 participants
20 patients
   data from a 12
8 mil-lion diabetic patients
16,492   patients
5380 patients
   data from a 2013
 data from 14,611
47 patients
79 patients
233 patients
81 patients
79 bedaquiline-  treated patients
4 other patients
8 patients
3   While people
8 million people
25 Choos-  ing Wisely participants
700 million people
total of 35
total of 25
1 Al-  though patients
n=1
12,000 patients
4  These patients
12,000 patients
total of 10
   data from a 12
300 new patients
25 million people
5000 people
250,000 people
total of 2686
 data   from 1974
2 For se-  verely ill patients
20 patients
100 patients
3 One group   of patients
142 patients
50 patients
250 patients
32,000 patients
150 million people
10 million   people
8 mil-lion diabetic patients
total of 84,000
6 million   people
19 million people
2 million people
43 patients
25,000   people
170   million people
n=1
6,000 of   patients
9,000   benefit cap for patients
50,000 drug.  Although many patients
1 million people
23 people
170   million people
600,000 women
1003 women
723 women
1000   women
1000 women
670 women
1184 menopausal   women
total of 1184
97,774 participants
4 billion people
2 Pregnant   women
5   Some pregnant women
37 million people
8 million people
3 million   have enrolled
8 million people
3 million   have enrolled
 data breach of 2009
2 When children be-  come patients
N = 207
N = 851
N = 444
3 But   why were a few people
4   Might patients
1 Unin-  sured people
9 million are enrolled
total of 576,535
total   of 484
1118   patients
5 Some patients
4000 people
1 and   patients
total of 576,535
1 and   patients
N=158
N=1227
N=3762
N=1294
N=11,423
18 other   people
2 Pregnant   women
100,000 people
5 Some patients
9 million people
84 patients
103   patients
N = 327,912
N = 605,376
103   patients
40,000 people
100,000 people
100,000 people
5 million people
1000 people
3 I see many such patients
250 contacts of infect-  ed persons
8 new patients
64 patients
2 patients
470,000 people
3 I see many such patients
900 people
5 million people
413,000 people
70 people
275,000 people
N=57
N=109
total   of 318
200   qualifying patients
900 patients
total of 36
total of 4
   data from 1
4   When patients
50 patients
20,000 women
23 and persons
69 In   healthy young persons
2 diabetic patients
100 million people
8 All people
1 billion people
22 For patients
5 patients
88 patients
1 mm per year among patients
6 mm per year among patients
416 consecutive patients
642 patients
416 patients
32 patients
300 patients
8  In such patients
20,000 trauma patients
36 patients
103   patients
614 critically ill patients
182 patients
17 patients
163 severely   head-injured patients
500 million persons
100 million   persons
total of 73
 data as of the 31
9004 persons
500 participants
101 patients
915 patients
527 patients
146 patients
126 patients
83 women
47 of these   pregnant women
220 consecutive pregnant women
12  HSV Infection  Pregnant women
18 Pregnant women
43 pregnant women
28   of these women
144 women
1373 women
45 Hispanic   women
13 After patients
20 For patients
68 patients
70 pe-  diatric patients
16 For patients
23 In patients
38 Among immunocom-  promised patients
40 Among immunocompetent patients
52 Most of   the infected patients
57 patients
19   In patients
100,000 people
100,000   people
115 patients
97 patients
22 In immunocompromised patients
71 patients
59 patients
28   In patients
973 patients
7000 participants
1 million people
95 patients
21 In   these patients
33 patients
total of 152
234 patients
130 patients
1118 patients
329 patients
14 â€” patients
4640 critically ill patients
305 patients
28 was lower among patients
686 patients
798 patients
517 patients
14 For these patients
50 patients
485 patients
500 patients
1223 patients
411 patients
272 patients
100 patients
N  =  10
N  =  13
N  =  46
N  =  30
N  =  49
N  =  50
N  =  68
N  =  23
N  =  15
N  =  65
total of 234
total of 798
total of 485
total of   411
11 and women
1960s few women
57 In motivated persons
1 billion people
3 billion people
39 and help prevent young   people
11 In patients
60  In patients
20 Although   many patients
37 patients
22 patients
73 All the patients
total of   37
1,000 participants
34,892 subjects
62  For patients
70 Such patients
100 Many patients
37  In some patients
61 In patients
2344 patients
total of 65,000
3 million patients
53  The children enrolled
 data from   1987
5 In patients
19 Untreated patients
45 For   patients
38 case patients
540 patients
147 patients
69   Among patients
210 patients
136 patients
349 patients
15 patients
8 patients
7 patients
70 patients
59 but patients
7 million people
1 million people
269 patients
1 month among patients
100,000 people
46,000 people
40,000 people
16 Among people
100,000 persons
total of 53,600
24 In patients
28  In patients
16  Most patients
1822 patients
19 In other patients
1034 patients
745 patients
36 In low-risk   patients
38 For patients
184 patients
216 patients
1500 patients
216 patients were   enrolled
43   women
109 participants
22 participants
87 participants
total of 22
61,523 patients
20 For   patients
612 patients
total of 4372
20 Some patients
13 million people
N = 109,341
N = 106,370
total of 101
20  Medicare patients
18 mil-  lion persons
total of 18
 data from the 2010
 data from   2005
5752   unique patients
13 patients
2281 patients
11 patients
N = 5516
N = 5224
total of 432
total of   207
total of 875
N = 21,463
N = 186,846
total of 82
 data from 2010
94,171 persons
33   For the treatment of persons
N = 94,171
N = 2,307,553
N = 112,039
N = 653,039
N = 105,848
N = 1,065,508
   data from 30
7 For   care of pediatric patients
20,000 people
24 Since a study involving   patients
10 million people
100,000   people
40   million people
8 million people
N = 420,449
total of 63
   data from 27
1000   persons
100 patients
63 patients
99 patients
54 patients
99 patients
54 patients
63 patients
99   patients
54   patients
99   patients
54   patients
99   patients
54   patients
466 patients
456 patients
67 patients
52 patients
23 patients
554 patients
548   patients
548 patients
306 patients
299 patients
118 patients
58 patients
37 patients
total of 4
118 patients
58 patients
37 patients
total of 4
1 patients
1 patients
1 patients
N = 20
